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Abstract 
Legislative reforms aimed at slowing growth of US healthcare costs are focused 
on achieving greater value, defined specifically as health outcomes achieved per dollar 
spent. To increase value while payments are diminishing and tied to individual outcomes, 
healthcare must improve at predicting risks and outcomes. 
One way to improve predictions is through better modeling methods. Current 
models are predominantly based on logistic regression (LR). This project applied 
Reconstructability Analysis (RA) to data on hip and knee replacement surgery, and 
considered whether RA could create useful models of outcomes, and whether these 
models could produce predictions complimentary to or even stronger than LR models. 
RA is a data mining method that searches for relations in data, especially non-
linear and higher ordinality relations, by decomposing the frequency distribution of the 
data into projections, several of which taken together define a model, which is then 
assessed for statistical significance. The predictive power of the model is expressed as the 
percent reduction of uncertainty (Shannon entropy) of the dependent variable (the DV) 
gained by knowing the values of the predictive independent variables (the IVs). 
Results showed that LR and RA gave the same results for equivalent models, and 
showed that exploratory RA provided better models than LR. Sixteen RA predictive 
models were then generated across the four DVs: complications, skilled nursing 
discharge, readmissions, and total cost. While the first three DVs are nominal, RA 
generated continuous predictions for cost by calculating expected values. Models 
included novel comorbidity variables and non-hypothesized interaction terms, and often 
resulted in substantial reductions in uncertainty.  
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Predictive variables consisted of both delivery system variables and binary patient 
comorbidity variables. Complications were predicted by the total number of patient 
comorbidities. Skilled nursing discharges were predicted both by patient-related factors 
and delivery system variables (location, surgeon volume), suggesting practice patterns 
influence utilization of skilled nursing facilities. Readmissions were not well predicted, 
suggesting the data used in this project lacks the right variables or that readmissions are 
simply unpredictable. Delivery system variables (surgeon, location, and surgeon volume) 
were found to be the predominant predictors of total cost. 
Risk ratios were generated as an additional measure of effect size. These risk 
ratios were used to classify the IV states of the models as indicating higher or lower risk 
of adverse outcomes. Some IV states showed nearly 25% of patients at increased risk, 
while other IV states showed over 75% of patients at decreased risk. In real time, such 
risk predictions could support clinical decision making and custom-tailored utilization of 
services. 
Future research might address the limitations of this project’s data and employ 
additional RA techniques and training-test splits. Implementation of predictive models is 
also discussed, with considerations for data supply lines, maintenance of models, 
organizational buy-in, and the acceptance of model output by clinical teams for use in 
real-time clinical practice. 
If outcomes and risk are adequately predicted, areas for potential improvement 
become clearer, and focused changes can be made to drive improvements in patient care. 
Better predictions, such as those resulting from the RA methodology, can thus support 
improvement in value—better outcomes at a lower cost. As reimbursement increasingly 
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evolves into value-based programs, understanding the outcomes achieved, and 
customizing patient care to reduce unnecessary costs while improving outcomes, will be 
an active area for clinicians, healthcare administrators, researchers, and data scientists for 
many years to come. 
 
 
- iv - 
Dedication 




- v - 
Acknowledgments 
I would like to thank my teacher and my mentor, Dr. Martin Zwick, for inspiring 
me to solve difficult problems and never doubting me.  
To my friend, Dr. Joe Fusion, for simplifying complexity over many years of 
inquiry and for his unwavering support and friendship. 
To my dad, Brad Froemke, for showing me how to be patient while figuring 
things out and to find something funny in most everything. 
To my awesome committee including Dr. Matt Carlson, Dr. Neal Wallace, and 
Dr. Carlos Crespo. Their patience, thoughtful feedback, and good humor helped me 
conclude this long process with positivity and laughter.  
To my early academic champions, Dr. Randy Blazak, Dr. Bob Leibman, and 
Dr. Rick Lockwood. Their recognition of my academic abilities was pivotal in my 
decision to pursue advanced study. 
I would also like to acknowledge Guy Feldman and Lian Wang for statistical 
consultation and to Dave Donell for his careful review and editing. 
To Dr. Phyllis Brown, Douglas Hagen, and Cher Donnell for all of their love. I 
am truly grateful to each of them for the encouragement, over many years, to complete 
this. 
And certainly not least, to my husband Matthew Hagen for constant support and 
for giving me the time and space I needed to accomplish this. And to my daughters Solja 




Table of Contents 
Abstract ................................................................................................................................ i 
Dedication .......................................................................................................................... iv 
Acknowledgments................................................................................................................v 
List of Tables ..................................................................................................................... ix 
List of Figures .................................................................................................................. xvi 
Chapter 1. Introduction ........................................................................................................1 
Transitioning to Value and the Role of Predictive Analytics ..................................1 
Problem Domain ......................................................................................................5 
Research Objectives .................................................................................................6 
Preliminary Research Objective: LR and RA Comparison .........................6 
Do RA and LR give the same results for equivalent 
models? ............................................................................................6 
Does exploratory RA provide better or novel models 
compared to LR? ..............................................................................6 
Main Research Objective: Find Predictive Models with RA.......................7 
What are the best RA models? .........................................................7 
Chapter 2. Review of Literature...........................................................................................8 
The Healthcare Context ...........................................................................................8 
Assessing Risk .......................................................................................................12 
Risk Models and Methodologies in Healthcare .....................................................16 
General Overview of LR and its Relation to RA ...................................................29 
An Overview of RA ...............................................................................................30 
Chapter 3. Methods ............................................................................................................41 
The Data .................................................................................................................41 
Comorbidity IVs ........................................................................................42 
Non-Comorbidity IVs ................................................................................44 
Binning Continuous IVs ............................................................................46 
Dependent Variables (DVs) .......................................................................47 
Binning the Total Cost DV and Calculating Expected 
Values ............................................................................................49 
Associations between the DVs .......................................................50 
Formatting Files for Input into Occam Software .......................................51 
Variable Reduction per DV .......................................................................52 
Rationale for noTraining-Test Split .......................................................................53 
Logistic Regression Analysis .................................................................................54 
- vii -
Regular Logistic Regression ......................................................................55 
Stepwise Logistic Regression ....................................................................56 
Determining the Best RA Models ..........................................................................57 
Fitting the RA Models to the Data & Identifying Important Model IV 
States ......................................................................................................................59 
Selection Criteria for Important Model IV States ......................................60 
Calculating Risk Ratios..............................................................................61 
Chapter 4. Results ..............................................................................................................64 
Preliminary Research Objective: LR & RA Comparison ......................................64 
Connecting to Previous LR Results from the Literature ............................64 
Do RA and LR give the same results for equivalent models? ...................67 
Does exploratory RA provide better or novel models compared to 
LR? .............................................................................................................69 
RA Exploratory and Stepwise LR..........................................................................71 
Main Research Objective: Find predictive models with RA .................................76 
DV: Complication (Cp)..............................................................................76 
Knee Analysis ................................................................................76 
Hip Analysis...................................................................................98 
Hip & Knee Summary of Results for Complication ....................112 
DV: Skilled Nursing Facility (SNF) ........................................................112 
Knee Analysis ..............................................................................112 
Hip Analysis.................................................................................125 
Hip & Knee Summary of Results for SNF ..................................135 
DV: Readmission (Re) .............................................................................136 
Knee Analysis ..............................................................................136 
Hip Analysis.................................................................................142 
Hip & Knee Summary for Readmissions.....................................150 
DV Total Cost (Tcb) ................................................................................150 
Knee Analysis ..............................................................................150 
Hip Analysis.................................................................................162 
Hip & Knee Summary for Total Cost ..........................................172 
Chapter 5. Discussion ......................................................................................................173 
Clinical and Healthcare Related Contributions....................................................174 
Best Models .............................................................................................174 
Important Predictors of Outcome Variables ............................................176 
Patient Variables vs. Delivery System Variables ....................................180 
Classifying Patients as Higher or Lower Risk for Adverse Ou 
tcomes ......................................................................................................187 
Complications ..............................................................................188 
Discharge to skilled nursing facility ............................................190 
Readmissions ...............................................................................191 
Total cost ......................................................................................192 
Methodological Considerations ...........................................................................193 
- viii -
Relating RA to LR ...................................................................................194 
Augmenting RA Occam Results ..........................................................................195 
Tiered Classification System of Important Predicting Variables ............195 
Decision Trees to Summarize Fit Results ................................................195 
Generating Continuous Predictions .........................................................196 
Risk Ratios ...............................................................................................197 
Future Research & Applications ..........................................................................199 
RA Analysis .............................................................................................199 
State-based Models ......................................................................199 
K-systems and U-systems Analysis .............................................200 
Training-Test Splits .....................................................................200 
Binning 201 
Enhancing the Data ..................................................................................201 
Updating Coded Data ...................................................................201 
Adding Post-Discharge Data........................................................202 
Adding the Delivery System Data Domain .................................203 
Reimbursement & Allocation of Payments .............................................204 
Translating Predictions into Value...........................................................205 
Real-Time Risk Prediction ...........................................................205 
Measuring Quality & Outcomes ..................................................207 
Value Beyond Orthopedics ..........................................................208 
References ........................................................................................................................212 
Appendix - Supplementary Tables...................................................................................222 
Component Fit Tables for Knee SNF (All IVs) ...................................................229 
Component Fit Tables for Knee (Comorbidity IVs Only) ...................................230 
Component Fit Tables for Hip SNF (All IVs) .....................................................231 
- ix -
List of Tables 
Table 1. Subset of Comorbidity IVs (Comorbidity IVs from Tier 1 Predictors). .............. 44 
Table 2. Subset of All IVs: Non-Comorbidity Variable Descriptions and IDs. ............... 45 
Table 3. Binned IVs for the Continuous Variables: Number of Risks, Age, and 
Surgeon Volume.  ................................................................................................. 46 
Table 4. Description of the Original Dependent Variables and Subsequent 
Transformed (binned) Final Dependent Variables. .............................................. 47 
Table 5. Binned IV (Tcb) for Total Cost Variable. ........................................................... 49 
Table 6. Association of DVs by %ΔH in Knee Data Set .................................................. 50 
Table 7. Association of DVs by %ΔH in Hip Data Set .................................................... 51 
Table 8. Example of an input file for Occam.................................................................... 52 
Table 9. Literature-based IVs Retained in all RA Exploratory Searches. ........................ 53 
Table 10. Previous Results Reported in (Jain et al., 2005), and Results from New 
LR Analysis on this Project’s Data. Δdf, ΔLR, and ΔAIC values are given 
in the table for later comparisons with RA calculations. ...................................... 66 
Table 11. Previous Results Reported in (Jain et al., 2005) for 3 IVs, and Results 
from New LR Analysis on this Project’s Data...................................................... 67 
Table 12. Similar RA Results Using this Project’s Data. ................................................. 68 
Table 13. Similar RA Results Using this Project’s Data with 3 new IVs. ........................ 69 
Table 14. Directed RA Search for DV Complication for 4 Variables. (Best Model 
by AIC in Bold.) ................................................................................................... 71 
Table 15. LR & RA Comparison of Results for Single Predicting Search. (Δdf=1 
for every model in this table.) ............................................................................... 73 
Table 16. Confirmatory LR Results for all 17 IVs and 6 IVs with p < 0.05. ................... 73 
Table 17. Stepwise LR Approach with 17 IVs. ................................................................ 74 
Table 18. RA Exploratory Search Results with 17 IVs (no interaction terms 
specified in advance)............................................................................................. 74 
Table 19. LR Analysis with the 10 IVs present in the Best RA Model. ........................... 75 
Table 20. Summary of Search Results (Knee) for All IVs. Search covers coarse 
and fine models. All p-values = 0. ........................................................................ 78 
Table 21. IV Rku Predicts Rrd (as DV), Demonstrating IV Overlap. .............................. 80 
Table 22. Summary of Search Results (Knee) for Comorbidity IVs. Search covers 
directed coarse and fine models. ........................................................................... 81 
- x -
Table 23. The 3-Tiered Classification of Predicting Variables for DV: 
Complication, Knee Analysis ............................................................................... 84 
Table 24. Full Fit Table (Knee) All IVs for Best Model: Ageb Cp : Nrb Cp : Ruh 
Cp : Rhd Cp : Rku Cp : Rro Cp. Blue rows indicate ratio < 0.90 and 
orange rows indicate ratio > 1.10. (Ratios between 0.91 and 1.09 are close 
to the margins and are indicated in gray.) ............................................................. 86 
Table 25. Number of Risks (Nrb) Bin Range & Frequency (Knee) ................................. 87 
Table 26. Age Binned (Ageb) Bin Range & Frequency (Knee). ...................................... 88 
Table 27.  Component Fit Table for IVAgeb in (Knee) All IVs Best Model: Ageb 
Cp : Nrb Cp : Ruh Cp : Rhd Cp : Rku Cp : Rro Cp. Blue rows indicate 
ratio < 0.90 and orange rows indicate ratio > 1.10. (Ratios between 0.91 
and 1.09 are close to the margins and are excluded.) ........................................... 89 
Table 28. Component Fit Table for IV Nrb in (Knee) All IVs Best Model: Ageb 
Cp : Nrb Cp : Ruh Cp : Rhd Cp : Rku Cp : Rro Cp. Blue rows indicate 
ratio < 0.90 and orange rows indicate ratio > 1.10. (Ratios between 0.91 
and 1.09 are close to the margins and are excluded.) ........................................... 89 
Table 29. Condensed Fit Table of Comorbidity Components for IVs Ruh, Rhd, 
Rku, Rro in (Knee) All IVs Best Model: Ageb Cp : Nrb Cp : Ruh Cp : Rhd 
Cp : Rku Cp : Rro Cp. Blue rows indicate ratio < 0.90 and orange rows 
indicate ratio > 1.10. (Ratios between 0.91 and 1.09 are close to the 
margins and are excluded.) ................................................................................... 90 
Table 30. Fit Table (Knee) All IVs for Best Coarse Model: Nrb Rku Cp. Blue 
rows indicate ratio < 0.90 and orange rows indicate ratio > 1.10. (IV states 
with frequency < 10 are not highlighted.) ............................................................. 93 
Table 31. Fit Table (Knee) with Comorbidity IVs for best model Ruh Raf Cp : Ros 
Cp : Rhd Cp : Rav Cp : Reg Cp : Rku Cp : Ruu Cp : Rro Cp. Blue rows 
indicate ratio < 0.90 and orange rows indicate ratio > 1.10. ................................. 96 
Table 32. Component Fit Table for IVs Ruh Raf (Knee) Comorbidity IVs Best 
Model Ruh Raf Cp : Ros Cp : Rhd Cp : Rav Cp : Reg Cp : Rku Cp : Ruu 
Cp : Rro Cp. Blue rows indicate ratio < 0.90 and orange rows indicate 
ratio > 1.10. ........................................................................................................... 98 
Table 33. Condensed Component Fit Table for IVs Ruh Raf (Knee) Comorbidity 
IVs Best Model Ruh Raf Cp : Ros Cp : Rhd Cp : Rav Cp : Reg Cp : Rku 
Cp : Ruu Cp : Rro Cp. Orange rows indicate ratio > 1.10. (Ratios between 
0.91 and 1.09 are close to the margins and are excluded.) ................................... 98 
Table 34. Summary of Search Results for All IVs for DV Complication (Hip). 
Search covers directed coarse, and fine models. All p values = 0. ....................... 99 
Table 35. Summary of Search Results for Comorbidity IVs (Hip). Search covers 
directed coarse, and fine models. ........................................................................ 101 
- xi -
Table 36. The 3-Tiered Classification of Predicting Variables for DV: 
Complication, Hip Analysis. ............................................................................... 104 
Table 37. Fit Table (Hip) for All IVs for Best Model Ageb Cp : Nrb Cp : Rrd Cp : 
Rca Cp : Rhd Cp : Rpl Cp. Blue rows indicate ratio < 0.90 and orange 
rows indicate ratio > 1.10. (Ratios between 0.91 and 1.09 are close to the 
margins and are excluded.) ................................................................................. 105 
Table 38. Number of Risks Binned (Nrb) Bin Range & Frequency (Hip). .................... 106 
Table 39. Age Binned (Ageb) Bin Range & Frequency (Hip). ...................................... 106 
Table 40. Component Fit Table for IVAgeb in (Hip) All IVs Best Model: Ageb Cp 
: Nrb Cp : Rrd Cp : Rca Cp : Rhd Cp : Rpl Cp. Blue rows indicate ratio < 
0.90 and orange rows indicate ratio > 1.10. ........................................................ 109 
Table 41. Component Fit Table for IV Nrb in (Hip) All IVs Best Model: Ageb Cp 
: Nrb Cp : Rrd Cp : Rca Cp : Rhd Cp : Rpl Cp. Blue rows indicate ratio < 
0.90 and orange rows indicate ratio > 1.10. ........................................................ 109 
Table 42. Condensed Component Fit Table for IVs Rhd, Rrd, Rpl and Rca in 
(Hip) All IVs Best Model: Ageb Cp : Nrb Cp : Rrd Cp : Rca Cp : Rhd Cp : 
Rpl Cp. Blue rows indicate ratio < 0.90 and orange rows indicate ratio > 
1.10. (Ratios between 0.91 and 1.09 are close to the margins and are 
excluded.) ............................................................................................................ 109 
Table 43. Fit Table (Hip) for Comorbidity IVs for Best Model Rdi Cp : Ruh Cp : 
Rhh Cp : Ram Cp : Rra Cp : Rhe Cp : Rrd Cp : Rca Cp : Rhd Cp : Rpl Cp 
: Rgp Cp : Rfr Cp. Blue rows indicate ratio < 0.90 and orange rows 
indicate ratio > 1.10. (Ratios between 0.91 and 1.09 are close to the 
margins and are excluded.) (Variables Rhh, Ram, Rra, Rhd, Rgp, and Rfr 
only take value 0 for these rows.) ....................................................................... 110 
Table 44. Condensed Component Fit Table for IVs Rhd, Ram, Rhh, Rgp, Rfr, 
Rra, Rrd, and Rpl in (Hip) Comorbidity IVs Best Model: Rdi Cp : Ruh Cp 
: Rhh Cp : Ram Cp : Rra Cp : Rhe Cp : Rrd Cp : Rca Cp : Rhd Cp : Rpl 
Cp : Rgp Cp : Rfr Cp. Orange rows indicate ratio > 1.10. (Ratios between 
0.91 and 1.09 are close to the margins and are excluded.) ................................. 112 
Table 45. Summary of Most Important IVs by Tier across Hip and Knee for 
Complication. ...................................................................................................... 112 
Table 46. Summary of Search Results for Knee data, DV SNF. Includes both All 
IVs for coarse and fine models. ........................................................................... 115 
Table 47. Summary of Search Results (Knee) for Comorbidity IVs for SNF. 
Search covers directed coarse, and fine models.................................................. 117 
Table 48. The 3-Tiered Classification of Predicting Variables for DV SNF, Knee 
Analysis............................................................................................................... 118 
Table 49. Fit Table (Knee) for All IVs for Best Model L SNF : Fc SNF : Ageb 
SNF : Svb SNF : Nrb SNF : Rmd SNF : Rug SNF : Rhf SNF. Blue rows 
- xii -
indicate ratio < 0.90 and orange rows indicate ratio > 1.10. (Ratios 
between 0.91 and 1.09 are close to the margins and are excluded.) ................... 120 
Table 50. Age bin distribution. ....................................................................................... 121 
Table 51. Component Fit Table for IV L in (Knee) All IVs Best Model L SNF : Fc 
SNF : Ageb SNF : Svb SNF : Nrb SNF : Rmd SNF : Rug SNF : Rhf SNF.. 
Blue rows indicate ratio < 0.90 and orange rows indicate ratio > 1.10. 
(Ratios between 0.91 and 1.09 are close to the margins and are excluded.) ...... 122 
Table 52. Component Fit Table for IV Fc in (Knee) All IVs Best Model L SNF : 
Fc SNF : Ageb SNF : Svb SNF : Nrb SNF : Rmd SNF : Rug SNF : Rhf 
SNF. Blue rows indicate ratio < 0.90 and orange rows indicate ratio > 
1.10...................................................................................................................... 123 
Table 53. Fit Table (Knee) for Comorbidity IVs, for Best Model, Rhy SNF : Rau 
SNF : Rmd SNF : Rpa SNF : Rug SNF : Rhe SNF : Rhf SNF : Rku SNF : 
Rbn SNF : Rin SNF. Blue rows indicate ratio < 0.90 and orange rows 
indicate ratio > 1.10. (Ratios between 0.91 and 1.09 are close to the 
margins and are indicated in gray.) ..................................................................... 124 
Table 54. Summary of Search Results (Hip) for All IVs for for SNF. Search covers 
coarse and fine models. ....................................................................................... 127 
Table 55. Summary of Search Results (Hip) for Comorbidity IVs for SNF. Search 
covers both coarse and fine models. ................................................................... 129 
Table 56. The 3-Tiered Classification of Predicting Variables for DV SNF, Hip 
Analysis............................................................................................................... 131 
Table 57. Fit Table (Hip) for All IVs for Best Model Fc SNF : Ageb SNF : Svb 
SNF : Nrb SNF. Blue rows indicate ratio < 0.90 and orange rows indicate 
ratio > 1.10. (Ratios between 0.91 and 1.09 are close to the margins and 
are excluded.) ...................................................................................................... 133 
Table 58. Fit Table (Hip) for Comorbidity IVs for Best Model Rhy SNF : Rhh 
SNF : Rug SNF : Rhe SNF : Rrd SNF : Rav Rbn SNF : Rao SNF : Rse 
SNF : Rnr SNF . Blue rows indicate ratio < 0.90 and orange rows indicate 
ratio > 1.10. (Ratios between 0.91 and 1.09 are close to the margins and 
are excluded.) ...................................................................................................... 134 
Table 59. Summary of Most Important IVs by Tier across Hip and Knee for SNF. ...... 135 
Table 60. Summary of Search Results (Knee) for All IVs for Readmission (Re). 
Search covers coarse and fine models. ............................................................... 137 
Table 61. Summary of Search Results (Knee) for Comorbidity IVs for DV 
Readmission (Re). Search covers coarse and fine models. ................................. 139 
Table 62. The 3-Tiered Classification of Predicting Variables for DV: Re, Knee 
Analysis............................................................................................................... 140 
- xiii -
Table 63. Full Fit Table (Knee) for both All IVs search and Comorbidity IVs 
search for Best Model: Rci Re : Rco Re : Rgp Re : Rcj Re. Blue rows 
indicate ratio < 0.90 and orange rows indicate ratio > 1.10. (Ratios 
between 0.91 and 1.09 are close to the margins and are indicated in gray.) ....... 141 
Table 64. Summary of Search Results (Hip) for All IVs for DV Readmit (Re). 
Search covers directed coarse, and fine models.................................................. 143 
Table 65. Summary of Search Results (Hip) for Comorbidity IVs. Search covers 
directed coarse, and fine models. ........................................................................ 145 
Table 66. The 3-Tiered Classification of Predicting Variables for DV: 
Readmission, Hip Analysis. ................................................................................ 146 
Table 67. Fit Table (Hip) for All IVs for Best Model Rhp Re : Rdd Re : Rpa Re : 
Rep Re : Rhe Re : Rys Re : Rki Re. Blue rows indicate ratio < 0.90 and 
orange rows indicate ratio > 1.10. (Frequencies < 10 and ratios between 
0.91 and 1.09 are close to the margins and are excluded.) ................................. 147 
Table 68. Condensed Fit Table of Components (Hip) All IVs Best Model Rhp Re : 
Rdd Re : Rpa Re : Rep Re : Rhe Re : Rys Re : Rki Re. Orange rows 
indicate ratio > 1.10. (Frequencies < 10 are indicated in gray). ......................... 148 
Table 69. Fit Table (Hip) for Comorbidity IVs for Best Model Rdd Re : Rpa Re : 
Rep Re : Rhe Re : Rys Re : Rer Re : Rki Re Blue rows indicate ratio < 
0.90 and orange rows indicate ratio > 1.10. ........................................................ 149 
Table 70. Condensed Fit Table of Components (Hip) All IVs Best AIC Model Rdd 
Re : Rpa Re : Rep Re : Rhe Re : Rys Re : Rer Re : Rki Re Re. Orange 
rows indicate ratio > 1.10. (Frequencies < 10 are indicated in gray). ................ 150 
Table 71. Summary of Most Important IVs by Tier across Hip and Knee for 
Readmission. ....................................................................................................... 150 
Table 72. Summary of Search Results (Knee) for All IVs for Total Cost Binned 
(Tcb). Search covers coarse and fine models. ..................................................... 151 
Table 73. Summary of Search Results (Knee) for Comorbidity IVs for DV 
Total Cost Binned (Tcb). Search covers coarse and fine models. All 
p values = 0. ........................................................................................................ 153 
Table 74. The 3-Tiered Classification of Predicting Variables for DV: Total Cost, 
Knee Analysis ..................................................................................................... 154 
Table 75. Bin values for DV Total Cost. ........................................................................ 155 
Table 76. Full Fit Table (Knee) All IVs for Best Model: S Tcb : Nrb Tcb. Blue 
rows indicate ratio < 0.90 and orange rows indicate ratio > 1.10 (ratios 
between 0.91 and 1.09 are close to the margins and are indicated in gray). ....... 155 
- xiv -
Table 77. Component Fit Table for IV S (Knee) All IVs Best Model: L Tcb : Svb 
Tcb : Nrb Tcb. Blue rows indicate ratio < 0.90 and orange rows indicate 
ratio > 1.10. (Ratios between 0.91 and 1.09 are close to the margins and 
are indicated in gray.) ......................................................................................... 158 
Table 78. Component Fit Table for IV Nrb (Knee) All IVs Best Model: L Tcb : 
Svb Tcb : Nrb Tcb. (Ratios between 0.91 and 1.09 are close to the margins 
and are indicated in gray.) ................................................................................... 159 
Table 79. Full Fit Table (Knee) with Comorbidity IVs for Best Model: Ruh Tcb : 
Rmo Tcb : Rde Tcb : Ros Tcb : Rhe Tcb. Blue rows indicate ratio < 0.90 
and orange rows indicate ratio > 1.10 (ratios between 0.91 and 1.09 are 
close to the margins and are indicated in gray). .................................................. 160 
Table 80. Summary of Search Results (Hip) for All IVs for Total Cost Binned 
(Tcb). Search covers directed coarse, and fine models. All p values = 0. .......... 162 
Table 81. Summary of Search Results (Hip) for Comorbidity IVs for DV Total 
Cost Binned (Tcb). Search covers coarse and fine models. All p values = 
0........................................................................................................................... 165 
Table 82. The 3-Tiered Classification of Predicting Variables for DV: Total Cost, 
Hip Analysis........................................................................................................ 166 
Table 83. Total Cost Range, Average Cost, and Frequency. .......................................... 167 
Table 84. Full Fit Table (Hip) with All IVs for Best Model: L Tcb : Svb Tcb : Nrb 
Tcb. Blue rows indicate ratio < 0.90 and orange rows indicate ratio > 1.10. 
(Ratios between 0.91 and 1.09 are close to the margins and are indicated 
in gray.) ............................................................................................................... 168 
Table 85. Component Fit Table for IV L (Hip) All IVs Best Model: L Tcb : Svb 
Tcb : Nrb Tcb. Blue rows indicate ratio < 0.90 and orange rows indicate 
ratio > 1.10. (Ratios between 0.91 and 1.09 are close to the margins and 
are indicated in gray.) ......................................................................................... 169 
Table 86. Component Fit Table for IV Svb (Hip) All IVs Best Model: L Tcb : Svb 
Tcb : Nrb Tcb. (Ratios between 0.91 and 1.09 are close to the margins and 
are indicated in gray.) ......................................................................................... 169 
Table 87. Component Fit Table for IV Nrb (Hip) All IVs Best Model: L Tcb : Svb 
Tcb : Nrb Tcb. (Ratios between 0.91 and 1.09 are close to the margins and 
are indicated in gray.) ......................................................................................... 170 
Table 88. Full Fit Table (Hip) with Comorbidity IVs for Best Model: Rmo Tcb : 
Rcp Tcb : Rrd Tcb : Rnr Tcb. Blue rows indicate ratio < 0.90 and orange 
rows indicate ratio > 1.10. (Ratios between 0.91 and 1.09 are close to the 
margins and are indicated in gray.) ..................................................................... 170 
Table 89. Component Fit Table (Hip) for morbid obesity (Rmo) with Comorbidity 
IVs for Best Model: Rmo Tcb : Rcp Tcb : Rrd Tcb : Rnr Tcb. Blue rows 
- xv -
indicate ratio < 0.90 and orange rows indicate ratio > 1.10. (Ratios 
between 0.91 and 1.09 are close to the margins and are indicated in gray.) ....... 171 
Table 90. Component Fit Table (Hip) for chronic pain (Rcp) with Comorbidity 
IVs for Best Model: Rmo Tcb : Rcp Tcb : Rrd Tcb : Rnr Tcb. Blue rows 
indicate ratio < 0.90 and orange rows indicate ratio > 1.10. (Ratios 
between 0.91 and 1.09 are close to the margins and are indicated in gray.) ....... 171 
Table 91. Summary of Most Important IVs by Tier across Hip and Knee for Total 
Cost. .................................................................................................................... 172 
Table 92. List of 16 Models sorted by %ΔH. ................................................................. 174 
Table 93. Top Important IVs across Hip and Knee Data Sets, and across the 4 
DVs. (Cp = Complication, SNF = Skilled Nursing Facility, Re = Readmit, 
and Tcb = Total Cost Binned.) Novel variables are indicated by *. The 
Shared column indicates IVs located in both hip and knee data sets. ................. 178 
Table 94. Delivery System vs. Patient Related Submodels Comparison of 
Reduction of Uncertainty for DV Complication (Cp). ....................................... 183 
Table 95. Delivery System vs. Patient Related Submodels Comparison of 
Reduction of Uncertainty for DV Skilled Nursing Facility (SNF). .................... 184 
Table 96. Delivery System vs. Patient Related Submodels Comparison of 
Reduction of Uncertainty for DV Readmission (Re). ......................................... 184 
Table 97. Delivery System vs. Patient Related Submodels Comparison of 
Reduction of Uncertainty for DV Total Cost (Tcb). ........................................... 186 
Table 98. Summary of Decreased and Increased IV States by DV (Cp = 
Complication, SNF = Skilled Nursing Facility, Re = Readmission, Tcb = 
Total Cost). ......................................................................................................... 188 
Table 99. Increased and Decreased Risk IV States for Complication (Cp). ................... 189 
Table 100. Increased and Decreased Risk IV States for Skilled Nursing Facility 
(SNF)................................................................................................................... 191 
Table 101. Increased and Decreased Risk IV States for Readmission (Re). .................. 192 
Table 102. Increased and Decreased Risk IV States for Total Cost (Tcb). .................... 193 
- xvi -
List of Figures 
Figure 1. Lattice of structures for 3 IVs and 1 DV. ...........................................................34 
Figure 2. Levels of refinement in RA. .............................................................................. 37 
Figure 3. Knowing the Season Reduces the Uncertainty of the No-Rain:Rain from 
1:1 to 2:1 or 1:2 odds. ........................................................................................... 62 
Figure 4. Decision Tree illustrating how knowing the Season Reduces the 
Uncertainty of the No-Rain:Rain from 1:1 to 2:1 or 1:2 odds. ............................. 62 
Figure 5. Simplified Decision Tree for DV Any Comp (Knee) All IVs, for Best 
Coarse Model Nrb Rku Cp. .................................................................................. 93 
Figure 6. Decision Tree for DV Any Comp (Knee) All IVs for Best Model Ageb 
Cp : Nrb Cp : Ruh Cp : Rhd Cp : Rku Cp : Rro Cp. ............................................. 94 
Figure 7. Decision Tree for DV Any Comp (Knee) with Comorbidity IVs for Best 
Model Ruh Raf Cp : Ros Cp : Rhd Cp : Rav Cp : Reg Cp : Rku Cp : Ruu 
Cp : Rro Cp. .......................................................................................................... 97 
Figure 8. Decision Tree for DV Any Comp (Hip) All IVs for Best Model Ageb Cp 
: Nrb Cp : Rrd Cp : Rca Cp : Rhd Cp : Rpl Cp. .................................................. 108 
Figure 9. Decision Tree for DV Any Comp (Hip) with Comorbidity IVs for Best 
Model Rdi Cp : Ruh Cp : Rhh Cp : Ram Cp : Rra Cp : Rhe Cp : Rrd Cp : 
Rca Cp : Rhd Cp : Rpl Cp : Rgp Cp : Rfr Cp. .................................................... 111 
Figure 10. Decision Tree for DV SNF (Knee) with Comorbidity IVs for Best 
Model Rhy SNF : Rau SNF : Rmd SNF : Rpa SNF : Rug SNF : Rhe SNF : 
Rhf SNF : Rku SNF : Rbn SNF : Rin SNF. ........................................................ 125 
Figure 11. Decision Tree for DV SNF (Hip) with Comorbidity IVs, for Best 
Model, Rhy SNF : Rhh SNF : Rug SNF :Rhe SNF : Rrd SNF : Rav Rbn 
SNF : Rao SNF : Rse SNF : Rnr SNF. ............................................................... 135 
Figure 12. Decision Tree for DV Readmit (Knee) for Best Model Rci Re : Rco Re 
: Rgp Re : Rcj Re. ............................................................................................... 142 
Figure 13. Decision Tree for DV Readmit (Hip) All IVs for Best AIC Model Rhp 
Re : Rdd Re : Rpa Re : Rep Re : Rhe Re : Rys Re : Rki Re. .............................. 148 
Figure 14. Decision Tree for DV Readmit (Hip) with Comorbidity IVs for Best 
AIC Model Rdd Re : Rpa Re : Rep Re : Rhe Re : Rys Re : Rer Re : Rki Re 
Re. ....................................................................................................................... 149 
Figure 15. Decision Tree for DV Total Cost (Knee) with Comorbidity IVs for Best 
Model Ruh Tcb : Rmo Tcb : Rde Tcb : Ros Tcb : Rhe Tcb. .............................. 161 
Figure 16. Decision Tree for DV Total Cost (Hip) with Comorbidity IVs for Best 
Model Rmo Tcb : Rcp Tcb : Rrd Tcb : Rnr Tcb. ................................................ 171 
Figure 17. New Partition of IVs into Delivery System and Patient-Related IVs. .......... 181 
- 1 -
Chapter 1.  Introduction 
Transitioning to Value and the Role of Predictive Analytics 
Healthcare in the United States is facing unprecedented challenges. The trajectory 
of spending in US healthcare costs is unsustainable. This has led to a national dialogue 
that is currently under way among the federal government, insurance payers, healthcare 
delivery systems, and patient advocates—all calling for substantial changes to the current 
system in order to improve the value of healthcare.  
One example where this challenge is clearly evident is in the field of orthopedics. 
The population in the United States that is age 65 and older is more active than in 
previous generations and expects to maintain a quality of life dependent on mobility. The 
demand for total joint replacement procedures is increasing. At the same time, Federal 
and state funding of Medicare and Medicaid services is in decline, and reimbursement 
rates are decreasing for these procedures.  
The Patient Protection and Affordable Care Act of 2010 has already resulted in 
significant changes in how Medicare pays providers. These payment reforms are 
designed to slow the growth in costs and push improvements in quality of healthcare 
delivery. The Centers for Medicare and Medicaid Services (CMS) has already 
implemented a mandatory bundled payment for hip and knee replacements, with other 
condition groups soon to follow. In 2015, the Medicare Access and CHIP 
Reauthorization Act (MACRA) was passed, which changes the way CMS pays 
physicians for Medicare covered patients and includes programs such as The Merit-based 
Incentive Payment System (MIPS) and Advanced Alternative Payment Models (APMs), 
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specifically tying payments to quality. In the last decade, the activation of healthcare 
reform is increasingly reflected in the policies and practices of both government and 
private health insurance payers and healthcare providers.  
Bundled payments, and other new models of reimbursement, are now charged 
with finding ways to assess physician performance and create payment systems that 
determine what physicians should be paid for what they actually do. These new payment 
models will simultaneously include increased financial risk for health systems, insist on 
better quality outcomes, and demand lower cost. Under traditional payment models, 
healthcare providers were paid per service provided, and the outcome of that service was 
not linked to payment. Under new payment models, payment is increasingly tied to 
performance based on outcomes.  
In fact, the dialogue among healthcare reform players has now focused on 
achieving value as the overarching goal of healthcare delivery. Value in healthcare has 
come to be specifically defined as the health outcomes achieved per dollar spent. The 
formula for value therefore places outcomes as the numerator and dollars spent as the 
denominator. A key driver of value is the aggregate set of services provided to a patient 
throughout an episode of care. The more focused and appropriate the services provided, 
given the unique patient factors, the more value can be achieved (Porter, 2010).  
In President Barack Obama’s 2015 State of the Union address, the President 
announced the Precision Medicine initiative, saying, “I want the country that eliminated 
polio and mapped the human genome to lead a new era of medicine—one that delivers 
the right treatment at the right time” (State of the Union Address, 2015). While precision 
medicine most frequently applies to the use of genomic level data, the term precision 
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delivery refers to the use of a patient’s electronic health record data to predict risk and 
tailor care to improve value. To increase value while payments are diminishing and tied 
to individual outcome quality, healthcare must improve at predicting risks and outcomes, 
and matching the right services to the right patient when needed.  
The time for precision delivery is now. With the advent of accountable 
care, the health care organizations that succeed will be those that deliver 
high value. Perhaps the most important step to improving value will be 
implementing clinical analytics in routine care. Organizations that 
adapt by integrating these tools may do better both clinically and 
financially going forward.  (Parikh, Kakad, & Bates, 2016).  
 
Some healthcare delivery system front runners are currently deploying predictive 
analytics in order to improve efficiency by tailoring the delivery of services to the 
individual patient. Delivery systems can focus costly resources on the higher-risk patient 
groups if patient risk is assessed in real time at the point of care. One way to improve 
predictions of risk is through better modeling methods. 
Historically, predictive methods used fall under the category of generalized linear 
modeling, and more specifically Regression Analysis. Regression Analysis methods, such 
as Logistic Regression, have been widely accepted as the default method of prediction 
and are still the predominant methodology in health outcomes research. More recently, 
machine learning and artificial intelligence are gaining popularity, particularly with real-
time analytics and risk prediction. Logistic Regression is broadly understood and has 
high “explainability,” thus allowing the clinicians clear insight into the mechanism of 
prediction. Artificial Intelligence (AI) methods, such as Neural Networks (NNs), may 
enhance predictions, but perhaps with a sacrifice of explainability. If a methodology is 
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both more predictive than LR and explainable, then this methodology will be worth 
considering. 
This project explores the possibility that there are other methods of predictive 
modeling that may be stronger than or at least complimentary to standard methods of 
prediction. Reconstructability Analysis (RA), which is the methodology that this study 
looks at, is a machine learning methodology developed in the systems science research 
community for finding relations in data, especially non-linear and higher ordinality 
relations. These relationships between the variables in the data can have high ordinality 
(involve many variables), and one need not impose any hypothetical relationship prior to 
RA. RA may perform as well as LR methods and may provide additional accuracy 
through detection of novel variables and interaction effects between independent 
variables. While LR can model interaction effects, in standard implementation of this 
method these interactions must be specified during model construction, usually based on 
empirical findings, and specific hypotheses of interaction tested. RA is truly exploratory 
in that no interactions need to be specified during model construction, but emerge 
through exploration. 
Reconstructability Analysis (RA) is a validated data mining method and has been 
used with success in other fields. It is relatively unknown, however, in health outcomes 
research. RA assesses hyper-graph structures either using set theoretic (SRA) or 
information theoretic (IRA) modeling. This study will use the information theoretic form 
IRA, which utilizes information theory to measure the uncertainty (entropy) in the output 
(dependent) variable(s), as a function of the known input (independent) variable(s). 
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The potential value of RA for the present study is threefold: 
 (1)  RA can play a confirmatory role. If RA results in similar findings as those 
arrived at through use of more commonly accepted methodologies (LR), then this 
confirmation of results increases the credibility of the research findings of the standard 
methodologies. 
(2)  RA can be used as a hypothesis generator, detecting variables that were not 
known a priori as strong predictors and then modeled using more standard regression 
analysis methods, therefore providing a complimentary and supportive approach. 
(3)  Further, RA might predict with better accuracy than LR. If this result is 
found, then RA is valuable as a stand-alone method that can replace LR in the creation 
of predictive risk models. 
Problem Domain 
Reform efforts are looking at joint replacement procedures as an area ripe for 
improvement in costs and outcomes because of the high cost, the high variation in 
outcomes, and the increasing demand for these procedures. This project presents 
condition specific models to predict outcomes that are important in hip and knee 
replacement. RA is used to look for predicting variables (including interaction effects) 
from a large set of patient comorbidities and delivery system variables on the following 
four dependent variables: Complication (inpatient), discharge to Skilled Nursing Facility 
(SNF), Readmission (90 day), and the continuous variable Total Cost (expected values 
are calculated for cost).  
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Research Objectives 
Within the specifics of the domain of hip and knee replacement surgery, this 
project aims to demonstrate that RA models are able to predict outcomes and provide 
additional insights that improve healthcare value, comparable to and beyond the 
capabilities of LR. 
Preliminary Research Objective: LR and RA Comparison 
Do RA and LR give the same results for equivalent models? 
Prior to exploratory modeling with Reconstructability Analysis, the first task is to 
demonstrate the validity of the data used in this project and the RA methodology. RA is 
validated by testing a logistic regression (LR)-generated model arrived at by a past study, 
using LR on this project’s data. If LR applied to this data approximately reproduces LR 
results reported in the literature, and if the results of RA applied to this data are similar to 
those from LR, then the RA and LR methods are comparable. Generating similar results 
using RA gives confidence in the use of RA for exploratory modeling.  
Does exploratory RA provide better or novel models compared to LR? 
It is possible that RA produces better models than models produced by LR. If RA 
generates stronger predictions, then RA is not only valuable as a method to confirm or 
augment LR, but as a stand-alone method that could replace LR in the creation of 
predictive risk models.  
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Main Research Objective: Find Predictive Models with RA 
What are the best RA models? 
The primary results of this project are a set of 16 predictive models. Each model 
provides a conditional probability distribution of the possible outcomes of four measures 
(DVs), given a set of comorbidities and delivery system variables (IVs). The models look 
not only at the probability distribution of outcomes given a single IV, or of multiple IVs 
taken individually, but also at the probability of outcomes given relationships between 
IVs, i.e., given complex interaction effects between the IVs and the DV. 
The exploratory phase of this project aims to detect predictive IVs and interaction 
effects among the IVs and each of the DVs. Relations between the IVs and the DV do not 
have to be specified up front, and thus their form does not need to be known or 
hypothesized. These relations can be discovered using RA. These interaction effects may 
offer better prediction than that of single IVs known from the current literature. 
Exploratory modeling with RA may even detect surprising predictive IVs. 
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 Chapter 2.  Review of Literature 
In this chapter, four areas of literature are described. The first body of literature is 
that of the healthcare context, and new payment models spurred by healthcare reform 
efforts aimed at increasing value by tying costs to outcomes. The second area concerns 
the assessment of risk for quality measurement and optimization of real-time patient care. 
This discussion of risk is enhanced by the third area of focus, where the literature 
surveyed looks at specific predictive models in the analysis of outcomes and, although 
much less common, the clinical care setting.  This literature shows that predictive models 
provide value, particularly condition/procedure-specific models.  A large body of 
literature exists for predictive modeling in adult cardiac surgery, but a much more limited 
body of literature exists for hip and knee replacement surgery. Of the studies that exist in 
hip and knee replacement surgery, none make use of data mining techniques to increase 
predictive ability. These studies use regression analysis methods with the most common 
approach being the logistic regression methodology. That being said, in the fourth main 
body of literature, data mining techniques are reviewed and the potential role for 
Reconstructability Analysis to add value as a methodology is highlighted. 
The Healthcare Context 
Costs in the US healthcare system have spiraled out of control, resulting in what 
is referred to as a healthcare crisis. This crisis is reflected not only in soaring costs, but 
also in lack of access to care and in variation in treatments and outcomes and many other 
issues (Fisher, 2003). National Health Expenditure Projects Americans will spend 
4.5 trillion dollars on healthcare by 2019 (Medicare, 2016). The US is an outlier in 
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healthcare spending, spending 40% more per capita then the next highest spending 
country (Lorenzoni, Belloni, & Sassi, 2014). This massive amount of spending has not 
resulted in better care. Glaring variations in services provided and outcomes have 
intensified efforts toward reforming the healthcare delivery system. In a system that has 
traditionally paid a fee for every service provided, current policy reform is essentially 
focused on removing the incentive to provide too much care by creating fixed payments, 
and guarding against poor care by incentivizing the delivery system on good performance 
based on quality (Doyle, Graves, & Gruber, 2015). In a seminal publication, Michael 
Porter captured the conflicting goals of stakeholders, including access to services, 
profitability, high quality, cost containment, safety, convenience, patient-centeredness, 
and satisfaction, and introduced the concept of value as the overarching goal to unite 
healthcare delivery (Porter, 2010). Arguing for value, Porter states “If value improves, 
patients, payers, providers, and suppliers can all benefit while the economic sustainability 
of the health care system increases” (Porter & Teisberg, 2006). 
Literature on healthcare reform shows the evolution toward value-based care over 
the last decade, through adoption of performance-based payment systems as a primary 
mechanism for the reduction of soaring healthcare costs and improvement in quality care  
(Nichols & O’Malley, 2006). The Patient Protection and Affordable Care Act (ACA) of 
2010 (“Patient Protection and Affordable Care Act of 2010,” 2010) has been a significant 
piece of legislation with myriad components and strategies. A central piece of this 
legislation provides for slowing growth in Medicare spending and promotes experiments 
in payment and delivery system reform (Oberlander, 2010). Under value-based payment 
systems, the fee-for-service payment system is retained but tied to efficiency and quality 
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by the delivery system. The transformation of healthcare is under way, with 30% of 
Medicare payments going through alternative payment models (APMs) (Obama, 2016). 
These APMs include bundled payments, where a single payment is reimbursed for all 
services falling within a pre-defined episode, or accountable care organizations (ACOs). 
According to CMS, an ACO is “an organization of health care practitioners that agrees to 
be accountable for the quality, cost, and overall care of Medicare beneficiaries who are 
enrolled in the traditional fee-for-service program who are assigned to it” (Centers for 
Medicare & Medicaid Services (CMS), HHS, 2011). 
One of the first specific clinical areas to face these reform efforts is hip and knee 
replacements. The demand for hip and knee replacements, coupled with the variation in 
cost and outcomes, has resulted in the first early bundled payment experiments, such as 
Bundled Payment for Care Improvement Initiative (BPCI) and now the first mandatory 
bundled payment for hip and knee replacement surgery by the Centers for Medicare and 
Medicaid Services (CMS). In the CMS Comprehensive Care for Joint Replacement (CJR) 
episode-based payment model, set target payments require hospitals, physicians, and 
post-acute care providers to coordinate in order to improve patient outcomes at an 
increasingly smaller target price (Centers for Medicare & Medicaid Services, 2015). 
Additionally, a large number of joint replacement commercial bundled contracts are in 
the marketplace today.  
Demand for total hip and knee replacement is expected to continue rapid growth 
in the next 10 years, largely due to the aging baby boomer population and the obesity 
epidemic (Fehring et al., 2010). One estimate places the total number of hip and knee 
replacements at over 4 million by 2030, an increase of 174% over 2007 volumes 
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(Kurtz S, 2007). Estimates place the prevalence of osteoarthritis, the disease causing total 
hip and knee replacement, at 18.2% by 2020 (Lawrence et al., 1998). Osteoarthritis 
increases with age (Pulido L, 2008) and “the higher life expectancy and the upcoming 
massive cohort from the ‘old baby boomers’ will lead to a higher number of joint 
arthroplasties being performed . . . it is hence plausible that a higher incidence of medical 
complications in this growing joint arthroplasty population will be observed” (p.139). 
The quality of elective total hip and total knee procedures is extremely varied (Tomek 
et al., 2012) and in fact, hip and knee replacements are among the procedures with the 
most varied payments. These variations in payment correspond in part to the fact that the 
profile of patient populations differ across regions and within regions by the fact that 
some hospitals receive larger burdens of higher-risk patients. Even after controlling for 
the differences between patient populations, there is still a large variation between 
payments for these procedures (Miller et al., 2011). The authors suggest that the 
unexplained remaining variation is possibly unwarranted, suggesting that there is room to 
improve. The literature shows a broad consensus that the medical system can perform 
better—providing good patient outcomes at a lower cost.  
Delivery systems contracted under bundled payments will have to deal with the 
issue of risk: what happens if the cost of care exceeds the set bundled price? In some 
bundle arrangements, the physician is a partner with the hospital on the gains, and in 
some scenarios also on the loss. A set bundled price therefore provides incentive to come 
in under the set fixed price as often as over it and therefore break even, or better yet, 
come in under the bundled price more often than not and therefore derive profit. 
Reducing costs alone will not solve the healthcare crisis, and achieving high quality 
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outcomes is an essential component of value. Porter states “Cost reduction without regard 
to the outcomes achieved is dangerous and self-defeating, leading to false “savings” and 
potentially limiting effective care.” (Porter & Teisberg, 2006). Alternative payment 
models reward cost effectiveness, and there is concern that without adjusting for patient 
comorbidities restricted access to care will be encouraged (Rozell, Courtney, Dattilo, Wu, 
& Lee, 2016). An increase in demand for total hip and knee replacement surgery in a 
market where surgeons must select only a subset of all surgical candidates for surgery 
and a reimbursement model that does not account for patient risk is a recipe for higher-
risk patients to be pushed out of the pool of surgical candidates.  
Assessing Risk 
Accounting for patient risk is important not only for optimizing the value equation 
and ensuring fair physician reimbursement, but for patients, ensuring that reimbursement 
is structured in a way that allows for broad and equitable patient access. With payments 
increasingly tied to outcomes, providers are demanding collection of better data on 
outcomes and improving risk adjustment techniques to account for underlying patient 
comorbidities and understanding what techniques lead to the best outcomes (Luft, 2009). 
There are two primary ways that the assessment of risk plays a role in this 
landscape. First, adequately understanding a patient’s risk allows for the measurement of 
outcomes adjusted by patient individual risk factors. This retrospective measure of 
quality is critical for the measurement of performance. Second, predicting risk can allow 
for-real time identification of high-risk patients likely to require expensive care or to 
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experience an adverse event (Bates, Saria, Ohno-Machado, Shah, & Escobar, 2014) as 
well as low-risk patients who may be appropriate candidates for fast-track care pathways. 
Whether the reimbursement is an APM bundled-payment model or not, there are 
challenges when tying payment to performance. In an article looking at pay-for-
performance in orthopedics, authors describe these challenges: 
The implementation of such a dramatic paradigm shift in healthcare 
payment policy is fraught with challenges. Those challenges include 
difficulty in defining and measuring quality and efficiency, cost of 
collecting and analyzing performance data, development and 
implementation of appropriate risk adjustment models, lack of additional 
funding to reward quality, unintended consequences of provider “gaming” 
and patient deselection (e.g., “cherry picking”), and impact on low-tier, 
low quality providers. (Bozic, Smith, & Mauerhan, 2007) 
 
There are several limitations that must be addressed before widespread 
implementation of new payment models that tie payment to quality. One of these 
limitations is inadequate risk adjustment for clinical outcome measures (Nichols & 
O’Malley, 2006). The authors state that: 
Inadequate information systems, as well as imperfect algorithms and data 
to control for patient-level comorbidities, severely limit the ability to risk 
adjust clinical outcomes measures. This is a major barrier to more 
widespread implementation of pay for performance (P4P) and to 
convincing some physicians, who manage complex patients on a daily 
basis, of the value of these measures. (Nichols & O’Malley, 2006).  
Risk adjustment models have been developed and implemented for the large-scale 
insurance market. This is the actuarial side of healthcare finance. Insurers have always 
understood that if they can attract healthier patients to their pool of enrollees then they 
will pay out less in medical claims. Health insurers have long used risk adjustment 
methods to group patients into risk cohorts for payment strategies. At present, the type of 
risk adjustment that occurs at the level of the health insurer is based on complex 
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algorithms with the sole purpose of making adjustments between populations of patients 
for financial balance in the insurance market. This type of risk adjustment is evolving 
under the Affordable Care Act, where Health Insurance Exchanges are now mandated. 
This new model of risk adjustment will utilize retrospective, diagnosis-based risk 
adjustment strategies as a way to compensate insurers with higher-risk populations 
(Weiner, Trish, Abrams, & Lemke, 2012). This large-scale risk adjustment performed in 
the insurance market is very different from the prospective risk models that will be 
created in this project. While the former is critical for a functional insurance market, it 
cannot be applied at the patient or physician level and cannot calculate an expected 
outcome.  
In order to assess physician performance based on patient outcomes, it is crucial 
to determine if the observed outcome for a group of patients is better or worse than 
expected based on the patient comorbidities rather than better or worse than a fixed target 
based on an average. Payments based on average targets are frequently referred to as 
global payments. With or without physician performance incentives, the practice of 
global payment is worrisome. If an expected outcome is simply a fixed target, providers 
are punished “whose complex patients, even if doing ‘better than expected,’ do not hit 
targets that are easier to achieve with healthier patients” (Ash AS, 2012). Target 
outcomes that adjust based on the patients’ risk are critical for assessing physician 
performance. Goroll and Schoenbaum (2012) describe robust, scientifically validated 
risk-adjustment models as critical in order to address the impediments to payment reform. 
Global payments, without risk adjustment, burden the providers with significant financial 
risk. Risk adjustment that accounts for performance based on expected outcomes versus 
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an average-based target will help alleviate this financial risk and deter providers from the 
“temptation inherent in global payment to cherry-pick patients.” Utilizing risk adjustment 
models at the provider level will enable patient-based expected outcomes to be generated, 
and can connect directly with pay-for-performance strategies. Goroll and Schoenbaum 
(2012) state that “Risk adjustment applied to payment for performance can serve to 
recognize, reward, and incentivize the extra work needed to achieve better-than-expected 
outcomes, helping to alleviate the concern that global payment will lead to less care.” 
Ellis and Ash (2012) are also concerned about the use of globally calculated performance 
measures and the lack of methods to make patient-based adjustments  stating that 
“Although using non-adjusted performance measures may create undesirable incentives 
for practices to avoid the sickest patients, even crude adjustments are rare.” 
A seminal report issued by the Institute of Medicine (IOM), an arm of the 
National Academy of Sciences titled “Crossing the Quality Chasm: A New Health 
System for the 21st Century,” makes the following request: 
The committee calls for all purchasers, both public and private, to 
carefully reexamine their payment policies to remove barriers that impede 
quality improvement and build in stronger incentives for quality 
enhancement. Clinicians should be adequately compensated for taking 
good care of all types of patients, neither gaining nor losing financially for 
caring for sicker patients or those with more complicated conditions. 
Payment methods also should provide an opportunity for providers to 
share in the benefits of quality improvement, provide an opportunity for 
consumers and purchasers to recognize quality differences in healthcare 
and direct their decisions accordingly, align financial incentives with the 
implementation of care processes based on best practices and the 
achievement of better patient outcomes, and enable providers to 
coordinate care for patients across settings and over time. 
Achieving high-quality outcomes can certainly be enhanced with retrospective 
measurement, appropriately adjusted for patient risk. Quality improvement programs 
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have been built using measures based on retrospective data. But the question remains: 
Can we do something to prevent rather than merely to adjust? If we can predict, we can 
prevent—or so the theory goes. With delivery systems accountable, predictive algorithms 
can help allocate resources more effectively for both high-risk and low-risk patients.  
Successful organizations will use a broad array of tools to predict important outcomes, 
including to identify patients likely to require expensive care, be readmitted, or 
experience a specific type of adverse event. (Bates, Saria, Ohno-Machado, Shah, & 
Escobar, 2014). 
Risk Models and Methodologies in Healthcare 
In this section of the literature review, existing risk models are reviewed. 
Literature shows that for condition-specific hip and knee replacement models, most are 
based on logistic regression (LR) and previously identified comorbidities in a 
retrospective analysis. Additionally, literature is reviewed showing some promising 
implementations of real-time risk prediction systems, offering the chance to prevent 
costly care and poor outcomes.  
Predicting risk of adverse outcomes is common practice in insurance and in 
research. Many insurers use risk assessment and risk adjustment models to identify 
patients who are at risk of high-cost care as well as to profile and rate physicians. High-
risk care management is used for patients identified as expected to incur high costs. 
However, broad risk profiling may not be suitable for subgroups of patients with specific 
clinical conditions and interventions. “Interventions that are appropriate and effective for 
one group will often do little to improve care and reduce costs for others” (Powers & 
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Chaguturu, 2016). Insurance companies have long been involved in risk adjustment, and 
have large pools of claims data for their members, yet are always on the lookout for 
better methodologies to improve predictions of expected utilization.  
There are a handful of general risk adjustment models that are based on pre-
operative clinical characteristics such as: Adjusted Clinical Group (ACG), Diagnostic 
Cost Group (DCG), Seattle Index of Comorbidity (SIC), Chronic Illness and Disability 
Payment System (CDPS), Charlson Index, RxRisk, Self-reported measures for 
demographic and health, and prior year expenditures. In one study, Maciejewski (2005) 
and Liu compared the predictive accuracy of these risk adjustors for prospective 
modeling of the expenditures in a year period of time. The goal of this study was to look 
at which measures were most predictive and ought to be considered in future studies. One 
of the interesting results from this study was that administrative-based data performed 
better than patient self-reported measures. Administrative data refers to data that is most 
often collected by government or commercial payers, typically for reimbursement 
purposes. 
Administrative data sets are large, inexpensive, structured, and readily available, 
however they lack important clinical information. As the authors state:  “VA provides an 
ideal setting to assess the performance of differing strategies to adjust for patient risk 
differences in observational or experimental studies because of the availability of 
extensive demographic, clinical, pharmacy, and economic data on several million 
veterans who use VA services” (Maciejewski & Liu, 2005). This type of model 
validation would be very difficult in hip and knee replacement, as there is little 
accessibility to comparable data.  
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The private sector has recognized an unmet need for risk prediction, and a handful 
of proprietary risk adjustment models exist. Currently, there are general risk calculators 
available to providers marketed by private companies such as Archimedes, which 
markets the product IndiGO. In this case, as is true with virtually all privately marketed 
risk models, the mechanisms by which prediction is calculated are at least partially a 
“black box,” meaning that the end user does not know exactly how a score was 
calculated. In IndiGO, patient data is entered into a software application, and after the 
data is entered, “IndiGO uses its advanced algorithms, based on the Archimedes Model, 
to create individualized guidelines. The individualized guidelines include person-specific 
risk of adverse events (such as heart attack, stroke, diabetes onset and its complications) 
. . .” (Bellows, Patel, & Young, 2014). The predictive value of these models can be—and 
has been—validated against compared with other models based simply on how well they 
predict. Not only are they comparable, but they can be included in other risk scoring 
models as well. For example, in the Global Outcomes Score (GO Score), Eddy, Adler & 
Morris (2012) use the IndiGO risk calculator as the method to predict multiple outcomes 
across many healthcare domains. The GO Score looks at a spectrum of outcomes, 
comorbidities and interventions. The GO Score takes aggregated predicted outcomes and 
measures them against the observed outcomes. The GO Score demonstrates the use of 
predicted versus observed outcome as a method to quantify and measure quality. Quality 
occurs when a patient does better (observed outcome) than expected (predicted risk). The 
GO Score could be augmented, and utilize another risk calculator, as the authors suggest: 
“Other risk calculators can be used to generate GO Scores, but they should be similarly 
validated” (Eddy, Adler & Morris, 2012). 
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While global risk models may be validated and useful at a general level, models 
constructed for specific procedures are needed. Each surgical procure has its own patient 
population with different rates of comorbidities, and disease-specific risk models are 
more precise in predicting outcomes. For example, newborn infants will have a different 
set of comorbidities than elderly patients prior to heart surgery. Not only are the 
comorbidities different, but the heart surgeries conducted on each are technically unique, 
and the adverse outcomes related to the procedure are distinct.  
The procedure-specific Aristotle Based Complexity (ABC) score is used to 
predict complications, mortality, and prolonged length of stay for surgeries performed by 
congenital cardiac surgeons (Jacobs JP, 2009). The ABC score classifies the procedure 
and assigns it a case complexity allowing placement of cases into low-risk or high-risk 
groups, thus enabling researchers to make adjustments based on risk in order to conduct 
outcomes analysis. The ABC score is uniquely created to apply to congenital heart 
surgery, performed almost entirely on infants and children, and has no widespread use 
outside of congenital heart surgery.  
The most widespread and commonly used procedure-specific risk models are 
found in adult cardiac surgery outcomes research. The body of literature on predictive 
modeling is largely composed of studies aiming to predict operative mortality and 
complications after adult cardiac surgery. These studies often use predictive risk models 
created and maintained by the Society of Thoracic Surgeons (STS) and EuroScore. The 
plethora of studies may have resulted from the fact that the STS and EuroScore models 
are available online as a simple-to-use calculator, allowing widespread application. 
Head et al. (2013) performed a systematic review of risk prediction and located 5,768 
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studies modeling outcomes in adult cardiac surgery. They ended up reviewing 844 
studies identifying preoperative independent comorbidities for adverse outcomes after 
adult cardiac surgery. In this review, the authors found many instances of independent 
variables that were found to be predictive of outcomes, but many of these variables were 
not frequently considered in the bulk of the predictive studies. The authors conclude, 
“Risk estimates of mortality, stroke, renal failure and length of stay may be improved by 
the inclusion of additional (non-traditional) innovative comorbidities. Current and future 
databases should consider collecting these variables” (p. 121). What this study 
demonstrates is the need for exploratory modeling to reveal unexpected variables that 
may have predictive strength. These would be what the authors refer to as “innovative” or 
“non-traditional” variables. 
Cagini (2012) discusses what may be considered the traditional variables popular 
in risk prediction in adult cardiac surgery, stating: 
A core set of variables associated with outcomes in cardiothoracic surgery 
have evolved over time. Accuracy of risk models developed based on 
administrative data in New York and Pennsylvania have been shown to be 
substantially improved by addition of a few critical clinical variables. . . . 
One may further question how many variables are actually needed to have 
a robust prediction model (p. 68). 
This quote illustrates that commonly-used predictive variables are empirically 
grounded on past studies, yet accuracy in these studies was improved by adding new 
variables. This raises the question of which variables, exactly, should be added. The 
authors ask, “How many variables are actually needed to have a robust prediction 
model?” (p. 68). The RA exploratory modeling approach is a response to exactly this type 
of question. RA can search through even thousands of variables, and can detect the 
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variables and their relations that are most predictive. However, exploratory results should 
be confirmed with confirmatory tests.  
Cagini (2012) further points out the primary methods used in the thousands of 
adult cardiac outcomes studies. The author determines that logistic regression models are 
the most common method for risk modeling and site comparative studies, demonstrating 
that logistic regression models offer the best overall performance. The author discusses 
potential advances that may be offered by the use of machine-learning techniques 
“as these models permit complex, nonlinear information processing. However, tests of 
these models have not yet shown significant improvement over logistic [. . .] models.” 
Like RA, the neural networks methodology often falls under the more general class of 
methods referred to as machine learning. The literature shows a very limited testing on 
the ability of machine learning to predict better than logistic regression, with studies 
largely falling within the arena of adult cardiac outcomes research (Lippmann, Kukolich 
& Shahian, 1995), (Tu JV, 1998). Lippmann and Shahian (Lippmann RP, 1997) 
compared a neural network model to logistic regression, finding that “a committee 
classifier combining the best neural network and logistic regression provided the best 
model calibration . . .”—suggesting that there is possibly a combination of methods used 
to get best prediction.  
Compared to the thousands of studies conducted in adult and congenital heart 
surgeries, studies conducted in the field of orthopedics are relatively few. Of the 
outcomes studies published in orthopedic journals, the majority look at the effect of 
traditional comorbidities on one or more adverse outcomes. Bjorgul, Novicoff & Saleh 
(2010) discuss this body of literature: 
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There is ample evidence that comorbidity is a major factor in determining 
the outcomes of various conditions, and there is a large body of literature 
discussing the multiple aspects of comorbidity. The general finding is a 
close relationship between comorbidities and complications, mortality, 
functional outcome, and consumption of healthcare resources (Bjorgul 
et al., 2010). 
Comorbidities previously found to be predictive of adverse outcomes include 
obesity (Andrew et al., 2008; Suleiman et al., 2012), diabetes (Bolognesi et al., 2008; 
Berbari et al., 1998; Everhart, Altneu & Calhoun, 2013), hypertension (Memtsoudis 
et al., 2010; Jafari, Huang, Joshi, Parvizi & Hozack, 2010), and age (Polanczyk et al., 
2001; Memtsoudis, González Della Valle, et al., 2010), heart failure, pulmonary issues 
(Bozic et al., 2012; Jain, Guller, Pietrobon, Bond & Higgins, 2005) among others. 
Almost without exception, these studies used logistic regression methods to test a 
hypothesis that a relationship exists between a comorbidity and the outcome of interest. 
Studies that looked at more than one potential comorbidity used multivariable logistic 
regression techniques to see if there was an effect on the outcome from more than one 
comorbidity. This body of literature illustrates the current approach to performing 
retrospective risk prediction in hip and knee replacement, which is limited to using 
previously validated comorbidities in order to predict adverse outcomes. A good portion 
of the literature on outcomes in hip and knee replacement is not focused on adverse 
outcomes at all, but is focused on the functional and general patient-reported health from 
follow-up surveys administered postoperatively and over the years of follow-up visits 
(Caracciolo & Giaquinto, 2005; Gandhi et al., 2010). These studies require data 
collection normally outside of the standard of care, are resource-intensive to collect, and 
require prognostic study design and close monitoring of patients for long-term follow-up. 
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The broad category of adverse outcomes includes not only post-surgical 
complications, but outcomes such as discharge destination, readmissions, length of stay, 
and total cost. These endpoints can all be measured with commonly available 
administrative claims databases, a prerequisite for a simple and widely available risk 
prediction. After hip or knee surgery, a patient may be sent directly home after the 
hospital stay or may be discharged from the hospital directly to an extended care facility 
(ECF). Researchers have looked at the impact of certain comorbidities on the discharge 
destination of patients after hip and knee replacement surgery (Bozic, Wagie, Naessens, 
Berry, & Rubash, 2006; Oldmeadow, McBurney, & Robertson, 2003; Barsoum et al., 
2010.) Munin et al., (1995) looked at the outcome of being discharged to an extended 
care facility (ECF) and found that patients discharged to an ECF had increased 
comorbidities prior to surgery. They developed a logistic regression model that was able 
to predict 76% of the discharges to an ECF. This high predictive ability included not only 
comorbidities, but operative and postoperative data as well. Using post-discharge data to 
calculate risk does not allow for prognostic risk calculation and makes unclear the extent 
to which the patient’s risk played a role relative to the in-hospital processes of care and 
medical complications that patient may have experienced.  
A prolonged length of stay (LOS) is another nonmedical indicator of adverse 
outcomes. Researchers have looked at the impact of certain comorbidities on length of 
stay of patients after hip and knee replacement surgery (Clague et al., 2002; Md, 
Elsharkawy, 2011; Cram, 2011; Polanczyk et al., 2001). Dall et al., (2009) looked at the 
association between various comorbidities and LOS using standard logistic regression 
techniques. Understanding the need for a simple and easily available calculator, the 
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authors discussed the possibility that findings from their research will contribute to the 
creation of a simple scoring system to predict LOS. This study discussed the need to have 
this available as a prognostic tool in order to increase patient flow in the hospital and 
adjust staffing levels based on case mix (Dall et al., 2009). Interestingly, this multivariate 
study found that the day of the week and the surgeon performing the surgery had an 
effect on LOS. Because this information is routinely collected and is easily available in 
claims data, future model development should include these variables alongside the 
patient’s medical comorbidities. Other research has confirmed surgical volume in a given 
hospital as predictive of complications after joint replacement (Schroer, 2008). 
A key opportunity for delivery systems to improve value is by limiting overuse of 
costly resources by focusing these resources on high-risk patient groups (Bates et al., 
2014). Screening patients for relevant comorbidities prior to surgery allows for increased 
medical interventions, which have proven to be successful in decreasing adverse 
outcomes (Meding, 2007). “Estimating the risk of complications when a patient first 
presents to a hospital can be useful for a number of reasons, such as managing staffing 
and bed resources, anticipating the need for a transfer to the appropriate unit, and 
informing overall strategy for managing the patient” (Bates et al., 2014). Radcliff et al. 
(2012) discuss the success of preoperative risk stratification on reducing cardiac and 
thromboembolic complications in elective hip and knee replacement surgery, but point 
out that few studies have been done on non-cardiac medical complications. The authors 
subsequently present a risk stratification tool constructed from comorbidities confirmed 
in previous studies and physician interviews. This study went beyond a demonstration of 
a relationship between comorbidities and non-cardiac complications, but provided a 
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method to increase and measure quality. The researchers in this study compared the 
observed outcomes of patients who were screened against the observed outcomes patients 
who were not screened (Radcliff et al., 2012). If the screened group has better outcomes 
than the group that was not screened, then the screening tool is shown to have a positive 
effect on quality. 
Oldmeadow et al. (2003) developed The Risk Assessment and Predictor Tool 
(RAPT) as a way to simply and easily predict a patient’s risk of requiring discharge to an 
extended care facility (ECF). Initially constructed from a logistic regression model, it was 
subsequently transformed into a simple points-based scoring system that was validated on 
patient populations in its development and applications. The RAPT score places patients 
into one of three risk groups. This score and the subsequent risk group the patient is 
placed in are designed specifically to provide an objective measure of who ought to be 
placed on a home pathway (those with a RAPT score >9) and those who need definite 
rehabilitative care (those with a RAPT score <6) (Dauty, Schmitt, Menu, Rousseau & 
Dubois, 2012).  
A risk calculator developed for total joint arthroplasty predicting discharge to 
skilled nursing facility (SNF) using logistic regression found age, dependent functional 
status, living location, and severity of illness (ASA score) to be predictive of SNF 
discharge (Gholson et al., 2016). However, it is quite well known that the utilization of 
SNF varies by surgeon and hospital location, but no specific studies look at the relative 
predictive effects of patient comorbidities versus provider practice patterns. This research 
project will look at SNF, and test the effects of patient-related versus delivery system 
predictors. 
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Romine, May, Taylor & Chimento (2013) created a total knee replacement risk 
calculator and found it to have predictive value of perioperative complications. This 
evaluation resulted in 19 comorbidities as predictive of “1 or more” complications 
modeled using logistic regression. The inputs for the calculator include the patient’s 
comorbidities, which are necessary for prognostic prediction and can support patient care 
decisions. While Romine et al.’s calculator predicts perioperative complications, 
including complications that occur in the hospital prior to discharge, it also includes 
complications that occur within 14 postoperative days. This post-discharge data is 
problematic in its inherent incompleteness since post-discharge data is available for only 
a fraction of the total population of the surgical cases. Another limitation of this 
calculator is that it was built using Medicare data, and then tested on a more diverse 
population of patients, resulting in an overestimate of complications due to the known 
fact that the Medicare population has a higher incidence of complications (Romine et al., 
2013). Because Medicare datasets are large, well validated, accessible, and comparable to 
other studies using the same data, Medicare data is commonly used. The difficulty in 
more widely applying a model derived from Medicare data points to the need to construct 
a model on data that includes the non-Medicare commercial patient mix as well. That 
being said, this risk calculator fills a void in the field of health outcomes research and is 
considered by Romine et al. (2013) to be: 
the first risk assessment calculator designed specifically for use in total 
joint arthroplasty. Despite limitations of our study design, and the lower 
than predicted complication rate, the TKA [total knee replacement] risk 
calculator represents the novel development of an objective risk 
assessment tool that does have predictive value, and is a tangible risk 
assessment device….Physicians may use the calculator to provide more 
individualized patient counseling and to better stratify risk. (p. 448). 
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Researchers at the Mayo Clinic developed a prognostic scoring system that 
identifies patients at high risk of developing a postoperative infection after total hip or 
knee replacement surgery (Berbari et al., 2012). The purpose of this risk score is for 
improved risk-stratified reporting and to target high-risk patients for additional 
preventative interventions. The Mayo model identified single predicting factors for 
prosthetic joint infection (PJI). Logistic regression was used to determine the magnitude 
of each of these associations and then combined into multivariable modeling with logistic 
regression to determine if there was a pairwise effect between two factors on the risk of 
infection. Current surgical site infection (SSI) models only take into consideration the 
patient’s American Society of Anesthesiologists (ASA) physical status classification 
system score; however, the Mayo study has shown that better risk stratification occurs 
with inclusion of additional important predictors such as BMI, prior arthroplasty, 
underlying immunosuppression, and prior surgery (Berbari et al., 2012). The authors 
discuss the importance of accurately accounting for risk, and appropriate risk adjustment 
will “assure tertiary referral institutions and specialty orthopedic institutions involved in 
the care of high-risk patients of their ability to perform surgeries on high-risk patients 
without the fear of being penalized for their relatively higher SSI rates” (p. 779). A 
limitation of the Mayo model is that in order to calculate a one-month score, data is 
needed from the preoperative, operative and one-month postoperative time frame. This 
postoperative information is critical in analyzing infection, as many surgical infections do 
not set in until the postoperative period. Postoperative data is limited only to those 
patients that returned to the same facility, or same hospital system if a common electronic 
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health record (EHR) system is used. Unless patients are being followed as part of the 
protocol for a clinical research study, then it is very difficult to achieve accurate 
postoperative patient information. The Mayo study may not easily be reproduced because 
patients were followed as part of a research study protocol, something that does not 
normally occur in the standard delivery of care for patients undergoing surgery. 
Furthermore, while the factors selected as candidates for the model indeed turned up 
predictive factors for infection, the question remains whether there are variables that were 
not included that would have increased the predictive strength of these factors. These 
non-traditional variables would not have appeared in the initial search of highly 
predictive individual factors, and may only be predictive in their relation to another 
factor.  
Hospital readmissions are a substantial driver of spending, with all-cause 30-day 
readmissions costing the US health system more than $41 billion annually (Hines Al, 
Barrett Ml, Jiang Hj & Steiner Ca, 2011). An application of machine learning techniques 
has resulted in the highly successful PIECESTM software (Amarasingham, 2012). 
PIECES functions on top of a health system’s EMR, identifying high-risk patients using a 
machine learning approach. Patients at high risk for readmission are flagged based on 
both social and clinical factors found in the patient’s chart. This model was implemented 
in a hospital, where clinical care was tailored for flagged patients, resulting in a 31% 
reduction in readmissions. 
With bigger data and new techniques for structuring data, disparate data sources 
will have opportunities to merge into vast repositories. The possibility of more predictive 
models, and the emergence of “data science” programs within healthcare systems, are 
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leading to increased testing of machine learning techniques. While LR will likely 
continue to be a very well performing method, exploration of new methods with the 
ability to search through expansive data repositories is an effort that may have significant 
payoffs when seeking to predict outcomes and custom tailor healthcare delivery in the 
pursuit of higher value care. 
General Overview of LR and its Relation to RA 
Hosmer and Lemeshow (2005) provide an overview of logistic regression (LR) 
models and discuss the recent explosion in the use of LR over the past decade. They state 
that from its origination in epidemiological research, LR has gained widespread use and 
acceptance in biomedical research. LR is typically used to analyze relationships between 
a dichotomous dependent variable and categorical or continuous independent variables. 
LR combines the independent variables to estimate the probability that a particular 
outcome will occur. For example, if we assume that Z represents the adverse outcome 
complication, we can create a formula in terms of the probability that a complication 
occurs, or Z = 1, shown below as p(Z1), and the probability that no complication occurs, 




) =   α0 +  α1A +  α2B +  α3C 
There are areas of overlap between RA and LR. For example, when nominal 
variable states in RA are re-coded into binary states, RA does resemble LR. Zwick (2011) 
points out that whether or to what degree the two methods are mathematically equivalent 
is under investigation. Regardless of the potential mathematical overlap however, RA is 
computationally distinct. LR maximizes likelihood most often with the Newton-Raphson 
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algorithm, while RA uses Iterative Proportional Fitting (IPF) to maximize entropy subject 
to the constraints of the data. LR software is not designed for exploratory modeling and 
does not easily handle interactions between multiple variables. Because of this, RA is 
distinctly useful for searching for novel variables and interaction effects. LR does not 
generate the lattice of structures nor provide an approach for searching this lattice 
(Zwick, 2011a). Unlike LR, but like ordinary regression, RA can also analyze continuous 
dependent variables such as total cost of hip or knee replacement surgery. 
An Overview of RA 
Almost without exception, the studies surveyed in the review of the literature 
generated models using logistic regression methods. While the models were well 
constructed and tested, there is a trend in the discussions of prior studies urging further 
testing and validation. One way to validate models is to use a different methodology on 
similar data and compare the outcomes. 
A model developed with RA will not only be an interesting test of comparison of 
methods, but will test whether additional variables may provide more predictive strength 
or whether non-hypothesized interaction effects offer additional predictive strength. For 
example, prior studies using logistic regression had found that APOE was a highly 
predictive genetic factor of Alzheimer’s disease. RA and Alzheimer researchers (Kramer, 
Westaway, Zwick & Shervais, 2012) conducted a study using RA which confirmed the 
gene APOE as highly predictive. However, RA has tentatively surfaced an additional 
factor—Education—which, when interacting with APOE, generates a model that is more 
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predictive than APOE or Education alone. This study looks at the questions of whether 
there is something similar in total hip and knee replacement surgery. 
It can be difficult to visualize what modeling actually does, especially when 
thinking about the differences between specific modeling methodologies. In the broadest 
terms, a model is intended to represent reality so as to explain, predict, or control features 
of that reality which otherwise would be too difficult to observe or manage (Krippendorff 
1981). In order to construct a model, data is collected to capture information about a 
system. Yet this data is inherently very complex, with many degrees of freedom. Using 
the data directly for prediction is likely to be flawed by overfitting, the postulation of 
predictive relations that may not be real. A model is a reduction of the data to a simpler 
structure, and simpler structures generalize better to new data. However, simplifying the 
data too much will result in a loss of critical information. This presents a tension inherent 
in the modeling process.  
The most common RA approach to modeling is to start with the independence 
model—which assumes no predictive relations between the IVs and DV—as a reference, 
and to then search the space of possible models for incremental additions of predictive 
relations. In RA, this bottom-up approach allows one to construct a model whose 
complexity is statistically justified, but is still not overly complex. 
RA developed from the early works of Ross Ashby (1964), who defined a process 
for systematically testing whether a seemingly complex constraint could be decomposed 
into several simpler constraints and then be recomposed to the original constraint without 
loss. Ashby utilized Shannon’s information theory (Shannon, 1948) because it 
generalized his constraint analysis to probabilistic systems and allowed for the creation of 
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an algebra of relations (Krippendorff, 2009). RA was then further developed by Broekstra 
(1979), Cavallo (1979), Conant (1981), Jones (1985), Klir (1976), Krippendorff (1981), 
Zwick (2001), and others. 
RA assesses hyper-graph structures using either set theoretic (SRA) or 
information theoretic (IRA) modeling. RA is a data mining method that searches for 
relations in data, especially nonlinear and higher-order relations. These relations between 
the variables in the data can have high ordinality, and one need not assume any 
hypothetical relationship prior to RA. For example, in a study applying RA to genomic 
data, researchers found that RA can detect gene-gene interactions that other methods 
could not detect (Shervais, Kramer, Westaway, Cox & Zwick, 2010). 
RA resembles log-linear statistical methods in the social sciences, and has diverse 
applications including time-series analysis, classification, decomposition, compression, 
pattern recognition, prediction, control, and decision analysis (Zwick, 2004). RA handles 
multivariate data with discrete values for nominal variables. Continuous data can be 
handled by discretizing (binning) into discrete binary or multi-valued states. There are 
multiple methods for binning data (e.g., rational binning, obvious clustering, and equal 
sample size). The more states of an IV, the better it can predict the outcome, but the 
number of states of a variable increases the sample size required, and a trade-off is 
necessary. 
In this study, the information-theoretic (IRA) version is used. IRA turns input data 
into frequency and probability distributions. IRA decomposes frequency distributions 
into projections, several of which taken together define a model, which is then assessed 
for statistical significance. The model maximizes entropy subject to the constraints of the 
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model structure. Maximum entropy solutions are often identical to maximum likelihood 
solutions of other methods. 
A “saturated model” represents the data without simplification and assumes the 
highest ordinality of relations amongst the variables. The “independence model” is the 
least complex of all models and assumes no predictive relations between the IVs and the 
DV. For example, a system with three IVs and one DV may be represented as ABCZ (the 
saturated model), where A, B, and C are the IVs and Z is the DV. No interaction between 
the IVs and the DVs is called the independence model and would here be characterized 
by the model ABC:Z. The model ABC:Z is the simplest model possible and signifies that 
the DV is not predicted by the IVs. Another possible model of the data ABCZ might be 
ABC:AZ:BZ:CZ where A, B, and C again are the independent variables and Z is the 
dependent variable. In the model ABC:AZ:BZ:CZ, A has an effect on Z, B has an effect 
on Z, and C has an effect on Z, but there is no interaction effect between the independent 
variables A, B, and C. In the independence model ABC:Z there are no relations between 
the IVs and the DV at all, so this model may be said to contain no information. The DV 
has maximum uncertainty. As used for prediction, an RA model is a conditional 
probability distribution of the DV, given the IVs. In the present case, for example, this 
might be expressed as Pmodel (Zl | AiBjCh). 
With four variables, as in the example ABCZ, multiple relations are possible. 
Each of these possible relations is a structure, without concern for order within or 
between the relations. There are 19 specific structures for three IVs and one DV. The 
lattice of structures for four variables is presented in Figure 1 below where the variables 
are lines and the relations are boxes. Increasing the number of IVs to four results in 167 
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specific structures, and increasing the number of IVs to five results in 7,580 specific 
structures. Data with hundreds of possible IVs will generate a massive lattice of 
structures. In this study, RA will search through the lattice of structures until it finds IVs 
that are informative about the probability of a specific outcome. 
 
Figure 1.  Lattice of structures for 3 IVs and 1 DV. 
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Continuing with the previous example, assume ABC:Z is the independence model 
for a directed system. The independence model will be the starting model (assuming 
no relations), and an ascending search will be performed, looking for models through the 
lattice of structures until difference from independence model and each increase in 
complexity are not statistically significant. For example, one of the possible model 
structures in this example search is model ABC:ABZ:CZ. In this model, the A and B 
variables in the (ABZ) component represent an interaction effect. Every interaction effect 
will be investigated further to interpret how the input variables combine to predict the 
output variable. 
Looking at multiple models relative to each other offers choices based on 
predictive strength versus simplicity. Maximally predictive models may be traded in for a 
simpler, less predictive model. Models that yield high information also are complex and 
have high degrees of freedom relative to models with less complex structures containing 
less information and lower degrees of freedom. The “best model” is often somewhere in 
the middle since overly complex models will do poorly when confronted with new data; 
this is known as “overfitting.”  
To avoid overfitting, a good model will capture a maximum amount of the 
information (the constraint) in the data while still being as simple as possible. After the 
best models are obtained through an exploratory search, the actual contents of this 
model—how it predicts the DV given the IV states—must be examined in detail. In 
Occam, the RA software used in this project, this latter detailed examination is called 
“fit,” to be distinguished from the first step which is called “search.” Several RA software 
applications exist, such as the Construct and Spectral applications (Krippendorff, 1981), 
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SAPS (Cellier & Yandell, 1987, Klir (1976), EDA (Conant, 1988) and Occam (Zwick, 
2000). For this project, the third version of the Occam software application is used, 
Occam3 (Willett & Zwick, 2004). 
Another approach is available which is finer-grained than the variable-based 
models previously described (Figure 2). Jones (1989) looked at systems in terms of states 
instead of variables. In variable-based RA, the structures are subsets of ABC:Z while in 
state-based RA, structures specify particular states of one or more variables. In the 
example of ABC:Z, where the component ABC does not predict Z, it may still be that a 
combination of specific states of A, B and C do in fact predict Z where the model may be 
depicted as ABC:Z:A1B1C1Z. This more detailed, and in principle more powerful, 
analysis can be done using state-based RA (Zwick & Johnson, 2004).  
Two levels of refinement in RA will be used in this study: variable-based RA 
without loops and variable-based RA with loops. The more refined the approach, the 
more predictive the model may be. It is possible that a more predictive fine-grained 
model will not have greater complexity (i.e., degrees of freedom) than the coarser-
grained variable-based models. These levels will be discussed in greater detail in the 
methodology chapter. 
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Figure 2.  Levels of refinement in RA. 
 
There are different criteria that can be used for model selection. In this project, 
Akaike Information Criterion (AIC) and Bayesian Information Criterion (BIC) are both 
used. AIC is a measure of the goodness of fit of a model that trades off the complexity of 
an estimated model against how much of the information in the data the model captures. 
BIC is a slightly different way of doing the same thing. BIC is more conservative than 
AIC and is thus generally preferred over AIC for selecting the best model. Another 
measure that will be considered when assessing the quality of a model is its information 
content. In RA, information is a measure of the constraint captured in a model. Since the 
data always contains 100% information, and models of the data decompose the relations 
into smaller components, one must test how far the data can be decomposed while still 
holding onto enough information to be predictive. While information is scaled from 0–1, 
the percent reduction of uncertainty of the dependent variable, represented as %ΔH(DV), 
is the actual reduction of uncertainty achieved by any model and is the actual predictive 
power of the model. The information measure indicates how much of the information in 
the data is incorporated into the model, yet the information in the data itself can be small 
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or large. This uncertainty reduction measure is calculated by multiplying the information 
content with the percent reduction of uncertainty of the data. For directed systems, the 
ability to quantify how predictable the outcome is, given the presence or absence of IVs, 
is expressed as the reduction of the entropy of Z (outcome), knowing A, B and C (3 IVs). 
For IRA, entropy reduction is derived from the conditional probability distribution of the 
model. Both information and entropy reduction measures do not involve a sample size 
and are therefore themselves non-statistical (Zwick, 2011a). The reduction in uncertainty 
is a central measure of RA and something that is not possible with other methods. 
A third criterion, the incremental p-value, will supplement AIC and BIC in order 
to select the model that reduces uncertainty the most, from which every incremental step 
from the independence model has an acceptable p-value. Knowing the sample size 
provides for the calculation of the likelihood ratio test (chi-squared, or 2), which then 
allows the researcher to determine the p-value for entropy reduction, relative to either 
independence or some other simpler model as reference. This is one of the measures that 
is used when assessing the trade-off between information and complexity in model 
selection (Zwick, 2011a). This p-value is the probability, if one has rejected the null 
hypothesis (that the model is the same as the reference model), that one is incorrect in 
that rejection. This project will apply RA using the independence model as the reference, 
where smaller p-values are preferred. As the search continues, new reference models are 
generated and an incremental p-value will show the statistical significance at each step 
through the lattice of possible model structures (Zwick, 2004). 
In this project, the lattice of all possible models will be searched using a 
bottom-up approach where the reference model is the independence model. With the 
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independence model as the reference, the search up the lattice of structures is an attempt 
to see if the data justifies a model with more complexity (degrees of freedom) than the 
independence model. Additionally, many types of models may be assessed in Occam, 
depending on the specification of search parameters. Going up the lattice, RA generates 
“parents” of the models at each level in the lattice of structures. A search “width” can be 
specified, which restricts the number of models retained at each level in the lattice. The 
maximum number of levels to be searched can also be specified, using the search “levels” 
parameter.  
The literature shows that RA has been validated as a supplementary method, 
strengthening research when used concurrently with other methods. A problem identified 
by researchers of the Neural Networks (NNs) methodology is that NNs are often applied 
on data without knowing what variables are the most valuable as inputs to the NN model, 
thus resulting in overly complex models. For example, Chambless, Lendaris, and Zwick 
(2001) applied RA to data and successfully “prestructured” the data, picking out the most 
important and predictive variables to reduce the neural network’s complexity  without 
significant loss of predictive accuracy. Cangur (2009) used RA as a method to augment 
LR in forecasting mortgage loan statuses. In this study, Cangur was able to improve on 
what had previously been known to be predictive of mortgage delinquencies, 
prepayments, defaults, and losses by detecting additional states as well as interaction 
effects. These interaction effects improved the accuracy of LR models used in the field of 
loan forecasting. Carletti (2004) generated an RA model that detects complex interactions 
and predicts health status more effectively than multiple linear regression. Carletti used 
state-based RA, surfacing literacy level in combination with occupational status and 
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intensity of performing strenuous activities as predictive of health status. Mist (2007) also 
has augmented LR with RA in an application predicting a Chinese Medicine diagnosis 
from patient pre-treatment questionnaires. In this study, both variable-based and state-
based RA were used and interaction effects found. These interaction terms were then 
introduced into a previously constructed LR model, resulting in an improvement of 
prediction for three of the most common Chinese Medicine diagnoses. 
What this literature demonstrates is that RA can do more than offer a 
confirmatory role in validating the results of previous studies; it can provide a 
complimentary approach to other methods, using multiple methods in tandem to 
strengthen each other. Furthermore, the past studies discussed in this review of the 
literature have shown that RA provided novel and valuable predictions undetected by the 
more standard and common statistical modeling techniques, and can be valuable as a 
stand-alone exploratory method. 
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Chapter 3. Methods  
This chapter starts with an overview of the data and provides the definitions of the 
independent and dependent variables used in this project. Procedural descriptions are 
provided describing how the data was transformed into the format used in the data 
analysis. After this overview of the data, the LR and the RA methods as applied in this 
project are described, as well as explanations of additional calculations used to augment 
the core methodologies. 
The Data 
Data used in this study derives from patients who underwent inpatient surgical 
procedures of either total hip replacement or total knee replacement at one of seven 
inpatient hospitals within an integrated healthcare system in a single state. Participant 
data consists of both hospital billing data and electronic health record system clinical 
data. Clinical and cost data were matched on the patient’s episode identifier, then 
de-identified and transformed into the variables used in this research project. This project 
has been granted exempt status from the Portland State University Institutional Review 
Board. 
Effective October 1, 2007, the hospital Uniform Bill (UB) requires hospital 
claims data to include a present on admit (POA) indicator for each diagnosis field. 
Diagnosis fields are represented by codes called the International Classification of 
Diseases, Ninth Revision (ICD-9). ICD-9 codes are created by the World Health 
Organization, and are the official classification system for surgical, diagnostic, and 
therapeutic procedures. In this project, ICD-9 codes are used to classify the procedure of 
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an elective total hip replacement (ICD-9 code 81.51) or an elective total knee 
replacement procedure (81.54). ICD-9 codes are also used in this project to classify the 
Comorbidity IVs and the DV Complication occurring for each hip and knee procedure.  
The data was divided into two data sets based on procedure type. The resulting 
knee data set and hip data set share the same variables, with some differences in 
comorbidities present. There were 3,205 cases in the hip data set, and 4,336 cases in the 
knee data set. Because the administrative claims database includes variables that are 
collected in diverse health systems across the nation, the resulting predictive models 
developed in this project have the potential for widespread use. 
Multiple analyses were conducted in this project, and two combinations of 
independent variables were assessed: All IVs and Comorbidity IVs. All IVs include the 
patient Comorbidity IVs as well as Non-Comorbidity IVs. 
Comorbidity IVs 
Diagnosis ICD-9 codes and corresponding POA status and rank were merged in 
order to create the set of Comorbidity IVs. If a diagnosis code appeared as present on 
admit and rank equaled 1, this was the primary diagnosis and was not included as a 
comorbidity. For example, it is common to see osteoarthritis as the diagnosis POA with 
rank = 1. If a diagnosis code was present on admit with a rank > 1, then this was 
considered to be a comorbidity. Each comorbidity present in the data was then turned into 
a binary variable with the possible states of present (1) or absent (0). If a diagnosis code 
was present in the data but was not present on admit, then this ICD-9 diagnosis code 
indicates a complication and was mapped into a complication grouping schema. 
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There were 912 individual comorbidity independent variables (Table 103). While 
the RA method can in principle utilize this many IVs, the data set would need to have a 
much larger sample size if one wanted to detect interaction effects involving very many 
IVs. 
In the hip data set, 643 of 912 comorbidities occurred in at least 1 of the 3,205 
cases, and 270 of these comorbidities were not present in any of the cases. There is a 
chi-squared rule of thumb that argues for a minimal average cell count of at least 5. There 
were 473 comorbidities that occurred in < 5 cases and 170 comorbidities that occurred in 
5–1464 cases (the comorbidity that showed up in 1,464 cases was essential hypertension). 
The final culled hip data set included 3,205 cases with these 170 Comorbidity IVs.  
In the knee data set, 671 of the 912 comorbidities were present in at least 1 case. 
Using the same rationale as the hip data set, the 483 Comorbidity IVs that were present in 
< 5 cases were removed, reducing the total number of Comorbidity IVs to 188 that 
occurred in 5–2,373 cases (the comorbidity essential hypertension showed up in 2,373 
cases). Thus the final knee data set contained 4,336 cases with these 188 Comorbidity 
IVs. 
The independent variable called number of risks (Nrb) is tallied by adding up any 
of the 912 Comorbidity IVs that are indicated as present on admit. While the full 912 IVs 
are not used in either data set, the Nrb variable in fact is dependent on the presence or 
absence one or many of the original 912 Comorbidity IVs. In other words, it was 
“possible” for the total number of risks for a patient to equal 912, even though fewer than 
200 comorbidities were retained in the hip and knee data sets. Table 1 shows a sample 
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subset of the individual patient Comorbidity IVs. A full list of Comorbidity IVs is 
available in Table 103. 
Table 1.  Subset of Comorbidity IVs (Comorbidity IVs from Tier 1 Predictors). 
ID IV Name 
Rhd Other chronic pulmonary heart diseases 
Ruh Other and unspecified hyperlipidemia 
Rrd Unspecified hypertensive renal disease 
Rgp Repair of cystocele with graft or prosthesis 
Rug Unspecified glaucoma 
Rca Coronary atherosclerosis of native coronary artery 
Rku Chronic kidney disease, unspecified 
Rci Chronic ischemic heart disease 
Rhf Heart failure 
Rcj Contracture of joint, lower leg 
Rco Chronic obstructive asthma 
Rmd Other persistent mental disorders due to conditions classified elsewhere 
Rpl Hyperplasia of prostate 
 
Non-Comorbidity IVs 
An additional eight independent variables were included that represent, 
non-binary patient risk factors (age, number of risks, and admit diagnosis) as well as 
variables suggested as important variables in the literature (Dall et al., 2009; Schroer 
WC, 2008) describing the delivery system (location, surgeon, surgeon volume, financial 
class, and day of admission).  
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Table 2.  Subset of All IVs: Non-Comorbidity Variable Descriptions and IDs. 
All IVs       
Non-Comorbidity 
IVs Variable Description (Knee) Variable Description (Hip) ID 
Location, 
multivalued 
Location documented as 1 of 7 
inpatient hospitals within a single 




One of 64 primary attending 
physicians as determined in the 
patient's medical chart  
Same as Knee, except 43 primary 
attending physicians  S 
Surgeon Volume, 
Continuous 
Total number of procedures per 
surgeon over the entire time period 
in the data set. Surgeon total volume 
ranged from 1 - 1,449 cases. 
Same as Knee, except volume 








Surgeon volume counts were binned 
into 12 equal sample sized bins, 
then rebinned into 3 bins:  
[1(1,2,3,4);2(5,6,7,8);3(9,10,11,12)] 
Surgeon volume counts were 
binned into 10 equal sample sized 
bins, then rebinned into 3 bins:  
[1(1,2,3,4);2(5,6,7);3(8,9,10)] Svb 
Day of Admit, 
multivalued 
Monday (1), Tuesday (2), 
Wednesday (3), Thursday (4), or 
Friday (5) 
Monday (1), Tuesday (2), 
Wednesday (3), Thursday (4), or 
Friday (5), Saturday (6) Da 
Financial Class, 
multivalued 
Medicare (1), Commercial (2), 
Medicaid (3), Workers Comp (4), 
Other Government (5), Self or Other 
(6)  Same as Knee  Fc 
Age, continuous 
Patient age at time of admission to 
hospital. Age ranges from 32-94 
years old.  
Same as Knee, except Age ranges 







Data was first binned into 12 equal 
sample size bins, then re-binned into 
3 equal size bins as follows: 
[1(1,2,3,4);2(5,6,7,8);3(9,10,11,12)] Same as Knee Ageb 
Admit Diagnosis, 
multivalued 
This is the primary (coded) 
diagnosis present on admit.  Same as Knee  Ad 
Number of Risks, 
continuous 
Individual diagnosis codes coded as 
present on admit = Y. Total number 
of risks per case ranged from 0 to 
18.  
Same as Knee, except risks per case 






Number of Risks, 
binned 
Number of risks were binned into 8 
equal sample sized bins, then 
rebinned into 3 equal sample size 
bins as follows: 
[1(1,2);2(3,4);3(5,6,7,8)] Same as Knee Nrb 
This project uses de-identified data and does not use or disclose specific names of 
these variables. Location or surgeon names, in combination with other variables, could be 
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used to identify a patient and can be considered protected health information (HIPAA, 
2009). 
Binning Continuous IVs 
Not only are there different sets of individual patient comorbidities present in the 
hip and knee populations, but the average age for knee patients is higher at 67.1 years 
versus 64.72 years for hip. The knee patients had an average of 3 patient comorbidities, 
while the hip patients averaged 2.81. Due to the differences in hip and knee populations, 
binning of the IVs was performed independently per data set. The independent variables 
age (Age), surgeon volume (Sv), and number of risks (Nr) were continuous variables that 
were discretized into the binned variables Ageb, Svb, and Nrb. These IVs were divided 
into three equal sample-sized bins, which will allow for the detection of nonlinear effects, 
within the hip data set, and then again in the knee data set as shown in Table 3 below. 
Table 3. Binned IVs for the Continuous Variables: 
Number of Risks, Age, and Surgeon Volume. 
Number of Risks Binned (Nrb) 
Knee Hip 
Bin Range Frequency Bin Range Frequency 
1 0-1 1309 1 0-1 1,111 
2 2-3 1474 2 2-3  1,081 
3 4-18 1553 3 4-19 1,013 
Age Binned (Ageb) 
Knee Hip 
Bin Range Frequency Bin Range Frequency 
1 32-62 1,490 1 15-59 1,090 
2 63-71 1,411 2 60-69 1,027 
3 72-95 1,435 3 70-96 1,088 
Surgeon Volume Binned (Svb) 
Knee Hip 
Bin Range Frequency Bin Range Frequency 
1 1-479 1,444 1 1-461 1,067 
2 550-922 1,518 2 479-778 761 
3 987-1449 1,374 3 779-1191 1,377 
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The primary purpose of the age variable in this project is to determine whether 
age has an effect at all. The standard practice to test if an IV is predictive is to use 
uniformly sampled bins. The more uniform an IV distribution is, the more predictive or 
explanatory it can be. So the question asked in this dissertation is whether age makes a 
difference. A subsequent question, not pursued in this project, could be to look at whether 
using bin definitions more common in the field (e.g., binning age by non-enrollment or 
enrollment in Medicare) might provide more useful or enhanced predictions. 
Dependent Variables (DVs) 
Four DVs were constructed for this project and are summarized below in Table 4. 
These DVs include adverse events Complication and Readmissions, and high cost 
indicators of Skilled Nursing Facility discharges and Total Cost. 
Table 4. Description of the Original Dependent Variables 
and Subsequent Transformed (binned) Final Dependent Variables. 
Dependent 
Variables (DVs): Variable Description (Knee) Variable Description (Hip) ID 
Complication 
Any (coded) diagnosis that was not 
present on admit.  
Same as Knee.  Cp 
Discharge 
Disposition 
Home Self (1), SNF (2), Home 
Health (3), Swing Bed (4), IP 
Rehab (5), ICF (6), Short Hospital 
(7), Expired (8), AMA (9) 








No SNF = 1, SNF = 2 
[1(1,3,4,5,6,7,8,9);2(2)] 





(within 90 days) 
Readmission (Yes/No) according to 
Premier inpatient quality reporting 
system. There were 113 total 
readmissions within 90 days to the 
same hospital as original surgery. 
Same as Knee, except 87 total 
readmissions within 90 days to the 




Hospital costed “total cost per 
case.” Range $5,945 - $96,880 per 
case.  
Same as Knee, except Range 






Total Cost was binned first into 12 
equal sample sized bins, then 
rebinned into 3 bins as follows: 
[1(1,2,3,4);2(5,6,7,8);3(9,10,11,12)] 
Same as Knee Tcb 
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The DV Complication, represented by the ID “Cp” (Table 4) was created by 
looking at the ICD-9 diagnosis codes with a POA indicator of 0, indicating the diagnosis 
was acquired after admission to the hospital. The knee data set contained 913 individual 
complications across 205 cases. The complication rate for the knee data set is then 
205/4336 or 4.7%. In the hip data set, there were 790 complications present across 164 
cases with a rate of 5.2%. 
The Skilled Nursing Facility (SNF) DV is constructed from the discharge 
disposition filed in the administrative database. There are nine possible discharge 
locations in the data: home health, skilled nursing facility (SNF), home self-care, 
inpatient rehab, swing bed, short term hospital, intermediate care facility (ICF), expired, 
and AMA (knee only). If the discharge location was SNF, then the DV SNF was assigned 
a 2. If the discharge location was any of the other locations, the value of the DV was 
assigned a 1. In the knee data, 17.6% of patients were discharged to a SNF and 14.3% of 
hip patients were discharged to a SNF. 
The Readmission DV is reported out of a nationally standardized quality reporting 
database called Premier. Premier utilizes a methodology for counting related 
readmissions. Premier is a common quality reporting system for hospitals across the 
nation and therefore provides reproducible analysis for readmissions (Grosso, 2012). 
While easily reproducible, this methodology of counting readmissions is limited in that it 
is counting only readmissions to an inpatient stay at the same hospital as discharge and 
therefore does not include visits to the ED or admissions to a different inpatient hospital 
than originally discharged from. For this project’s Readmission DV, if a patient had one 
or more readmissions within 90 days to the same hospital as discharge, then this case was 
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assigned a 1. If no readmission was detected, then the case was assigned a 0. This method 
results in many fewer readmissions counted and a very sparse DV with 2.6% of knee 
patients readmitted within 90 days from discharge and 2.7% of hip patients. Premier is 
adopting a new readmission methodology which will look across inpatient hospitals. In 
this new method, it will be possible to count readmissions that occurred at locations 
different from the discharging location. 
Binning the Total Cost DV and Calculating Expected Values 
Total Cost is a continuous DV with dollar amounts that ranged from $8,553 to 
$96,880. There was an average Total Cost of $18,502 in the knee data, and a range of 
$11,147 to $71,264, with an average of $18,593, in the hip data. Total Cost was binned 
into three equal sample-size bins (low, medium, high).  
Table 5. Binned IV (Tcb) for Total Cost Variable. 
Knee, Total Cost Binned (Tcb) 
Bin Min Cost Max Cost Average Cost Frequency 
1 $8,553 $16,780 $15,269 1446 
2 $16,781 $19,139 $17,922 1445 
3 $19,140 $96,880 $22,318 1445 
Hip, Total Cost Binned (Tcb) 
Bin Min Cost Max Cost Average Cost Frequency 
1 $11,147  $16,768  $15,244  1068 
2 $16,772  $19,192  $17,997  1069 
3 $19,195  $71,264  $22,534  1068 
 
Each of these bins has an average cost, and along with the product of the 
probabilities of each bin, an expected value is calculated and used in the interpretation of 
the results for the Total Cost DV. Binning the DV in this way is referred to as 
“b-systems” analysis, where continuous values are derived from a binned DV (Zwick, 
Fusion, & Wilmot). The model’s conditional probability distribution includes the 
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calculated probability of each of the model’s IV states for the low-cost (bin 1), mid-cost 
(bin 2), and high cost (bin 3) bins. The product of the probabilities of each bin and each 
bin’s average Total Cost was used to calculate an Expected Value (predicted Total Cost) 
for each IV state: 
𝐸𝑥𝑝𝑒𝑐𝑡𝑒𝑑 𝑉𝑎𝑙𝑢𝑒 =  
𝑝(Tcb1) × 𝐴𝑣𝑔(Bin1) + 𝑝(Tcb2) × 𝐴𝑣𝑔(Bin2) + 𝑝(Tcb3) × 𝐴𝑣𝑔(Bin3)
100
  
Associations between the DVs 
A preliminary analyses was performed looking at the amount of uncertainty 
reduced for each of the DVs, given the other DVs (set as IVs). There is some association 
between the DVs. For example, in the knee data set, Total Cost (Tcb) reduces the 
uncertainty (ΔH) of Complication (Cp) by 8.67% (Table 6). 
Table 6. Association of DVs by %ΔH in Knee Data Set 
Complication (Cp) 
MODEL Δdf ΔBIC %ΔH 
Tcb Cp 2 125.95 8.67 
SNF Cp 1 47.93 3.42 
Re Cp 1 0.38 0.53 
Skilled Nursing (SNF) 
Tcb SNF 2 119.75 3.39 
Cp SNF 1 47.93 1.40 
Re SNF 1 12.78 0.53 
Readmission (Re) 
Tcb Re 2 6.02 2.17 
SNF Re 1 12.78 2.02 
Cp Re 1 0.38 0.84 
Total Cost (Tcb) 
Cp Tcb 2 125.95 1.50 
SNF Tcb 2 119.75 1.43 
Re Tcb 2 6.02 0.24 
 
In the hip data set, Total Cost (Tcb) also has an association with Complication 
(Cp) with a %ΔH of 7.93, and with Skilled Nursing Facility (SNF) with a %ΔH of 7.37 
(Table 7). 
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Table 7. Association of DVs by %ΔH in Hip Data Set 
Complication (Cp) 
MODEL Δdf ΔBIC %ΔH 
Tcb Cp 2 85.57 7.93 
SNF Cp 1 27.50 2.77 
Re Cp 1 -6.65 0.11 
Skilled Nursing (SNF) 
Tcb SNF 2 176.61 7.37 
Cp SNF 1 27.50 1.36 
Re SNF 1 -6.17 0.07 
Readmission (Re) 
Tcb Re 2 -0.91 1.91 
SNF Re 1 -6.17 0.24 
Cp Re 1 -6.65 0.18 
Total Cost (Tcb) 
SNF Tcb 2 176.61 2.74 
Cp Tcb 2 85.57 1.45 
Re Tcb 2 -0.91 0.22 
 
Formatting Files for Input into Occam Software 
The data files were transformed into a format accepted by the Occam software. 
These Occam input files specify the variables and include the data to be analyzed. The 
data file is a plain-text ASCII file saved in a “.txt” format. Initial input files were created 
for both hip and knee separately. The All IVs and the DVs looked the same; however, the 
specifications of the Comorbidities are different, as the data sets have different sets of 
Comorbidity IVs and of course the data itself is different in each. Below is an example of 
one of the input files. After the variable name, the first number indicates the cardinality 
(number of states) of the variable (e.g., there are 7 Location states); the second number is 
1 for an IV, 2 for a DV, and 0 for “ignore this variable”; the third string of characters is a 
short name for the variable; for some variables, a rebinning string specifies aggregation 
of multiple states into fewer rebinned states (e.g., for Age binned, previous bins 1,2,3,4 
are collapsed into new bin 1). 
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Table 8. Example of an Input File for Occam. 
:nominal 
     Location ,7,1,l 
    Principal Surgeon ,43,1,s 
    Day of admit ,6,1,da 
    Financial Class ,6,1,fc 
    Age binned ,12,1,ageb, [1(1,2,3,4);2(5,6,7,8);3(9,10,11,12)] 
Surgeon Volume Binned ,10,1,svb,  [1(1,2,3,4);2(5,6,7);3(8,9,10)] 
 Admit Diagnosis ,39,1,ad 
    Number of Risks Binned ,7,1,nrb,  [1(1,2);2(3,4);3(5,6,7)] 
 Complication  ,2,2,cp 
    Skilled Nursing Facility ,8,0,dd,  [1(1,3,4,5,6,7,8);2(2)] 
  Total Cost Binned ,12,0,tcb 
    Readmission 90 Days 
     RISK_185 ,2,1,Rnp 
    RISK_238.75 ,2,1,Rmp 
    RISK_244 ,2,1,Rh 
    RISK_255.41 ,2,1,Rgd 
    RISK_266.2 ,2,1,Rbc 
    RISK_268.2 ,2,1,Rou 
    RISK_268.9 ,2,1,Rvd 
    RISK_272 ,2,1,Rli 
    
      :no-frequency  
 
:data 
     #nrb cp Rnp Rmp Rh Rhy 
6 1 0 0 0 0 
1 0 0 0 0 0 
2 0 0 0 0 0 
3 0 0 0 0 0 
5 0 0 0 0 0 
7 0 0 0 0 0 
1 0 0 0 0 0 
4 0 0 0 0 0 
 
Variable Reduction per DV 
As discussed above, the criterion of occurrence in at least five cases was used to 
reduce the IVs to188 in the knee data and 170 in the hip data. Preliminary analyses 
indicated that a further reduction of IVs was necessary, since even simple models 
included many IV states with zero or very low frequencies. To do this additional variable 
reduction, a level = 1 loopless search was performed to assess the predictive strengths, 
expressed in %ΔH reduction, of the 188 and 170 IVs. A single predicting IV was 
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considered to have predictive value if its p-value was ≤.05. An overview of IV selection, 
and the resulting number of IVs per analysis, is provided in each of the results sections. 
Additionally, sorting these predictive IVs by greatest %ΔH to least showed the single 
predicting IVs with the greatest value. This variable reduction method was performed for 
hip and knee data sets for each of the DVs. IVs that were found to have predictive value 
in the literature were retained for the searches as well, and are summarized in Table 9 
below. 
Table 9. Literature-based IVs Retained in all RA Exploratory Searches. 
ICD-9 Code ICD-9 Description ID Knee Hip 
RISK 250 Diabetes mellitus Rdi yes yes 
RISK 250.4 Diabetes with renal manifestations Rdr yes no 
RISK 250.5 Diabetes with ophthalmic manifestations Rdo yes no 
RISK 250.6 Diabetes with neurological manifestations Rdn yes yes 
RISK 278 Overweight, obesity and other hyperalimentation Roo yes yes 
RISK 278.01 Morbid obesity Rmo yes yes 
RISK 278.02 Overweight Rov yes yes 
RISK 401.1 Benign essential hypertension Rbe yes yes 
RISK 401.9 Unspecified essential hypertension Rhe yes yes 
RISK 414 Other forms of chronic ischemic heart disease Rci yes yes 
RISK 414.01 Coronary atherosclerosis of native coronary artery Rca yes yes 
RISK 428 Heart failure Rhf yes yes 
RISK 428.3 Diastolic heart failure Rdh yes yes 
RISK 428.32 Chronic diastolic heart failure Rdf yes no 
RISK 443 Other peripheral vascular disease Rpe yes yes 
RISK 443.9 Peripheral vascular disease, unspecified Rpv yes yes 
RISK 491.2 Obstructive chronic bronchitis Rcb yes no 
RISK 491.9 Unspecified chronic bronchitis Rbh yes no 
RISK 492.8 Other emphysema Rem yes yes 
RISK 493 Asthma Ras yes no 
RISK 493.2 Chronic obstructive asthma Rco yes yes 
RISK 493.9 Asthma unspecified Rua yes yes 
RISK 496 Chronic airway obstruction, not elsewhere classified Rao yes yes 
 
Rationale for No Training/Test Split 
Preliminary analyses were conducted with training/test splits, but these resulted in 
changes to the %correct measure that were small and misleading. While performing 
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training/test splits is common in machine learning research, it is often done with larger 
sample sizes and fewer variables.  This project’s primary objective was exploratory 
modeling, in which it does not seek to report definitive results, but offers variables and 
models which should be subjected to subsequent confirmatory testing. Training/test splits 
were thus not considered to be a necessary component of this project, and were not 
pursued further. 
Logistic Regression Analysis 
Prior to using RA for exploratory modeling and selecting the best predictive 
models, a preliminary comparison of RA with LR was conducted.  Using LR, the 
researcher can specify the predictor variables expected to be useful in predicting the 
outcome. This is considered a confirmatory, and not an exploratory, approach. In this 
project, LR (as programed in R) was used in a confirmatory approach in order to validate 
both the data used in this project and the RA method. In this analysis, binomial LR 
analysis was performed to recreate a previous study where the outcomes assessed were 
binary DVs. The goal of this analysis was confirmatory—to test an a priori hypothesis of 
the predictive strength of a model that includes predictor IVs predetermined from the 
literature to be useful in predicting postoperative complications and non-homebound 
discharge. 
Next, the relatively modest exploratory capabilities of LR were used to compare 
the relative abilities of LR and RA in finding the most predictive models. This analysis 
was conducted using a stepwise approach. In the “backward stepwise” (versus forward) 
method of LR exploratory analysis, the saturated model (all variables) is used with no 
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specifications of interactions. This stepwise LR approach is more comparable than purely 
confirmatory LR modeling to the exploratory modeling using RA.  
Regular Logistic Regression 
In order to evaluate the logistic regression models, the “stats” package from R 
was used (R. Core Team., 2016). The variables included in the LR analysis were 
converted into “factors” in order for R to treat them as nominal variables. 
LR falls within a broader category of models called “general linear models” that 
includes ordinary regression, log-linear regression, and ANOVA. In this analysis, the 
“glm” (used to fit “general linear models”) function in R was used. The “glm” function is 
specified through the use of arguments. Arguments specified under family functions 
allowed the creation of models in the binomial family and of the “logit” type. 
A reference point, in this case the “null model,” was created as an object from the 
data. In this reference model the DV was specified, but no predicting variables were 
specified. The “null model” as reference allowed for the calculations of measures 
necessary for comparison across LR and RA methods, such as df. For comparison, the 
reference models are shown for both Occam and R: 
 R:  Tcb ~ 1 
 Occam: IV : Tcb 
A second model was then created as a model object from the data. This second 
model was the model to evaluate against the reference model. Here, the predictor IVs 
were specified, including any hypothesized interaction terms. Again, here are models 
written in both forms: 
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 R:   Tcb ~ Rdi + Rdn + Roo + Rmo 
 Occam:  IV : RdiTcb : RdnTcb : RooTcb : RmoTcb 
With the null model as the reference, and the model to evaluate defined, the 
following measures were calculated: 
 df: take the difference in DF values of the two models. 
 AIC: take the difference in AIC values of the two models. 
 LR: take the difference in deviance values of the two models. 
 alpha: calculate an “ANOVA” table for the two models with test type 
“Chisq” and select the desired value from the resulting table. 
 
Stepwise Logistic Regression 
The previous method measures a specified model to the null reference model, but 
does not explore or propose additional models. In order to find a new and perhaps more 
predictive model, a stepwise search, using the “step” function from the R “stats” package, 
was used. This function can search either upward or downward, adding or removing 
components from a model within specified boundaries (described below). In this stepwise 
approach, the search considered all single steps that could be made from the model and 
then selected the best of those by the specified metric. This process was repeated until no 
better models were found, or a boundary or other termination condition was met. The 
stepwise search in R is similar to the Occam searches with the parameter “width” = 1, but 
only considering LR models and not Occam’s loopless or all-models searches. 
To begin a stepwise search for an LR model, models were prepared as described 
previously, using the “glm” and the binomial family arguments. Using this stepwise 
method, search direction can be upward from the null model (independence), or 
downward from the model containing all the variables (saturated model), or searching in 
both directions from some model “in the middle” that contains some of the variables in 
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the data. In the LR analysis for this project, both upward and downward searchers were 
performed.  
The “step” function uses AIC by default as its criterion for model comparison; 
however, the function can also be modified to instead select based on BIC. Additionally, 
an upper boundary for the search scope was specified by providing a model; for instance, 
a model that includes all variables of interest but excludes others in the data. The lower 
boundary was also be specified, either as the null model (the default) or another model. 
The stepwise search then results in the model that has been found through this series of 
single-variable additions and/or subtractions (steps), with the best value for AIC. 
Determining the Best RA Models 
In order to search for the most predictive models for each of the DVs, the 
reference model used was always the bottom, or the “independence model,” with a search 
direction of “up.” This method allows for moving up the lattice of structures, away from 
independence (no relations) toward a more complex model. Unjustified complexity 
results in large cumulative or incremental alphas that indicate the search has gone too far. 
In this project, cumulative p-values  ≥ 0.05 indicated the model was more complex than 
warranted, and a model lower in the lattice was subsequently selected.   
Models without loops, and models allowing for loops, were both considered and 
are provided in the model search results. During the search process, models were sorted 
by BIC, with a preference for larger values.  Each search was initially specified to keep 
three models at each level, and to search up to seven levels in the lattice for both loopless 
searches (coarse models), and searches allowing for models with loops (fine-grained 
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searches). For the loopless search, a seven-level search means that models with 
interaction effects involving up to seven IVs could in principle be considered. For the 
search that allows loops, models that add seven steps of complexification of the 
independence model are considered, where a step is either adding another variable to an 
interaction effect that is already being modeled or adding an additional predicting 
component to the model. 
If the search results indicated the best model by either BIC or AIC criterion was at 
the topmost level (Level 7 according to the initial settings) then additional searches were 
conducted looking higher than seven levels. The number of levels varied per search, but 
the protocol used always added levels until it was certain that the best models by BIC or 
AIC were not at the highest level that was examined. Additionally, a similar protocol was 
used for determining the width of the searches. Once a level was determined, width was 
increased to see if a better model was found. Once a model remained unchanged, either 
by increasing search levels or search widths, then this was considered the “best model” 
for that search. 
The best models that are the primary results of this project are selected according 
to BIC. The benefit of using the conservative BIC model selection criterion—as opposed 
to, say, using the AIC criterion—is that overfitting is unlikely; in being conservative, 
however, it is possible that the models selected were not aggressive enough, with a 
consequence of missing real interactions. (AIC was, however, used in RA-LR 
comparisons, because the LR software used this criterion.) BIC models are always 
“cumulatively” statistically significant; i.e., their difference from independence is always 
significant. In addition, in all of the BIC models reported there is always a path where 
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every step of increasing complexity from independence to the model is statistically 
significant, the significance of each step being given by the Occam measure Incremental 
Alpha.    
Fitting the RA Models to the Data & Identifying Important Model IV States 
The “fit” action of Occam displays the model’s internal structure, the conditional 
probability distribution for the DV, given the predicting IVs. In this project, best models 
were obtained for 16 searches, each resulting in a conditional probability distribution. 
Each distribution shows the conditional DV % for each of the IV composite states for the 
model and include frequencies and observed probabilities calculated from the data, as 
well as the calculated probabilities from the model. The frequency of all the IV states 
observed in the data, the data’s marginal probabilities, and the calculated IV conditional 
probabilities of the model are used for selecting important IV states, discussed further in 
the next section. 
The model fit analysis also displays the individual model component’s projections 
and is frequently informative. Each individual component may be a single variable, or 
more than one variable if a relation (interaction term) was found in the model.  
For both the model’s full table and the individual components’ tables, if the 
conditional probabilities for particular IV states are higher or lower than the margins, 
then the IVs have provided new (predictive) information. In this project, conditional 
probabilities that appear different from the margins are indicted by the blue and orange 
shaded cells. Whether or not this effect size is significant is assessed by a chi-square 
p-value, calculated from the margins, the IV state’s conditional probabilities, and the 
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frequencies for that IV state. This p-value indicates the statistical significance of the 
difference between the conditional distribution for particular IV states, namely q(DV|IV), 
and the sample margins, namely p(DV). The important IV states for each of the models is 
then communicated in a decision tree when possible. If the number of variables and their 
number of states make the decision tree too large for inclusion, then the decision tree is 
omitted. The decision trees provide a more intuitive visualization of the model’s 
predictors and their effect on the DV.  
Selection Criteria for Important Model IV States 
All observed IV states for each of the models are included in the original RA 
output from Occam. In this project, a criterion is used that considers only IV states that 
occur in 10 or more cases (freq ≥ 10). This decision is suggested by the Chi-square rule 
of thumb that calls for on average at least five values per cell. For DVs with cardinalities 
of two, requiring at least 10 cases doubles this guideline and imposes it on every IV state; 
this implements a conservative position on making assertions from the model conditional 
probability distribution. The position thus adopted here thus is that a p-value is assessed 
only if an IV state occurs in 10 or more cases. If p ≤ 0.05, then the IV state is retained; 
otherwise the IV state is omitted. 
Of these remaining IV states, a “risk ratio” is then calculated. If the IV state has a 
ratio ≥ 1.10, it is considered to be a higher-risk state, and if the ratio is ≤ 0.90, then it is 
considered to be a lower-risk state. Any IV state that is between 0.91 and 1.09 is 
considered to have a small effect size and is thus not considered an important IV state. 
These risk ratios are a primary measure of effect size, and while 5% is often considered 
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standard for an important effect size, this project doubles it to 10%, which is another 
conservative choice. 
Calculating Risk Ratios 
The risk ratio of an IV state is a measure of its effect size, whereas the p-value 
assesses the statistical significance of the difference between the conditional probability 
of the IV and the margins. This ratio will be used as part of the selection criteria for 
selecting important IV states in the model, as discussed in the next section, Results. 
Risk ratios help explain effect size, as does the reduction of uncertainty (ΔH), but 
provide a different way to look at the effect. For ΔH, even small uncertainty reductions 
could be large in effect size (like 1:1 to 2:1). The measure ΔH is like %variance 
explained, with the major exception that low %variance explained means the effect size is 
ignorable. However, for ΔH, even small numbers can have large effect sizes (this is 
because there is a log). The following example is used to help explain what the risk ratio 
means. This is important because the risk ratio is the primary measure by which 
decreased or increased risk is assessed. 
In this example, the season can be either summer or winter, and the possibilities 
for weather can be either rain or no rain (Figure 3 below). If you do not know what 
season it is, then you face maximum uncertainty with a 1:1 chance of no-rain to rain. 
However, if you know the season, the uncertainty is reduced. If you know it is winter, 
then there is a 1:2 odds of no rain:rain. If you know it is summer, then there is a 2:1 odds 
of no rain:rain. Knowing the season changes the odds. This is a big effect size and 
correlates to a %ΔH of 8.   
 







/6 2/6 1/2 
winter 
2




 Figure 3. Knowing the Season Reduces the Uncertainty 
of the No-Rain:Rain from 1:1 to 2:1 or 1:2 odds. 
 
In a decision tree with probabilities, this would look like Figure 4. 
Figure 4. Decision Tree Illustrating How Knowing the Season 
Reduces the Uncertainty of the No-Rain:Rain from 1:1 to 2:1 or 1:2 Odds. 
 
In this example, the risk ratio is the probability of an outcome (e.g., rain) for a 
particular IV state (e.g., summer) divided by the marginal probability of the outcome 
(maximum uncertainty): 
.33 or .67 
.5  .5 
  
For the three binary DVs (Complication, SNF, and Readmission), the risk ratio is 
the probability of an outcome for a particular adverse IV state divided by the marginal 
probability of this outcome for the whole sample. For the DV Total Cost, however, the 
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ratio is instead the Expected Value of an IV state divided by the average cost for the total 
sample.  
Trying out many models in an exploratory modeling approach can lead to false 
positives, and it is valuable to try to guard against this. In this project, decisions were 
made that were systematically conservative by (a) dropping Comorbidity IVs that were 
infrequent in the data, (b) requiring a frequency ≥ 10 for each of the IV states in the 
model, (c) using ΔBIC as model selection criterion, and (d) establishing the effect size of 
at least 10% in the Risk Ratio of IV states. 
The general LR and RA methodologies were described in the Literature Review 
chapter, and project-specific applications and extensions of these methods are described 
above in this Methodology chapter. In the following chapter, the LR and RA analysis is 
performed, and the results are presented. 
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Chapter 4.  Results 
In the last chapter, an overview of the data and methods was provided. In this 
chapter, the first research objective aims to connect this project to the literature, and then 
compare Logistic Regression (LR) and Reconstructability Analysis (RA) in both 
confirmatory and exploratory modes. The second research question aims to find 
predictive models with RA. This chapter describes the analyses and presents the results in 
detail. These results are then summarized in the following Discussion chapter.  
Preliminary Research Objective: LR & RA Comparison  
To establish a connection to results from the literature, results are presented from 
an LR analysis of this project’s data, using a limited set of variables. Then, to address the 
question whether RA and LR give the same results for equivalent models, results are 
presented for the comparison of RA to LR using the same limited set of variables. To 
answer the question whether exploratory RA can provide better or novel models 
compared to LR, results are presented from an exploratory RA analysis, first on the 
limited data set and then on a larger subset of variables. This larger subset of variables is 
also analyzed with stepwise LR for comparison. These analyses provide a sequence of 
(limited) connections from LR results in the literature, to LR results from this project’s 
data, to RA results on this project’s data. 
Connecting to Previous LR Results from the Literature 
Prior to LR and RA comparisons, the results of a previously published study that 
used LR was re-created, also using LR, on this project’s data. The re-creation of this past 
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study confirmed that this data set was comparable to the data set used in that study, thus 
validating this project’s data. 
Previous research has assessed the effect of comorbidities (hypertension (H), 
diabetes (D), obesity (O), and their combinations) on postoperative complications and 
non-homebound discharge for patients with hip and knee arthroplasty (Jain et al., 2005). 
In the Jain study, LR was used to determine that postoperative complications were more 
likely in patients with hypertension (H), diabetes (D), or obesity (O) as compared with 
patients without these individual comorbidities. Jain et al, used the large National 
Inpatient Sample (NIS) database to create a data set of over a million joint replacement 
cases—a much larger sample than the data set used in this project. However, the 
procedure and diagnosis coding methodology and the way DVs postoperative 
complications and non-homebound discharges were determined are identical. The 
similarity of patient cohort and variable definitions makes it possible to validate the data 
used in this project. 
The hip and knee data sets used in this project were transformed into a combined 
data set (n = 6,612) similar to the data set used in the Jain study (Jain et al., 2005). The 
statistical software package R was used to perform LR and obtain odds ratios to quantify 
effect sizes and p-values to assess significance. Results demonstrate that odds ratios 
determined from this project’s data are comparable to findings of the Jain study. 
The Jain study (Jain et al., 2005) showed that hypertension had an effect on 
postoperative complications with an odds ratio (OR) of 1.07. Results of the new LR 
analysis (Table 10) show a slightly higher odds ratio at 1.18, although this result was not 
significant (p = 0.18). Previous results showed that for patients with the comorbidity of 
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obesity, there was a 31% greater chance of developing postoperative complications 
(OR = 1.31), while in the new LR analysis an odds ratio of 1.39 was found with a 
significant p-value of 0.03. Previous results indicate that diabetes increased risk of a 
postoperative complication by 6% (Jain et al., 2005), while patients with diabetes in this 
new analysis were 2.9 times more likely to have a postoperative complication than their 
non-diabetic counterparts (p = 0.00). The odds of diabetes are much higher in the new LR 
analysis than the previous results, yet the rate of diabetes is similar in both cohorts. There 
was a prevalence of diabetes of 10.04% in the Jain study cohort compared with 12.66% 
in the new LR analysis cohort.   
Table 10. Previous Results Reported in (Jain et al., 2005), and 
Results from New LR Analysis on This Project’s Data. 
Δdf, ΔLR, and ΔAIC values are given in the table for later comparisons with RA calculations. 








1.07 <0.001 1.18 0.18 1 1.78 -0.22 
Nonhomebound 
Discharge 




1.31 <0.001 1.39 0.03 1 4.48 2.48 
Nonhomebound 
Discharge 




1.06 0.010 2.90 0.00 1 49.56 47.56 
Nonhomebound 
Discharge 
1.30 <0.001 1.48 0.00 1 27.58 25.58 
 
The likelihood of a non-homebound discharge was 12% greater for patients with 
hypertension in the previous study (OR = 1.12), and 7% greater in the new LR analysis 
(p = 0.17) (Table 10).  Previous results showed that patients with diabetes had a 45% 
greater chance of a non-homebound discharge, while new LR results showed a 22% 
greater chance (p = 0.00). Diabetes was a comorbidity that increased likelihood of a 
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non-homebound discharge in both previous and current LR analysis, with a 30% greater 
chance (OR = 1.30) in previous results compared to a 48% greater chance in the new LR 
results. While there were differences in the effect sizes, the odds ratios were roughly 
comparable. The lack of significance in the effect size for hypertension on both DVs in 
the new LR analysis could be due to the much smaller cohort. 
The previous study (Jain et al., 2005) also looked at patients who had 
combinations of two comorbidities. These were not hypothesized interaction terms to be 
analyzed, but rather three new variables created. Again, the new LR analysis showed 
comparable results in terms of odds ratios with most results being significant (Table 11).  
Table 11. Previous Results Reported in (Jain et al., 2005) for 3 IVs, 
and Results from New LR Analysis on this Project’s Data. 




    
From Table 4, 
(Jain et al., 
2005) 
IVs recoded into new variables 
1=(both risks), 0=(not both risks) 





1.04 0.280 1.96 0.00 1 13.02 11.02 
Non-homebound 
Discharge 





1.27 <0.001 1.33 0.13 1 2.34 0.34 
Non-homebound 
Discharge 





1.22 0.020 2.32 0.00 1 13.13 11.13 
Non-homebound 
Discharge 
1.75 <0.001 1.51 0.00 1 12.59 10.59 
 
Do RA and LR give the same results for equivalent models? 
Results from the previous LR analysis were reproduced using the RA method 
instead. Here, RA was not used for exploratory modeling, but rather used in a 
confirmatory mode starting with the hypothesized model that was recreated in the LR 
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analysis. In this comparison, RA as programmed in the software “Occam” was used in a 
confirmatory mode starting with the models used in the LR study. RA generated identical 
results to LR, demonstrating that where the methods overlap, they are equivalent. The 
ΔAIC and Alpha measures are identical between LR and RA (Table 10 and Table 12, 
respectively).  
Table 12. Similar RA Results Using this Project’s Data. 
    New Results (RA in “Occam”) 




1.18 0.18 0.08 1 1.78 -0.22 
Non-homebound 
Discharge 




1.39 0.03 0.20 1 4.48 2.48 
Non-homebound 
Discharge 




2.90 0.00 2.19 1 49.56 47.56 
Non-homebound 
Discharge 
1.48 0.00 0.30 1 27.58 25.58 
 
Results from RA are summarized as conditional probability distributions, which 
were transformed into joint probability distributions from which the odds ratios were 
calculated. The odds ratios are identical to those calculated by LR. RA provides an 
additional measure of effect size in the percent reduction of uncertainty of the dependent 
variable given the comorbidity IV states: %ΔH(DV), as seen in Table 12. This reduction 
of uncertainty is a unique and central feature in the RA methodology and will be 
emphasized in the upcoming exploratory modeling section. It might be viewed as a way 
of summarizing several odds ratios in a single measure. Uncertainty is the nominal 
variable “equivalent” of variance, and so a %reduction of uncertainty resembles a 
%variance explained. (For Gaussian distributions, there is in fact an equation that directly 
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relates the two.) However, uncertainty reduction numbers that are small can still represent 
large effect sizes, because of the logarithm term in the expression for uncertainty 
(Shannon entropy). 
Using RA to generate results for patients who had two comorbidities again 
resulted in identical ΔAIC, alpha, and odds ratio numbers (Table 13). However, the 
%ΔH(DV) is rather low, with the largest reduction in uncertainty at 0.57%. Perhaps there 
were other IVs that would have provided more information about the DV. The fact that 
even low reductions of uncertainty can correspond to odds ratio values whose difference 
from 1 is statistically significant should be kept in mind when uncertainty reduction 
values are reported in the next section.  
Table 13. Similar RA Results Using this Project’s Data with 3 New IVs. 
    New Results (RA) 





1.96 0.00 0.57 1 13.02 11.02 
Non-homebound 
Discharge 





1.33 0.13 0.10 1 2.34 0.34 
Non-homebound 
Discharge 





2.32 0.00 0.58 1 13.13 11.13 
Non-homebound 
Discharge 
1.51 0.00 0.14 1 12.59 10.59 
 
Does exploratory RA provide better or novel models compared to LR? 
This preliminary comparison was then expanded, and RA was then used in an 
exploratory mode, providing an initial example of the type of unique results that are 
possible from using RA. This question is first answered using a simple RA exploratory 
search using the limited variable set from the above LR and RA analysis. Then, to further 
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demonstrate RA’s exploratory search capabilities, a larger subset of the data with 17 IVs 
was analyzed with LR and RA.  
Using this simplified data set with only four variables—the IVs, hypertension (H), 
diabetes (D), and obesity (O), and the DV, complications (C), shows a simple example of 
RA exploratory modeling, which in this case can evaluate the complete set of all possible 
models. In Table 14 below, the bottom row shows the independence model, where there 
is no relation or constraint between the IVs and the DVs with zero reduced DV 
uncertainty (%ΔH(DV) = 0.00). Moving up the table, or up the lattice of structures of all 
possible models for this four-variable system, the top row shows the data, the “saturated 
model,” which has information = 1 and maximum complexity (Δdf = 7). The models in 
between independence and the data were all considered by RA. While by the AIC 
criterion the best model was determined to be IV:HDC, there was an opportunity to 
consider models with loops, such as those highlighted in orange in Table 14 below. In 
this simple analysis, the model chosen did not have a loop, but in other situations, 
a model with loops may be the best model by AIC or another criterion. Note that IV:DC 
has information of 0.81, and adding HC (to give model IV:DC:HC) does not increase this 
value, but going up and adding a genuine interaction effect (to give model IV:HDC) 
increases the information to 0.98. Note also that although O predicts C better than 
H predicts C, the HD interaction predicts C better (information = 0.98, uncertainty 
reduction = 2.67%) than the DO interaction (information = 0.83, uncertainty 
reduction = 2.24%). 
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Table 14. Directed RA Search for DV Complication for 4 Variables. 
(Best Model by AIC in Bold.) 
MODEL Level Δdf ΔLR Inf %ΔH(DV) ΔAIC Alpha 
HDOC (Data) 7 7 61.44 1.00 2.71 47.44 0.00 
IV:HDC:HOC:DOC 6 6 61.12 0.99 2.69 49.12 0.00 
IV:HDC:DOC 5 5 61.11 0.99 2.69 51.11 0.00 
IV:HDC:OC 4 4 60.80 0.99 2.68 52.80 0.00 
IV:HDC:HOC 5 5 60.80 0.99 2.68 50.80 0.00 
IV:HDC 3 3 60.47 0.98 2.67 54.47 0.00 
IV:HOC:DOC 5 5 51.29 0.83 2.26 41.29 0.00 
IV:HC:DOC 4 4 50.89 0.83 2.24 42.89 0.00 
IV:DOC 3 3 50.85 0.83 2.24 44.85 0.00 
IV:HOC:DC 4 4 50.48 0.82 2.23 42.48 0.00 
IV:HC:DC:OC 3 3 49.88 0.81 2.20 43.88 0.00 
IV:DC:OC 2 2 49.82 0.81 2.20 45.82 0.00 
IV:HC:DC 2 2 49.57 0.81 2.19 45.57 0.00 
IV:DC 1 1 49.56 0.81 2.18 47.56 0.00 
IV:HOC 3 3 5.83 0.09 0.26 -0.17 0.12 
IV:HC:OC 2 2 5.37 0.09 0.24 1.37 0.07 
IV:OC 1 1 4.48 0.07 0.20 2.48 0.03 
IV:HC 1 1 1.78 0.03 0.08 -0.22 0.18 
IV:C (Independence model) 0 0 0.00 0.00 0.00 0.00 1.00 
MODEL Level Δdf ΔLR Inf %ΔH(DV) ΔAIC Alpha 
 
RA Exploratory and Stepwise LR 
This previous example illustrated a very simple comparison where LR had been 
used in its most standard form.  In the next example, an exploratory “stepwise” approach 
was used that illustrates a more typical research approach. This stepwise LR approach is 
more comparable than confirmatory modeling to the exploratory modeling using RA. 
In this example, the literature was surveyed in order to select a set of variables 
that have been reported to have an effect on outcomes similar to those in this study.  The 
resulting 17 literature-based predictors became the IVs used in this analysis. With these 
17 IVs, LR (as implemented in R) was then used in both its regular and stepwise 
variations. Without any additional hypothesis, the best models using LR are presented. 
RA as implemented in “Occam” is then used with the same 17 IVs. RA looked at models 
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not considered in the LR stepwise approach. The models from each method are compared 
and discussed.  
In the first example, 17 Comorbidity IVs were selected that have been found to be 
potentially predictive of cost from the literature, and were included in the hip or knee data 
sets used in the RA exploratory searches. This example analysis was performed on the 
hip data set for the DV Total Cost (Tcb). While total cost was binned into three states for 
RA exploratory modeling in the next results section, Tcb is binned into two states in 
order to perform a simple LR comparison. (LR can be used with the DV having more 
than two states, but the analysis is cumbersome.) 
 Single IV Predictors 
First, a single predicting search was performed with the 17 IVs specified. As is 
seen in Table 15, RA and LR produced identical results. In this single predicting search, 
six IVs were individually predictive with p < 0.05. 
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Table 15. LR & RA Comparison of Results for Single Predicting Search. 
(Δdf=1 for every model in this table.) 
Logistic Regression Results   RA Results 
MODEL ΔAIC ΔLR Alpha 
 
MODEL ΔAIC %ΔH ΔLR % C Alpha 
17 IVs 
(single 
predicting)       
17 IVs 
(single 
predicting)           
Rmo Tcb 47.11 49.11 0.00 Rmo Tcb  47.11 1.11 49.11 52.48 0.00 
Rdi Tcb 8.19 10.19 0.00 Rdi Tcb  8.19 0.23 10.19 51.64 0.00 
Rhf Tcb 5.07 7.07 0.01 Rhf Tcb  5.07 0.16 7.07 50.58 0.01 
Rdh Tcb 4.94 6.94 0.01 Rdh Tcb  4.94 0.16 6.94 50.14 0.01 
Rao Tcb 2.81 4.81 0.03 Rao Tcb  2.81 0.11 4.81 50.61 0.03 
Rua Tcb 2.75 4.75 0.03 Rua Tcb  2.75 0.11 4.75 50.92 0.03 
Roo Tcb 1.46 3.46 0.06 Roo Tcb  1.46 0.08 3.46 50.92 0.06 
Rpv Tcb 0.52 2.52 0.11 Rpv Tcb  0.52 0.06 2.52 50.23 0.11 
Rhe Tcb 0.38 2.38 0.12 Rhe Tcb  0.38 0.05 2.38 51.36 0.12 
Rci Tcb 0.24 2.24 0.13 Rci Tcb  0.24 0.05 2.24 50.42 0.13 
Rov Tcb -0.30 1.70 0.19 Rov Tcb  -0.30 0.04 1.70 50.14 0.19 
Rbe Tcb -0.35 1.65 0.20 Rbe Tcb  -0.35 0.04 1.65 50.11 0.20 
Rco Tcb -0.70 1.30 0.25 Rco Tcb  -0.70 0.03 1.30 50.17 0.25 
Rca Tcb -1.09 0.91 0.34 Rca Tcb  -1.09 0.02 0.91 50.36 0.34 
Rem Tcb -1.10 0.90 0.34 Rem Tcb  -1.10 0.02 0.90 50.11 0.34 
Rdn Tcb -1.30 0.70 0.40 Rdn Tcb  -1.30 0.02 0.70 50.08 0.40 
Rpe Tcb -1.91 0.09 0.76 Rpe Tcb  -1.91 0.00 0.09 50.02 0.76 
 
Looking at all 17 of the IVs together results in a ΔAIC of 51.85, as seen in 
Table 16. Looking at a model that includes only the six IVs that were individually 
predictive of total cost with alpha < 0.05 resulted in the LR model Rmo Tcb : Rdi Tcb : 
Rhf Tcb : Rdh Tcb :  Rao Tcb : Rua Tcb with a ΔAIC of 60.51 (Table 16), which is an 
improvement over the model with all 17 IVs. 
Table 16. Confirmatory LR Results for all 17 IVs and 6 IVs with p < 0.05. 
Model Δdf ΔAIC ΔLR Alpha 
All 17 variables 
  17 51.85 85.85 0.00 
Model Δdf ΔAIC ΔLR Alpha 
Model with the 6 IVs variables that individually have p < 0.05 
Rmo Tcb : Rdi Tcb :  Rhf Tcb :   Rdh Tcb :  Rao Tcb :  Rua Tcb   6 60.51 72.51 0.00 
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Using the same 17 IVs, a stepwise LR approach yielded model Rdi Tcb : Roo 
Tcb : Rmo Tcb : Rov Tcb : Rhf Tcb : Rdh Tcb : Rua Tcb : Rao Tcb with a ΔAIC of 
62.66 (Table 17), an improvement over the previous best LR model from Table 16.  
Table 17. Stepwise LR Approach with 17 IVs. 
Model Δdf ΔAIC ΔLR Alpha 
Best model from a stepwise search using AIC 
Rdi Tcb: Roo Tcb: Rmo Tcb : Rov Tcb : Rhf Tcb : Rdh Tcb : 
Rua Tcb : Rao Tcb 
8 62.66 78.66 0.00 
 
While the researcher must specify interaction terms for an LR analysis, even with 
17 IVs, RA (as implemented in Occam) automatically considers these models in its 
standard search. In addition, RA considers models that include multivariate interaction 
effects that are not possible with LR. The best fine-grained model by ΔAIC in the 
17-variable search using RA was Rd Rao Tcb : Roo Rpv Tcb : Rmo Rci Tcb : Rmo Rao 
Tcb : Rov Rua Tcb : Rhf Rua Tcb : Rdh Tcb with a ΔAIC of 66.57 (Table 18), an 
improvement over the model from the LR stepwise search in Table 17.   
Table 18. RA Exploratory Search Results with 17 IVs (no interaction terms specified in advance). 
MODEL Δdf ΔAIC %ΔH ΔLR % C alpha Variable description 
FINE, best models (with loops) 
ΔAIC (best model) 
RdiRaoTcb : 
RooRpvTcb : 





16 66.57 2.22 98.57 55.69 0.08 
Diabetes mellitus (RISK 250) + Chronic 
airway obstruction, not elsewhere 
classified (RISK 496), Overweight, 
obesity and other hyperalimentation 
(RISK 278) +  Peripheral vascular 
disease, unspecified (RISK 443.9), 
Morbid obesity (RISK 278.01) + Other 
forms of chronic ischemic heart disease 
(RISK 414), Morbid obesity (RISK 
278.01) + Chronic airway obstruction, 
not elsewhere classified (RISK 496), 
Overweight (RISK 278.02) + Asthma 
unspecified (RISK 493.9), Heart failure 
(RISK 428) + Asthma unspecified 




- 75 - 
RA has previously been used by several researchers to detect interaction terms 
that are then specified for LR analysis (Cangur, 2009; Carletti, 2004; Mist, 2007). The 
RA analysis detected interaction effects and in fact, each predicting component in the 
best model by AIC from the RA search had an interaction term (Table 18). In this 
analysis, the RA exploratory search appears to be more capable of finding predictive 
interactions. When using the 10 IVs (out of the original 17 IVs) that are present in the 
best model from the RA search (with no interaction terms), an LR analysis resulted in a 
ΔAIC of 61.67 (Table 19). However, RA found a more interesting and informative 
(ΔAIC = 66.57) model that LR could not find, because RA automatically searches for 
significant interaction effects. 
Table 19. LR Analysis with the 10 IVs present in the Best RA Model. 
Model Δdf ΔAIC ΔLR Alpha 
Model with 10 variables that are present in Occam's “best model by AIC” 
Rdi Tcb : Rao Tcb : Roo Tcb : Rpv Tcb : Rmo Tcb : Rci Tcb : 
Rov Tcb : Rua Tcb : Rhf Tcb : Rdh Tcb 
10 61.67 81.67 0.00 
 
In this example looking at just 17 IVs, RA generated models with quantifiable 
additional predictive power by considering models that were not considered in the LR 
analysis. Note that RA and LR looked at the same set of IVs. The higher AIC value for 
the RA model means that its additional complexity (the RA model in Table 18 is twice as 
complex as the LR model in Table 17) is more than justified by the increase in predictive 
efficacy that it gives. 
In the next section, a much larger set of IVs is considered when looking at each of 
the dependent variables of this study. In addition to the previously known predicting IVs, 
RA may detect something novel, particularly through the form of an interaction term. 
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These combination effects may add predictive strength relative to the set of known single 
predicting IVs available in the current literature and may even detect surprising IVs.  
The first example in this preliminary comparison section recreated a previous 
study and addressed any concern of whether RA is approximately similar to LR where 
they overlap methodologically. This validated RA as a method and confirmed the results 
from a previous LR study. The second example showed that RA can provide novel 
predictions and better relative performance, and therefore RA was shown to have value as 
a method to augment or supplant LR. 
Main Research Objective: Find predictive models with RA 
In this results section, a series of best models whose measure of goodness is 
% reduction of uncertainty of the DV are proposed and analyzed in detail for the 
following DVs: (a) Complication, (b) (discharge to) Skilled Nursing Facility, 
(c) Readmission, and (d) Total Cost, for both Knee and Hip replacement data. In each of 
these eight studies, searches were performed looking at (a) All IVs together, and (b) only 
the Comorbidity IVs. 
DV: Complication (Cp) 
Knee Analysis 
 All IVs 
o Coarse Searches (Models without Loops) 
First, loopless models were examined for the dependent variable Complication 
(Cp). These loopless models were sorted from the most predictive to the least predictive, 
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and models were selected with single IV predictors having p  0.05, which resulted in 
marking 53 IVs to keep for the next round of searches. In addition to these single 
predicting variables, IVs were retained that were found to be predictive in the literature 
on similar outcome variables. In this literature, there were 25 variables that were 
predictive of complications or discharge destination that were retained in the data; 16 of 
these literature-based IVs also had a p value < 0.05 in the single predicting search, while 
nine of the literature-based variables had p values > 0.05. The search results for the top 
10 models are included in Table 20. Additional single predicting IVs are provided in 
Table 20 if the IV was not listed in the top 10 but was included in one of the best models 
by the BIC or AIC criterion. In results tables where p values always equaled zero to two 
significant figures (i.e., p < 0.005), the column indicating p value was omitted. A model 
in the table specifies IVs (e.g., Nrb, Rku) that predict the DV (here, Cp). It is followed 
first by df = df(model) – df(reference), the difference between the degrees of freedom of 
the model and the reference or independence model. The next value is 
BIC = BIC(reference) – BIC(model), for which improvements in the model compared 
to the reference are reflected in larger values. The next measurement is  %H = H(DV) –
 H(DV|IV), the %reduction of uncertainty of the DV given the IVs. The reduction of 
uncertainty measure indicates how predictive the IVs are. The BIC measure indicates 
how efficient the prediction is; i.e., how predictive the IVs are, given their complexity 
(degrees of freedom). Best models are chosen based on their BIC measures, which results 
in a highly conservative choice of models. Table 18 summarizes the results of single and 
multiple predictors in loopless and all-model (with loops) searches.  
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Table 20. Summary of Search Results (Knee) for All IVs. 
Search covers coarse and fine models. All p-values = 0. 
MODEL Δdf ΔBIC %ΔH Variable description 
COARSE, single predictors (top 10) 
S Cp 62 -412.74 6.45 Surgeon 
Nrb Cp 2 77.29 5.69 Number of risks (binned) 
Rrd Cp 1 43.04 3.11 Unspecified hypertensive renal disease (403.9) 
Rku Cp 1 39.63 2.91 Chronic kidney disease, unspecified (585.9) 
Ruh Cp 1 33.56 2.54 Other and unspecified hyperlipidemia (272.4) 
L Cp 6 -9.04 2.50 Location 
Ad Cp 27 -185.33 2.47 Admission diagnosis 
Ageb Cp 2 14.61 1.90 Age (binned) 
Raf Cp 1 11.46 1.20 Atrial fibrillation (427.31) 
Rhf Cp 1 10.79 1.16 Heart failure (428) 
MODEL Δdf ΔBIC %ΔH Variable description 
COARSE, IVs in AIC or BIC models but not in top 10 
Rhd Cp (rank 12) 1 9.90 1.11 Other chronic pulmonary heart disease (416.8) 
Rro Cp (rank 18) 1 3.22 0.70 Rosacea (695.3) 
Reg Cp (rank 20) 1 1.95 0.63 Esophagitis (530.1) 
MODEL Δdf ΔBIC %ΔH Variable description 
COARSE, best model (loopless) 
ΔBIC (best model) 
Nrb Rku Cp 5 83.23 7.58 
Number of risks (binned), Chronic kidney disease, 
unspecified (585.9) 
Inc.P & ΔAIC (same best model) 
Nrb Rhd Rku Cp 11 52.71 8.77 
Number of risks (binned), Other chronic pulmonary heart 
disease (416.8), Chronic kidney disease (585.9) 
MODEL Δdf ΔBIC %ΔH Variable description 
FINE, best models (with loops) 
ΔBIC (best model) 
Ageb Cp : Nrb Cp : 
Ruh Cp:Rhd Cp : 
Rku Cp : Rro Cp 
8 104.71 10.40 
Age (binned), Number of risks (binned), Other and 
unspecified hyperlipidemia (272.4), Other chronic 
pulmonary heart disease (416.8), Chronic kidney disease, 
unspecified (585.9), Rosacea (695.3) 
Inc.P & ΔAIC  (same best model) 
Ageb Cp : Nrb Cp : 
Ruh Cp: Rhd Cp : 
Reg Cp : Rku Cp : 
Rro Cp 
9 104.23 10.88 
Age (binned), Number of risks (binned), Other and 
unspecified hyperlipidemia (272.4), Other chronic 
pulmonary heart disease (416.8), Esophagitis (530.1), 
Chronic kidney disease, unspecified (585.9), Rosacea 
(695.3) 
 
Knowing the surgeon who performed the surgery (S) reduces uncertainty by 
6.45% (Table 20). Likewise, knowing only if the patient had unspecified hypertensive 
renal disease (Rrd) reduces uncertainty by 3.11%, and knowing that the patient had 
unspecified chronic kidney disease (Rku) reduces uncertainty by 2.91%. The best coarse 
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model in Table 20 shows that, for this data set, simply knowing the total number of 
comorbidities a patient had (Nrb) along with chronic kidney disease (Rku) reduces the 
uncertainty in predicting if Complication (Cp) occurred by 7.58%. 
o Fine Searches (Models with Loops) 
The next type of search considers models with loops, which allows for multiple 
components that predict the DV. Within each component, there may be interaction effects 
among the IVs in their prediction of the DV, just as an interaction effect was observed in 
the best BIC model, Nrb Rku Cp, and the best loopless IncrP/AIC model, Nrb Rhd Rku 
Cp, as shown in Table 20. 
Note that some single predicting variables do not show up in the best coarse or 
fine models, indicating that the IVs are not independent from each other. There are six 
single predicting variables in the best BIC fine-grained model: Ageb Cp : Nrb Cp : Ruh 
Cp : Rhd Cp : Rku Cp : Rro Cp. Five of these variables—Ageb, Nrb, Ruh, Rhd, and 
Rku—also appear in the top 10 single predicting components, while Rro is the 18th  in 
the list of single predicting components (Appendix C). This apparently low-value 
variable was included when the RA search methodology sought to improve a model 
already containing the better individual predictors Ageb, Nrb, Ruh, Rhd, and Rku. Rro 
was found to be the variable that added more additional information to that model, 
relative to any of the better singly-predicting IVs above it.  
The best single predictor, S (surgeon) does not appear in the best fine-grained 
model, presumably in part because S has high cardinality and the information added by S 
is not worth the complexity of including it in the model, and perhaps in part also because 
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the predictive effect of S is already provided by the Ageb, Nrb, Ruh, Rhd, and/or Rku 
predictors. Similarly, Ageb, Nrb, Ruh, Rhd, and Rku contain the information offered by 
the other single predictors all the way down to Rro. The third-best single predictor, Rrd, 
also does not appear in the best fine-grained model. Again, the information added by Rrd 
is presumably not worth the additional complexity to be added to the model. This 
explanation is supported by the fact that if Rrd were the DV, it is well predicted by Ageb, 
Nrb, Ruh, Rhd, and Rku. In fact, Rku alone predicts Rrd with a %ΔH of 53.14%, 
demonstrating significant overlap between Rku and Rrd. Nrb and other variables also 
explain information in Rrd, as seen in Table 21. This demonstrates the lack of 
independence between the IVs, which is analogous to collinearity among IVs in 
regression analysis. 
Table 21. IV Rku Predicts Rrd (as DV), 
Demonstrating IV Overlap. 
MODEL Δdf %ΔH(DV) ΔBIC 
Rku Rrd 1 53.14 548.21 
Rkd 1 18.64 186.83 
Rhe Rrd 1 17.45 174.39 
Nrb Rrd 2 17.13 162.69 
S Rrd 62 11.42 -399.60 
Fc Rrd 5 4.63 6.64 
Ageb Rrd 2 4.31 28.43 
Rdi Rrd 1 4.19 35.46 
Ruh Rrd 1 4.16 35.20 
Ad Rrd 27 3.43 -190.21 
 
Recall that the IV Nrb is a binned variable that tallies up the number of 
comorbidities a patient has upon admission, and says nothing about the specific 
comorbidities and their effects. The Nrb IV is tallied based on the presence or absence of 
the 912 potential Comorbidity IVs present in the original data set. Because the specific 
effect of individual or interactive Comorbidities are of interest, the Comorbidity only 
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search excludes Nrb and other All IVs and thus focuses explicitly on the potential effects 
of each individual comorbidity.  
 Comorbidity IVs 
o Coarse Searches (Models without Loops) 
In the next search, Comorbidity IVs alone were considered as possible predictors. 
The two predicting All IVs [Number of Risks Binned (Nrb) and Age Binned (Ageb)] from 
Table 20 are thus not included in the results from this search (Table 22). The 
Comorbidities IVs from Table 20 also show up—in the same order as in Table 20—as the 
most predictive single predictive IVs, and two additional single predicting IVs appear: 
aortic valve disorders (Rav), and coronary atherosclerosis of native coronary artery 
(Rca). 
While the results of the search including both All IVs resulted in the best model 
Nrb Cp by the BIC criterion with a %ΔH of 6.73 (Table 20), the results of this search 
yielded a best model in which other and unspecified hyperlipidemia (Ruh) and 
unspecified hypertensive renal disease (Rrd) together predict Complication (Cp) with a 
%ΔH of 5.04 Table 22 below. 
Table 22. Summary of Search Results (Knee) for Comorbidity IVs. 
Search covers directed coarse and fine models. 
MODEL Δdf ΔBIC %ΔH Alpha Variable description 
COARSE, single predictors           
Rrd Cp 1 43.04 3.11 0.00 Unspecified hypertensive renal disease (403.9) 
Rku Cp 1 39.63 2.91 0.00 Chronic kidney disease, unspecified (585.9) 
Ruh Cp 1 33.56 2.54 0.00 Other and unspecified hyperlipidemia (272.4) 
Raf Cp 1 11.46 1.20 0.00 Atrial fibrillation (427.31) 
Rhf Cp 1 10.79 1.16 0.00 Heart failure (428) 
Rhd Cp 1 9.90 1.11 0.00 Other chronic pulmonary heart disease (416.8) 
Ros Cp 1 9.81 1.10 0.00 Obstructive sleep apnea (327.23) 
Rdi Cp 1 8.45 1.02 0.00 Diabetes mellitus (250) 
Rav Cp 1 6.54 0.90 0.00 Aortic valve disorders (RISK 424.1) 
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MODEL Δdf ΔBIC %ΔH Alpha Variable description 
Rca Cp 1 6.48 0.90 0.00 
Coronary atherosclerosis of native coronary 
artery (RISK 414.01) 
MODEL Δdf ΔBIC %ΔH Alpha Variable description 
COARSE, IVs in AIC or BIC models but not in top 10 
Rro Cp (rank 18) 1 3.22 0.70 0.00 Rosacea (695.3) 
Rmo Cp (rank 19) 1 2.72 0.67 0.00 Morbid Obesity (278.01) 
Reg Cp (rank 20) 1 1.95 0.63 0.00 Esophagitis (530.1) 
Rlb Cp (rank 21) 1 1.95 0.63 0.00 Legal blindness (369.4) 
Rkd Cp (rank 22) 1 1.84 0.62 0.00 Chronic kidney disease, unspecified (585.9) 
Ruu Cp (rank 28) 1 -0.13 0.50 0.00 
Other disorders of urethra and urinary tract 
(599) 
Rpn Cp (rank 32) 1 -1.44 0.42 0.01 
Unspecified hereditary and idiopathic peripheral 
neuropathy (356.9) 
Rcb Cp (rank 36) 1 -2.59 0.35 0.02 Obstructive chronic bronchitis (491.2) 
Rpy Cp (rank41) 1 -3.11 0.32 0.02 Polymyalgia rheumatica (725) 
Rhe Cp (rank42) 1 -3.14 0.32 0.02 Unspecified essential hypertension (401.9) 
Rsy Cp (rank 44) 1 -3.33 0.31 0.02 Other synovitis and tenosynovitis (727.09) 
Rs Cp (rank 46) 1 -3.40 0.30 0.03 Sarcoidosis (135) 
Rtu Cp (rank 47) 1 -3.48 0.30 0.03 Tobacco use disorder (305.1) 
Rdf Cp (rank 48) 1 -4.05 0.26 0.04 Chronic diastolic heart failure (428.32) 
MODEL Δdf ΔBIC %ΔH Alpha Variable description 
COARSE, best model 
(loopless)           
ΔBIC (best model) 
Ruh Rrd Cp 3 58.21 5.04 0.00 
Other and unspecified hyperlipidemia (272.4), 
Unspecified hypertensive renal disease (403.9) 
ΔAIC (best model) 
Ruh Ros Raf Rku Cp 15.0 4.62 7.89 0.00 
Other and unspecified hyperlipidemia (272.4) + 
Obstructive sleep apnea (327.23) + Atrial 
fibrillation (427.31) + Chronic kidney disease, 
unspecified (585.9) 
Inc.P (best model) 
Ruh Ros Raf Rku Cp 15.0 4.62 7.89 0.00 
Other and unspecified hyperlipidemia (272.4) + 
Obstructive sleep apnea (327.23) + Atrial 
fibrillation (427.31) + Chronic kidney disease, 
unspecified (585.9) 
MODEL Δdf ΔBIC %ΔH Alpha Variable description 
FINE, best models 
(with loops)           
ΔBIC (best model) 
Ruh Raf Cp : Ros Cp : Rhd 
Cp : Rav Cp : Reg Cp : Rku 
Cp : Ruu Cp : Rro Cp 
10 87.76 10.39 0.00 
Other and unspecified hyperlipidemia (272.4) + 
Atrial fibrillation (427.31), Obstructive sleep 
apnea (327.23), Other chronic pulmonary heart 
disease (416.8), Aortic valve disorders (424.1), 
Esophagitis (530.1), Chronic kidney disease, 
unspecified (585.9), Other disorders of urethra 
and urinary tract (599), Rosacea (695.3) 
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MODEL Δdf ΔBIC %ΔH Alpha Variable description 
Inc.P & ΔAIC (same best model) 
Rs Cp : Ruh Raf Cp : Rmo 
Cp : Rtu Raf Cp : Ros Rhd 
Cp : Rpn Raf Cp : Rlb Cp : 
Rhe Rro Cp : Rhe Rsy Cp : 
Rca Cp : Rav Cp : Rdf Cp : 
Rcb Cp : Reg Cp : Rkd Cp : 
Rku Cp : Ruu Cp : Rpy Cp 
27 87.02 16.57 0.00 
Sarcoidosis (135), Other and unspecified 
hyperlipidemia (272.4) + Atrial fibrillation 
(427.31), Morbid Obesity (278.01), Tobacco use 
disorder (305.1) + Atrial fibrillation (427.31), 
Obstructive sleep apnea (327.23) + Other 
chronic pulmonary heart disease (416.8), 
Unspecified hereditary and idiopathic peripheral 
neuropathy (356.9) + Atrial fibrillation (427.31), 
Legal blindness (369.4), Unspecified essential 
hypertension (401.9) + Rosacea (695.3), 
Unspecified essential hypertension (401.9) + 
Other synovitis and tenosynovitis (727.09), 
Coronary atherosclerosis of native coronary 
artery (414.01), Aortic valve disorders (424.1), 
Chronic diastolic heart failure (428.32), 
Obstructive chronic bronchitis (491.2), 
Esophagitis (530.1), Chronic kidney disease, 
Stage III (585.3), Chronic kidney disease 
(585.9), Other disorders of urethra and urinary 
tract (599), Polymyalgia rheumatica (725) 
 
o Fine Searches (Models with Loops) 
Performing a search that allowed for loops with only Comorbidity IVs (Table 22) 
resulted in the best BIC model Ruh Raf Cp : Ros Cp : Rhd Cp : Rav Cp : Reg Cp : Rku 
Cp : Ruu Cp : Rro Cp, with a corresponding reduction in uncertainty of 10.39%, a very 
slight improvement over the model in Table 20, namely Ageb Cp : Nrb Cp : Ruh Cp : 
Rhd Cp : Rky Cp : Rro Cp, at a cost of an increase of complexity: Δdf = 10, compared 
to 8. The first component of this model, Ruh Raf Cp shows an interaction effect between 
Ruh and Raf in their combined effect on the DV. Thus, in the best model found that using 
Comorbidities IVs, other and unspecified hyperlipidemia (Ruh) and atrial fibrillation 
(Raf) form one predictive component, followed by obstructive sleep apnea (Ros), other 
chronic pulmonary heart disease (Rhd), aortic valve disorders (Rav), esophagitis (Reg), 
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chronic kidney disease, unspecified (Rku), other disorders of urethra and urinary tract 
(Ruu), and rosacea (Rro). 
Similar to the results from Table 20, the best model from Table 21, Ruh Raf Cp : 
Ros Cp : Rhd Cp : Rav Cp : Reg Cp : Rku Cp : Ruu Cp : Rro Cp, also excludes Rrd 
(the top single predicting variable in the Comorbidity only search). Just like the model in 
Table 20, the other variables in the model presumably cover the information in Rrd. 
 Comparing Search Results (Knee, Cp) 
The All IVs and the Comorbidity IVs searches yield two sets of results that can be 
compared to each other and interpreted with a 3-tiered classification of results, as 
described below and summarized in Table 23. 
Table 23. The 3-Tiered Classification of 
Predicting Variables for DV: 
Complication, Knee Analysis 
Tier Variables 
Tier 1 – Most Important Nrb, Ageb, Ruh, Rhd, Rku 
Tier 2 Reg, Raf, Ros, Rav, Ruu 
Tier 3 Rro 
 
Tier 1 contains variables from the best-by-BIC model from the dataset All IVs. 
This is the most complete search, and the one that provides the most conservative 
predictors. The selected variables (Nrb, Ageb, Ruh, Rhd, Rku, Rro) are shown in the first 
row of Table 23, and are considered the most important predicting variables.  
Tier 2 contains variables not in Tier1, but found in the AIC (less conservative) 
model of All IVs AND in the BIC model of Comorbidity IVs. For the Knee Analysis of 
DV Complication, this selects the variables Reg, Raf, Ros, Rav, Ruu as the next-most 
important predicting variables. These are shown in the second row of Table 23. 
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Finally, this classification places into Tier 3 any variables present elsewhere in the 
best model search results, but not included in Tier 1 or Tier 2. That is, any variables 
unique to one of the two searches: variables in the AIC model of All IVs but not in the 
BIC model of Comorbidity IVs, as well as variables in the BIC model of Comorbidity IVs 
but not in the AIC model from All IVs. In this case, there were no variables that met these 
specifications. Strictly speaking, by the criteria set forth for Tier 1, Rro should have been 
included, but it has been “demoted” to Tier3 for reasons that will be explained below. 
 Model FIT 
Having found a best model, the next step is to analyze its detailed content; i.e., the 
conditional probability distribution for the DV, given the predicting IVs. This distribution 
is shown in Table 24 below, for the best fine-grained model from the search with All IVs, 
namely Ageb Cp : Nrb Cp : Ruh Cp : Rhd Cp : Rku Cp : Rro Cp. The columns of the 
table are: the model number, to be able to refer to models easily; the six IVs in the model 
and their different states; the frequency of each particular IV (vector) state; the 
conditional probability p(Cp = 0|IV) and p(Cp = 1|IV) in the data given as percentages 
(so they add up to 100%); these two conditional probabilities in the model (which is an 
approximation to the data) written as q(Cp = 0|IV) and q(Cp = 1|IV); the “risk ratio” of 
q(Cp = 1|IV) / q(Cp = 1); i.e., the probability of complications for a particular IV state 
divided by the marginal probability of complications for the whole sample. So, for 
example, the first row specifies the IV state (Ageb, Nrb, Ruh, Rhd, Rku, Rro) = 
(1,1,0,0,0,0), which occurs 502 times in the sample, for which the conditional 
probabilities for the data (p) and the model (q) are given in percent, where ratio 
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0.19 = 0.89/4.73, and where the p-value for the comparison of (99.11, 0.89) to the 
margins (95.27, 4.73) is 0. The “risk ratio” conveys the effect size, while the p-value 
conveys the significance of the effect size. The p-values are important and are used to 
retain significant results only; however, it is the ratio—the effect size—that is used in 
selecting the states that result in an effect, either protective (blue) or risky (orange), 10% 
above or below the risk ratio of 1. 
Table 24. Full Fit Table (Knee) All IVs for Best Model: 
Ageb Cp : Nrb Cp : Ruh Cp : Rhd Cp : Rku Cp : Rro Cp. 
Blue rows indicate ratio < 0.90 and orange rows indicate ratio > 1.10. 
(Ratios between 0.91 and 1.09 are close to the margins and are indicated in gray.) 
IVs Data Model 
 
  
obs. p(DV|IV) calc. q(DV|IV) 
 # Ageb Nrb Ruh Rhd Rku Rro freq Cp=0 Cp=1 Cp=0 Cp=1 ratio p(margin) 
1 1 1 0 0 0 0 502 99.00 1.00 99.11 0.89 0.19 0.00 
2 1 1 1 0 0 0 1 100.00 0.00 98.46 1.54 0.33 0.88 
3 1 2 0 0 0 0 457 98.69 1.31 97.77 2.24 0.47 0.01 
4 1 2 0 0 0 1 1 100.00 0.00 80.86 19.14 4.05 0.50 
5 1 2 0 0 1 0 2 100.00 0.00 91.86 8.14 1.72 0.82 
6 1 2 0 1 0 0 1 0.00 100.00 87.38 12.62 2.67 0.71 
7 1 2 1 0 0 0 34 91.18 8.82 96.17 3.83 0.81 0.81 
8 1 3 0 0 0 0 380 96.05 3.95 95.90 4.10 0.87 0.56 
9 1 3 0 0 0 1 1 100.00 0.00 69.34 30.66 6.48 0.22 
10 1 3 0 0 1 0 8 100.00 0.00 85.80 14.20 3.00 0.24 
11 1 3 0 1 0 0 2 100.00 0.00 78.75 21.25 4.49 0.27 
12 1 3 1 0 0 0 96 89.58 10.42 93.07 6.93 1.47 0.31 
13 1 3 1 0 0 1 1 100.00 0.00 56.47 43.53 9.21 0.07 
14 1 3 1 0 1 0 3 66.67 33.33 77.61 22.39 4.74 0.15 
15 1 3 1 1 0 0 1 0.00 100.00 68.01 31.99 6.77 0.20 
16 2 1 0 0 0 0 421 99.29 0.71 98.78 1.22 0.26 0.00 
17 2 1 0 1 0 0 1 100.00 0.00 92.78 7.22 1.53 0.91 
18 2 1 1 0 0 0 6 100.00 0.00 97.90 2.10 0.44 0.76 
19 2 2 0 0 0 0 420 96.91 3.10 96.96 3.04 0.64 0.10 
20 2 2 1 0 0 0 50 90.00 10.00 94.82 5.18 1.10 0.88 
21 2 3 0 0 0 0 349 93.98 6.02 94.47 5.53 1.17 0.48 
22 2 3 0 0 0 1 3 33.33 66.67 62.26 37.74 7.98 0.01 
23 2 3 0 0 1 0 10 60.00 40.00 81.51 18.49 3.91 0.04 
24 2 3 0 1 0 0 3 66.67 33.33 73.00 27.00 5.71 0.07 
25 2 3 0 1 1 0 1 100.00 0.00 41.10 58.90 12.46 0.01 
26 2 3 1 0 0 0 137 95.62 4.38 90.74 9.26 1.96 0.01 
27 2 3 1 0 1 0 9 44.44 55.56 71.66 28.34 5.99 0.00 
28 2 3 1 1 0 0 1 100.00 0.00 60.80 39.21 8.29 0.11 
29 3 1 0 0 0 0 376 97.87 2.13 98.11 1.90 0.40 0.01 
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30 3 1 1 0 0 0 2 50.00 50.00 96.74 3.26 0.69 0.92 
31 3 2 0 0 0 0 447 95.08 4.92 95.32 4.68 0.99 0.96 
32 3 2 0 0 0 1 1 0.00 100.00 66.30 33.71 7.13 0.17 
33 3 2 0 0 1 0 7 100.00 0.00 84.01 15.99 3.38 0.19 
34 3 2 1 0 0 0 54 94.44 5.56 92.11 7.89 1.67 0.27 
35 3 3 0 0 0 0 341 90.62 9.38 91.60 8.41 1.78 0.00 
36 3 3 0 0 0 1 2 100.00 0.00 51.29 48.71 10.30 0.00 
37 3 3 0 0 1 0 28 75.00 25.00 73.77 26.23 5.55 0.00 
38 3 3 0 1 0 0 7 57.14 42.86 63.31 36.70 7.76 0.00 
39 3 3 0 1 1 0 1 100.00 0.00 30.81 69.19 14.63 0.00 
40 3 3 1 0 0 0 148 87.84 12.16 86.21 13.79 2.92 0.00 
41 3 3 1 0 0 1 1 0.00 100.00 37.65 62.35 13.19 0.01 
42 3 3 1 0 1 0 18 66.67 33.33 61.74 38.26 8.09 0.00 
43 3 3 1 1 0 0 2 50.00 50.00 49.74 50.26 10.63 0.00 
       
4336 95.27 4.73 95.27 4.73 1.00 
 
# Ageb Nrb Ruh Rhd Rku Rro freq Cp=0 Cp=1 Cp=0 Cp=1 ratio p(margin) 
  
The values for the All IVs: number of risks binned (Nrb) and age binned (Ageb) 
are either states 1, 2, or 3 and are the three bins that the data was discretized to. Bin 
ranges and frequencies are summarized in Table 25 and Table 26 below. With three states 
possible for each of Ageb and Nrb, and two states possible for each of Ruh, Rhd, Rku and 
Rro, one might expect to see 144 rows—one row for each possible combination of states. 
However, fit tables don’t show rows for IV states that did not occur in the data. In 
Table 24, for example, instead of 144 rows there are 43 rows. Additionally, fit tables in 
the remainder of the results section will include only the rows that meet the protocol of 
this project, which requires a frequency of 10 or more and a p(margin) of 0.05 or less. 
Table 25. Number of Risks (Nrb) 
Bin Range & Frequency (Knee) 
Bin Range Frequency 
1 0-1 1309 
2 2-3 1474 
3 4-18 1553 
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Table 26. Age Binned (Ageb) Bin Range 
& Frequency (Knee). 
Bin Range Frequency 
1 32-62 1,490 
2 63-71 1,411 
3 72-95 1,435 
 
For the independence model, which is the reference, we do not know the state of 
Ageb or Nrb or if a comorbidity was present, so all of the uncertainty of the DV comes 
from its marginal distribution, which is the last line of the table, for which the data and 
model conditional probabilities are the same. For the calculated model, knowing the bin 
states of All IVs (Nrb, Ageb) or the presence or absence of the individual Comorbidity IVs 
(Ruh, Rhd, Rku, Rro) tells us about the probability of Cp occurring. The model 
conditional probabilities are more appropriate to use than the observed (data) conditional 
probabilities because the model is simpler than the data and thus generalizes better.  
Each of the model’s components, namely Ageb Cp or Nrb Cp or Ruh Cp or Rhd 
Cp or Rku Cp or Rro Cp, has an individual conditional probability distribution and is 
individually informative.  Table 27 is a compressed table summarizing the conditional 
probability distributions for one component only. For example, looking only at Age 
(Table 27), the conditional probability of Cp = 1 given Ageb = 1 is 2.82% with the risk 
ratio of 0.60 (row 9), Ageb = 2 has a neutral risk ratio close to 1 and was excluded, and 
Ageb = 3 shows increased risk with a ratio = 1.52 (row 6). In other words, knowing only 
Ageb, regardless of the states of the other IVs in the model, there is a significant 
difference in the probability of Cp = 1; i.e., a significant difference in the probability of 
complications between the Ageb values—a decrease in risk for the low bin and an 
increase in risk for the high bin. 
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The individual model component’s projections alone do not explain the DV as 
fully as the joint probability distribution (the calculated distribution of the entire model). 
Table 27 shows that Ageb high (bin = 3) predicts an increase in risk; yet in the table for 
the model that combines these components (Table 24), Ageb = 3 appears in row 29 along 
with Nrb = 1 and Ruh, Rhd, Rku and Rro all absent that has a significantly reduced risk 
ratio of 0.40. This is supported by Table 28, which looks at the Nrb Cp component alone, 
which suggests that when Nrb = 1, the risk is reduced (ratio = 0.27) as compared to when 
Nrb = 3 and the risk is increased (ratio = 1.82). On the other hand, when Ruh, Rhd, Rku 
and Rro are present, the risk increases with a sizeable effect, as seen in the condensed 
component table (Table 29) for the model’s comorbidity components (ratio = 2.29, 7.40, 
5.59, and 8.46, respectively).   
Table 27.  Component Fit Table for IVAgeb in (Knee) All IVs Best Model: 
Ageb Cp : Nrb Cp : Ruh Cp : Rhd Cp : Rku Cp : Rro Cp. 
Blue rows indicate ratio < 0.90 and orange rows indicate ratio > 1.10. 
(Ratios between 0.91 and 1.09 are close to the margins and are excluded.) 
 
IV Data obs. p(DV|IV) 
  
# Ageb freq Cp=0 Cp=1 Ratio p(margin) 
1 1 1490 97.18 2.82 0.60 0.00 
3 3 1435 92.82 7.18 1.52 0.00 
  
4336 95.27 4.73 1.00 
 
 
Table 28. Component Fit Table for IV Nrb in (Knee) All IVs Best Model: 
Ageb Cp : Nrb Cp : Ruh Cp : Rhd Cp : Rku Cp : Rro Cp. 
Blue rows indicate ratio < 0.90 and orange rows indicate ratio > 1.10. 
(Ratios between 0.91 and 1.09 are close to the margins and are excluded.) 
 
IV Data obs. p(DV|IV) 
  
# Nrb freq Cp=0 Cp=1 Ratio p(margin) 
1 1 1309 98.70 1.30 0.27 0.00 
2 2 1474 96.34 3.66 0.77 0.05 
3 3 1553 91.37 8.63 1.82 0.00 
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Table 29. Condensed Fit Table of Comorbidity Components for 
IVs Ruh, Rhd, Rku, Rro in (Knee) All IVs Best Model: 
Ageb Cp : Nrb Cp : Ruh Cp : Rhd Cp : Rku Cp : Rro Cp. 
Blue rows indicate ratio < 0.90 and orange rows indicate ratio > 1.10. 
(Ratios between 0.91 and 1.09 are close to the margins and are excluded.) 
  
Data obs. p(DV|IV) 
  
IV State freq Cp=0 Cp=1 Ratio p(margin) 
Ruh 0 3772 96.18 3.82 0.81 0.01 
Ruh 1 564 89.18 10.82 2.29 0.00 
Rhd 1 20 65.00 35.00 7.40 0.00 
Rku 1 87 73.56 26.44 5.59 0.00 
Rro 1 10 60.00 40.00 8.46 0.00 
  
4336 95.27 4.73 1.00 
 
 
The marginal distribution (last line) of the integrated Table 24 above shows that 
in the total population of 4,336 knee replacement cases, Complication (Cp) was actually 
present (observed) in 4.73% and was absent in 95.27% of the cases. If the conditional 
probabilities for particular IV states are higher or lower than the margins, then the IVs 
have provided new (predictive) information. Looking at the conditional probabilities of 
the model in Table 24 shows a number of rows whose calculated probabilities appear 
very different from the margins (the blue and orange shaded cells).  
For Table 24, rows are highlighted with p(margin) ≤ 0.05 and frequency > 10. 
The distribution for Cp is highly skewed, since Cp = 1 occurs in only 4.73% of the cases; 
therefore, only if a model predicts more than 50% chance of Cp = 1 will the prediction 
rule be to predict “yes” for Cp. This occurs only for IV states where the frequencies are 
1 or 2 (rows 25, 39, and 41), and predictions with such low frequencies are here judged 
not significant even if their calculated p-values are under the typical 0.05 threshold 
(because of their extreme difference from the margins). In fact, in the tiered search results 
(Table 23) Rro had been demoted from Tier 1 to Tier 3 precisely for this reason. Rro did 
not appear in any of the IV states after the removal of IV states with a frequency < 10 
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even though the p-value had been significant. Aside from these very low-frequency IV 
states, the model distribution always predicts Cp = 0, which is just what the marginal 
distribution predicts even without any IV information. What the model predicts beyond 
the independence model is the risk of occurrence. While there were no IV states with 
sizeable frequencies that predicted greater than 50% probability of Cp = , there are 
probabilities that are significantly different than the margins, which demonstrate either 
a protective effect (< 4.73%) or a higher risk of Cp = 1 (> 4.73%). These effects are 
indicated in the column labeled “ratio” which is model q(DV|IV) for Cp = 1 divided by 
its marginal q(DV) value. It is the probability of a complication for a type of patient 
divided by probability of complication for the full sample. When this ratio is < 0.90 
(and is statistically significant), risk is reduced (blue cells); when the ratio is > 1.10 
(and statistically significant), risk is increased (orange cells). 
Row 1 (Table 24), for example, shows a protective effect of age binned 
(Ageb) < 63 (bin = 1) and number of risks binned (Nrb) is low (bin = 1) with number of 
risks ≤ 1 with the probability of Cp = 1 at 0.89% (ratio = 0.19), markedly lower than the 
margin of 4.73%. Row 16 shows a similar protective effect, where even with Ageb range 
63–71 (bin 2), as long as Nrb < 1 (bin 1), the probability is 1.22%, which is lower than 
the margin (ratio = 0.26). Row 29 (Table 24) also offers a protective effect where even 
with Ageb range 72–95 (bin3) as long as Nrb < 1 (bin 1), then the probability of Cp = 1 
is still lower than the margin at 2.13% (ratio = 0.40). Row 3 (Table 24) shows that even 
where there is an increase in number of comorbidities with Nrb = 2 or 3 (bin 2), when 
Ageb = 1, there is still a protective effect with probability of Cp = 1 of 2.24% 
(ratio = 0.47). 
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In each of these three cases where there was a protective effect, the four 
Comorbidity IVs, Ruh, Rhd, Rku and Rro, were all absent. To recapitulate: the results 
show that if these Comorbidity IVs are absent and Nrb = 1, then Ageb can be in any of its 
three potential states and the risk is still low. Risk is also reduced if Ruh, Rhd, Rku and 
Rro are not present, even if there are more comorbidities present (Nrb = 2), if the age is 
low (Ageb = 1). 
Row 35 (Table 24) shows IV states that predict higher risk of Cp = 1. With Ageb 
72–95 (bin 3), and Nrb between 4 and 18 (bin 3), there is a higher probability of Cp at 
8.41% (ratio = 1.78). In this state, there was no presence of one of the four Comorbidity 
IVs (Ruh, Rhd, Rku & Rro). In row 23, however, with the presence of Rku and with lower 
Ageb 63–71 (bin 2), and with Nrb again between 4 and 18 (bin 3), the risk of Cp is 
18.49% (ratio = 3.91). 
Compare row 35 also with row 37 in Table 24 (freq = 28), where again Ageb = 3 
and Nrb = 3, but Rku is present and we get a much higher risk ratio of 5.5, a 0.2623 
probability of Cp = 1 which is over five times the risk of the whole sample. 
One way of summarizing the model predictions is through the use of a decision 
tree. The decision tree provides an operational branching of questions one could ask, and 
the answers that result. Before looking at the decision tree for model Ageb Cp : Nrb Cp : 
Ruh Cp : Rhd Cp : Rku Cp : Rro Cp, three decision trees are shown for a much simpler 
model in order to explain the meaning of the decision tree and show how these decision 
trees will be constructed for the remainder of the analyses. In this example, the best BIC 
model from the All IVs loopless model search (Table 20) is used: Nrb Rku Cp. The fit 
table for this model is shown in Table 30 below. 
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Table 30. Fit Table (Knee) All IVs for Best Coarse Model: Nrb Rku Cp. 
Blue rows indicate ratio < 0.90 and orange rows indicate ratio > 1.10. 
(IV states with frequency < 10 are not highlighted.) 
 IVs Data Model  
   obs. p(DV|IV) calc. q(DV|IV)  
# Nrb Rku freq Cp=0 Cp=1 Cp=0 Cp=1 ratio p(margin) 
1 1 0 1309 98.70 1.30 98.70 1.30 0.27 0.00 
2 2 0 1465 96.31 3.69 96.31 3.69 0.78 0.06 
3 2 1 9 100.00 0.00 100.00 0.00 0.00 0.53 
4 3 0 1475 92.48 7.53 92.48 7.53 1.59 0.00 
5 3 1 78 70.51 29.49 70.51 29.49 6.24 0.00 
 
  
4336 95.27 4.73 95.27 4.73 1.00 
  
These results from the fit table can be communicated in a decision tree. The full 
decision tree, showing all possible combinations of IV states, is not included in this 
project as the relevance and size are prohibitive. The decision trees used in this project 
omit IV states that are not observed (Nrb = 1, Rku = 1) or whose distribution is not 
significantly different from the marginal distribution. The protocol in this project selects 
only scenarios with a frequency ≥ 10 and a p(margin) ≤ 0.05, and these rows were 
excluded in the fit tables as well as the corresponding branching on the decision trees. 












Figure 5. Simplified Decision Tree for DV Any Comp (Knee) All IVs, 
for Best Coarse Model Nrb Rku Cp. 
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The decision tree for model Ageb Cp : Nrb Cp : Ruh Cp : Rhd Cp : Rku Cp : 
Rro Cp (Table 24) is shown in Figure 6. Note that while Rro appears in the BIC model, 
none of the IV states in this table involving Rro = 1 meets the criterion of p-value < 0.05 
and freq  10.  For this reason, Rro does not appear in the decision tree (Figure 6). 
 
Figure 6. Decision Tree for DV Any Comp (Knee) All IVs for Best Model 
Ageb Cp : Nrb Cp : Ruh Cp : Rhd Cp : Rku Cp : Rro Cp. 
 
The decision tree in Figure 6 shows clearly that regardless of Age (Ageb = 1, 2, 
or 3), as long as number of risks are low (Nrb = 1) then the risk of Complication Cp is 
substantially lower than 1. If a patient has two or three comorbidities (Nrb = 2), there is 
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still lower risk as long as the patient is in the lowest age group (Ageb = 1), which is 62 
and younger.  
The details of the best fine BIC model from the Comorbidity only search, 
Ruh Raf Cp : Ros Cp : Rhd Cp : Rav Cp : Reg Cp : Rku Cp : Ruu Cp : Rro Cp 
(Table 22), are given in Table 31. The Comorbidity IVs, Ruh, Ros, Rhd, Rav, Raf, Reg, 
Rku, Ruu, Rro, are listed in the nine IV columns. As discussed with Table 24, the 
probabilities of Cp = 1 may differ significantly from the model’s marginal probabilities. 
Each of the IVs is either 0 (comorbidity absent) or 1 (comorbidity present). In Table 31, 
only p(margin) < .05 are shown due to the size of the table.  
Row 1 (Table 31) is the case where all of the Comorbidity IVs are absent, with a 
frequency of 3,311. Having none of these comorbidities lowers the risk ratio to 0.57, 
where having any one of the comorbidities increases the risk of Cp. There are a few cases 
where having a particular comorbidity increases risk of Cp = 1 substantially, such as is 
seen in rows 4 (ratio = 3.07), 6 (ratio = 1.9), 9 (ratio = 2.88), 24 (ratio = 7.32), and 29 
(ratio = 3.57). 
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Table 31. Fit Table (Knee) with Comorbidity IVs for Best Model 
Ruh Raf Cp : Ros Cp : Rhd Cp : Rav Cp : Reg Cp : Rku Cp : Ruu Cp : Rro Cp. 
Blue rows indicate ratio < 0.90 and orange rows indicate ratio > 1.10. 
IVs Data Model  





























freq Cp=0 Cp=1 Cp=0 Cp=1 ratio p(margin) 
1 0 0 0 0 0 0 0 0 0 3311 97.37 2.63 97.30 2.70 0.57 0.00 
2 0 0 0 0 0 0 1 0 0 45 82.22 17.78 85.46 14.54 3.07 0.00 
3 0 0 0 0 1 0 0 0 0 184 92.39 7.61 91.03 8.97 1.90 0.01 
4 1 0 0 0 0 0 0 0 0 442 92.08 7.92 92.07 7.93 1.68 0.00 
5 1 0 0 0 0 0 1 0 0 25 64.00 36.00 65.41 34.59 7.32 0.00 
6 1 1 0 0 0 0 0 0 0 35 82.86 17.14 83.11 16.89 3.57 0.00 
          
4336 95.27 4.73 95.27 4.73 1.00 
 
 
 The decision tree for Table 31 (Figure 7) shows that when unspecified 
hyperlipidemia (Ruh) is present, regardless of the states of the other Comorbidity IVs in 
the model, there is an increased risk of Cp. In fact, the only protective effect offered 
against Cp occurring is to have none of the Comorbidity IVs. Having only 1 on the 
Comorbidity IVs Ruh, Rku, Ros, or Raf results in an increased risk ratio. The presence of 
both Ruh and Rku leads to the highest risk ratio of 7.32.  
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Figure 7. Decision Tree for DV Any Comp (Knee) with Comorbidity IVs for Best Model 
Ruh Raf Cp : Ros Cp : Rhd Cp : Rav Cp : Reg Cp : Rku Cp : Ruu Cp : Rro Cp. 
 
Each of the model’s components (Ruh, Ros, Rhd, Rav, Raf, Reg, Rku, Ruu, Rro), 
shown below, is individually informative in its conditional probability distribution. To 
illustrate with one of these components, Table 32 shows that when both Ruh and Raf 
(one component with two IVs, showing an interaction effect) are absent, there is a 
protective effect with a risk ratio of 0.71. The risk ratio of Cp increases when either Ruh 
or Raf is present (2.3 and 2.45, respectively), and when they are both present (2.2). It 
might seem odd that the ratio is lower when both are present than when only one is 
present, but the differences between these ratio values are probably not statistically 
significant.  Table 33 shows the conditional probability distribution, with highest risk 
ratio at the top, of the other components in the model. 
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Table 32. Component Fit Table for IVs Ruh Raf (Knee) Comorbidity IVs Best Model  
Ruh Raf Cp : Ros Cp : Rhd Cp : Rav Cp : Reg Cp : Rku Cp : Ruu Cp : Rro Cp. 
Blue rows indicate ratio < 0.90 and orange rows indicate ratio > 1.10. 
 IVs Data obs. p(DV|IV)   
# Ruh Raf freq Cp=0 Cp=1 ratio p(margin) 
1 0 0 3565 96.63 3.37 0.71 0.00 
2 0 1 207 88.41 11.59 2.45 0.00 
3 1 0 516 89.15 10.85 2.30 0.00 
4 1 1 48 89.58 10.42 2.20 0.06 
   
4336 95.27 4.73 1.00 
 
 
Table 33. Condensed Component Fit Table for IVs Ruh Raf (Knee) Comorbidity IVs 
Best Model Ruh Raf Cp : Ros Cp : Rhd Cp : Rav Cp : Reg Cp : Rku Cp : Ruu Cp : Rro Cp. 
Orange rows indicate ratio > 1.10. 
(Ratios between 0.91 and 1.09 are close to the margins and are excluded.) 
   Data obs. p(DV|IV)   
# IV IV State freq Cp=0 Cp=1 ratio p(margin) 
1 Reg 1 6 50 50 10.58 0.00 
2 Rro 1 10 60 40 8.46 0.00 
3 Ruu 1 8 62.5 37.5 7.93 0.00 
4 Rhd 1 20 65 35 7.4 0.00 
5 Rku 1 87 73.56 26.44 5.59 0.00 
6 Rav 1 33 75.76 24.24 5.13 0.00 
7 Ros 1 225 88.44 11.56 2.44 0.00 
   




In this portion of the results section, a similar series of results to the knee analysis 
are presented. Here, two sets of results are again produced: (a) All IVs and 
(b) Comorbidity IVs. The hip data set contains the same eight administrative All IVs but a 
different set of Comorbidity IVs. 
 All IVs 
o Coarse Searches (Models without Loops) 
The hip data set, with 3,205 cases, originally had 170 Comorbidity IVs. A loopless 
search for individually predictive variables provided the rationale in reducing the total 
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Comorbidity IVs. Individually predictive variables were kept in addition to the 
Comorbidity IVs that were found to be predictive in the literature. The resulting data set 
consisted of 45 variables. The top 10 predicting variables are below in Table 34. 
Table 34. Summary of Search Results for All IVs for DV Complication (Hip). 
Search covers directed coarse and fine models. All p values = 0. 
MODEL Δdf ΔBIC %ΔH Variable description 
COARSE, single predictors (top 10) 
Nrb Cp 2 70.88 6.72 Number of risks (binned) 
S Cp 42 -272.10 5.17 Surgeon 
Ad Cp 38 -246.01 4.69 Admit diagnosis 
Ageb Cp 2 38.11 4.19 Age (binned) 
Rrd Cp 1 38.60 3.61 Unspecified hypertensive renal disease (403.9) 
Fc Cp 5 1.35 3.22 Financial class 
Rca Cp 1 27.91 2.78 
Coronary atherosclerosis of native coronary artery 
(414.01) 
Ruh Cp 1 27.11 2.72 Other and unspecified hyperlipidemia (272.4) 
Rku Cp 1 21.67 2.30 Chronic kidney disease, unspecified (585.9) 
Rpl Cp 1 19.16 2.10 Hyperplasia of prostate (600) 
MODEL Δdf ΔBIC %ΔH Variable description 
COARSE, IVs in AIC or BIC models but not in top 10 
Rhd Cp (rank 11) 1 14.76 1.76 Other chronic pulmonary heart disease (416.8) 
Rgp Cp (rank 25) 1 -0.25 0.60  Repair of cystocele with graft or prosthesis (70.54) 
MODEL Δdf ΔBIC %ΔH Variable description 
COARSE, best model (loopless) 
ΔBIC (best model) 
Nrb Rrd Cp 5 71.05 8.61 
Number of risks (binned), Unspecified hypertensive 
renal disease (403.9) 
Inc.P & ΔAIC (same best model) 
Ageb Nrb Cp 2 66.21 10.10 Age (binned), Number of risks (binned) 
MODEL Δdf ΔBIC %ΔH Variable description 
FINE, best models (with loops) 
ΔBIC (best model) 
Ageb Cp : Nrb Cp : Rrd Cp : 
Rca Cp : Rhd Cp : Rpl Cp 
8 109.68 13.46 
Age (binned), Number of risks (binned), Unspecified 
hypertensive renal disease (403.9), Coronary 
atherosclerosis of native coronary artery (414.01), 
Other chronic pulmonary heart diseases (416.8), 
Hyperplasia of prostate (600) 
Inc.P & ΔAIC  (same best model) 
Ageb Cp :Nrb Cp : Rrd Cp : 
Rca Cp : Rhd Cp : Rpl Cp : 
Rgp Cp 
9 109.23 14.05 
Age (binned), Number of risks (binned), Unspecified 
hypertensive renal disease (403.9), Coronary 
atherosclerosis of native coronary artery (414.01), 
Other chronic pulmonary heart diseases (416.8), 
Hyperplasia of prostate (600), Repair of cystocele 
with graft or prosthesis (70.54) 
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Looking at the single predicting variables, simply knowing the total number of 
comorbidities a patient had (Nrb) reduces the uncertainty in predicting Complication 
(Cp) by 6.72%. Knowing only the surgeon (S) that performed the surgery reduces 
uncertainty by 5.17%, admit diagnosis (Ad) by 4.69% and age (Ageb) by 4.19%. The 
first predictive individual comorbidity is hypertensive renal disease (Rrd) which reduces 
uncertainty by 3.61%, and so on. The best loopless coarse model shows that knowing 
both Nrb and Rrd reduces the uncertainty by 8.61%.   
o Fine Searches (Models with Loops) 
As with the knee analysis, a fine-grained search has allowed for multiple 
components in the prediction of Complication (Cp). While this type of search allows for 
the detection of interaction effects, none were discovered in the best models for this 
search. There are 6 single predicting variables in the best BIC fine-grained model Ageb 
Cp : Nrb Cp : Rrd Cp : Rca Cp : Rhd Cp : Rpl Cp. Five of these variables are in the 
top 10 as seen in Table 41 above, and the sixth, Rhd, is the 11th single predicting 
variable. While one might expect to see the more predictive of the single predicting 
variables included in the best fine-grained BIC model, the variables surgeon (S), admit 
diagnosis (Ad), financial class (Fc) and the two Comorbidity IVs hyperlipidemia (Ruh) 
and chronic kidney disease (Rku) did not make it into the best BIC model. Any predictive 
effects offered by these variables may overlap with those of the variables already in the 
model, and so be excluded, or the effects may not improve the model enough to balance 
the cost that each incurs in increased complexity. The next variable that added new 
information was chronic pulmonary heart disease (Rhd). 
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 Comorbidity IVs 
o Coarse Searches (Models without Loops) 
The most predictive Comorbidity IVs (top 10) are listed below in Table 35, which 
shows the search results including only the Comorbidity IVs. The comorbidities are in the 
same order as in Table 34 but show additional predictive comorbidities that were in a 
sense hidden by the more predictive All IVs Ageb and Nrb.  
Table 35. Summary of Search Results for Comorbidity IVs (Hip). 
Search covers directed coarse, and fine models. 
MODEL Δdf ΔBIC %ΔH Alpha Variable description 
COARSE, single 
predictors     
  
Rrd Cp 1 38.60 3.61 0.00 Unspecified hypertensive renal disease (403.9) 
Rca Cp 1 27.91 2.78 0.00 
Coronary atherosclerosis of native coronary artery 
(414.01) 
Ruh Cp 1 27.11 2.72 0.00 Other and unspecified hyperlipidemia (272.4) 
Rku Cp 1 21.67 2.30 0.00 Chronic kidney disease, unspecified (585.9) 
Rpl Cp 1 19.16 2.10 0.00 Hyperplasia of prostate (600) 
Rhd Cp 1 14.76 1.76 0.00 Other chronic pulmonary heart diseases (416.8) 
Rdi Cp 1 13.79 1.69 0.00 Diabetes mellitus (250) 
Rkd Cp 1 11.98 1.55 0.00 
Chronic kidney disease, Stage III (moderate) 
(585.3) 
Raf Cp 1 11.35 1.50 0.00 Atrial fibrillation (427.31) 
Rck Cp 1 6.55 1.13 0.00 Anemia in chronic kidney disease (285.21) 
MODEL Δdf ΔBIC %ΔH Alpha Variable description 
COARSE, IVs in AIC or BIC models but not in top 10 
Rhe Cp (rank 12) 1 4.52 0.97 0.00 Unspecified essential hypertension (401.9) 
Rhh Cp (rank15) 1 2.96 0.85 0.00 Hyposmolality and/or hyponatremia (276.1) 
Ram Cp (rank 17) 1 1.81 0.76 0.00 Unspecified deficiency anemia (281.9) 
Rgp Cp (rank 19) 1 -0.25 0.60 0.00 Repair of cystocele with graft or prosthesis (70.54) 
Rfr Cp (rank 23) 1 -1.02 0.54 0.01 Nonunion of fracture (733.82) 
Rra Cp (rank 26) 1 -1.68 0.49 0.01 Alcohol abuse, in remission (305.03) 
MODEL Δdf ΔBIC %ΔH Alpha Variable description 
COARSE, best model 
(loopless) 
          
ΔBIC (best model) 
Rrd Rca Cp 3 52.96 5.96 0.00 
Unspecified hypertensive renal disease (403.9), 
Coronary atherosclerosis of native coronary artery 
(414.01),  
ΔAIC (best model) 
Ruh Rrd Rca Rpl Cp 15 8.98 10.05 0.00 
Other and unspecified hyperlipidemia (272.4), 
Unspecified hypertensive renal disease (403.9), 
Coronary atherosclerosis of native coronary artery 
(414.01), Hyperplasia of prostate (600) 
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With the All IVs included, the best coarse model by the BIC criterion was Nrb Rrd 
Cp, which had a %ΔH of 8.61. The best coarse model in the Comorbidity IVs search is 
Rrd Rca Cp, with a %ΔH of 5.96. Hypertensive renal disease (Rrd) in fact is the top 
single predicting comorbidity in both hip and knee searches, and is included in the best 
BIC model for loopless searches. In the knee data set, Ruh was predictive and was 
included in the best loopless model along with Rrd. Just as in the knee data set, in the hip 
data set Ruh is the third most predictive single variable. In the hip search results Ruh is 
Inc.P (best model) 
Ruh Rrd Rca Raf Rpl Cp 31 -93.15 12.14 0.01 
Other and unspecified hyperlipidemia (272.4), 
Unspecified hypertensive renal disease (403.9), 
Coronary atherosclerosis of native coronary artery 
(414.01), Atrial fibrillation (427.31), Hyperplasia 
of prostate (600) 
MODEL Δdf ΔBIC %ΔH Alpha Variable description 
FINE, best models 
(with loops) 
          
ΔBIC (best model) 
Rdi Cp : Ruh Cp : Rhh 
Cp : Ram Cp : Rra Cp : 
Rhe Cp : Rrd Cp : Rca 
Cp : Rhd Cp : Rpl Cp : 
Rgp Cp : Rfr Cp 
12 101.79 15.35 0.00 
Diabetes mellitus (250), Other and unspecified 
hyperlipidemia (272.4), Hyposmolality and/or 
hyponatremia (276.1), Unspecified deficiency 
anemia (281.9), Alcohol abuse, in remission 
(305.03), Unspecified essential hypertension 
(401.9), Unspecified hypertensive renal disease 
(403.9), Coronary atherosclerosis of native 
coronary artery (414.01), Other chronic 
pulmonary heart diseases (416.8), Hyperplasia of 
prostate (600), Repair of cystocele with graft or 
prosthesis (70.54), Nonunion of fracture (733.82) 
Inc.P & ΔAIC (same best model) 
Rdi Cp : Ruh Cp : Rhh 
Cp : Ram Cp : Rra Cp : 
Rhe Cp : Rrd Cp : Rca 
Cp : Rhd Cp : Raf Cp : 
Rpl Cp : Rgp Cp : Rfr 
Cp 
13 100.13 15.84 0.01 
Diabetes mellitus (250), Other and unspecified 
hyperlipidemia (272.4), Hyposmolality and/or 
hyponatremia (276.1), Unspecified deficiency 
anemia (281.9), Alcohol abuse, in remission 
(305.03), Unspecified essential hypertension 
(401.9), Unspecified hypertensive renal disease 
(403.9), Coronary atherosclerosis of native 
coronary artery (414.01), Other chronic 
pulmonary heart diseases (416.8), Atrial 
fibrillation (427.31), Hyperplasia of prostate 
(600), Repair of cystocele with graft or prosthesis 
(70.54), Nonunion of fracture (733.82) 
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not selected by BIC but rather is selected by the AIC criterion as a predicting component 
in the loopless search. More comparisons between the hip and knee data sets within the 
DV are provided at the end of this section. 
o Fine Searches (Models with Loops) 
In the search that allows loops, the best model by BIC with Comorbidity IVs 
resulted in Rdi Cp : Ruh Cp : Rhh Cp : Ram Cp : Rra Cp : Rhe Cp : Rrd Cp : Rca Cp : 
Rhd Cp : Rpl Cp : Rgp Cp : Rfr Cp with a %ΔH of 15.35 (Table 35), a large 
improvement over the loopless model in this Comorbidity IVs search, and slight 
improvement over the best model from the prior search that included All IVs which had a 
%ΔH of 13.46 (Table 34). This best model does not have any interaction terms, and the 
comorbidities are all individually predictive of Cp. Overall, however, there is a type of 
interaction effect—not the familiar kind—due to the combination of the multiple 
components of the model (Zwick, 2011c). Each of these IVs, diabetes mellitus (Rdi) 
other and unspecified hyperlipidemia (Ruh), hyposmolality and/or hyponatremia (Rhh), 
unspecified deficiency anemia (Ram), alcohol abuse, in remission (Rra), unspecified 
essential hypertension (Rhe), unspecified hypertensive renal disease (Rrd), coronary 
atherosclerosis of native coronary artery (Rca), other chronic pulmonary heart diseases 
(Rhd), hyperplasia of prostate (Rpl), repair of cystocele with graft or prosthesis (Rgp), 
nonunion of fracture (Rfr), is examined in detail in the model’s joint conditional 
probability distribution in Table 43. 
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 Comparing Search Results (Hip, Cp) 
All IVs and the Comorbidity IVs searches yield two sets of results that can be 
compared to each other and interpreted into a three-tiered classification of predicting 
variables, as summarized in Table 36. 
Table 36. The 3-Tiered Classification of Predicting Variables for DV: 
Complication, Hip Analysis. 
Tier Variables 
Tier 1 (Most Important) Ageb, Nrb, Rrd, Rca, Rhd, Rpl 
Tier 2 Rgp 
Tier 3 Rdi, Ruh, Rhh, Ram, Rra, Rhe, Rfr 
 
Tier 1 contains variables from the best-by-BIC model from the dataset All IVs. 
This is the most complete search, and the one that provides the most conservative 
predictors. The selected variables (Ageb, Nrb, Rrd, Rca, Rhd, Rpl) are shown in the first 
row of Table 36, and are considered the most important predicting variables.  
Tier 2 contains variables not in Tier 1, but found in the AIC (less conservative) 
model of All IVs AND in the BIC model of Comorbidity IVs. For the Hip Analysis of DV 
Complication, this selects the variable Rgp as the next-most important predicting variable 
as shown in the second row of Table 36. 
Finally, this classification places into Tier 3 any variables present elsewhere in the 
best model search results, but not included in Tier 1 or Tier 2. That is, any variables 
unique to one of the two searches: variables in the AIC model of All IVs but not in the 
BIC model of Comorbidity IVs, and variables in the BIC model of Comorbidity IVs but 
not in the AIC model from All IVs. These variables (Rdi, Ruh, Rhh, Ram, Rra, Rhe, Rfr) 
are in the last row of Table 36. 
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 Model FIT  
The detailed content of the best fine-grained BIC model from the All IVs search, 
Ageb Cp : Nrb Cp : Rrd Cp : Rca Cp : Rhd Cp : Rpl Cp, is shown as a conditional 
probability distribution in Table 37 below. This joint probability distribution contains 
many fewer rows than the distribution from the best BIC model from the knee data in 
Table 24, because rows have been excluded that either are not significant (p > 0.05) or 
have too low a frequency (< 10), to focus on more informative results. 
Table 37. Fit Table (Hip) for All IVs for Best Model 
Ageb Cp : Nrb Cp : Rrd Cp : Rca Cp : Rhd Cp : Rpl Cp. 
Blue rows indicate ratio < 0.90 and orange rows indicate ratio > 1.10. 
(Ratios between 0.91 and 1.09 are close to the margins and are excluded.) 
 
The values for the All IVs: number of risks binned (Nrb) and age binned (Ageb) 
are the variables that number of risks and age were discretized to with possible states 
being either in bin 1, 2, or 3. The bin ranges and frequencies are summarized in Table 38 
and Table 39. 
 IVs Data Model 
        obs. p(DV|IV) calc. q(DV|IV)  
# Ageb Nrb Rrd Rca Rhd Rpl freq Cp=0 Cp=1 Cp=0 Cp=1 Ratio p(margin) 
1 1 1 0 0 0 0 475 97.90 2.11 98.49 1.52 0.30 0.00 
3 1 2 0 0 0 0 348 97.70 2.30 98.27 1.73 0.34 0.00 
13 2 1 0 0 0 0 355 98.03 1.97 98.25 1.76 0.34 0.00 
16 2 2 0 0 0 0 337 97.63 2.37 98.00 2.00 0.39 0.01 
37 3 3 0 0 0 0 312 87.82 12.18 89.66 10.34 2.02 0.00 
38 3 3 0 0 0 1 24 83.33 16.67 71.68 28.32 5.53 0.00 
40 3 3 0 1 0 0 55 78.18 21.82 79.84 20.17 3.94 0.00 
43 3 3 1 0 0 0 31 70.97 29.03 72.42 27.58 5.39 0.00 
46 3 3 1 1 0 0 11 54.55 45.46 54.53 45.47 8.89 0.00 
       
3205 94.88 5.12 94.88 5.12 1.00 
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Table 38. Number of Risks Binned (Nrb) 
Bin Range & Frequency (Hip). 
Bin Range Frequency 
1 0-1 1,111 
2 2-3 1,081 
3 4-19 1,013 
 
Table 39. Age Binned (Ageb) 
Bin Range & Frequency (Hip). 
Bin Range Frequency 
1 15-59 1,090 
2 60-69 1,027 
3 70-96 1,088 
 
Each of the component’s individual projections is informative, yet not as 
informative as the full model’s joint distribution (Table 37). In the component table 
below (Table 40) for Ageb = 2, the probability of Cp was 3.51% with a risk ratio of 0.68. 
In the model’s full joint distribution in row 13, when Ageb = 2 and when Nrb was its 
lowest in bin 1 and the comorbidities in the model are all absent, then the probability of a 
complication is essentially cut in half at 1.76%, with a risk ratio of 0.34. Row 16 shows 
almost the same scenario; however, with Nrb slightly higher (Nrb = 2), the probability of 
Cp of 2% was still lower than the overall data (the margins), with a ratio of 0.39. Once 
Ageb and Nrb get to their highest states, we see increased risk (rows 37, 38, 40, 43, 46). 
Row 37 shows that when Ageb and Nrb were both in bin 3, and the individual 
comorbidities were absent, the risk of Cp increased to 10.34%, much higher than the 
complication rate for the whole sample, with a risk ratio of 2.02. Introduce the presence 
of Rpl (hyperplasia of prostate), and the risk more than doubles, with a probability of 
Cp = 28.32% and a ratio of 5.53 (row 38). With Ageb and Nrb each in bin 3, the presence 
of Rca (coronary atherosclerosis of native coronary artery) alone nearly doubled the risk 
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to 20.17%, with a ratio of 3.94 (row 40). The presence of just Rrd (hypertensive renal 
disease) with Ageb and Nrb each in bin 3 increased risk of Cp to 7.58% with a ratio of 
5.39 (row 43). When either hyperplasia of prostate (Rpl), coronary atherosclerosis of 
native coronary artery (Rca), or hypertensive renal disease (Rrd) were present along with 
high Ageb and a higher total number of risks in total (Nrb), then the probability of 
developing a complication increased at least four times that of the probability of entire 
sample. Row 46 shows what happens when an additional comorbidity, Rca, is present in 
the model when Ageb = 3, Nrb = 3, and Rrd is present. In cases where these states occur, 
the patient had a 45.47% (ratio 8.89) probability of Complication (Cp) occurring. 
The decision tree version of the conditional probability distribution provides a 
different perspective of the same results (Figure 8). 
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Figure 8. Decision Tree for DV Any Comp (Hip) All IVs for Best Model 
Ageb Cp : Nrb Cp : Rrd Cp : Rca Cp : Rhd Cp : Rpl Cp. 
  
Each component of the model has its own individual probability distribution. 
Table 40 shows the conditional probability of Cp = 1 given Ageb = 1 is 2.57%, with a 
risk ratio of 0.50; when Ageb = 2, the probability of Cp = 1 is 3.51%; and when 
Ageb = 3, the risk increased with the probability of Cp = 1 at 9.19%, with a risk ratio of 
1.80. As was seen with the knee data, lower age offered a protective effect while higher 
age increased risk of Cp. Additional model components are listed in Table 41 and 
Table 42, but are self-explanatory.  
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Table 40. Component Fit Table for IVAgeb in (Hip) All IVs Best Model: 
Ageb Cp : Nrb Cp : Rrd Cp : Rca Cp : Rhd Cp : Rpl Cp. 
Blue rows indicate ratio < 0.90 and orange rows indicate ratio > 1.10. 
 
IV Data obs. p(DV|IV) 
  
# Ageb freq Cp=0 Cp=1 ratio p(margin) 
1 1 1090 97.43 2.57 0.50 0.00 
2 2 1027 96.50 3.51 0.68 0.02 
3 3 1088 90.81 9.19 1.80 0.00 
  
3205 94.88 5.12 1.00 
 
 
Table 41. Component Fit Table for IV Nrb in (Hip) All IVs Best Model: 
Ageb Cp : Nrb Cp : Rrd Cp : Rca Cp : Rhd Cp : Rpl Cp. 
Blue rows indicate ratio < 0.90 and orange rows indicate ratio > 1.10. 
 
IV Data obs. p(DV|IV) 
  
# Nrb freq Cp=0 Cp=1 ratio p(margin) 
1 1 1111 97.84 2.16 0.42 0.00 
2 2 1081 97.04 2.96 0.58 0.00 
3 3 1013 89.34 10.66 2.08 0.00 
  
3205 94.88 5.12 1.00 
 
 
Table 42. Condensed Component Fit Table for IVs Rhd, Rrd, Rpl and Rca in (Hip) 
All IVs Best Model: Ageb Cp : Nrb Cp : Rrd Cp : Rca Cp : Rhd Cp : Rpl Cp. 
Blue rows indicate ratio < 0.90 and orange rows indicate ratio > 1.10. 
(Ratios between 0.91 and 1.09 are close to the margins and are excluded.) 
  
Data obs. p(DV|IV) 
  
IV IV States freq Cp=0 Cp=1 Ratio p(margin) 
Rhd 1 10 40.00 60.00 11.73 0.00 
Rrd 0 3128 95.46 4.54 0.89 0.14 
Rrd 1 77 71.43 28.57 5.58 0.00 
Rpl 1 77 77.92 22.08 4.31 0.00 
Rca 0 3039 95.56 4.44 0.87 0.09 
Rca 1 166 82.53 17.47 3.41 0.00 
  
3205 94.88 5.12 1.00 
 
 
The joint probability distribution below in Table 43 show the details for the best 
fine model from the hip Comorbidity IVs search Rdi Cp : Ruh Cp : Rhh Cp : Ram Cp : 
Rra Cp : Rhe Cp : Rrd Cp : Rca Cp : Rhd Cp : Rpl Cp : Rgp Cp : Rfr Cp. In this 
distribution, each of the IVs are either 0 (comorbidity absent) or 1 (comorbidity present). 
Row 1 is the case where all of the comorbidities included in the model are absent, which 
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lowers the risk of Complication (Cp) from 5.12% (the model’s marginal probability) to 
1.92%, with a ratio of 0.37. 
Table 43. Fit Table (Hip) for Comorbidity IVs for Best Model Rdi Cp : Ruh Cp : Rhh Cp : 
Ram Cp : Rra Cp : Rhe Cp : Rrd Cp : Rca Cp : Rhd Cp : Rpl Cp : Rgp Cp : Rfr Cp. 
Blue rows indicate ratio < 0.90 and orange rows indicate ratio > 1.10. 
(Ratios between 0.91 and 1.09 are close to the margins and are excluded.) 
(Variables Rhh, Ram, Rra, Rhd, Rgp, and Rfr only take value 0 for these rows.) 
 
IVs Data Model 
 






































freq Cp=0 Cp=1 Cp=0 Cp=1 Ratio p(margin) 
1 0 0 0 0 0 0 0 0 0 0 0 0 1414 98.16 1.84 98.09 1.92 0.37 0.00 
13 0 0 1 0 0 0 0 0 0 0 0 0 893 96.42 3.58 96.60 3.40 0.66 0.02 
31 0 1 0 1 0 0 0 0 0 0 0 0 10 100.00 0.00 79.03 20.97 4.10 0.02 
37 0 1 1 0 0 1 1 1 1 1 1 1 10 90.00 10.00 76.53 23.47 4.59 0.01 
39 0 1 1 0 1 0 0 0 0 0 0 0 26 76.92 23.08 83.37 16.63 3.25 0.01 
51 1 0 1 0 1 0 0 0 0 0 0 0 15 73.33 26.67 80.68 19.32 3.78 0.01 
57 1 1 1 0 0 0 0 0 0 0 0 0 49 87.76 12.25 86.98 13.02 2.55 0.01 
   
          3205 94.88 5.12 94.88 5.12 1.00 
 
 
Having only the comorbidity Rhe (essential hypertension) still keeps the risk 
lower, with a ratio of 0.66 (row 13). However, with the additional presence of either Rdi 
(diabetes mellitus), Ruh (hyperlipidemia), Rca (coronary atherosclerosis of native 
coronary artery) or Rpl (Hyperplasia of prostate), the risk increases. Row 37 shows that 
in addition to the presence of Rhe (essential hypertension), the presence of Ruh 
(hyperlipidemia) and Rpl (Hyperplasia of prostate) increases risk of Cp to 23.47% 
(ratio = 4.59). Row 39 shows that with Rhe and Ruh present, but with the additional Rca 
comorbidity, the probability of Cp = 16.63% (ratio = 3.25). Row 51 shows that with Rhe 
present again, but this time along with Rdi and Rca, the probability of Cp = 19.32% 
(ratio = 3.78), and with Rhe and Rdi both present, but with Ruh, the probability of 
Cp = 13.0% (ratio = 2.55). Risk is also increased over Hypertension alone when even a 
single other comorbidity is present, as with diabetes mellitus (Rdi), hyperlipidemia (Ruh), 
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coronary atherosclerosis of native coronary artery (Rca), and/or hyperplasia of prostate 
(Rpl). For these cases, the risk of Complication (Cp) increases from the marginal 
probability of 5.12% to between 13.02% and 23.47%. 
The decision tree for the conditional probability distribution for model Rdi Cp : 
Ruh Cp : Rhh Cp : Ram Cp : Rra Cp : Rhe Cp : Rrd Cp : Rca Cp : Rhd Cp : Rpl Cp : 
Rgp Cp : Rfr Cp (Figure 9) offers perhaps a simplified way of looking at how the 
presence or absence of each Comorbidity IV, and their combinations, lead to increased or 
decreased risk of Complication (Cp).  
 
Figure 9. Decision Tree for DV Any Comp (Hip) with Comorbidity IVs for Best Model Rdi Cp : Ruh 
Cp : Rhh Cp : Ram Cp : Rra Cp : Rhe Cp : Rrd Cp : Rca Cp : Rhd Cp : Rpl Cp : Rgp Cp : Rfr Cp. 
 
 The individual components of the model each have a fit table, condensed into a 
single table below (Table 44). 
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Table 44. Condensed Component Fit Table for IVs Rhd, Ram, Rhh, Rgp, Rfr, Rra, 
Rrd, and Rpl in (Hip) Comorbidity IVs Best Model: Rdi Cp : Ruh Cp : Rhh Cp : 
Ram Cp : Rra Cp : Rhe Cp : Rrd Cp : Rca Cp : Rhd Cp : Rpl Cp : Rgp Cp : Rfr Cp. 
Orange rows indicate ratio > 1.10. 
(Ratios between 0.91 and 1.09 are close to the margins and are excluded.) 
   Data obs. p(DV|IV)   
# IV IV State freq Cp=0 Cp=1 Ratio p(margin) 
1 Rhd 1 10 40.00 60.00 11.73 0.00 
2 Ram 1 6 50.00 50.00 9.77 0.00 
3 Rhh 1 10 60.00 40.00 7.82 0.00 
4 Rgp 1 8 62.50 37.50 7.33 0.00 
5 Rfr 1 9 66.67 33.33 6.51 0.00 
6 Rra 1 10 70.00 30.00 5.86 0.00 
7 Rrd 1 77 71.43 28.57 5.58 0.00 
8 Rpl 1 77 77.92 22.08 4.31 0.00 
9 Rca 1 166 82.53 17.47 3.41 0.00 
10 Rdi 1 305 88.53 11.48 2.24 0.00 
11 Ruh 1 466 88.63 11.37 2.22 0.00 
12 Rhe 1 1464 93.37 6.63 1.29 0.01 
   
3205 94.88 5.12 1.00 
 
 
Hip & Knee Summary of Results for Complication 
The most important IVs are summarized in Table 45. The IVs that show up in 
both searches are number of risks (Nrb), age (Ageb), chronic pulmonary heart disease 
(Rhd), and hyperlipidemia (Ruh).  
Table 45. Summary of Most Important IVs by Tier 
across Hip and Knee for Complication. 
  Complication (Cp) 
Tier Knee Hip 
1 Nrb, Ageb, Ruh, Rhd, Rku Ageb, Nrb, Rrd, Rca, Rhd, Rpl 
2 Reg, Raf, Ros, Rav, Ruu Rgp 
3 Rro Rdi, Ruh, Rhh, Ram, Rra, Rhe, Rfr 
 
DV: Skilled Nursing Facility (SNF) 
Knee Analysis 
In this results section, the analysis is conducted with the same knee data set as 
with DV Complication (Cp), but using the DV Skilled Nursing Facility (SNF) instead. 
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SNF is a binary variable, with a patient either being discharged to a SNF or not. SNF 
occurs much more frequently in the data than DV Cp, with approximately 17% of 
patients discharged to a SNF after a knee replacement compared to the occurrence of DV 
Cp of 4.7%. In this analysis, a new series of best models, whose measure of goodness is 
also % reduction of uncertainty, are described and analyzed in detail. This analysis also 
looks at (a) All IVs, and (b) only the Comorbidity IVs. 
(This SNF analysis results section is briefer than that provided above for DV Cp, 
with less discussion of the methodology. To the extent that each results section uses the 
same methodology, the detailed discussion given for Cp can be used for reference, as can 
the RA methodology portion of the Methods chapter.) 
 All IVs 
o Coarse Searches (Models without Loops) 
 The final knee data set for SNF contained 67 IVs. The variable reduction method 
of performing a loopless search for single predicting variables found 55 IVs to be 
individually predictive of SNF with p ≤ 0.05. Of these 55 IVs, 12 were also found to be 
predictive of similar outcomes in the literature. However, the literature had found 12 IVs 
to be predictive that were not found to be individually predictive in the loopless search 
conducted in this project. These 12 IVs were retained in the knee data set for this 
analysis. 
In the prior analysis section, the search to predict Complication (Cp) in the knee 
data found the best single predictor to be surgeon (S) with a %ΔH of 6.45. The top single 
predicting IV of SNF is financial class (Fc) with a %ΔH of 10.55 (Table 46). The top 10 
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single predicting IVs for SNF are listed below in Table 46 and are ordered smallest to 
largest for alpha, which is the inverse of %ΔH. 
Age (Ageb) reduces uncertainty of SNF by 10.5% and by simply knowing the 
surgeon (S) there is a %ΔH of 7.18. Number of risks (Nrb) has a %ΔH of 2.57, hospital 
location (L) a %ΔH of 2.14, and admit diagnosis (Ad) a %ΔH of 1.03. The first 
individual patient Comorbidity IV that is predictive of SNF is heart failure (Rhf), with a 
%ΔH of 0.95, followed by glaucoma (Rug), with a value of 0.9, and then persistent 
mental disorders (Rmd) at 0.85. 
 
- 115 - 
Table 46. Summary of Search Results for Knee data, DV SNF. 
Includes both All IVs for coarse and fine models. 
MODEL Δdf ΔBIC %ΔH Alpha Variable description 
COARSE, single predictors (top 10) 
Fc SNF 5 383.00 10.55 0.00 Financial class 
Ageb SNF 2 406.13 10.50 0.00 Age binned 
S SNF 62 -229.95 7.18 0.00 Surgeon 
Nrb SNF 2 86.87 2.57 0.00 Number of risks binned 
L SNF 6 35.81 2.14 0.00 Location 
Ad SNF 27 -184.59 1.03 0.04 Admit diagnosis 
Rhf SNF 1 29.93 0.95 0.00 Heart Failure (428) 
Rug SNF 1 27.95 0.90 0.00 Unspecified glaucoma (365.9), 
Rmd SNF 1 26.03 0.85 0.00 Persistent mental disorders (294.8) 
Svb SNF 2 15.18 0.79 0.00 Surgeon volume binned 
MODEL Δdf ΔBIC %ΔH Alpha Variable description 
COARSE, IVs in AIC or BIC models but not in top 10 
Rpa SNF (rank 21) 1 2.99 0.28 0.00 Parkinson's disease (332) 
Rbp SNF (rank 26) 1 1.06 0.23 0.00 Other and unspecified bipolar disorders (296.8) 
MODEL Δdf ΔBIC %ΔH Alpha Variable description 
COARSE, best model (loopless) 
ΔBIC (best model) 
Ageb Nrb SNF 8 451.49 12.87 0.00 Age binned + Number of risks binned 
ΔAIC & Inc.P (same best model) 
AgebNrbRmdSNF 
17 401.43 13.50 0.00 
Age binned + Number of risks binned + persistent 
mental disorders (294.8) 
MODEL Δdf ΔBIC %ΔH Alpha Variable description 
FINE, best models (with loops) 
ΔBIC (best model) 
L SNF : Fc SNF : 
Ageb SNF : Svb 
SNF : Nrb SNF : 
Rmd SNF: Rug 
SNF: Rhf SNF 
20 635.69 19.94 0.00 
location, financial class, age binned, surgeon 
volume binned, number of risks binned, persistent 
mental disorders (294.8), Unspecified glaucoma 
(365.9),  Heart Failure (428) 
Inc.P & ΔAIC  (same best model) 
L SNF : Fc SNF : 
Ageb SNF : Svb 
SNF : Nrb SNF 
:Rmd SNF: Rbp 
SNF : Rpa SNF : 
Rug SNF : Rhf 
SNF 
22 634.61 20.33 0.00 
location, financial class, age binned, surgeon 
volume binned, number of risks binned, persistent 
mental disorders (294.8), Other and unspecified 
bipolar disorders (296.8),  Parkinson's disease 
(332), Unspecified glaucoma (365.9), Heart Failure 
(428) 
  
The best coarse model allowing for more than one IV (but not allowing for loops) 
is Ageb Nrb SNF, with a corresponding %ΔH of 12.87 and a Δdf of 8. Financial class 
(Fc), while individually predictive, is not included as it does not provide additional 
information worth the complexity over the combined IVs of Ageb and Nrb. Ageb and 
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Nrb form a conventional interaction effect that is different from the simple combination 
of two separate components (i.e., Ageb SNF : Nrb SNF).  
o Fine Searches (Models with Loops) 
Allowing for multiple components and loops, the best model by BIC found 8 IVs 
in the model L SNF : Fc SNF : Ageb SNF : Svb SNF : Nrb SNF : Rmd SNF : Rug SNF : 
Rhf SNF. All 8 of these IVs are also listed in the top 10 single predicting IVs of 
Table 46. Similar to the search results for Cp, surgeon (S) is individually predictive but 
does not appear in the best fine-grained model, presumably because of the high 
cardinality of S (63 states). Location (L), financial class (Fc), age binned (Ageb), 
surgeon volume binned (Svb), number of risks binned (Nrb), persistent mental disorders 
(Rmd), unspecified glaucoma (Rug), and heart failure (Rhf) reduce uncertainty of SNF 
by 19.94% with a Δdf of 20.  
Both the coarse and fine-grained searches were dominated by the effects of the 
non-comorbidity variables present in All IVs. In order to look only at the effect of the 
patient’s individual comorbidities, a Comorbidity IVs search is performed. 
 Comorbidity IVs 
o Coarse Searches (Models without Loops) 
Considering only Comorbidity IVs as predictors, the most predictive individual 
comorbidities are uncovered, yet no single comorbidity has a %ΔH over 1 (Table 47). 
Individual comorbidities alone do not seem very predictive of discharge to SNF. 
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Table 47. Summary of Search Results (Knee) for Comorbidity IVs for SNF. 
Search covers directed coarse, and fine models. 
MODEL Δdf ΔBIC %ΔH Alpha Variable description 
COARSE, single predictors 
Rhf SNF 1 29.93 0.95 0.00 Heart failure (428) 
Rug SNF 1 27.95 0.90 0.00 Unspecified glaucoma (365.9), 
Rmd SNF 1 26.03 0.85 0.00 Persistent mental disorders (294.8) 
Rku SNF 1 21.81 0.75 0.00 Chronic kidney disease (585.9) 
Rrd SNF 
1 19.04 0.68 0.00 
Unspecified hypertensive renal disease 
(403.9) 
Rbn SNF 1 16.49 0.62 0.00 Other disorders of bone and cartilage (733) 
Rin SNF 1 13.77 0.55 0.00 Urinary incontinence (788.3) 
Rhy SNF 1 12.34 0.51 0.00 Hypothyroidism (244.9) 
Rhd SNF 
1 9.67 0.45 0.00 
Other chronic pulmonary heart diseases 
(416.8) 
Rau SNF 1 9.04 0.43 0.00 Anemia, unspecified (285.9) 
MODEL Δdf ΔBIC %ΔH Alpha Variable description 
COARSE, IVs in AIC or BIC models but not in top 10 
Rhe SNF (rank 14) 1 5.06 0.33 0.00 Essential hypertension (401.9) 
Rpa SNF (rank 15) 1 2.99 0.28 0.00 Parkinson's disease (332) 
MODEL Δdf ΔBIC %ΔH 
 
Variable description 
COARSE, best model (loopless) 
ΔBIC (best model) 
RugRhf SNF 3 50.72 1.88 0.00 
Unspecified glaucoma (365.9) +  Heart 
Failure (428) 
ΔAIC (best model) 
RmdRugRhfRku SNF 15 9.20 3.35 0.00 
persistent mental disorders (294.8) + 
Unspecified glaucoma (365.9) +  Heart 
Failure (428) + Chronic kidney disease 
(585.9) 
Inc.P (best model) 
RmdRugRhfRkuRbn SNF 31 -98.97 3.99 0.02 
persistent mental disorders (294.8) + 
Unspecified glaucoma (365.9) +  Heart 
Failure (428) + Chronic kidney disease 
(585.9) + Other disorders of bone and 
cartilage (733) 
MODEL Δdf ΔBIC %ΔH 
 
Variable description 
FINE, best models (with loops) 
ΔBIC, Inc.P & ΔAIC (same best model) 
Rhy SNF : Rau SNF : 
Rmd SNF : Rpa SNF : 
Rug SNF : Rhe SNF : 
Rhf SNF : Rku : 
Rbn SNF : Rin SNF 
10 138.61 5.52 0.00 
Hypothyroidism (244.9), Anemia (285.9),  
persistent mental disorders (294.8), 
Parkinson's disease (332),  Unspecified 
glaucoma (365.9), Essential hypertension 
(401.9), Heart failure (428),  Chronic 
kidney disease (585.9), Other disorders of 
bone and cartilage (733), Urinary 
incontinence (788.3) 
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The results of a coarse search allowing for multiple IVs yields a best BIC model 
Rug Rhf SNF. Together, Rug and Rhf have a %ΔH of 1.88, close to what adding their 
separate effects of 0.9 and 0.95 would give. 
o Fine Searches (Models with Loops) 
In a search that allows for loops, the best BIC model is Rhy SNF : Rau SNF : 
Rmd SNF : Rpa SNF : Rug SNF : Rhe SNF : Rhf SNF : Rku SNF : Rbn SNF : Rin SNF, 
with a corresponding reduction in uncertainty of 5.52% and a Δdf of 10. Hypothyroidism 
(Rhy), anemia (Rau), persistent mental disorders (Rmd), Parkinson’s disease (Rpa), 
unspecified glaucoma (Rug), essential hypertension (Rhe), heart failure (Rhf), chronic 
kidney disease (Rku), other disorders of bone and cartilage (Rbn), and urinary 
incontinence (Rin) are not nearly as predictive as the model that allowed for All IVs.  
 Comparing Search Results (Knee, SNF) 
All IVs and the Comorbidity IVs searches yield two sets of results that can be 
compared to each other and interpreted into a three-tiered classification of predicting 
variables, as shown in Table 48.  
Table 48. The 3-Tiered Classification of Predicting 
Variables for DV SNF, Knee Analysis. 
Tier Variables 
Tier 1 (Most Important) L, Fc, Ageb, Svb, Nrb, Rmd, Rug, Rhf 
Tier 2 Rpa 
Tier 3 Rbp, Rhy, Rau, Rhe, Rku, Rbn, Rin 
 
As with earlier analyses, the Tier 1 variables are those from the BIC model from 
All IVs. This is the most complete and conservative search, and these are deemed the 
most important predicting variables: L, Fc, Ageb, Svb, Nrb, Rmd, Rug, and Rhf. 
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The Tier 2 variables are those not in Tier 1, but still found in the best models of 
both searches: the AIC (less conservative) model of All IVs, and the BIC model of 
Comorbidity IVs. This selects Rpa as the best IV by Tier 2. 
Finally, Tier 3 contains the variables in only one of the best models (the same as 
with Tier 2), but not in both. For DV SNF, these lowest-tier predicting variables are: 
Rbp, Rhy, Rau, Rhe, Rku, Rbn, and Rin. 
 Model FIT 
The best fine-grained model, L SNF : Fc SNF : Ageb SNF : Svb SNF : Nrb 
SNF : Rmd SNF : Rug SNF : Rhf SNF, is explained in detail by the joint conditional 
probability distribution in Table 49 below. 
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Table 49. Fit Table (Knee) for All IVs for Best Model L SNF : Fc SNF : Ageb SNF : Svb SNF : Nrb 
SNF : Rmd SNF : Rug SNF : Rhf SNF. Blue rows indicate ratio < 0.90 and orange rows indicate ratio 
> 1.10. (Ratios between 0.91 and 1.09 are close to the margins and are excluded.) 
 
IVs Data Model 
 
 obs. p(DV|IV) calc. q(DV|IV)  
# L Fc Ageb Svb Nrb Rmd Rug Rhf freq SNF =1 SNF =2 SNF =1 SNF =2 Ratio p(margin) 
1 1 2 1 2 1 0 0 0 55 100.00 0.00 97.89 2.11 0.12 0.00 
2 2 1 2 1 3 0 0 0 41 78.05 21.95 66.44 33.56 1.91 0.01 
3 2 1 2 2 3 0 0 0 52 63.46 36.54 66.08 33.92 1.93 0.00 
5 2 1 3 1 1 0 0 0 20 70.00 30.00 64.65 35.35 2.01 0.04 
6 2 1 3 1 2 0 0 0 62 66.13 33.87 55.08 44.92 2.56 0.00 
7 2 1 3 1 3 0 0 0 41 46.34 53.66 44.47 55.53 3.16 0.00 
11 2 1 3 2 1 0 0 0 30 63.33 36.67 64.28 35.73 2.04 0.01 
12 2 1 3 2 2 0 0 0 62 51.61 48.39 54.68 45.32 2.58 0.00 
14 2 1 3 2 3 0 0 0 70 47.14 52.86 44.07 55.93 3.19 0.00 
18 2 1 3 3 2 0 0 0 134 68.66 31.34 69.97 30.04 1.71 0.00 
19 2 1 3 3 3 0 0 0 84 64.29 35.71 60.34 39.66 2.26 0.00 
22 2 2 1 1 1 0 0 0 49 97.96 2.04 96.38 3.62 0.21 0.01 
23 2 2 1 1 2 0 0 0 61 93.44 6.56 94.70 5.30 0.30 0.01 
24 2 2 1 2 1 0 0 0 55 98.18 1.82 96.33 3.67 0.21 0.01 
25 2 2 1 2 2 0 0 0 77 96.10 3.90 94.62 5.38 0.31 0.01 
26 2 2 1 2 3 0 0 0 68 89.71 10.29 91.99 8.01 0.46 0.04 
27 2 2 1 3 1 0 0 0 119 99.16 0.84 98.06 1.94 0.11 0.00 
28 2 2 1 3 2 0 0 0 118 95.76 4.24 97.14 2.86 0.16 0.00 
29 2 2 1 3 3 0 0 0 73 93.15 6.85 95.69 4.32 0.25 0.00 
30 2 2 2 3 1 0 0 0 35 97.14 2.86 97.06 2.94 0.17 0.03 
31 2 2 2 3 2 0 0 0 55 92.73 7.27 95.67 4.33 0.25 0.01 
33 3 1 3 1 3 0 0 0 84 58.33 41.67 70.84 29.16 1.66 0.01 
36 3 1 3 2 3 0 0 0 55 70.91 29.09 70.51 29.49 1.68 0.02 
39 3 2 1 1 1 0 0 0 40 100.00 0.00 98.78 1.22 0.07 0.01 
40 3 2 1 1 2 0 0 0 63 96.83 3.18 98.19 1.81 0.10 0.00 
41 3 2 1 1 3 0 0 0 49 100.00 0.00 97.25 2.75 0.16 0.01 
42 3 2 1 2 1 0 0 0 22 100.00 0.00 98.76 1.24 0.07 0.04 
43 3 2 1 2 2 0 0 0 34 100.00 0.00 98.16 1.84 0.10 0.02 
44 3 2 1 2 3 0 0 0 32 100.00 0.00 97.21 2.79 0.16 0.03 
45 3 2 1 3 1 0 0 0 21 100.00 0.00 99.35 0.65 0.04 0.05 
46 3 2 1 3 2 0 0 0 23 100.00 0.00 99.04 0.96 0.05 0.04 
47 3 2 1 3 3 0 0 0 37 100.00 0.00 98.54 1.47 0.08 0.01 
48 4 1 2 2 3 0 0 0 24 83.33 16.67 63.34 36.66 2.09 0.01 
52 4 1 3 2 1 0 0 0 21 76.19 23.81 61.47 38.53 2.20 0.01 
53 4 1 3 2 2 0 0 0 25 36.00 64.00 51.69 48.31 2.75 0.00 
54 4 1 3 2 3 0 0 0 46 34.78 65.22 41.14 58.86 3.35 0.00 
56 6 1 2 1 1 0 0 0 37 94.60 5.41 94.70 5.30 0.30 0.05 
         
4336 82.45 17.55 82.45 17.55 1.00 
 
# L Fc Ageb Svb Nrb Rmd Rug Rhf freq SNF =1 SNF =2 SNF =1 SNF =2 Ratio p(margin) 
 
Financial class (Fc) at first seemed that it might be redundant with age. However, 
financial class = 1 (Medicare) can cover patients who are age 65 and over, or those 
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younger than 65 and receiving disability benefits. Moreover, the age bins do not line up 
along age requirements for Medicare, and the highest age bin has a minimum age of 72 
(Table 50). 
Table 50. Age bin distribution. 
Bin Range Frequency 
1 32-62 1,490 
2 63-71 1,411 
3 72-95 1,435 
 
There is some association between financial class (Fc) and age binned (Ageb), 
which is supported by the finding that when Fc is made the DV, its single best predictor 
is Ageb with %ΔH(Fc) of 38.37. However, the best model selected to predict SNF 
includes both Fc and Ageb, which indicates that each of these IVs offers additional 
information worth the added complexity. 
For the calculated model, knowing the states of All IVs (L, Fc, Ageb, Svb, Nrb) or 
the presence or absence of the individual Comorbidity IVs (Rmd, Rug, Rhf) tells us about 
the probability of SNF occurring. Each of the model’s components, namely L SNF or Fc 
SNF or Ageb SNF or Svb SNF or Nrb SNF or Rmd SNF or Rug SNF or Rhf SNF, has 
an individual conditional probability distribution and is individually informative.  For 
example, looking only at location (L) (Table 51), the conditional probability of SNF 
given location 1 is 12.3%, with the risk ratio of 0.70. Additional locations that seem with 
low projected discharges to SNF include locations 3, 6, and 7, with risk ratios 0.69, 0.62, 
and 0.17. Locations 2 and 4 show increased risk with ratios (1.15 and 1.67 respectively). 
Location 5 has a neutral risk ratio, with the projected discharge to SNF similar to that of 
the observed rate in the data with a risk ratio of 0.96. In other words, knowing only the 
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location of the surgery, regardless of the states of the other IVs in the model, there is a 
significant difference in the probability of SNF = 2 between the locations.  
Table 51. Component Fit Table for IV L in (Knee) All IVs Best Model 
L SNF : Fc SNF : Ageb SNF : Svb SNF : Nrb SNF : Rmd SNF : Rug SNF : Rhf SNF. 
Blue rows indicate ratio < 0.90 and orange rows indicate ratio > 1.10. 
(Ratios between 0.91 and 1.09 are close to the margins and are excluded.) 
 IV Data obs. p(DV|IV)   
# L freq SNF=1 SNF=2 Ratio p(margin) 
1 1 244 87.71 12.30 0.70 0.03 
2 2 2143 79.75 20.25 1.15 0.00 
3 3 1138 87.87 12.13 0.69 0.00 
4 4 349 70.77 29.23 1.67 0.00 
6 6 267 89.14 10.86 0.62 0.00 
7 7 34 97.06 2.94 0.17 0.03 
  
4336 82.45 17.55 1.00 
 
 
Knowing only the financial class (Fc) is individually informative as well. 
Financial class 1 is Medicare, and patients with Medicare have 26.89% chance of 
discharging to SNF compared to 17.55% overall, with a risk ratio of 1.53. Patients with 
financial class 2 (commercial payers) have a very low projection of discharging to a SNF 
at 4.4% and a risk ratio of 0.25. Patients with financial class 3 (Medicaid) had an 
increased risk of SNF at 21.13%, with a ratio of 1.2. Both financial classes 4 and 5 
(Workers Comp and Other Government) offered decreased risk of SNF with risk ratios of 
0.19 and 0. Perhaps financial class 4 and 5 payers did not offer a skilled nursing facility 
benefit, something worth looking into in any future confirmatory analysis. The individual 
component table for Fc is below in Table 52, while the remainder of the individual 
component tables are available in Appendix I: Supplementary Tables. 
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Table 52. Component Fit Table for IV Fc in (Knee) All IVs Best Model  
L SNF : Fc SNF : Ageb SNF : Svb SNF : Nrb SNF : Rmd SNF : Rug SNF : Rhf SNF. 
Blue rows indicate ratio < 0.90 and orange rows indicate ratio > 1.10. 
 IV Data obs. p(DV|IV)   
# Fc freq SNF=1 SNF=2 Ratio p(margin) 
1 1 2484 73.11 26.89 1.53 0.00 
2 2 1727 95.60 4.40 0.25 0.00 
3 3 71 78.87 21.13 1.20 0.43 
4 4 30 96.67 3.33 0.19 0.04 
5 5 17 100.00 0.00 0.00 0.07 
6 6 7 85.71 14.29 0.81 0.83 
  
4336 82.45 17.55 1.00 
 
 
The cardinality of the All IVs for this knee analysis search and fit for SNF are 
many-valued, with seven possible states for location (L), six possible states for financial 
class (Fc), and three possible states each for age binned (Ageb), surgeon volume binned 
(Svb), and number of risks binned (Nrb). Therefore, the combinations of IVs that are 
summarized above in Table 49 resulted in a very large decision tree. However, one can 
determine blue or orange by looking at Fc alone. For Fc = 1, one gets orange. For Fc = 2, 
one gets blue. There is only one exception to this in line 56, which has Fc = 1 and is blue 
(Table 49). Decision trees have two purposes in the present context: (1) to distinguish 
coarsely between blue and orange (between decreased risk and increased risk IV states), 
and (2) to distinguish more finely between degrees of protectiveness or riskiness, as 
shown by the ratio values.  
The details from the best fine model from the Comorbidity IVs search, Rhy SNF : 
Rau SNF : Rmd SNF : Rpa SNF : Rug SNF : Rhe SNF : Rhf SNF : Rku SNF : 
Rbn SNF : Rin SNF, are provided in Table 53 below and also in the decision tree in  
Figure 10 below. Again, each comorbidity is either present or absent. The absence of all 
of the comorbidities offers a protective effect against SNF with a risk ratio of 0.66. 
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With only the presence of essential hypertension (Rhe), there is still a slight protective 
effect with ratio = 0.90.  
Table 53. Fit Table (Knee) for Comorbidity IVs, for Best Model, Rhy SNF : Rau SNF : 
Rmd SNF : Rpa SNF : Rug SNF : Rhe SNF : Rhf SNF : Rku SNF : Rbn SNF : Rin SNF. 
Blue rows indicate ratio < 0.90 and orange rows indicate ratio > 1.10. 
(Ratios between 0.91 and 1.09 are close to the margins and are indicated in gray.) 
 




































freq SNF=0 SNF=1 SNF=0 SNF=1 ratio p(margin) 
1 0 0 0 0 0 0 0 0 0 0 1501 88.61 11.39 88.44 11.56 0.66 0.00 
2 0 0 0 0 0 0 0 1 0 0 43 74.42 25.58 68.89 31.11 1.77 0.02 
3 0 0 0 0 0 1 0 0 0 0 1771 84.30 15.70 84.27 15.73 0.90 0.05 
4 0 0 0 0 0 1 0 0 0 1 21 52.38 47.62 59.91 40.09 2.28 0.01 
5 0 0 0 0 0 1 0 0 1 0 51 62.75 37.26 69.83 30.17 1.72 0.02 
6 0 0 0 0 0 1 1 0 0 0 41 60.98 39.02 60.66 39.34 2.24 0.00 
7 0 0 0 0 1 1 0 0 0 0 31 58.07 41.94 59.20 40.80 2.32 0.00 
8 0 1 0 0 0 1 0 0 0 0 41 65.85 34.15 70.14 29.86 1.70 0.04 
9 1 0 0 0 0 0 0 1 0 0 18 50.00 50.00 59.81 40.19 2.29 0.01 
10 1 0 0 0 0 1 0 0 0 0 329 78.42 21.58 78.26 21.74 1.24 0.05 
11 1 0 0 0 0 1 0 0 1 0 16 50.00 50.00 60.87 39.13 2.23 0.03 
12 1 1 0 0 0 1 0 0 0 0 13 84.62 15.39 61.22 38.78 2.21 0.05 
           
4336 82.45 17.55 82.45 17.55 
  
 
 These results show that the occurrence of one or more of the Comorbidity IVs—
hypothyroidism (Rhy), anemia (Rau), persistent mental disorders (Rmd), Parkinson’s 
disease (Rpa), unspecified glaucoma (Rug), heart failure (Rhf), chronic kidney disease 
(Rku), other disorders of bone and cartilage (Rbn), and urinary incontinence (Rin)—
increases the risk of discharge to a skilled nursing facility (SNF). The model 
component’s individual fit table is provided in Appendix I: Supplementary Tables. 
Another view of the combinations of these comorbidities is presented in the decision tree 
in  
Figure 10 below. 
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Figure 10. Decision Tree for DV SNF (Knee) with Comorbidity IVs for Best Model Rhy SNF : 
Rau SNF : Rmd SNF : Rpa SNF : Rug SNF : Rhe SNF : Rhf SNF : Rku SNF : Rbn SNF : Rin SNF. 
 
Hip Analysis 
As in the Knee Analysis presented for SNF above, this section analyzes the hip 
data seen previously in the analysis of DV Cp, but with the DV Skilled Nursing Facility 
(SNF) instead. SNF is a binary variable, and the positive value marks cases where a 
patient has been discharged to a skilled nursing facility after a hip replacement. The 
occurrence of SNF is more common than with the DV Cp, present in approximately 14% 
of cases, while DV Cp had positive occurrence of approximately 5% (Table 37). As 
before, new searches were conducted with Occam to select best models, considering the 
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combined All IVs, and then separately the Comorbidity IVs alone. The set of eight 
administrative All IVs remains the same for these analyses. 
All IVs 
o Coarse Searches (Models without Loops) 
The hip data set used for SNF analysis contained 71 IVs, selected through the 
same variable reduction method described in previous sections. That is, variables found 
to be individually predictive with p ≤ 0.05 were retained, as were a subset of IVs from the 
literature. The results of searching for predictive models with this data set are 
summarized in Table 54. As with other analyses presented here, the summary first 
presents the ten variables that best predict SNF individually. The best of these is financial 
class (Fc), with a reduction of uncertainty (%ΔH) of 12.57%. This IV was also the top 
single predictor for the Knee Analysis of DV SNF. The other top single predictors are 
listed as well, sorted by the reduction in uncertainty for each model. The top seven of 
these predictors are all Hospital IVs, and only two of the ten are Comorbidity IVs. 
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Table 54. Summary of Search Results (Hip) for All IVs for SNF. 
Search covers coarse and fine models. 
MODEL Δdf ΔBIC %ΔH Alpha Variable description 
COARSE, single predictors (top 10) 
Fc SNF 5 289.60 12.57 0.00 Financial class 
Ageb SNF 2 299.44 12.02 0.00 Age binned 
S SNF 42 -32.63 11.67 0.00 Surgeon 
Svb SNF 2 181.53 7.53 0.00 Surgeon volume binned 
L SNF 6 86.84 5.15 0.00 Location 
Nrb SNF 2 78.28 3.60 0.00 Number of risks binned 
Ad SNF 38 -219.99 3.30 0.00 Admit diagnosis 
Rhy SNF 1 30.41 1.47 0.00 Unspecified acquired hypothyroidism (244.9) 
Da SNF 5 -2.44 1.44 0.00 Day of admit 
Rhe SNF 1 25.46 1.28 0.00 Unspecified essential hypertension (401.9) 
MODEL Δdf ΔBIC %ΔH Alpha Variable description 
COARSE, IVs in AIC or BIC models but not in top 10 
Rnr SNF (rank 15) 1 11.29 0.74 0.00 
Aseptic necrosis of head and neck of femur 
(733.42) 
Rhd SNF (rank 24) 1 4.82 0.49 0.00 Acquired hypothyroidism (244) 
Rml SNF (rank 29) 1 2.84 0.42 0.00 Memory loss (780.93) 
MODEL Δdf ΔBIC %ΔH Alpha Variable description 
COARSE, best model (loopless) 
ΔBIC (best model) 
Ageb Svb SNF 8 445.91 19.44 0.00 Age binned, Surgeon volume binned 
Inc.P & ΔAIC  (same best model) 
Ageb Svb Rhy Rmo SNF 35 297.19 22.08 0.00 
Age binned, Surgeon volume binned, Unspecified 
acquired hypothyroidism (244.9), Morbid obesity 
(278.01) 
MODEL Δdf ΔBIC %ΔH Alpha Variable description 
FINE, best models (with loops) 
ΔBIC (best model) 
Fc SNF : Ageb SNF : 
Svb SNF :Nrb SNF 
11 531.17 23.61 0.00 
Financial class, Age binned, Surgeon volume 
binned, Number of risks binned 
Inc.P & ΔAIC  (same best model) 
Fc SNF : Ageb SNF : 
Svb SNF : Nrb SNF : 
Rhd SNF : Rnr SNF : 
Rml SNF 
14 527.73 24.41 0.01 
Financial class, Age binned, Surgeon volume 
binned, Number of risks binned, Acquired 
hypothyroidism (244), Aseptic necrosis of head and 
neck of femur (733.42), Memory loss (780.93) 
 
After the single-predictor models, the next models to consider are those also 
selected by coarse (or loopless) search, but now also allowing for multiple predicting 
variables in the single component. (These are given in Table 54, under “COARSE, best 
model (loopless)”). The best of these models, selected by the ΔBIC criterion, is Ageb Svb 
SNF, where the IVs Age binned (Ageb) and Surgeon volume binned (Svb) predict SNF 
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with a of %ΔH 19.44. As in other searches, the best model selected does not necessarily 
reflect the top single-predicting variables, indicating that the included variables (Ageb 
and Svb) together balanced the reduction of uncertainty and increase in complexity (here, 
a Δdf = 8) better than other IV combinations. 
o Fine Searches (Models with Loops) 
When allowing for multiple predicting components (that is, models with loops), 
the search for best model selects a model with four components: Fc SNF : Ageb SNF : 
Svb SNF : Nrb SNF. This model is the best by the BIC criterion for predicting the 
DV SNF in the Hip data set of All IVs. This model reduces uncertainty by 23.61% 
(%ΔH), using 11 degrees of freedom (Δdf). All four of the IVs included in this model are 
All IVs: Financial class (Fc), Age binned (Ageb), Surgeon volume binned (Svb), Number 
of risks binned (Nrb). The best model under the less conservative criterion of ΔAIC also 
includes three Comorbidity IVs, and is more complex as a result, with Δdf of 14. In the 
similar results for Knee analysis of DV SNF, Comorbidity IVs were included in the 
models selected by each criterion. 
 Comorbidity IVs Only 
o Coarse Searches (Models without Loops) 
When considering only the variables in the Comorbidity IVs data set, the most 
predictive models are substantially different. The results given in Table 54 above include 
relatively more of the All IVs and few of the Comorbidity IVs, so the list of the ten best 
single predictors in Table 55 is mostly different by necessity. (The reductions in 
uncertainty (%ΔH) for these predictors are also lower than the best values in Table 54, or 
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else they would have been included in that table.) The best single predictor of the 
Comorbidity IVs by uncertainty reduction is unspecified acquired hypothyroidism (Rhy), 
with a %ΔH of 1.47. 
Table 55. Summary of Search Results (Hip) for Comorbidity IVs for SNF. 
Search covers both coarse and fine models. 
MODEL Δdf ΔBIC %ΔH Alpha Variable description 
COARSE, single predictors 
Rhy SNF 1 30.41 1.47 0.00 Unspecified acquired hypothyroidism (244.9) 
Rhe SNF 1 25.46 1.28 0.00 Unspecified essential hypertension (401.9) 
Rav SNF 1 15.99 0.92 0.00 Aortic valve disorders (424.1) 
Rrd SNF 1 15.89 0.91 0.00 Unspecified hypertensive renal disease (403.9) 
Rao SNF 1 15.61 0.90 0.00 Chronic airway obstruction (496) 
Rhf SNF 1 12.87 0.80 0.00 Heart failure (428) 
Rnr SNF 
1 11.29 0.74 0.00 
Aseptic necrosis of head and neck of femur 
(733.42) 
Rbn SNF 1 10.25 0.70 0.00 Other disorders of bone and cartilage (733) 
Rhh SNF 1 7.98 0.61 0.00 Hyposmolality and/or hyponatremia (276.1) 
Rkd SNF 1 7.80 0.60 0.00 Chronic kidney disease, Stage III (585.3) 
MODEL Δdf ΔBIC %ΔH Alpha Variable description 
COARSE, IVs in AIC or BIC models but not in top 10 
Rin SNF (rank 12) 1 6.36 0.55 0.00 Urinary incontinence (788.3) 
Rse SNF (rank 13) 1 6.08 0.54 0.00 Senile osteoporosis (733.01) 
Rug SNF (rank 19) 1 3.21 0.43 0.00 Unspecified glaucoma (365.9) 
Rml SNF (rank 21) 1 2.84 0.42 0.00 Memory loss (780.93) 
MODEL Δdf ΔBIC %ΔH Alpha Variable description 
COARSE, best model (loopless) 
ΔBIC (best model) 
Rhy Rhe Rrd SNF 7 46.95 3.94 0.00 
Unspecified acquired hypothyroidism (244.9), 
Unspecified essential hypertension (401.9), 
Unspecified hypertensive renal disease (403.9) 
ΔAIC (best model) 
Rhy Rhe Rrd Rao SNF 15 7.77 4.91 0.00 
Unspecified acquired hypothyroidism (244.9), 
Unspecified essential hypertension (401.9), 
Unspecified hypertensive renal disease (403.9), 
Chronic airway obstruction (496) 
Inc.P (best model) 
Rhy Rhe Rrd Rbn Rin 
SNF 
31 -95.30 5.90 0.03 
Unspecified acquired hypothyroidism (244.9), 
Unspecified essential hypertension (401.9), 
Unspecified hypertensive renal disease (403.9), 
Other disorders of bone and cartilage (733), 
Urinary incontinence (788.3) 
MODEL Δdf ΔBIC %ΔH Alpha Variable description 
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FINE, best models (with loops) 
ΔBIC (best model) 
Rhy SNF : Rhh SNF : 
Rug SNF : Rhe SNF : 
Rrd SNF : Rav Rbn 
SNF : Rao SNF : Rse 
SNF : Rnr SNF 
11 111.97 7.65 0.00 
Unspecified acquired hypothyroidism (244.9), 
Hyposmolality and/or hyponatremia (276.1), 
Unspecified glaucoma (365.9), Unspecified 
essential hypertension (401.9), Unspecified 
hypertensive renal disease (403.9), Aortic valve 
disorders (424.1) + Other disorders of bone and 
cartilage (733), Chronic airway obstruction (496), 
Senile osteoporosis (733.01), Aseptic necrosis of 
head and neck of femur (733.42) 
Inc.P & ΔAIC (same best model) 
Rhy SNF : Rhh SNF : 
Rug SNF : Rhe SNF : 
Rrd SNF : Rav Rbn 
SNF : Rao SNF : Rse 
SNF : Rnr SNF : Rml 
SNF : Rin SNF 
13 110.79 8.22 0.01 
Unspecified acquired hypothyroidism (244.9), 
Hyposmolality and/or hyponatremia (276.1), 
Unspecified glaucoma (365.9), Unspecified 
essential hypertension (401.9), Unspecified 
hypertensive renal disease (403.9), Aortic valve 
disorders (424.1) + Other disorders of bone and 
cartilage (733), Chronic airway obstruction (496), 
Senile osteoporosis (733.01), Aseptic necrosis of 
head and neck of femur (733.42), Memory loss 
(780.93), Urinary incontinence (788.3) 
 
When the coarse search is widened to include more than one predicting variable 
in its (loopless) models, the best model by ΔBIC is Rhy Rhe Rrd SNF. This model 
combines the IVs unspecified acquired hypothyroidism (Rhy), unspecified essential 
hypertension (Rhe), and unspecified hypertensive renal disease (Rrd), resulting in a %ΔH 
of only 3.94. This is much lower than the value for the model above that included All IVs 
(Ageb Svb SNF), which reduced uncertainty by 19.44%. 
o Fine Searches (Models with Loops) 
The final step in the Hip analysis of the Comorbidity IVs data set is to allow for 
the inclusion of models with loops. Like the search for loopless models with this data set, 
the results continue to show that the Comorbidity IVs do not predict as well as the All IVs 
do. The best model by ΔBIC (Rhy SNF : Rhh SNF : Rug SNF : Rhe SNF : Rrd SNF : 
Rav Rbn SNF : Rao SNF : Rse SNF : Rnr SNF) includes 10 IVs in nine components, but 
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only reduces uncertainty by 7.65%. This model uses 11 degrees of freedom, which is also 
the Δdf of the best model from the All IVs data set, though that model achieved a %ΔH of 
23.61 for the same complexity, with four predicting variables. 
 Comparing Search Results (Hip, SNF) 
All IVs and the Comorbidity IVs searches yield two sets of results that can be 
compared to each other and interpreted into a three-tiered classification of predicting 
variables for DV SNF. These three sets of IVs are shown in Table 56. 
Table 56. The 3-Tiered Classification of 
Predicting Variables for DV SNF, Hip Analysis. 
Tier Variables 
Tier 1 – Most Important Fc, Ageb, Svb, Nrb 
Tier 2 Rhy, Rur 
Tier 3 Rml, Rhh, Rug, Rhe, Rrd, Rav, Rnn, Rao, Rse 
 
The first tier includes the most important predicting variables, which are those 
that were included in the best model by BIC in the All IVs data set: Fc, Ageb, Svb, and 
Nrb.  
The Tier 2 variables are those that appeared both in the best model by AIC in the 
combined All IVs search, and in the best model by BIC in the Comorbidity IVs search. 
This tier adds the two Comorbidity IVs, Rhy and Rur.  
Tier 3 includes those variables that occur in either of the two searches from Tier 2 
but not both. This tier includes nine Comorbidity IVs Rml, Rhh, Rug, Rhe, Rrd, Rav, 
Rnn, Rao, and Rse. 
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 Model FIT  
The best fine-grained model for All IVs, Fc SNF : Ageb SNF : Svb SNF : 
Nrb SNF, which reduced uncertainty by 23.61%, is explained in detail by the conditional 
probability distribution in Table 57 below. When Financial class (Fc) = 1, one tends to 
get orange, and when Fc = 2, one tends to get blue, but there are some exceptions on lines 
16, 17, 25, 26 (Table 57). Note that in this composite table one gets only Fc = 1 or 2; 
Fc can also be 3, 4, 5, 6, but these other states have much lower frequencies, so one 
doesn’t see them in a composite table. 
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Table 57. Fit Table (Hip) for All IVs for Best Model 
Fc SNF : Ageb SNF : Svb SNF : Nrb SNF. 
Blue rows indicate ratio < 0.90 and orange rows indicate ratio > 1.10. 
(Ratios between 0.91 and 1.09 are close to the margins and are excluded.) 
 IVs Data Model     
     
 
obs. p(DV|IV) calc. q(DV|IV) 
  
# Fc Ageb Svb Nrb freq SNF=0 SNF=1 SNF=0 SNF=1 Ratio p(margin) 
15 1 2 2 3 56 71.43 28.57 73.48 26.52 1.86 0.01 
16 1 2 3 1 43 97.67 2.33 98.27 1.73 0.12 0.02 
17 1 2 3 2 53 100.00 0.00 97.58 2.42 0.17 0.01 
19 1 3 1 1 85 71.77 28.24 75.77 24.23 1.70 0.01 
20 1 3 1 2 128 69.53 30.47 69.00 31.00 2.17 0.00 
21 1 3 1 3 172 60.47 39.54 55.69 44.31 3.11 0.00 
22 1 3 2 1 94 61.70 38.30 67.29 32.71 2.29 0.00 
23 1 3 2 2 114 56.14 43.86 59.41 40.59 2.85 0.00 
24 1 3 2 3 142 47.89 52.11 45.25 54.75 3.84 0.00 
25 1 3 3 1 83 97.59 2.41 94.41 5.59 0.39 0.02 
26 1 3 3 2 110 91.82 8.18 92.32 7.68 0.54 0.05 
28 2 1 1 1 131 99.24 0.76 97.56 2.45 0.17 0.00 
29 2 1 1 2 95 97.90 2.11 96.60 3.40 0.24 0.00 
31 2 1 2 1 127 98.43 1.58 96.33 3.67 0.26 0.00 
32 2 1 2 2 104 97.12 2.89 94.92 5.08 0.36 0.01 
34 2 1 3 1 160 99.38 0.63 99.54 0.46 0.03 0.00 
35 2 1 3 2 116 99.14 0.86 99.35 0.65 0.05 0.00 
36 2 1 3 3 85 98.82 1.18 98.86 1.14 0.08 0.00 
37 2 2 1 1 51 98.04 1.96 97.11 2.89 0.20 0.02 
38 2 2 1 2 46 93.48 6.52 95.99 4.01 0.28 0.05 
40 2 2 2 1 48 93.75 6.25 95.67 4.33 0.30 0.05 
43 2 2 3 1 90 98.89 1.11 99.45 0.55 0.04 0.00 
44 2 2 3 2 91 98.90 1.10 99.23 0.77 0.05 0.00 
45 2 2 3 3 54 98.15 1.85 98.65 1.35 0.09 0.01 
     
3204 85.74 14.26 85.74 14.26 1.00 
 
# Fc Ageb Svb Nrb freq SNF=0 SNF=1 SNF=0 SNF=1 Ratio p(margin) 
 
Each of the component’s individual projections is somewhat informative, yet not 
as informative as the full model’s joint distribution. These components are provided in 
the Appendix I: Supplementary Tables, Table 111 through Table 117.  
The joint probability distribution below in Table 58 shows the details for the best 
fine model from the hip Comorbidity IVs search Rhy SNF : Rhh SNF : Rug SNF : 
Rhe SNF : Rrd SNF : Rav Rbn SNF : Rao SNF : Rse SNF : Rnr SNF. In this 
distribution, each of the IVs is either 0 (comorbidity absent) or 1 (comorbidity present). 
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Row 1 is the case where all of the comorbidities included in the model are absent, which 
lowers the risk of Skilled Nursing Facility (SNF) from 14.26% (the model’s marginal 
probability) to 7.85%, with a ratio of 0.55 
Table 58. Fit Table (Hip) for Comorbidity IVs for Best Model Rhy SNF : 
Rhh SNF : Rug SNF : Rhe SNF : Rrd SNF : Rav Rbn SNF : Rao SNF : Rse SNF : Rnr SNF . 
Blue rows indicate ratio < 0.90 and orange rows indicate ratio > 1.10. 
(Ratios between 0.91 and 1.09 are close to the margins and are excluded.) 
  IVs Data Model     
 



































freq SNF=0 SNF=1 SNF=0 SNF=1 ratio p(margin) 
1 0 0 0 0 0 0 0 0 0 0 1371 92.34 7.66 92.15 7.85 0.55 0.00 
10 0 0 0 0 1 0 0 0 0 0 42 71.43 28.57 74.60 25.40 1.78 0.04 
18 0 0 0 1 0 0 0 0 0 1 49 73.47 26.53 68.93 31.07 2.18 0.00 
20 0 0 0 1 0 0 0 1 0 0 43 79.07 20.93 75.02 24.98 1.75 0.04 
22 0 0 0 1 0 0 1 0 0 0 26 76.92 23.08 72.01 27.99 1.96 0.05 
26 0 0 0 1 0 1 0 0 0 0 10 50.00 50.00 44.64 55.37 3.88 0.00 
50 1 0 0 0 1 0 0 0 0 0 14 78.57 21.43 59.33 40.67 2.85 0.01 
53 1 0 0 1 0 0 0 0 0 0 171 74.85 25.15 75.84 24.16 1.69 0.00 
56 1 0 0 1 0 0 0 1 0 0 12 66.67 33.33 59.87 40.13 2.81 0.01 
           
3204 85.74 14.26 85.74 14.26 
  
 
The additional IV states show if one or more of the comorbidities from the model 
are present, the risk is increased. This is illustrated in the decision tree below in 
Figure 11. 
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Figure 11. Decision Tree for DV SNF (Hip) with Comorbidity IVs, 
for Best Model, Rhy SNF : Rhh SNF : Rug SNF :Rhe SNF : 
Rrd SNF : Rav Rbn SNF : Rao SNF :  Rse SNF : Rnr SNF. 
 
Hip & Knee Summary of Results for SNF 
 The most important IVs are summarized in Table 59. The IVs that are important 
across both hip and knee searches are number of risks (Nrb), age (Ageb), surgeon volume 
(Svb), financial class (Fc), glaucoma (Rug), essential hypertension (Rhe), and acquired 
hypothyroidism (Rhy)  
Table 59. Summary of Most Important IVs by Tier across Hip and Knee for SNF. 
Tier Knee Hip 
1 L, Fc, Ageb, Svb, Nrb, Rmd, Rug, Rhf Fc, Ageb, Svb, Nrb 
2 Rpa Rhy, Rur 
3 Rbp, Rhy, Rau, Rhe, Rku, Rbn, Rin Rml, Rhh, Rug, Rhe, Rrd, Rav, Rnn, Rao, Rse 
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DV: Readmission (Re) 
Knee Analysis 
In this results section, another series of best models are proposed and analyzed in 
detail. This section looks both at (a) All IVs together, and (b) only the Comorbidity IVs. 
 All IVs 
o Coarse Searches (Models without Loops) 
The original 188 patient Comorbidity IVs were reduced to 35 IVs, of which 17 
had p ≤ 0.05 in a single predicting search for the dependent variable Readmission (Re), 
18 were literature-based but not individually predictive in the search, and five were found 
both in the literature and in the single predicting search. The search results for the top 10 
models are listed in Table 60. 
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Table 60. Summary of Search Results (Knee) for All IVs for Readmission (Re). Search covers coarse 
and fine models. 
MODEL Δdf ΔBIC %ΔH Alpha Variable description 
COARSE, single predictors (top 10) 
Fc Re 5 -28.66 1.26 0.02 Financial class 
Nrb Re 2 -4.02 1.22 0.00 Number of risks binned 
L Re 6 -37.85 1.18 0.05 Location 
Rco Re 1 3.88 1.17 0.00 Chronic obstructive asthma (493.2) 
Rgp Re 1 1.73 0.96 0.00 Repair of cystocele with graft or prosthesis (70.54) 
Rcj Re 1 0.66 0.86 0.00 Contracture of joint, lower leg (718.46) 
Rci Re 1 -0.43 0.76 0.00 Other forms of chronic ischemic heart disease (414) 
Rhf Re 1 -1.58 0.65 0.01 Heart failure (428) 
Rca Re 1 -1.83 0.63 0.01 
Coronary atherosclerosis of native coronary artery 
(414.01) 
Rdf Re 1 -1.87 0.62 0.01 Chronic diastolic heart failure (428.32) 
MODEL Δdf ΔBIC %ΔH Alpha Variable description 
COARSE, IVs in AIC or BIC models but not in top 10 
Rep Re (Rank 12) 1 -2.54 0.56 0.02 Epilepsy (345.9) 
MODEL Δdf ΔBIC %ΔH Alpha Variable description 
COARSE, best model (loopless) 
ΔBIC (best model) 
Rco Re 1 3.88 1.17 0.00 Chronic obstructive asthma (493.2) 
Inc.P & ΔAIC  (same best model) 
Rco Rcj Rin Re 
7 -23.56 3.35 0.01 
Chronic obstructive asthma (493.2) + Contracture of 
joint, lower leg (718.46) + Urinary incontinence (788.3) 
FINE, best models (with loops) 
ΔBIC (best model) 
Rci Re : Rco Re : 
Rgp Re : Rcj Re 
4 6.00 3.77 0.00 
Other forms of chronic ischemic heart disease (414), 
Chronic obstructive asthma (493.2), Repair of cystocele 
with graft or prosthesis (70.54), Contracture of joint, 
lower leg (718.46) 
Inc.P & ΔAIC  (same best model) 
Rep Re : Rci Re : 
Rca Re : Rdf Re : 
Rco Re : Rgp Re : 
Rcj Re 
7 42.78 5.42 0.02 
Epilepsy (345.9), Other forms of chronic ischemic heart 
disease (414), Coronary atherosclerosis of native 
coronary artery (414.01), Chronic diastolic heart failure 
(428.32), Chronic obstructive asthma (493.2), Repair of 
cystocele with graft or prosthesis (70.54), Contracture of 
joint, lower leg (718.46) 
 
Knowing the financial class (Fc) of the patient is the most predictive single 
variable, reducing uncertainty (%ΔH) by 1.26%. Number of risks (Nrb) followed with a 
%ΔH of 1.22 and then location (L) at a %ΔH of 1.18 (Table 60). The Comorbidity IV 
that is individually the post predictive of Readmission (Re) is chronic obstructive 
asthma (Rco) with a %ΔH of 1.17, with additional comorbidities listed in Table 60. The 
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best coarse model by ΔBIC is the top Comorbidity IV single predictor, Rco Re with a 
%ΔH of 1.17.  
o Fine Searches (Models with Loops) 
In this next search, models with loops are considered. The best fine model by 
ΔBIC is Rci Re : Rco Re : Rgp Re : Rcj Re with a %ΔH of 3.77 and Δdf =4 (Table 60). 
In this model, chronic ischemic heart disease (Rci), chronic obstructive asthma (Rco), 
repair of cystocele with graft or prosthesis (Rgp), and contracture of joint, lower leg 
(Rcj) provide the most information balanced by their complexity (Δdf). While this project 
uses the ΔBIC criterion for model selection, it is interesting to see that even with the AIC 
criterion, the best model selected contains only Comorbidity IVs, and not the top three 
single predicting variables, which were the All IVs financial class (Fc), number of risks 
(Nrb), and location (L). 
 Comorbidity IVs 
o Coarse Searches (Models without Loops)  
In the next search, only Comorbidity IVs are considered. These search results 
exclude the three All IVs from the previous search, and therefore an additional three 
Comorbidity IVs are included in the top 10 single predictors in Table 61. The best models 
by BIC are the exact same models selected from the prior search. In other words, the best 
coarse model is Rco Re with a %ΔH of 1.17.  
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Table 61. Summary of Search Results (Knee) for Comorbidity IVs for DV Readmission (Re). 
Search covers coarse and fine models. 
MODEL Δdf ΔBIC %ΔH Alpha Variable description 
COARSE, single predictors 
Rco Re 1 3.88 1.17 0.00 Chronic obstructive asthma (493.2) 
Rgp Re 1 1.73 0.96 0.00 Repair of cystocele with graft or prosthesis (70.54) 
Rcj Re 1 0.66 0.86 0.00 Contracture of joint, lower leg (718.46) 
Rci Re 1 -0.43 0.76 0.00 Other forms of chronic ischemic heart disease (414) 
Rhf Re 1 -1.58 0.65 0.01 Heart failure (428) 
Rca Re 1 -1.83 0.63 0.01 
Coronary atherosclerosis of native coronary artery 
(414.01) 
Rdf Re 1 -1.87 0.62 0.01 Chronic diastolic heart failure (428.32) 
Rse Re 1 -2.44 0.57 0.01 Senile osteoporosis (733.01) 
Rep Re 1 -2.54 0.56 0.02 Epilepsy (345.9) 
Ros Re 1 -2.92 0.52 0.02 Obstructive sleep apnea (327.23) 
MODEL Δdf ΔBIC %ΔH Alpha Variable description 
COARSE, best model (loopless) 
ΔBIC (best model) 
Rco Re 1 3.88 1.17 0.00 Chronic obstructive asthma (493.2) 
Inc.P & ΔAIC (same best model) 
Rco Rcj Rin Re 7 -23.56 3.35 0.01 
Chronic obstructive asthma (493.2) + Contracture of 
joint, lower leg (718.46) +  Urinary incontinence (788.3) 
MODEL Δdf ΔBIC %ΔH Alpha Variable description 
FINE, best models (with loops) 
ΔBIC (best model) 
Rci Re : Rco Re : 
Rgp Re : Rcj Re 
4 6.00 3.77 0.00 
Other forms of chronic ischemic heart disease (414), 
Chronic obstructive asthma (493.2), Repair of cystocele 
with graft or prosthesis (70.54), Contracture of joint, 
lower leg (718.46) 
Inc.P & ΔAIC (same best model) 
Rep Re : Rci Re : 
Rca Re : Rdf Re : 
Rco Re : Rgp Re : 
Rcj Re 
7 -1.84 5.42 0.02 
Epilepsy (345.9), Other forms of chronic ischemic heart 
disease (414), Coronary atherosclerosis of native 
coronary artery (414.01), Chronic diastolic heart failure 
(428.32), Chronic obstructive asthma (493.2), Repair of 
cystocele with graft or prosthesis (70.54), Contracture of 
joint, lower leg (718.46) 
 
o Fine Searches (Models with Loops) 
The Comorbidity IVs search provided no additional best model beyond what was 
previously identified in the Hospital-Based + Comorbidities search. The best fine-grained 
BIC model is again Rci Re : Rco Re : Rgp Re : Rcj Re with a %ΔH of 3.77 (Table 61). 
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 Comparing Search Results (Knee, Re) 
All IVs and the Comorbidity IVs searches yield two sets of results that can be 
compared to each other and interpreted into a three-tiered classification of results, as 
described below and summarized in Table 62. 
Table 62. The 3-Tiered Classification of 
Predicting Variables for DV: Re, Knee Analysis. 
Tier Variables 
Tier 1 – Most Important Rci, Rco, Rgp, Rcj 
Tier 2 None 
Tier 3 Rep, Rca, Rdf 
 
Tier 1 contains variables from the best-by-BIC model from the dataset All IVs. 
This is the most complete search, and the one that provides the most conservative 
predictors. The selected variables Rci, Rco, Rgp, and Rcj are shown in the first row of 
Table 62, and are considered the most important predicting variables.  
 Tier 2 contains variables not in Tier1, but found in the AIC (less conservative) 
model of All IVs AND in the BIC model of Comorbidity IVs. For the Knee Analysis of 
DV Readmission, there are no additional predictors. These are shown in the second row 
of Table 62.  
Finally, this classification places into Tier 3 any variables present elsewhere in the 
best model search results, but not included in Tier 1 or Tier 2; that is, any variables 
unique to one of the two searches—variables in the AIC model of All IVs but not in the 
BIC model of Comorbidity IVs, and variables in the BIC model of Comorbidity IVs but 
not in the AIC model from All IVs. The next most important predicting variables are Rep, 
Rca, and Rdf as summarized in row 3 of Table 62. 
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 Model FIT  
The best models for both All IVs search and the Comorbidity IVs search yielded 
the same best model of Rci Re : Rco Re : Rgp Re : Rcj Re. The detailed content of this 
model is shown below in the joint conditional probability distribution of the model 
(Table 63). Rows with a frequency < 10 and p > 0.05 are excluded. 
Table 63. Full Fit Table (Knee) for both All IVs search and Comorbidity IVs 
search for Best Model: Rci Re : Rco Re : Rgp Re : Rcj Re. 
Blue rows indicate ratio < 0.90 and orange rows indicate ratio > 1.10. 
(Ratios between 0.91 and 1.09 are close to the margins and are indicated in gray.) 
 IVs Data Model     
       obs. p(DV|IV) calc. q(DV|IV)     
# Rci Rco Rgp Rcj freq Re=0 Re=1 Re=0 Re=1 ratio p(margin) 
2 0 0 0 1 22 86.36 13.64 84.44 15.56 5.97 0.00 
4 0 1 0 0 38 86.84 13.16 85.73 14.27 5.48 0.00 
6 1 0 0 0 141 93.62 6.38 93.29 6.71 2.57 0.00 
     
4334 97.39 2.61 97.39 2.61 1.00 
 
 
The presence of contracture of joint, lower leg (Rcj) increases the chance of 
readmission (Re) from 2.61% to 15.56%, with a risk ratio of 5.97 (Table 63). Chronic 
obstructive asthma (Rco) increases readmission (Re) to 14.27%, with a ratio of 5.48, and 
chronic ischemic heart disease (Rci) increases risk of readmission to 6.71%, with a ratio 
of 2.57. This is shown clearly in the decision tree below in Figure 12. 
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Figure 12. Decision Tree for DV Readmit (Knee) for 
Best Model Rci Re : Rco Re : Rgp Re : Rcj Re. 
 
Hip Analysis 
In this portion of the results section, a similar series of results to the knee analysis 
are presented for the dependent variable Readmission (Re). Here, two sets of results are 
again produced: (a) All IVs, and (b) Comorbidity IVs. The hip data set contains the same 
eight administrative All IVs but a different set of Comorbidity IVs. 
 All IVs 
o Coarse Searches (Models without Loops) 
A single predicting search reduced the IVs in the Hip data set to 30, of which 14 
were found to be predictive with p ≤ 0.05, 16 were retained as literature-based IVs, and 
only one IV in common. 
The top 10 individual predicting variables are listed below in Table 64. The most 
predictive IV is surgeon (S) with a %ΔH of 8.41 and a Δdf of 42. The day of admit (Da) 
interestingly is the next single predictor with %ΔH of 2.03 and a Δdf of 5. The best 
 
- 143 - 
loopless coarse model by the ΔBIC criterion is the independence model, meaning that 
nothing predicts Readmission (Re). 
Table 64. Summary of Search Results (Hip) for All IVs for DV Readmit (Re). 
Search covers directed coarse, and fine models. 
MODEL Δdf ΔBIC %ΔH Alpha Variable description 
COARSE, single predictors (top 10) 
S Re 42 -271.92 8.41 0.01 Surgeon 
Da Re 5 -24.18 2.03 0.01 Day of admit 
Nrb Re 2 -3.19 1.62 0.00 Number of risk binned 
Ageb Re 2 -5.14 1.38 0.00 Age binned 
Svb Re 2 -7.91 1.03 0.02 Surgeon volume binned 
Rdd Re 1 -0.29 0.97 0.01 Dysthymic disorder (300.4) 
Rer Re 1 -0.95 0.89 0.01 Esophageal reflux (530.81) 
Rki Re 1 -1.03 0.88 0.01 Chronic kidney disease, Stage II (585.2) 
Rhp Re 1 -1.70 0.80 0.01 Hypopotassemia (276.8) 
Rys Re 1 -1.70 0.80 0.01 Cardiac dysrhythmias (427) 
MODEL Δdf ΔBIC %ΔH Alpha Variable description 
COARSE, IVs in AIC or BIC models but not in top 10 
Rep (rank 11) 1 -2.04 0.75 0.01 Epilepsy (345.9) 
Rpa (rank 12) 1 -2.75 0.67 0.02 Parkinson's disease (332) 
Rhe (rank 13) 1 -3.11 0.62 0.03 Essential hypertension (401.9) 
MODEL Δdf ΔBIC %ΔH Alpha Variable description 
COARSE, best model (loopless) 
ΔBIC (best model) 
Re 0 0.00 0.00 0.00 * Independence model is the best model 
ΔAIC (best model) 
Rep Rer Re 3 -7.53 2.09 0.00 Epilepsy (345.9) + Esophageal reflux (530.81) 
Inc.P (best model) 
S Re 42 -272.01 8.38 0.01 Surgeon 
MODEL Δdf ΔBIC %ΔH Alpha Variable description 
FINE, best models (with loops) 
ΔBIC (best model) 
Re 0 0.00 0.00 0.00 * Independence model is the best model 
ΔAIC (best model) 
Rhp Re : Rdd 
Re : Rpa Re : 
Rep Re : Rhe 
Re : Rys Re : 
Rki Re 
7 -12.33 5.53 0.04 
Hypopotassemia (276.8), Dysthymic disorder (300.4), 
Parkinson's disease (332), Epilepsy (345.9), Essential 
hypertension (401.9), Cardiac dysrhythmias (427), 
Chronic kidney disease, Stage II (585.2) 
Inc.P (best model) 
S Re 42 -272.01 8.38 0.01 Surgeon 
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o Fine Searches (Models with Loops) 
The best fine-grained search allowing for multiple components and models with 
loops by BIC is simply shown as Re, saying again that nothing predicts better than the 
independence model (Table 64). In the hip data, the occurrence of readmission was 
comparable to the knee data readmission rate at 2.72%. For purposes of the readmission 
analysis, the AIC model will be used. The best fine-grained model by AIC, Rhp Re : 
Rdd Re : Rpa Re : Rep Re : Rhe Re : Rys Re : Rki Re, is less conservative but suggests 
that hypopotassemia (Rhp), dysthymic disorder (Rdd), Parkinson's disease (Rpa), 
epilepsy (Rep), essential hypertension (Rhe), cardiac dysrhythmias (Rys), and chronic 
kidney disease (Rki) reduce the uncertainty of readmission with %ΔH of 5.53 and 
Δdf = 7.  
 Comorbidity IVs 
o Coarse Searches (Models without Loops) 
The top 10 variables from a search only considering the Comorbidity IVs are 
shown in Table 65. The top single predicting comorbidity for Readmission (Re) is 
dysthymic disorder (Rdd) followed by additional comorbidities listed in the table below.  
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Table 65. Summary of Search Results (Hip) for Comorbidity IVs. 
Search covers directed coarse, and fine models. 
MODEL Δdf ΔBIC %ΔH Alpha Variable description 
COARSE, single predictors 
Rdd Re 1 -0.29 0.97 0.01 Dysthymic disorder (300.4) 
Rer Re 1 -0.95 0.89 0.01 Esophageal reflux (530.81) 
Rki Re 1 -1.03 0.88 0.01 Chronic kidney disease, Stage II (585.2) 
Rhp Re 1 -1.71 0.80 0.01 Hypopotassemia (276.8) 
Rys Re 1 -1.71 0.80 0.01 Cardiac dysrhythmias (427) 
Rep Re 1 -2.06 0.75 0.01 Epilepsy (345.9) 
Rpa Re 1 -2.76 0.66 0.02 Parkinson's disease (332) 
Rhe Re 1 -3.09 0.62 0.03 Essential hypertension (401.9) 
Rcm Re 1 -4.17 0.49 0.05 Other primary cardiomyopathies (425.4) 
Rvi Re 1 -4.44 0.45 0.06 Venous (peripheral) insufficiency (459.81) 
MODEL Δdf ΔBIC %ΔH Alpha Variable description 
COARSE, best model (loopless) 
ΔBIC (best model) 
Re 0 0.00 0.00 0.00 * Independence model is the best model 
ΔAIC (best model) 
Rep Rca Rer Re 7 -27.76 3.60 0.02 
Epilepsy (345.9) + Coronary atherosclerosis of 
native coronary artery (414.01) + Esophageal 
reflux (530.81) 
Inc.P (best model) 
Rpa Rep Rca Rer Re 15 -78.88 5.28 0.04 
Parkinson's disease (332) + Epilepsy (345.9) + 
Coronary atherosclerosis of native coronary artery 
(414.01) + Esophageal reflux (530.81) 
MODEL Δdf ΔBIC %ΔH Alpha Variable description 
FINE, best models (with loops) 
ΔBIC (best model) 
Re 0 0.00 0.00 0.00 * Independence model is the best model 
Inc.P & ΔAIC (same best model) 
Rdd Re : Rpa Re : 
Rep Re : Rhe Re : 
Rys Re : Rer Re : 
Rki Re 
7 -12.40 5.52 0.03 
Dysthymic disorder (300.4), Parkinson's disease 
(332), Epilepsy (345.9), Essential hypertension 
(401.9), Cardiac dysrhythmias (427), Esophageal 
reflux (530.81), Chronic kidney disease, Stage II 
(585.2) 
 
o Fine Searches (Models with Loops) 
In the search that allows for loops, and as was seen with the prior search results, 
the best model by BIC is the independence model, and therefore the best model by AIC 
will be used for additional analysis. The AIC model is slightly different: Rdd Re : 
Rpa Re : Rep Re : Rhe Re : Rys Re : Rer Re : Rki Re, with a %ΔH of 5.52. Unlike the 
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best AIC from the prior search, this model includes esophageal reflux (Rer) and excludes 
hypopotassemia (Rhp). 
 Comparing Search Results (Hip, Re) 
All IVs and the Comorbidity IVs searches yield 2 sets of results that can be 
compared to each other and interpreted into a 3-tiered classification of results, as follows.   
Table 66. The 3-Tiered Classification of Predicting 
Variables for DV: Readmission, Hip Analysis. 
Tier Variables 
Tier 1 (Most Important) *Independence model 
Tier 2 None 
Tier 3 Rhp, Rdd, Rpa, Rep, Rhe, Rys, Rki 
 
Tier 1 contains variables from the best-by-BIC model from the dataset All IVs. 
This is the most complete search, and the one that provides the most conservative 
predictors. In the Readmission analysis for Hip, there were no predictors better than the 
independence model according to BIC.   
Tier 2 contains variables not in Tier1, but found in the AIC (less conservative) 
model of All IVs AND in the BIC model of Comorbidity IVs. For the Hip Analysis of DV 
Readmission, there were no variables that remained. 
Finally, this classification places into Tier 3 any variables present elsewhere in the 
best model search results, but not included in Tier 1 or Tier 2; that is, any variables 
unique to one of the two searches—variables in the AIC model of All IVs but not in the 
BIC model of Comorbidity IVs, and variables in the BIC model of Comorbidity IVs but 
not in the AIC model from All IVs. Tier 3 is the only classification that shows the 
predictors for Readmission (Rhp, Rdd, Rpa, Rep, Rhe, Rys, and Rki). 
 
- 147 - 
 Model FIT  
The detailed content of the best fine-grained AIC model from the All IVs search, 
Rhp Re : Rdd Re : Rpa Re : Rep Re : Rhe Re : Rys Re : Rki Re, is shown as a 
conditional probability distribution in Table 67. 
Table 67. Fit Table (Hip) for All IVs for Best Model Rhp Re : 
Rdd Re : Rpa Re : Rep Re : Rhe Re : Rys Re : Rki Re. 
Blue rows indicate ratio < 0.90 and orange rows indicate ratio > 1.10. 
(Frequencies < 10 and ratios between 0.91 and 1.09 are close to the margins and are excluded.) 
 




obs. p(DV|IV) calc. q(DV|IV) 
  
# Rhp Rdd Rpa Rep Rhe Rys Rki freq Re=0 Re=1 Re=0 Re=1 ratio p(margin) 
1 0 0 0 0 0 0 0 1680 98.10 1.91 98.26 1.75 0.64 0.01 
2 0 0 0 1 0 0 0 12 91.67 8.33 86.89 13.11 4.82 0.03 
3 0 1 0 0 1 0 0 27 81.48 18.52 87.04 12.96 4.77 0.00 
        
3200 97.28 2.72 97.28 2.72 1 
 
 
This resulted in a conditional probability distribution where after deleting rows 
with p > 0.05 and freq < 10, only three rows remained. Table 67 and the following 
decision tree in Figure 13 show that when none of the comorbidities are present, there is a 
protective effect relative to the margins with a risk of readmission at 1.75% and a risk 
ratio of 0.64, compared to 2.72% observed in the data. When epilepsy (Rep) alone is 
present, or dysthymic disorder (Rdd) along with essential hypertension (Rhe), the risk 
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Figure 13. Decision Tree for DV Readmit (Hip) All IVs for Best AIC Model 
Rhp Re : Rdd Re : Rpa Re : Rep Re : Rhe Re : Rys Re : Rki Re. 
 
The individual components of the model each have a fit table, condensed into a 
single table below (Table 68). 
Table 68. Condensed Fit Table of Components (Hip) All IVs 
Best Model Rhp Re : Rdd Re : Rpa Re : Rep Re : Rhe Re : Rys Re : Rki Re. 
Orange rows indicate ratio > 1.10. 
(Frequencies < 10 are indicated in gray). 
   Data obs. p(DV|IV)   
# IV State freq Re=0 Re=1 ratio p(margin) 
1 Rhp 1 7 71.43 28.57 10.51 0.00 
2 Rdd 1 58 89.66 10.35 3.80 0.00 
3 Rpa 1 9 77.78 22.22 8.17 0.00 
4 Rep 1 19 84.21 15.79 5.81 0.00 
5 Rhe 1 1462 96.58 3.42 1.26 0.10 
6 Rys 1 7 71.43 28.57 10.51 0.00 
7 Rki 1 6 66.67 33.33 12.26 0.00 
   
3200 97.28 2.72 1.00 
 
 
The Comorbidity IVs model, Rdd Re : Rpa Re : Rep Re : Rhe Re : Rys Re : 
Rer Re : Rki Re, resulted in a conditional probability distribution where after deleting 
rows with p > 0.05 and freq < 10, only two rows remained (Table 69). 
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Table 69. Fit Table (Hip) for Comorbidity IVs for Best Model Rdd Re : 
Rpa Re : Rep Re : Rhe Re : Rys Re : Rer Re : Rki Re. 
Blue rows indicate ratio < 0.90 and orange rows indicate ratio > 1.10. 
 IVs Data Model   
  
 
obs. p(DV|IV) calc. q(DV|IV)   
# Rdd Rpa Rep Rhe Rys Rer Rki freq Re=0 Re=1 Re=0 Re=1 ratio p(margin) 
1 0 0 0 0 0 0 0 1462 98.36 1.64 98.39 1.61 0.59 0.01 
2 1 0 0 1 0 0 0 18 83.33 16.67 89.21 10.79 3.97 0.04 
        3200 97.28 2.72 97.28 2.72 1.00 
 
 
The decision tree providers a very simple explanation where the occurrence of 
dysthymic disorder (Rdd) along with essential hypertension (Rhe) result in increased risk 
of readmission with a ratio of 3.97, and the absence of the comorbidities result in a 
reduced risk with ratio 0.59.   
 
Figure 14. Decision Tree for DV Readmit (Hip) with Comorbidity IVs 
for Best AIC Model Rdd Re : Rpa Re : Rep Re : 
Rhe Re : Rys Re : Rer Re : Rki Re Re. 
 
The individual components of the model each have a fit table, condensed into a 
single table below (Table 70). 
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Table 70. Condensed Fit Table of Components (Hip) All IVs 
Best AIC Model Rdd Re : Rpa Re : Rep Re : Rhe Re : Rys Re : Rer Re : Rki Re Re. 
Orange rows indicate ratio > 1.10. (Frequencies < 10 are indicated in gray). 
   Data obs. p(DV|IV)   
# IV State freq Re=0 Re=1 ratio p(margin) 
1 Rdd 1 58 89.66 10.35 3.80 0.00 
2 Rpa 1 9 77.78 22.22 8.17 0.00 
3 Rep 1 19 84.21 15.79 5.81 0.00 
4 Rhe 1 1462 96.58 3.42 1.26 0.10 
5 Rys 1 7 71.43 28.57 10.51 0.00 
6 Rer 1 554 95.49 4.51 1.66 0.01 
7 Rki 1 6 66.67 33.33 12.26 0.00 
   
3200 97.28 2.72 1.00 
 
 
Hip & Knee Summary for Readmissions 
The most important IVs are summarized in Table 71. The only IV that shows up 
in both searches is epilepsy (Rep). 
Table 71. Summary of Most Important IVs by Tier Across Hip and Knee for Readmission. 
  Readmission (Re) 
Tier Knee Hip 
1 Rci, Rco, Rgp, Rcj *Independence model  
2 None None 
3 Rep, Rca, Rdf Rhp, Rdd, Rpa, Rep, Rhe, Rys, Rki 
 
DV Total Cost (Tcb) 
Knee Analysis 
 All IVs 
o Coarse Searches (Models without Loops) 
After examining loopless models for the dependent variable Total Cost Binned 
(Tcb), single predicting variables with p ≤ 0.05 were retained, resulting in 57 IVs to keep 
for the next round of searches. The reduced data set contained 68 IVs in total, of which 
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57 were individually predictive with p ≤ 0.05. Of the 23 literature-based IVs, 11 were not 
found individually predictive but were retained regardless, and 12 literature-based IVs 
were found to be in common with the individually predictive IVs. The top 10 predicting 
variables are below in Table 72. 
Table 72. Summary of Search Results (Knee) for All IVs for Total Cost Binned (Tcb). Search covers 
coarse and fine models.  
MODEL Δdf ΔBIC %ΔH Alpha Variable description 
COARSE, single predictors (top 10) 
S Tcb 124 1220.44 23.71 0.00 Surgeon 
L Tcb 12 408.12 5.34 0.00 Location 
Svb Tcb 4 406.28 4.62 0.00 Surgeon volume binned 
Da Tcb 8 200.53 2.81 0.00 Day of admit 
Ad Tcb 54 -190.79 2.74 0.00 Admit diagnosis 
Nrb Tcb 4 140.10 1.82 0.00 Number of risks binned 
Rmo Tcb 2 31.17 0.50 0.00 Morbid obesity (278.01) 
Ros Tcb 2 19.72 0.38 0.00 Obstructive sleep apnea (327.23) 
Rde Tcb 2 17.37 0.36 0.00 Depressive disorder (311) 
Ruh Tcb 2 12.95 0.31 0.00 Hyperlipidemia (272.4) 
MODEL Δdf ΔBIC %ΔH Alpha Variable description 
COARSE, IVs in AIC or BIC models but not in top 10 
Rht Tcb (rank 29) 2 -6.68 0.11 0.01 Heart disease (429.9) 
Rnn Tcb (rank 30) 2 -7.00 0.10 0.01 Nephritis and nephropathy (583.81) 
Rmn Tcb (rank 40) 2 -8.16 0.09 0.01 Mononeuritis (355.9) 
Rug Tcb (rank 46) 2 -9.01 0.08 0.02 Glaucoma (365.9) 
MODEL Δdf ΔBIC %ΔH Alpha Variable description 
COARSE, best model (loopless) 
ΔBIC, Inc.P & ΔAIC   (same best model) 
S Tcb 124 1220.44 23.71 0.00 Surgeon 
MODEL Δdf ΔBIC %ΔH Alpha Variable description 
FINE, best models (with loops) 
ΔBIC (best model) 
S Tcb : Nrb Tcb 128 1322.66 25.13 0.00 Surgeon, Number of Risks Binned 
Inc.P & ΔAIC  (same best model) 
S Tcb : Nrb Tcb : 
Rmo Tcb : Rmn Tcb : 
Rug Tcb : Rht Tcb : 
Rnn Tcb 
138 1296.32 25.74 0.01 
Surgeon, Number of Risks Binned, 
Morbid obesity (278.01), Mononeuritis 
(355.9), Glaucoma (365.9), Heart disease 
(429.9), Nephritis and nephropathy 
(583.81) 
 
 Simply knowing the surgeon (S) reduces the uncertainty in predicting Total Cost 
Binned (Tcb) by 23.71% (Table 72). This is a very substantial %ΔH, the relevance of 
which will be discussed further in the discussion chapter. Because surgeon (S) has 64 
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possible states, the Δdf is quite large. Location (L) is the next most individually 
predictive, with a %ΔH of 5.34, followed by surgeon volume binned (Svb) with %ΔH at 
4.62. In fact, the most predictive single variables with a %ΔH greater than 1% are in 
All IVs. Day of admit (Da), admit diagnosis (Ad), and number of risks binned (Nrb) all 
have %ΔH > 1 at 2.81, 2.74, and 1.82 respectively (Table 72). In coarse searches that 
allow for more than one predicting IV, the best model, S Tcb, still has only one predictor, 
namely the top single predicting variable S. 
o Fine Searches (Models with Loops) 
The fine-grained search allows for multiple components as well as interaction 
effects, but none were found in any of the fine-grained models, regardless of selection 
criteria used for picking the best model. There is an improvement in %ΔH with the 
addition of number of risks binned (Nrb), resulting in the best fine-grained model by BIC 
of S Tcb : Nrb Tcb with a %ΔH of 25.13. In the single predicting variable search, Nrb 
was the sixth most individually predictive, but in the fine-grained model Nrb added the 
most information relative to its added complexity than the four All IVs that were 
individually more predictive of Tcb (L, Svb, Da, and Ad).  
 Comorbidity IVs 
o Coarse Searches (Models without Loops) 
The most predictive comorbidity, in the Comorbidity IVs search is morbid obesity 
(Rmo), which was the seventh most predictive individual variable with a %ΔH of 0.50. 
Obstructive sleep apnea (Ros), depressive disorder (Rde), and hyperlipidemia (Ruh) are 
then the next most predictive Comorbidity IVs, but with relatively small predictive value 
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on Tcb compared to the All IVs. Additional predictive single Comorbidity IVs are listed 
in Table 73. 
Table 73. Summary of Search Results (Knee) for Comorbidity IVs 
for DV Total Cost Binned (Tcb). Search covers coarse and fine models. 
All p values = 0. 
MODEL Δdf ΔBIC %ΔH Variable description 
COARSE, single predictors 
Rmo Tcb 2 31.17 0.50 Morbid obesity (278.01) 
Ros Tcb 2 19.72 0.38 Obstructive sleep apnea (327.23) 
Rde Tcb 2 17.37 0.36 Depressive disorder (311) 
Ruh Tcb 2 12.95 0.31 Hyperlipidemia (272.4) 
Rrd Tcb 2 7.54 0.25 Hypertensive renal disease (403.9) 
Rcp Tcb 2 5.55 0.23 Chronic pain (338.29) 
Rad Tcb 2 5.11 0.23 Anxiety, dissociative and somatoform disorders (300) 
Rer Tcb 2 4.44 0.22 Esophageal reflux (530.81) 
Rhe Tcb 2 0.29 0.18 Essential hypertension (401.9) 
Rdi Tcb 2 -0.01 0.18 Diabetes mellitus (250) 
MODEL Δdf ΔBIC %ΔH Variable description 
COARSE, best model (loopless) 
ΔBIC (best model) 
Rmo Tcb 2 31.17 0.50 Morbid obesity (278.01) 
ΔAIC (best model) 
Ruh Rmo Rde Ros Tcb 30 -104.39 1.54 
Hyperlipidemia (272.4) + Morbid obesity (278.01) + 
Depressive disorder (311) + Obstructive sleep apnea 
(327.23) 
Inc.P (best model) 
Ruh Rmo Rde Ros Rhe 
Tcb 
62 -319.60 2.10 
Hyperlipidemia (272.4) + Morbid obesity (278.01) + 
Depressive disorder (311) + Obstructive sleep apnea 
(327.23) + Essential hypertension (401.9) 
MODEL Δdf ΔBIC %ΔH Variable description 
FINE, best models (with loops) 
ΔBIC (best model) 
Ruh Tcb : Rmo Tcb : 
Rde Tcb : Ros Tcb : 
Rhe Tcb 
10 60.11 1.51 
Hyperlipidemia (272.4) + Morbid obesity (278.01) + 
Depressive disorder (311) + Obstructive sleep apnea 
(327.23) + Essential hypertension (401.9) 
Inc.P & ΔAIC (same best model) 
Ruh Tcb : Rmo Tcb : 
Rad Tcb : Rde Tcb : 
Ros Tcb : Rcp Tcb : 
Rhe Tcb 
14 56.49 1.82 
Hyperlipidemia (272.4) + Morbid obesity (278.01) + 
Anxiety, dissociative and somatoform disorders (300) + 
Depressive disorder (311) + Obstructive sleep apnea 
(327.23) + Chronic pain (338.29) + Essential 
hypertension (401.9) 
 
o Fine Searches (Models with Loops) 
The best model by BIC for Comorbidity IVs is Ruh Tcb : Rmo Tcb : Rde Tcb : 
Ros Tcb : Rhe Tcb, with a %ΔH of 1.51 (Table 73) and a Δdf of 10. 
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 Comparing Search Results (Knee, Tcb) 
The All IVs and the Comorbidity IVs searches yield two sets of results that can be 
compared to each other and interpreted with a three-tiered classification of results, as 
described below and summarized in Table 74. 
Table 74. The 3-Tiered Classification of Predicting 
Variables for DV: Total Cost, Knee Analysis 
Tier Variables 
Tier 1 – Most Important S, Nrb 
Tier 2 Rmo 
Tier 3 Rmn, Rug, Rht, Rnn, Ruh, Rde, Ros, Rhe 
 
Tier 1 contains variables from the best-by-BIC model from the dataset All IVs. 
This is the most complete search, and the one that provides the most conservative 
predictors. The selected variables (S, Nrb) are shown in the first row of Table 74, and are 
considered the most important predicting variables.  
Tier 2 contains variables not in Tier1, but found in the AIC (less conservative) 
model of All IVs AND in the BIC model of Comorbidity IVs. For the Knee Analysis of 
DV Total Cost Binned (Tcb), this selects the variable Rmo as the next-most important 
predicting variable. These are shown in the second row of Table 74. 
Finally, this classification places into Tier 3 any variables present elsewhere in the 
best model search results, but not included in Tier 1 or Tier 2; that is, any variables 
unique to one of the two searches—variables in the AIC model of All IVs but not in the 
BIC model of Comorbidity IVs, and variables in the BIC model of Comorbidity IVs but 
not in the AIC model from All IVs. This criterion shows the next most important 
predicting variables (Rmn, Rug, Rht, Rnn, Ruh, Rde, Ros, and Rhe) as seen in row 3 of 
Table 74. 
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 Model FIT  
The detailed content of the best BIC model from the All IVs search, S Tcb : Nrb 
Tcb, is shown as a conditional probability distribution in Table 76 below. The values for 
Total Cost were discretized into 3 bins. The bin ranges, averages, and frequencies are 
below in Table 75. 
Table 75. Bin values for DV Total Cost. 
Bin Min Cost Max Cost Average Cost Frequency 
1 $8,553 $16,780 $15,269 1446 
2 $16,781 $19,139 $17,922 1445 
3 $19,140 $96,880 $22,318 1445 
 
In the conditional probability distribution below, the ratio is based on the 
Expected Value column. Here, the ratio is calculated by taking the expected cost for a 
row and dividing it by the expected cost for the marginal distribution. 
Table 76. Full Fit Table (Knee) All IVs for Best Model: S Tcb : Nrb Tcb. 
Blue rows indicate ratio < 0.90 and orange rows indicate ratio > 1.10 
(ratios between 0.91 and 1.09 are close to the margins and are indicated in gray). 
 
IVs Data Model     
    obs. p(DV|IV) calc. q(DV|IV)     
# S Nrb freq Tcb=1 Tcb=2 Tcb=3 Tcb=1 Tcb=2 Tcb=3 Exp. Value Ratio rule p(margin) 
1 1 1 32 96.88 3.13 0.00 96.84 3.16 0.00 $15,353.04 0.83 1 0.00 
2 1 2 21 100.00 0.00 0.00 95.66 4.34 0.00 $15,384.34 0.83 1 0.00 
3 1 3 16 87.50 12.50 0.00 93.26 6.74 0.00 $15,448.07 0.83 1 0.00 
5 2 2 21 0.00 23.81 76.19 2.41 22.46 75.13 $21,160.63 1.14 3 0.00 
6 2 3 24 4.17 12.50 83.33 1.01 14.98 84.01 $21,588.06 1.17 3 0.00 
8 4 1 10 0.00 40.00 60.00 0.00 36.03 63.97 $20,733.93 1.12 3 0.05 
9 4 2 11 0.00 27.27 72.73 0.00 33.56 66.44 $20,842.54 1.13 3 0.04 
10 4 3 16 0.00 25.00 75.00 0.00 23.16 76.84 $21,299.87 1.15 3 0.00 
14 8 1 28 67.86 25.00 7.14 71.40 22.16 6.44 $16,311.11 0.88 1 0.00 
15 8 2 32 65.63 31.25 3.13 63.64 27.46 8.90 $16,624.95 0.90 1 0.00 
17 9 1 32 12.50 0.00 87.50 26.00 12.45 61.55 $19,937.71 1.08 3 0.00 
18 9 2 12 33.33 25.00 41.67 18.74 12.48 68.78 $20,448.31 1.11 3 0.03 
19 9 3 17 23.53 23.53 52.94 8.43 8.94 82.63 $21,330.66 1.15 3 0.00 
24 12 3 21 0.00 14.29 85.71 1.57 22.62 75.81 $21,212.89 1.15 3 0.00 
28 14 1 35 51.43 37.14 11.43 56.22 34.58 9.21 $16,835.67 0.91 1 0.00 
29 14 2 32 53.13 37.50 9.38 47.41 40.55 12.04 $17,193.74 0.93 1 0.04 
32 15 2 37 13.51 43.24 43.24 12.82 49.56 37.62 $19,235.69 1.04 2 0.02 
35 16 2 37 10.81 35.14 54.05 14.37 34.70 50.93 $19,780.04 1.07 3 0.03 
36 16 3 53 9.43 26.42 64.15 6.98 26.88 66.14 $20,644.05 1.12 3 0.00 
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37 17 1 203 20.20 11.33 68.47 20.04 11.19 68.78 $20,413.64 1.10 3 0.00 
41 18 2 95 24.21 36.84 38.95 21.23 46.99 31.78 $18,756.09 1.01 2 0.01 
42 18 3 98 13.27 47.96 38.78 11.73 41.37 46.91 $19,672.84 1.06 3 0.00 
43 19 1 23 65.22 30.44 4.35 73.04 21.17 5.79 $16,239.04 0.88 1 0.00 
44 19 2 29 72.41 20.69 6.90 65.54 26.41 8.06 $16,537.72 0.89 1 0.00 
47 21 1 41 2.44 51.22 46.34 6.82 59.03 34.15 $19,242.29 1.04 2 0.00 
48 21 2 73 6.85 56.16 36.99 4.81 57.86 37.33 $19,435.38 1.05 2 0.00 
49 21 3 110 2.73 50.91 46.36 2.45 46.87 50.69 $20,085.28 1.09 3 0.00 
53 23 1 19 0.00 42.11 57.90 0.00 42.12 57.89 $20,466.61 1.11 3 0.01 
54 24 1 24 12.50 62.50 25.00 8.85 45.80 45.35 $19,680.98 1.06 2 0.05 
55 24 2 34 5.88 41.18 52.94 6.19 44.58 49.22 $19,921.44 1.08 3 0.00 
56 24 3 26 0.00 23.08 76.92 2.97 34.04 63.00 $20,612.53 1.11 3 0.00 
58 26 1 30 6.67 56.67 36.67 1.91 59.77 38.32 $19,555.86 1.06 2 0.00 
59 26 2 67 0.00 68.66 31.34 1.32 57.54 41.13 $19,695.28 1.06 2 0.00 
60 26 3 83 0.00 37.35 62.65 0.65 45.19 54.15 $20,285.32 1.10 3 0.00 
61 27 1 44 18.18 72.73 9.09 31.31 60.27 8.42 $17,461.73 0.94 2 0.00 
62 27 2 47 27.66 57.45 14.89 24.43 65.38 10.19 $17,722.09 0.96 2 0.00 
63 27 3 43 25.58 62.79 11.63 15.68 66.86 17.46 $18,273.95 0.99 2 0.00 
73 32 1 50 96.00 4.00 0.00 90.10 7.13 2.77 $15,653.51 0.85 1 0.00 
74 32 2 38 89.47 5.26 5.26 86.38 9.50 4.12 $15,811.37 0.85 1 0.00 
75 32 3 21 57.14 28.57 14.29 76.77 13.46 9.77 $16,314.99 0.88 1 0.00 
79 35 1 48 85.42 12.50 2.08 74.95 20.74 4.31 $16,123.06 0.87 1 0.00 
80 35 2 84 66.67 27.38 5.95 67.85 26.10 6.05 $16,387.88 0.89 1 0.00 
81 35 3 100 50.00 36.00 14.00 54.02 33.12 12.86 $17,054.47 0.92 1 0.00 
87 37 3 34 5.88 41.18 52.94 5.51 36.62 57.88 $20,320.42 1.10 3 0.00 
90 38 3 18 5.56 5.56 88.89 4.48 2.99 92.53 $21,870.39 1.18 3 0.00 
96 41 1 163 73.01 22.09 4.91 69.06 23.09 7.84 $16,434.82 0.89 1 0.00 
97 41 2 190 60.00 29.47 10.53 60.94 28.33 10.73 $16,777.31 0.91 1 0.00 
98 41 3 112 41.07 33.04 25.89 45.22 33.51 21.27 $17,657.72 0.95 1 0.01 
101 44 1 146 70.55 27.40 2.06 72.01 23.99 4.01 $16,187.92 0.87 1 0.00 
102 44 2 217 62.21 32.26 5.53 64.54 29.89 5.57 $16,454.65 0.89 1 0.00 
103 44 3 163 55.22 31.29 13.50 50.80 37.50 11.70 $17,089.05 0.92 1 0.00 
105 45 2 68 29.41 50.00 20.59 27.15 52.44 20.40 $18,098.80 0.98 2 0.00 
106 45 3 81 14.82 55.56 29.63 16.43 50.58 32.99 $18,936.35 1.02 2 0.00 
115 49 3 36 11.11 38.89 50.00 8.92 29.92 61.17 $20,374.21 1.10 3 0.00 
118 51 2 12 0.00 0.00 100.00 0.00 6.58 93.42 $22,028.56 1.19 3 0.00 
119 51 3 44 0.00 6.82 93.18 0.00 4.03 95.97 $22,140.51 1.20 3 0.00 
120 52 1 15 0.00 20.00 80.00 4.92 31.97 63.11 $20,565.84 1.11 3 0.03 
121 52 2 22 0.00 27.27 72.73 3.34 30.19 66.47 $20,755.05 1.12 3 0.00 
122 52 3 36 5.56 27.78 66.67 1.46 21.01 77.53 $21,291.19 1.15 3 0.00 
127 54 3 72 19.44 27.78 52.78 21.13 31.01 47.86 $19,465.04 1.05 3 0.02 
142 60 2 17 0.00 11.77 88.24 2.76 16.75 80.49 $21,387.00 1.16 3 0.00 
143 60 3 14 0.00 14.29 85.71 1.13 10.92 87.95 $21,758.27 1.18 3 0.00 
149 63 1 33 0.00 27.27 72.73 2.09 32.63 65.28 $20,736.38 1.12 3 0.00 
150 63 2 62 3.23 33.87 62.90 1.40 30.52 68.08 $20,877.44 1.13 3 0.00 
151 63 3 73 0.00 20.55 79.45 0.61 20.97 78.42 $21,353.26 1.15 3 0.00 
   
4336 33.35 33.33 33.33 33.35 33.33 33.33 $18,502.55 1.00 1 
 
# S Nrb freq Tcb=1 Tcb=2 Tcb=3 Tcb=1 Tcb=2 Tcb=3 Exp. Value Ratio rule p(margin) 
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Surgeon 1, regardless of the number of risks (Nrb) of the patient, consistently is 
expected to have low cost. This is shown in rows 1, 2, and 3 of Table 76. Surgeons 8 and 
9 also have low expected total cost, although their cases both had Nrb in states 1 or 2 
(rows 14–18). Surgeons 32 and 35, regardless of Nrb state also are predicted to have low 
expected cost (rows 73–81), although there is an increase in expected cost as the number 
of risks increase. Surgeons 41 and 44 also have consistently low expected costs 
regardless of Nrb (rows 96–103), although a couple of these rows have risk ratio under, 
but close to 1. Surgeons 52 and 63 (rows 120–122 and 149–151, respectively) have high 
expected total cost regardless of Nrb state (Table 76). 
Each component of the model is interesting, particularly in the analysis of Tcb. In 
this project, the names of the individual surgeons are not included. However, each S state 
correlates to an individual surgeon. The surgeon component table shows the observed 
p(DV|IV). In Table 77, the probability of Tcb = 1 given surgeon (S) = 1 is 95.65% 
compared to the margin projections of 33.4%. Given this surgeon, with 69 knee surgeries 
in this data set, the Expected Value (the expected total cost) per case is $15,385 
compared to the average overall for all knee patients at $18,503. Surgeon (S) = 2 has 
comparable volume (freq = 52) but only 1.92% of observed cases in the low total cost 
bin, and just over 19% in bin 2. This surgeon has 78.6% of cases in the high-cost bin, 
with an expected total cost of $21,337. The surgeon (S) with the highest Expected Value 
is surgeon 51, with 62 surgeries in the data set and an expected total cost of $22,105. 
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Table 77. Component Fit Table for IV S (Knee) All IVs 
Best Model: L Tcb : Svb Tcb : Nrb Tcb. 
Blue rows indicate ratio < 0.90 and orange rows indicate ratio > 1.10. 
(Ratios between 0.91 and 1.09 are close to the margins and are indicated in gray.) 
 
IV Data     
   obs. p(DV|IV)     
# S freq Tcb=1 Tcb=2 Tcb=3 Exp. Value Ratio rule p(margin) 
1 1 69 95.65 4.35 0.00 $15,384.61 0.83 1 0.00 
2 2 52 1.92 19.23 78.85 $21,336.88 1.15 3 0.00 
3 3 2 0.00 0.00 100.00 $22,317.68 1.21 3 0.14 
4 4 37 0.00 29.73 70.27 $21,010.96 1.14 3 0.00 
5 5 3 0.00 33.33 66.67 $20,852.60 1.13 3 0.37 
6 7 2 50.00 0.00 50.00 $18,793.47 1.02 *1 0.61 
7 8 84 61.91 27.38 10.71 $16,750.88 0.91 1 0.00 
8 9 61 19.67 11.48 68.85 $20,426.53 1.10 3 0.00 
9 10 8 0.00 25.00 75.00 $21,218.86 1.15 3 0.03 
10 11 1 100.00 0.00 0.00 $15,269.25 0.83 1 0.37 
11 12 37 2.70 27.03 70.27 $20,939.25 1.13 3 0.00 
12 13 17 0.00 35.29 64.71 $20,766.41 1.12 3 0.01 
13 14 107 44.86 40.19 14.95 $17,389.42 0.94 1 0.00 
14 15 78 12.82 47.44 39.74 $19,329.28 1.04 2 0.00 
15 16 110 11.82 30.91 57.27 $20,126.16 1.09 3 0.00 
16 17 206 19.90 11.17 68.93 $20,424.10 1.10 3 0.00 
17 18 244 18.85 44.26 36.89 $19,043.25 1.03 2 0.00 
18 19 78 62.82 26.92 10.26 $16,706.44 0.90 1 0.00 
19 20 1 0.00 100.00 0.00 $17,922.40 0.97 2 0.37 
20 21 224 4.02 52.68 43.30 $19,719.31 1.07 2 0.00 
21 22 7 0.00 57.14 42.86 $19,806.09 1.07 2 0.20 
22 23 19 0.00 42.11 57.90 $20,467.05 1.11 3 0.01 
23 24 84 5.95 41.67 52.38 $20,066.78 1.08 3 0.00 
24 25 2 50.00 50.00 0.00 $16,595.83 0.90 *1 0.61 
25 26 180 1.11 52.22 46.67 $19,944.07 1.08 2 0.00 
26 27 134 23.88 64.18 11.94 $17,813.60 0.96 2 0.00 
27 28 40 42.50 42.50 15.00 $17,454.10 0.94 *1 0.05 
28 29 20 0.00 50.00 50.00 $20,120.04 1.09 *2 0.01 
29 30 3 0.00 66.67 33.33 $19,387.48 1.05 2 0.37 
30 31 1 0.00 100.00 0.00 $17,922.40 0.97 2 0.37 
31 32 109 86.24 9.17 4.59 $15,835.96 0.86 1 0.00 
32 33 5 0.00 60.00 40.00 $19,680.51 1.06 2 0.25 
33 34 1 0.00 100.00 0.00 $17,922.40 0.97 2 0.37 
34 35 232 63.36 28.02 8.62 $16,620.23 0.90 1 0.00 
35 36 35 5.71 48.57 45.71 $19,779.88 1.07 2 0.00 
36 37 57 8.77 40.35 50.88 $19,925.85 1.08 3 0.00 
37 38 28 7.14 3.57 89.29 $21,657.26 1.17 3 0.00 
38 39 40 32.50 50.00 17.50 $17,829.30 0.96 2 0.04 
39 40 2 0.00 50.00 50.00 $20,120.04 1.09 *2 0.61 
40 41 465 60.00 27.74 12.26 $16,869.28 0.91 1 0.00 
41 42 1 0.00 0.00 100.00 $22,317.68 1.21 3 0.37 
42 43 2 0.00 50.00 50.00 $20,120.04 1.09 *2 0.61 
43 44 526 62.36 30.61 7.03 $16,576.96 0.90 1 0.00 
44 45 187 24.06 50.80 25.13 $18,388.66 0.99 2 0.00 
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45 46 4 0.00 0.00 100.00 $22,317.68 1.21 3 0.02 
46 47 2 0.00 0.00 100.00 $22,317.68 1.21 3 0.14 
47 48 14 28.57 50.00 21.43 $18,106.23 0.98 2 0.42 
48 49 61 13.12 32.79 54.10 $19,952.20 1.08 3 0.00 
49 50 10 20.00 50.00 30.00 $18,710.35 1.01 2 0.50 
50 51 62 0.00 4.84 95.16 $22,104.99 1.19 3 0.00 
51 52 73 2.74 26.03 71.23 $20,980.59 1.13 3 0.00 
52 53 3 33.33 66.67 0.00 $17,038.03 0.92 2 0.37 
53 54 209 33.49 31.58 34.93 $18,568.96 1.00 3 0.84 
54 55 4 25.00 25.00 50.00 $19,456.75 1.05 3 0.78 
55 56 1 0.00 0.00 100.00 $22,317.68 1.21 3 0.37 
56 57 10 90.00 10.00 0.00 $15,534.57 0.84 1 0.00 
57 58 25 32.00 56.00 12.00 $17,600.83 0.95 2 0.03 
58 59 17 0.00 17.65 82.35 $21,542.04 1.16 3 0.00 
59 60 40 2.50 15.00 82.50 $21,482.18 1.16 3 0.00 
60 61 21 52.38 33.33 14.29 $17,160.56 0.93 1 0.11 
61 62 9 55.56 33.33 11.11 $16,936.78 0.92 1 0.31 
62 63 168 1.19 26.79 72.02 $21,056.48 1.14 3 0.00 
63 64 2 0.00 0.00 100.00 $22,317.68 1.21 3 0.14 
  
4336 33.35 33.33 33.33 $18,502.55 1.00 1 
 
# S freq Tcb=1 Tcb=2 Tcb=3 Exp. Value Ratio rule p(margin) 
 
The component Fit table for Nrb does not seem to show a strong effect for the Nrb 
component alone. In fact, the ratios for all of the bins of Nrb are close to the average for 
the entire sample and are within ± 0.10 of 1. So the effect size is small. However, because 
of the large frequencies of these three Nrb states, these effects are statistically significant, 
as the very small p-values indicate. 
Table 78. Component Fit Table for IV Nrb (Knee) All IVs 
Best Model: L Tcb : Svb Tcb : Nrb Tcb. 
(Ratios between 0.91 and 1.09 are close to the margins and are indicated in gray.) 
 IV Data     
   obs. p(DV|IV)     
# Nrb freq Tcb=1 Tcb=2 Tcb=3 Expected Value Ratio rule p(margin) 
1 1 1309 41.79 28.50 29.72 18119.85 0.98 1 0.00 
2 2 1474 37.31 36.09 26.59 18101.13 0.98 1 0.00 
3 3 1553 22.47 34.77 42.76 19205.40 1.04 3 0.00 
  
4336 33.35 33.33 33.33 18502.55 1.00 1 
 
  
 The Comorbidity IVs search resulted in the best model Ruh Tcb : Rmo Tcb : 
Rde Tcb : Ros Tcb : Rhe Tcb that had a relatively small reduction in uncertainty of 
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1.5%. The conditional probability distribution for this model does not provide for very 
meaningful predictions of expected total cost (Table 79). For the few rows that had a 
p(margin) ≤ 0.05 (rows 1, 2, 10, 12, and 18), the ratio is within ± 0.10 of 1, signifying 
that one would not expect a total cost much different than the average cost for the entire 
population. However, these small effects are statistically significant. These small effects 
could add up given high numbers of patients. While the ratio does indicate an important 
effect size, even small effects could have important financial impact given a large enough 
population of patients. 
Table 79. Full Fit Table (Knee) with Comorbidity IVs for Best Model: 
Ruh Tcb : Rmo Tcb : Rde Tcb : Ros Tcb : Rhe Tcb. 
Blue rows indicate ratio < 0.90 and orange rows indicate ratio > 1.10 
(ratios between 0.91 and 1.09 are close to the margins and are indicated in gray). 
 IVs Data Model     

















freq Tcb=1 Tcb=2 Tcb=3 Tcb=1 Tcb=2 Tcb=3 Exp. Value Ratio rule p(margin) 
1 0 0 0 0 0 1563 37.56 30.20 32.25 37.97 30.31 31.72 $18,309.15 0.99 1 0.00 
2 0 0 0 0 1 1559 36.37 36.24 27.39 36.17 36.27 27.57 $18,174.41 0.98 2 0.00 
3 0 0 0 1 0 37 24.32 21.62 54.05 27.99 23.76 48.25 $19,300.57 1.04 3 0.15 
4 0 0 0 1 1 76 31.58 27.63 40.79 27.48 29.31 43.22 $19,092.76 1.03 3 0.18 
5 0 0 1 0 0 134 28.36 31.34 40.30 27.21 30.33 42.46 $19,066.79 1.03 3 0.07 
6 0 0 1 0 1 170 27.06 35.88 37.06 26.15 36.62 37.23 $18,865.04 1.02 3 0.14 
7 0 0 1 1 0 9 33.33 22.22 44.44 18.50 21.93 59.57 $20,049.81 1.08 3 0.29 
8 0 0 1 1 1 11 0.00 54.55 45.46 18.43 27.44 54.13 $19,812.98 1.07 3 0.32 
9 0 1 0 0 0 31 25.81 32.26 41.94 19.94 32.40 47.66 $19,487.92 1.05 3 0.18 
10 0 1 0 0 1 106 19.81 38.68 41.51 19.15 39.09 41.76 $19,249.77 1.04 3 0.01 
11 0 1 0 1 0 7 28.57 14.29 57.14 13.06 22.56 64.38 $20,405.46 1.10 3 0.26 
12 0 1 0 1 1 26 7.69 23.08 69.23 13.04 28.31 58.66 $20,154.71 1.09 3 0.02 
13 0 1 1 0 0 8 0.00 50.00 50.00 12.93 29.34 57.73 $20,116.60 1.09 3 0.29 
14 0 1 1 0 1 25 4.00 40.00 56.00 12.62 35.97 51.40 $19,846.72 1.07 3 0.06 
15 0 1 1 1 0 4 25.00 0.00 75.00 7.92 19.12 72.96 $20,918.99 1.13 3 0.23 
16 0 1 1 1 1 6 0.00 50.00 50.00 8.04 24.38 67.58 $20,679.17 1.12 3 0.18 
17 1 0 0 0 0 128 31.25 32.81 35.94 27.82 30.94 41.24 $18,996.71 1.03 3 0.15 
18 1 0 0 0 1 293 24.57 38.91 36.52 26.67 37.26 36.07 $18,800.37 1.02 2 0.05 
19 1 0 0 1 0 4 50.00 50.00 0.00 19.08 22.57 58.35 $19,981.08 1.08 3 0.57 
20 1 0 0 1 1 29 13.79 27.59 58.62 18.95 28.17 52.89 $19,744.07 1.07 3 0.07 
21 1 0 1 0 0 24 4.17 25.00 70.83 18.79 29.18 52.03 $19,710.74 1.07 3 0.12 
22 1 0 1 0 1 38 31.58 21.05 47.37 18.26 35.62 46.12 $19,465.14 1.05 3 0.11 
23 1 0 1 1 0 3 0.00 0.00 100.00 11.95 19.75 68.30 $20,607.26 1.11 3 0.43 
24 1 0 1 1 1 8 12.50 25.00 62.50 12.07 25.04 62.90 $20,366.80 1.10 3 0.19 
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25 1 1 0 0 0 8 25.00 25.00 50.00 13.32 30.17 56.51 $20,052.45 1.08 3 0.32 
26 1 1 0 0 1 17 17.65 35.29 47.06 12.96 36.88 50.16 $19,783.03 1.07 3 0.18 
27 1 1 0 1 0 2 0.00 0.00 100.00 8.23 19.81 71.97 $20,867.33 1.13 3 0.50 
28 1 1 0 1 1 2 0.00 0.00 100.00 8.33 25.20 66.48 $20,623.37 1.11 3 0.58 
29 1 1 1 0 0 1 0.00 0.00 100.00 8.28 26.17 65.56 $20,584.28 1.11 3 0.77 
30 1 1 1 0 1 6 0.00 33.33 66.67 8.20 32.56 59.24 $20,308.86 1.10 3 0.31 
31 1 1 1 1 1 1 0.00 100.00 0.00 4.97 20.98 74.06 $21,045.75 1.14 3 0.68 
      


















freq Tcb=1 Tcb=2 Tcb=3 Tcb=1 Tcb=2 Tcb=3 Exp. Value Ratio rule p(margin) 
 
The decision tree for the Comorbidities IVs fit table shows that when the 
individual comorbidities are all absent, or when only Rhe is present, the expected cost is 
less than the average (Figure 15). Notice that these risk ratios are all very close to 1, 
however, and while significant, the difference is small. 
 
Figure 15. Decision Tree for DV Total Cost (Knee) with Comorbidity IVs 
for Best Model Ruh Tcb : Rmo Tcb : Rde Tcb : Ros Tcb : Rhe Tcb. 
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Hip Analysis 
 All IVs 
o Coarse Searches (Models without Loops) 
In the final data set there were a total of 54 IVs retained after variable reduction 
by a single predicting search. Of these IVs, four were found to be individually predictive 
with p ≤ 0.05, 17 were from the literature and six of these 17 were in common with the 
single predicting variables from the search, while 11 IVs were found in the literature but 
did not have significant p-values in the single predicting search. The top 10 single 
predicting variables are shown in Table 80. 
Table 80. Summary of Search Results (Hip) for All IVs for Total Cost Binned (Tcb). 
Search covers directed coarse, and fine models. All p values = 0. 
MODEL Δdf ΔBIC %ΔH Variable description 
COARSE, single predictors (top 10) 
S Tcb 84 1026.62 24.2 Surgeon 
L Tcb 12 849.389 13.4 Location 
Svb Tcb 4 893.509 13.1 Surgeon volume binned 
Da Tcb 10 414.476 7.03 Day of admit 
Ad Tcb 76 -333.31 3.98 Admit diagnosis 
Fc Tcb 10 -7.3465 1.04 Financial class 
Nrb Tcb 4 29.68 0.88 Number of risks binned 
Rmo Tcb 2 19.2819 0.5 Morbid obesity (278.01) 
Ageb Tcb 4 1.754 0.48 Age binned 
Rrd Tcb 2 14.5431 0.44 Hypertensive renal disease (403.9) 
MODEL Δdf ΔBIC %ΔH Variable description 
COARSE, best model (loopless) 
ΔBIC 
Svb Tcb 40 1173.50 21.25 Surgeon volume binned 
Inc.P & ΔAIC (same best model) 
S Tcb 84 1026.62 24.21 Surgeon 
MODEL Δdf ΔBIC %ΔH Variable description 
FINE, best models (with loops) 
ΔBIC (best model) 
L Tcb : Svb Tcb : 
Nrb Tcb 
20 1330.92 21.19 
Location, Surgeon volume binned, Number of risks 
binned 
Inc.P & ΔAIC (same best model) 
S Tcb : Nrb Tcb 88 1084.66 25.49 Surgeon, Number of risks binned 
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Very similar to the knee analysis, the hip search results show that knowing the 
surgeon (S) reduces the uncertainty in predicting Total Cost Binned (Tcb) by 24.2% 
(Table 80), just a slight increase from the knee analysis. Location (L) is the next most 
individually predictive, with a %ΔH of 13.4, followed by surgeon volume binned (Svb) 
with %ΔH at 13.1. These are the same top three single predicting IVs as for the knee, but 
the %ΔH is quite a bit higher in the hip data. Financial class (Fc) and age (Ageb) show 
up in the top 10 single predictors with %ΔH of 1.04 and 0.48. The best coarse model that 
allows for more than one predicting component is L Svb Tcb (Table 80). Surgeon (S) is 
not in the best model selected by BIC, presumably because the complexity of the model 
(Δdf = 84) is not worth the information it adds. Apparently, surgeon volume (Svb) along 
with location (L) have enough information worth the complexity (Δdf = 40) with a %ΔH 
of 21. 25. The best coarse model allowing for more than one predicting variable 
(Table 80), L Svb Tcb (%ΔH = 21.25), has less than half the Δdf of single predicting 
model S Tcb (%ΔH  = 24.2). 
o Fine Searches (Models with Loops) 
The fine-grained search did not detect an interaction effect, but found three single 
predicting components that together resulted in a %ΔH of 21.19. This best fine-grained 
model by BIC, L Tcb : Svb Tcb : Nrb Tcb, has a slightly smaller %ΔH than the best 
coarse model L Svb Tcb of 21.25%, but the Δdf is exactly half with a Δdf of 20 rather 
than 40. This reduction in complexity more than compensates for the slightly smaller 
%ΔH. 
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 Comorbidity IVs 
o Coarse Searches (Models without Loops) 
The most predictive comorbidity in the Comorbidity IVs search is morbid obesity 
(Rmo), with a %ΔH of 0.50 (Table 81), identical to the most predictive single variable 
from the Comorbidity IVs search in the knee analysis (Table 73). The best coarse model 
that allows for more than one predicting variable adds hypertensive renal disease (Rrd), 
resulting in the best coarse model Rmo Rrd Tcb with a %ΔH of 0.97 and a Δdf of 6 
(Table 81). These are very small reductions of uncertainty. 
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Table 81. Summary of Search Results (Hip) for Comorbidity IVs for DV Total Cost Binned (Tcb). 
Search covers coarse and fine models. All p values = 0. 
MODEL Δdf ΔBIC %ΔH Variable description 
COARSE, single predictors 
Rmo Tcb 2 19.28 0.50 Morbid obesity (278.01) 
Rrd Tcb 2 14.54 0.44 Hypertensive renal disease (403.9) 
Rkd Tcb 2 9.23 0.36 Chronic kidney disease, Stage III (585.3) 
Rnr Tcb 2 5.08 0.30 Aseptic necrosis of head and neck of femur (733.42) 
Rcp Tcb 2 4.17 0.29 Chronic pain (338.29) 
Raf Tcb 2 1.92 0.26 Atrial fibrillation (427.31) 
Rdi Tcb 2 1.06 0.24 Diabetes mellitus (250) 
Rog Tcb 2 -0.26 0.23 Osteoarthrosis (715.96) 
Rku Tcb 2 -1.55 0.21 Chronic kidney disease (585.9) 
Rin Tcb 2 -2.52 0.19 Urinary incontinence (788.3) 
MODEL Δdf ΔBIC %ΔH Variable description 
COARSE, IVs in AIC or BIC models but not in top 10 
Rcg (rank 23) 2 -5.14 0.16 Other disorders of bone and cartilage (733.99) 
MODEL Δdf ΔBIC %ΔH Variable description 
COARSE, best model (loopless) 
ΔBIC (best model) 
RmoRrd Tcb 6 19.91 0.97 
Morbid obesity (278.01) + Hypertensive renal disease 
(403.9) 
ΔAIC (best model) 
RmoRrdRnr Tcb 14 -18.73 1.34 
Morbid obesity (278.01) + Hypertensive renal disease 
(403.9) + Aseptic necrosis of head and neck of femur 
(733.42) 
Inc.P (best model) 
RmoRcpRrdRnr Tcb 30 -121.70 1.71 
Morbid obesity (278.01) + Chronic pain (338.29) + 
Hypertensive renal disease (403.9) + Aseptic necrosis of 
head and neck of femur (733.42) 
MODEL Δdf ΔBIC %ΔH Variable description 
FINE, best models (with loops) 
ΔBIC (best model) 
Rmo Tcb : Rcp Tcb : 
Rrd Tcb : Rnr Tcb 
8 41.95 1.51 
Morbid obesity (278.01), Chronic pain (338.29), 
Hypertensive renal disease (403.9), Aseptic necrosis of 
head and neck of femur (733.42) 
Inc.P & ΔAIC (same best model) 
Rmo Tcb : Rcp Tcb : 
Rrd Tcb : Raf Tcb : 
Rog Tcb : Rnr Tcb : 
Rcg Tcb 
14 33.79 2.08 
Morbid obesity (278.01), Chronic pain (338.29), 
Hypertensive renal disease (403.9), Atrial fibrillation 
(427.31), Osteoarthrosis (715.96), Aseptic necrosis of 
head and neck of femur (733.42), Other disorders of bone 
and cartilage (733.99) 
 
o Fine Searches (Models with Loops) 
The best model by BIC for Comorbidity IVs is Rmo Tcb : Rcp Tcb : Rrd Tcb : 
Rnr Tcb, with a %ΔH of 1.51 (Δdf = 8). Morbid obesity (Rmo), chronic pain (Rcp), 
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hypertensive renal disease (Rrd), and aseptic necrosis of head and neck of femur (Rnr) 
are looked at in detail in the model’s conditional probability distribution, given below.  
 Comparing Search Results (Hip, Tcb) 
The All IVs and the Comorbidity IVs searches yield two sets of results that can be 
compared to each other and interpreted with a three-tiered classification of results, as 
described below and summarized in Table 82. 
Table 82. The 3-Tiered Classification of Predicting 
Variables for DV: Total Cost, Hip Analysis 
Tier Variables 
Tier 1 – Most Important L, Svb, Nrb 
Tier 2 None 
Tier 3 S, Rmo, Rcp, Rrd, Rnr 
 
Tier 1 contains variables from the best-by-BIC model from the dataset All IVs. 
This is the most complete search, and the one that provides the most conservative 
predictors. The selected variables (L, Svb, and Nrb) are shown in the first row of 
Table 82, and are considered the most important predicting variables. 
Tier 2 contains variables not in Tier1, but found in the AIC (less conservative) 
model of All IVs AND in the BIC model of Comorbidity IVs. For the Hip Analysis of 
DV Total Cost, there are no variables remaining. 
Finally, this classification places into Tier 3 any variables present elsewhere in the 
best model search results, but not included in Tier 1 or Tier 2l that is, any variables 
unique to one of the two searches—variables in the AIC model of All IVs but not in the 
BIC model of Comorbidity IVs, and variables in the BIC model of Comorbidity IVs but 
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not in the AIC model from All IVs. This shows the next most important predicting 
variables (S, Rmo, Rcp, Rrd, and Rnr) in the last row of Table 82. 
 Model FIT  
 The detailed joint conditional probability distribution for best model L Tcb : Svb 
Tcb : Nrb Tcb from the All IVs search is shown in Table 84. Total Cost was binned into 3 
bins, with the ranges, frequencies, and average costs shown in Table 83. 
Table 83. Total Cost Range, Average Cost, and Frequency. 
Bin Min Cost Max Cost Average Cost Frequency 
1 $11,147 $16,768 $15,244 1068 
2 $16,772 $19,192 $17,997 1069 
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Table 84. Full Fit Table (Hip) with All IVs for Best Model: L Tcb : Svb Tcb : Nrb Tcb. 
Blue rows indicate ratio < 0.90 and orange rows indicate ratio > 1.10. 
(Ratios between 0.91 and 1.09 are close to the margins and are indicated in gray.) 
 
IVs Data Model     
     obs. p(DV|IV) calc. q(DV|IV)     
# L Svb Nrb freq Tcb=1 Tcb=2 Tcb=3 Tcb=1 Tcb=2 Tcb=3 Exp. Value Ratio rule p(margin) 
1 1 1 1 21 0.00 23.81 76.19 2.05 23.53 74.42 $21,317.04 1.15 3 0.00 
2 1 2 1 81 2.47 25.93 71.61 1.94 26.00 72.06 $21,213.25 1.14 3 0.00 
3 2 1 1 215 12.56 48.84 38.61 11.01 50.34 38.65 $19,447.72 1.05 2 0.00 
4 2 1 2 214 4.21 44.39 51.40 7.51 45.10 47.39 $19,940.50 1.07 3 0.00 
5 2 1 3 198 3.54 35.35 61.11 4.13 37.68 58.19 $20,523.33 1.10 3 0.00 
6 2 2 1 172 9.30 59.88 30.81 10.05 53.77 36.18 $19,362.02 1.04 2 0.00 
7 2 2 2 193 7.25 50.78 41.97 6.90 48.48 44.63 $19,832.19 1.07 2 0.00 
8 2 2 3 168 7.14 37.50 55.36 3.83 40.87 55.31 $20,401.00 1.10 3 0.00 
9 3 1 1 52 11.54 40.39 48.08 21.05 37.29 41.66 $19,307.42 1.04 3 0.17 
10 3 1 2 77 12.99 31.17 55.84 14.52 33.81 51.67 $19,941.54 1.07 3 0.00 
11 3 1 3 125 4.80 32.00 63.20 8.02 28.33 63.65 $20,664.32 1.11 3 0.00 
12 3 2 1 36 8.33 30.56 61.11 19.60 40.63 39.77 $19,261.82 1.04 2 0.23 
13 3 2 2 48 10.42 27.08 62.50 13.57 36.95 49.49 $19,868.89 1.07 3 0.01 
14 3 2 3 51 7.84 29.41 62.75 7.53 31.15 61.32 $20,571.98 1.11 3 0.00 
15 3 3 1 393 77.10 19.08 3.82 74.65 18.86 6.48 $16,235.60 0.87 1 0.00 
16 3 3 2 396 68.94 23.23 7.83 67.20 22.31 10.49 $16,622.80 0.89 1 0.00 
17 3 3 3 354 53.67 27.40 18.93 53.97 27.22 18.81 $17,364.37 0.93 1 0.00 
18 4 1 1 13 46.15 30.77 23.08 5.24 40.73 54.03 $20,304.03 1.09 3 0.10 
19 4 1 2 19 42.11 42.11 15.79 3.36 34.33 62.31 $20,731.58 1.12 3 0.01 
20 4 1 3 15 20.00 60.00 20.00 1.73 26.80 71.48 $21,192.62 1.14 3 0.00 
21 4 3 1 42 19.05 33.33 47.62 39.05 43.29 17.66 $17,723.28 0.95 2 0.09 
22 4 3 2 67 22.39 43.28 34.33 30.58 44.55 24.87 $18,283.50 0.98 2 0.13 
23 4 3 3 48 16.67 43.75 39.58 19.89 44.01 36.11 $19,087.69 1.03 2 0.12 
24 5 3 1 27 51.85 29.63 18.52 53.73 32.70 13.58 $17,133.84 0.92 1 0.04 
25 5 3 2 30 43.33 36.67 20.00 44.36 35.48 20.16 $17,690.49 0.95 1 0.26 
26 5 3 3 20 35.00 40.00 25.00 30.97 37.62 31.42 $18,569.76 1.00 2 0.92 
27 6 1 1 47 91.49 6.38 2.13 89.53 6.01 4.46 $15,734.15 0.85 1 0.00 
28 6 1 2 37 86.49 5.41 8.11 84.91 7.49 7.61 $16,004.23 0.86 1 0.00 
29 6 1 3 34 70.59 11.77 17.65 74.97 10.04 14.99 $16,612.93 0.89 1 0.00 
30 7 2 1 12 0.00 0.00 100.00 0.00 0.00 100.00 $22,533.93 1.21 3 0.00 
    
3205 33.32 33.35 33.32 33.32 33.35 33.32 $18,591.45 1.00 2 
 
# L Svb Nrb freq Tcb=1 Tcb=2 Tcb=3 Tcb=1 Tcb=2 Tcb=3 Exp. Value Ratio rule p(margin) 
 
 Location 1 with a lower surgeon volume (Svb) and patients with low number of 
risks (Nrb 1 or 2) has high expected costs (rows 1 and 2) as seen in Table 84. For 
location = 2, regardless of the state of Svb or Nrb, it is consistently close to the observed 
average total cost in the data, and even though p < 0.05 criteria, the ratio is within ± 0.10. 
For location 3, when Svb is low (bin 1 or 2), and Nrb is 2 or 3, the costs are expected to 
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be higher (rows 11 and 14). For that same location, when Svb is high (bin 3), Nrb is 
lower in bins 1 and 2, and the costs are expected to be lower (rows 15 and 16). In any of 
the rows for location 4 where p ≤ 0.05, the surgeon volume (Svb) is low (bin 1) and 
number of risks higher (bin 1 and 2) each time, resulting in expected higher costs. 
Rows 27–29 show that location 6, with Svb low in bin 1 and regardless of Nrb, always 
has lower expected costs (Table 84). 
 The individual component table for location (L) in Table 85 below show that 
location = 4 alone does not predict expected cost much higher than the average 
(ratio 1.02). However, when combined with surgeon volume (Svb) and number of risks 
(Nrb) in the joint distribution (Table 84), location = 4 has higher ratios (1.12 and 1.14 in 
rows 19 and 20, respectively).  
Table 85. Component Fit Table for IV L (Hip) All IVs Best Model: L Tcb : Svb Tcb : Nrb Tcb. 
Blue rows indicate ratio < 0.90 and orange rows indicate ratio > 1.10. 
(Ratios between 0.91 and 1.09 are close to the margins and are indicated in gray.) 
 IV Data obs. p(DV|IV)     
# L freq Tcb=1 Tcb=2 Tcb=3 Expected Value Ratio rule p(margin) 
1 1 102 1.96 25.49 72.55 $21,234.61 1.14 3 0.00 
2 2 1160 7.33 46.03 46.64 $19,911.36 1.07 3 0.00 
3 3 1532 52.22 25.33 22.45 $17,577.82 0.95 1 0.00 
4 4 204 23.53 41.67 34.80 $18,928.35 1.02 2 0.01 
5 5 77 44.16 35.07 20.78 $17,724.06 0.95 1 0.04 
6 6 118 83.90 7.63 8.48 $16,071.44 0.86 1 0.00 
7 7 12 0.00 0.00 100.00 $22,533.93 1.21 3 0.00 
  
3205 33.32 33.35 33.32 $18,591.45 1.00 2 
 
 
Table 86. Component Fit Table for IV Svb (Hip) All IVs Best Model: L Tcb : Svb Tcb : Nrb Tcb. 
(Ratios between 0.91 and 1.09 are close to the margins and are indicated in gray.) 
 IV Data obs. p(DV|IV)     
# Svb freq Tcb=1 Tcb=2 Tcb=3 Expected Value Ratio rule p(margin) 
1 1 1067 16.96 36.55 46.49 $19,638.90 1.06 3 0.00 
2 2 761 7.36 42.58 50.07 $20,066.20 1.08 3 0.00 
3 3 1377 60.35 25.78 13.87 $16,964.92 0.91 1 0.00 
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Table 87. Component Fit Table for IV Nrb (Hip) All IVs Best Model: L Tcb : Svb Tcb : Nrb Tcb. 
(Ratios between 0.91 and 1.09 are close to the margins and are indicated in gray.) 
 IV Data obs. p(DV|IV)     
# Nrb freq Tcb=1 Tcb=2 Tcb=3 Expected Value Ratio rule p(margin) 
1 1 1111 38.52 33.30 28.17 $18,214.59 0.98 1 0.00 
2 2 1081 35.06 34.41 30.53 $18,416.77 0.99 1 0.14 
3 3 1013 25.77 32.28 41.96 $19,191.18 1.03 3 0.00 
  
3205 33.32 33.35 33.32 $18,591.45 1.00 2 
 
 
The Comorbidity IVs search resulted in the best BIC model Rmo Tcb : Rcp Tcb : 
Rrd Tcb : Rnr Tcb, whose conditional probability distribution is shown in Table 88. 
Row 11 shows that when morbid obesity (Rmo) and chronic pain (Rcp) are both present 
(freq = 11), the expected cost is $20,841, significantly higher than the margin of $18,591.  
Table 88. Full Fit Table (Hip) with Comorbidity IVs for 
Best Model: Rmo Tcb : Rcp Tcb : Rrd Tcb : Rnr Tcb. 
Blue rows indicate ratio < 0.90 and orange rows indicate ratio > 1.10. 
(Ratios between 0.91 and 1.09 are close to the margins and are indicated in gray.) 
 
IVs Data Model     














freq Tcb=1 Tcb=2 Tcb=3 Tcb=1 Tcb=2 Tcb=3 Exp. Value Ratio rule p(margin) 
1 0 0 0 0 2797 35.65 33.82 30.53 35.73 33.83 30.44 $18,394.66 0.99 1 0.00 
2 0 0 0 1 88 20.46 30.68 48.86 19.36 28.12 52.53 $19,847.44 1.07 3 0.00 
3 0 0 1 0 69 11.59 31.88 56.52 10.96 30.99 58.05 $20,329.12 1.09 3 0.00 
4 0 0 1 1 1 0.00 0.00 100.00 4.50 19.53 75.97 $21,319.72 1.15 3 0.65 
5 0 1 0 0 94 26.60 25.53 47.87 24.51 26.72 48.78 $19,535.15 1.05 3 0.01 
6 0 1 0 1 6 0.00 0.00 100.00 11.10 18.56 70.35 $20,883.27 1.12 3 0.15 
7 0 1 1 0 6 0.00 16.67 83.33 6.01 19.58 74.41 $21,207.25 1.14 3 0.09 
8 1 0 0 0 128 15.63 34.38 50.00 14.67 35.32 50.01 $19,862.43 1.07 3 0.00 
9 1 0 0 1 4 0.00 0.00 100.00 6.43 23.75 69.83 $20,988.02 1.13 3 0.28 
10 1 0 1 0 1 0.00 0.00 100.00 3.40 24.47 72.13 $21,175.72 1.14 3 0.69 
11 1 1 0 0 11 0.00 45.46 54.55 8.52 23.62 67.86 $20,841.43 1.12 3 0.04 
  
    
3205 33.32 33.35 33.32 33.32 33.35 33.32 $18,591.45 1.00 2 
 
 
 The decision tree for model Rmo Tcb : Rcp Tcb : Rrd Tcb : Rnr Tcb (Figure 16) 
shows that when Rmo and Rcp are both present, the ratio for expected cost is 1.12. 
 
- 171 - 
Table 89. Component Fit Table (Hip) for morbid obesity (Rmo) with Comorbidity IVs 
for Best Model: Rmo Tcb : Rcp Tcb : Rrd Tcb : Rnr Tcb. 
Blue rows indicate ratio < 0.90 and orange rows indicate ratio > 1.10. 
(Ratios between 0.91 and 1.09 are close to the margins and are indicated in gray.) 
 IV Data obs. p(DV|IV)     
# Rmo freq Tcb=1 Tcb=2 Tcb=3 Expected Value Ratio rule p(margin) 
1 0 3061 34.24 33.32 32.44 $18,526.04 1.00 1 0.48 
2 1 144 13.89 34.03 52.08 $19,977.69 1.07 3 0.00 
  
3205 33.32 33.35 33.32 $18,591.45 1.00 2 
 
 
Table 90. Component Fit Table (Hip) for chronic pain (Rcp) with Comorbidity IVs 
for Best Model: Rmo Tcb : Rcp Tcb : Rrd Tcb : Rnr Tcb. 
Blue rows indicate ratio < 0.90 and orange rows indicate ratio > 1.10. 
(Ratios between 0.91 and 1.09 are close to the margins and are indicated in gray.) 
 IV Data obs. p(DV|IV)     
# Rcp freq Tcb=1 Tcb=2 Tcb=3 Expected Value Ratio rule p(margin) 
1 0 3088 33.78 33.65 32.58 $18,545.18 1.00 1 0.68 
2 1 117 21.37 25.64 52.99 $19,812.92 1.07 3 0.00 
    3205 33.32 33.35 33.32 $18,591.45 1.00 2   
 
 
Figure 16. Decision Tree for DV Total Cost (Hip) with Comorbidity IVs 
for Best Model Rmo Tcb : Rcp Tcb : Rrd Tcb : Rnr Tcb. 
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Hip & Knee Summary for Total Cost 
The most important IVs across both the hip and knee searches for Total Cost 
(Tcb) are summarized in Table 91. The IVs in common are surgeon (S), number of risks 
(Nrb) and morbid obesity (Rmo).  
Table 91. Summary of Most Important IVs by Tier 
Across Hip and Knee for Total Cost. 
  Total Cost (Tcb) 
Tier Knee Hip 
1 S, Nrb L, Svb, Nrb 
2 Rmo None 
3 Rmn, Rug, Rht, Rnn, Ruh, Rde, Ros, Rhe S, Rmo, Rcp, Rrd, Rnr 
 
 In this chapter, LR and RA were compared using both confirmatory and 
exploratory modes. Then, RA was used for exploratory modeling, resulting in 16 
predictive models. These best predictors were determined, and the models themselves 
were analyzed in detail. The Results chapter looked at each DV separately. In the next 
chapter, Discussion, summaries are provided that look across the DVs. After 
summarizing predictors and risk ratios within and between DVs, conclusions are offered 
that aim to relay a few key insights resulting from this project. 
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Chapter 5.  Discussion 
This project applied Reconstructability Analysis (RA) to outcomes in hip and 
knee replacement surgery, and asked if RA could create useful models of outcomes, and 
whether these models could produce predictions complimentary to—and even stronger 
than—models produced by LR. This inquiry resulted in substantive findings of interest to 
clinical and healthcare administrative professionals as well as to researchers and data 
scientists interested in improving the methodological toolkit for predictive analytics.  
The discussion that follows summarizes the contributions of the project in the 
terms and interests of these audiences. The first section, organized around a healthcare 
perspective, includes (a) identifying important predictors of outcome variables, 
(b) distinguishing between patient-centered and delivery system-centered predictors, and 
(c) classifying patients as being of higher or lower risk for adverse outcomes. The second 
section, organized toward a methodological perspective, includes (a) relating RA, the 
primary methodology used in this project, to the more commonly used approach of 
logistic regression, and (b) augmenting the use of RA for the analysis of this type of 
biomedical data. Finally, additional discussion that addresses future research and 
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Clinical and Healthcare-Related Contributions 
Best Models 
A primary purpose of this project was to perform RA exploratory analysis and 
16 best models predictive of each of the DVs. The amount of uncertainty reduced (%ΔH) 
is the primary measure indicating prediction (similar to %variance).  The 16 models are 
listed below in Table 92. These models are sorted by %ΔH, with the most predictive 
models at the top. The IV descriptions are provided with novel IVs indicated in blue and 
any interaction terms underlined.  
Table 92. List of 16 Models sorted by %ΔH. 
Data Set MODEL %ΔH Variable description 
Knee, All 
IVs 
S Tcb : Nrb Tcb 25.13 Surgeon, Number of Risks Binned 
Hip, All 
IVs 
Fc SNF : Ageb SNF : 
Svb SNF :Nrb SNF 
23.61 
Financial class, Age binned, Surgeon volume binned, 
Number of risks binned 
Hip, All 
IVs 
L Tcb : Svb Tcb : 
Nrb Tcb 
21.19 




L SNF : Fc SNF : 
Ageb SNF : 
Svb SNF : Nrb SNF : 
Rmd SNF: Rug SNF: 
Rhf SNF 
19.94 
Location, financial class, age binned, surgeon volume 
binned, number of risks binned, persistent mental 
disorders (294.8), Unspecified glaucoma (365.9),  
Heart Failure (428) 
Hip, Como 
IVs 
Rdi Cp : Ruh Cp : 
Rhh Cp : Ram Cp : 
Rra Cp : Rhe Cp : 
Rrd Cp : Rca Cp : 
Rhd Cp : Rpl Cp : 
Rgp Cp : Rfr Cp 
15.35 
Diabetes mellitus (250), Other and unspecified 
hyperlipidemia (272.4), Hyposmolality and/or 
hyponatremia (276.1), Unspecified deficiency anemia 
(281.9), Alcohol abuse, in remission (305.03), 
Unspecified essential hypertension (401.9), 
Unspecified hypertensive renal disease (403.9), 
Coronary atherosclerosis of native coronary artery 
(414.01), Other chronic pulmonary heart diseases 
(416.8), Hyperplasia of prostate (600), Repair of 




Ageb Cp : Nrb Cp : 
Rrd Cp : Rca Cp : 
Rhd Cp : Rpl Cp 
13.46 
Age (binned), Number of risks (binned), Unspecified 
hypertensive renal disease (403.9), Coronary 
atherosclerosis of native coronary artery (414.01), 
Other chronic pulmonary heart diseases (416.8), 
Hyperplasia of prostate (600) 
Knee, All 
IVs 
Ageb Cp : Nrb Cp : 
Ruh Cp:Rhd Cp : 
Rku Cp : Rro Cp 
10.4 
Age (binned), Number of risks (binned), Other and 
unspecified hyperlipidemia (272.4), Other chronic 
pulmonary heart disease (416.8), Chronic kidney 
disease, unspecified (585.9), Rosacea (695.3) 
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Knee, 
Como IVs 
Ruh Raf Cp : 
Ros Cp : Rhd Cp : 
Rav Cp : Reg Cp : 
Rku Cp : Ruu Cp : 
Rro Cp 
10.39 
Other and unspecified hyperlipidemia (272.4) + Atrial 
fibrillation (427.31), Obstructive sleep apnea (327.23), 
Other chronic pulmonary heart disease (416.8), Aortic 
valve disorders (424.1), Esophagitis (530.1), Chronic 
kidney disease, unspecified (585.9), Other disorders of 
urethra and urinary tract (599), Rosacea (695.3) 
Hip, Como 
IVs 
Rhy SNF : Rhh SNF : 
Rug SNF :Rhe SNF : 
Rrd SNF : 
Rav Rbn SNF : 
Rao SNF : Rse SNF : 
Rnr SNF 
7.65 
Unspecified acquired hypothyroidism (244.9), 
Hyposmolality and/or hyponatremia (276.1), 
Unspecified glaucoma (365.9),  Unspecified essential 
hypertension (401.9), Unspecified hypertensive renal 
disease (403.9), Aortic valve disorders (424.1) + Other 
disorders of bone and cartilage (733), Chronic airway 
obstruction (496), Senile osteoporosis (733.01), Aseptic 
necrosis of head and neck of femur (733.42) 
Hip, All 
IVs 
Rhp Re : Rdd Re : 
Rpa Re : Rep Re : 
Rhe Re : Rys Re : 
Rki Re (by AIC, 
p=.04) 
5.53 
Hypopotassemia (276.8), Dysthymic disorder (300.4), 
Parkinson's disease (332), Epilepsy (345.9), Essential 
hypertension (401.9), Cardiac dysrhythmias (427), 
Chronic kidney disease, Stage II (585.2) 
Knee, 
Como IVs 
Rhy SNF : Rau SNF : 
Rmd SNF : Rpa 
SNF : Rug SNF : 
Rhe SNF : Rhf SNF : 
Rku : Rbn SNF : 
Rin SNF 
5.52 
Hypothyroidism (244.9), Anemia (285.9),  persistent 
mental disorders (294.8), Parkinson's disease (332),  
Unspecified glaucoma (365.9), Essential hypertension 
(401.9), Heart failure (428),  Chronic kidney disease 
(585.9), Other disorders of bone and cartilage (733), 
Urinary incontinence (788.3) 
Hip, Como 
IVs 
Rdd Re : Rpa Re : 
Rep Re : Rhe Re : 
Rys Re : Rer Re : 
Rki Re (by AIC, 
p=.03) 
5.52 
Dysthymic disorder (300.4), Parkinson's disease (332), 
Epilepsy (345.9), Essential hypertension (401.9), 
Cardiac dysrhythmias (427), Esophageal reflux 
(530.81), Chronic kidney disease, Stage II (585.2) 
Knee, All 
IVs 
Rci Re : Rco Re : 
Rgp Re : Rcj Re 
3.77 
Other forms of chronic ischemic heart disease (414), 
Chronic obstructive asthma (493.2), Repair of cystocele 
with graft or prosthesis (70.54), Contracture of joint, 
lower leg (718.46) 
Knee, 
Como IVs 
Rci Re : Rco Re : 
Rgp Re : Rcj Re 
3.77 
Other forms of chronic ischemic heart disease (414), 
Chronic obstructive asthma (493.2), Repair of cystocele 
with graft or prosthesis (70.54), Contracture of joint, 
lower leg (718.46) 
Knee, 
Como IVs 
Ruh Tcb : Rmo Tcb : 
Rde Tcb : Ros Tcb : 
Rhe Tcb 
1.51 
Hyperlipidemia (272.4), Morbid obesity (278.01), 
Depressive disorder (311), Obstructive sleep apnea 
(327.23), Essential hypertension (401.9) 
Hip, Como 
IVs 
Rmo Tcb : Rcp Tcb : 
Rrd Tcb : Rnr Tcb 
1.51 
Morbid obesity (278.01), Chronic pain (338.29), 
Hypertensive renal disease (403.9), Aseptic necrosis of 
head and neck of femur (733.42) 
 
The models listed above in Table 92 are the models selected by BIC, and do not 
readily demonstrate the importance of the individual predictors. In the next discussion, 
these predictors are discussed across the data sets and DVs.  
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Important Predictors of Outcome Variables 
One of the purposes of this research project was to determine the variables that 
were the most predictive of each of the DVs. A sample of previously known IVs was 
included in the data sets for this project, and results validated many as indeed important 
predictors, while excluding others. This finding serves to confirm the importance of 
previously known comorbidity variables. Additionally, the exploratory modeling 
approach used in this project sought to detect novel or surprising IVs that may not have 
been hypothesized previously in the literature. Indeed, a number of novel IVs were found 
to be important, and these are summarized in the following discussion. 
In the search results for each of the DVs, the best models by both BIC and AIC 
were reported (the “search” action of Occam).  While BIC was the criterion used for 
selecting the best models to analyze in detail (the “fit” action of Occam), the variables 
included in the AIC models have importance as well. Variables from both the BIC and 
AIC models were included in the three-tiered classification of results after the search 
results in each of the DV sections. In this three-tiered classification, the IVs from both 
All IVs and the Comorbidity IVs are integrated. The Tier 1 variables include the most 
important predicting variables, which are those that were included in the best model by 
BIC in the All IVs data set. The Tier 2 variables are those additional variables that 
appeared both in the best model by AIC in the combined All IVs search, and in the best 
model by BIC in the Comorbidity IVs search. Tier 3 includes those variables that 
occurred in either of the two searches from Tier 2 but not both.  
To get a better understanding of the importance of variables throughout all of the 
analyses, a simple ranking system was created as follows. Every time an IV was flagged 
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as a Tier 1 variable, it was assigned 3 points, Tier 2 IVs were assigned 2 points, and 
Tier 3 IVs were assigned 1 point. When applied across the 4 DVs and across both the hip 
and knee data sets, this simple point system shows which IVs were the most influential 
overall (Table 93). The single most influential IV is number of risks binned (Nrb), which 
shows up as a Tier 1 IV in both hip and knee searches for Complication (Cp), Skilled 
Nursing Facility (SNF), and Total Cost (Tcb).  The second most influential variable is 
patient age (Ageb), which shows up as a Tier 1 variable in both the hip and knee searches 
for Cp and SNF. The top five most influential IVs were from All IVs, which were seen to 
have significant effects in the prediction of the DVs. Of the IVs with an assigned point 
value of 5 or greater, only hypertensive renal disease (Rrd) was not shared across the hip 
and knee searches; however, Rrd is an important variable for hip cases for the DVs Cp 
(Complication), SNF (Skilled Nursing Facility), and Tcb (Total Cost Binned). 
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Table 93. Top Important IVs across Hip and Knee Data Sets, and across the 4 DVs. 
(Cp = Complication, SNF = Skilled Nursing Facility, Re = Readmit, and Tcb = Total Cost Binned.) 
Novel variables are indicated by *. 
The Shared column indicates IVs located in both hip and knee data sets. 

























    



























Nrb Number of Risks (binned) 1 1 1 1 
  
1 1 yes 18 
Ageb Age (binned) 1 1 1 1 
    
yes 12 
Svb Surgeon volume (binned) 
  
1 1 
   




    
1 yes 6 
Fc Financial class 
  
1 1 
    
yes 6 
Rhd Other chronic pulmonary heart diseases 1 1 
      
yes 6 
Rhe Unspecified essential hypertension 
 





Ruh Other and unspecified hyperlipidemia 1 3 


















   
yes 5 








      
1 3 yes 4 
Rca 





   
yes 4 
Rku Chronic kidney disease, unspecified 1 
 
3 
      
4 
Rci Chronic ischemic heart disease 
    
1 
    
3 
Rhf Heart failure 
  
1 
      
3 
Rav Aortic valve disorders 2 
  
3 
    
yes 3 
Rmo Morbid obesity 
      
2 3 yes 3 
Rcj Contracture of joint, lower leg 
    
1 
    
3 
Rco Chronic obstructive asthma 
    
1 
    
3 
*Rmd 
Other persistent mental disorders due to 
conditions classified elsewhere   
1 
      
3 







*Rhy Unspecified acquired hypothyroidism 
  
3 2 
    
yes 3 
*Rpl Hyperplasia of prostate 
 
1 
       
3 
*Ros Obstructive sleep apnea 2 




Raf Atrial fibrillation 2 
        
2 
Rur Retention of urine 
   
2 
     
2 
Ruu Other disorders of urethra and urinary tract 2 
        
2 
*Rnn Nephritis and nephropathy 






*Rep Epilepsy unspecified 




*Reg Esophagitis 2 
        
2 





     
2 
Rdf Chronic diastolic heart failure 
    
3 
    
1 
Rht Heart disease, unspecified 




Rys Cardiac dysrhythmias 
     
3 
   
1 
Rdi Diabetes mellitus 
 
3 
       
1 
Rki Chronic kidney disease, Stage II (mild) 
     
3 
   
1 
Rin Urinary incontinence 
  
3 
      
1 
Rbn Other disorders of bone and cartilage 
  
3 
      
1 
Rnr Aseptic necrosis of head and neck of femur 
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Rfr Nonunion of fracture 
 
3 
       
1 
Rmn Mononeuritis of unspecified site 




Rse Senile osteoporosis 
   
3 
     
1 
Rao Chronic airway obstruction 
   
3 
     
1 
Rcp Other chronic pain 




*Rde Depressive disorder 




*Rbp Other and unspecified bipolar disorders 
  
3 
      
1 
*Rdd Dysthymic disorder 
     
3 
   
1 
*Rra Alcohol abuse, in remission 
 
3 
       
1 
*Rml Memory loss 
   
3 
     
1 
*Rhp Hypopotassemia 
     
3 
   
1 
*Rau Anemia, unspecified 
  
3 
      
1 
*Ram Unspecified deficiency anemia 
 
3 
       
1 
*Rro Rosacea 3 
        
1 




























Recall that some of the IVs used in the final data sets for the exploratory searches 
were retained because they had an individual predictive value with p-value ≤ 0.05. 
Additionally, recall that there were some IVs that were kept, not because of their 
predictive value in the analysis of this project, but because they were found to be 
predictive in the literature (Table 9).  There is an extensive literature that discusses 
additional comorbidities for joint replacement and other surgeries that does not offer 
actual predictive models that include them. These were not flagged as “literature-based 
IVs” in this project, yet they are also not “surprising.” For example, in Table 93, the 
IV hypertensive renal disease (Rrd) is important for Cp, SNF, and Tcb. The IV Rrd was 
not used in any of the predictive models from the literature; however, diabetes was. 
Clinically, it is well known that diabetes is associated with, and may lead to, renal 
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disease, and therefore it is not that surprising or novel that hypertensive renal disease 
(Rrd) shows up as having an effect in the exploratory searches in this project.  
However, there are 19 predictive IVs in Table 93 that seem to be surprising and 
novel. An asterisk next to an IV name in Table 93 indicates that the IV was a novel 
variable that has not been present in the literature of hip and knee outcomes thus far. For 
example, unspecified glaucoma (Rug) is not a comorbidity found in the literature 
(Table 9) to be predictive of outcomes in hip or knee replacement, or for other surgeries. 
These novel IVs should be considered in future confirmatory research, and their clinical 
relevance should be explored.  
Patient Variables versus Delivery System Variables  
Predictive analytics in healthcare is still relatively new, but the use of predictive 
tools is going to play an increasingly important role in measuring quality and the 
provisioning of resources in care delivery. In healthcare analytics today, predictive 
analytics are often discussed as methods to predict outcomes per patient, given a set of 
patient-specific clinical diagnoses (and more recently genomic data). Without a doubt, 
personalized medicine will increase providers’ ability to diagnose with better accuracy 
and apply more appropriate targeted therapies.  
The delivery system, however, has hardly turned the lens on itself. Applying 
advanced predictive modeling techniques on patient level data, without including data 
about the way care is delivered, will miss large opportunities. This research showed that 
by looking at variables related to the delivery system (hospital, surgeon, surgeon 
volume), there is quite a bit of information that clearly shows, regardless of the patient’s 
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risk profile, that the delivery system itself is highly predictive of discharge practices and 
costly outcomes.  
In this section of the discussion, variables are now partitioned into either Patient-
Related IVs or Delivery System IVs. This partitioning of IVs is not the same as the 
All IVs and Comorbidity IVs schema. The rationale for this is to see how much of the 
predicted “risk.” per outcome, is really attributable to a patient’s risk versus the amount 
of “risk” that is actually attributable to the Delivery System itself—in other words, the 
manner in which we deliver care. 
The Comorbidity IVs were the binary, individual patient comorbidities that were 
generated from the ICD-9 diagnosis codes that were indicated as present on admit. 
All IVs contained both the individual patient Comorbidity IVs in addition to non-
comorbidity patient-related IVs and delivery system-centered IVs. The IVs from All IVs 
that are non-comorbidity patient-related are number of risks binned (Nrb), patient age 
(Ageb), and admit diagnosis (Ad). These are now considered alongside the individual 
Comorbidity IVs as Patient-Related (Figure 17). The All IVs that are delivery system-
centered are location (L), surgeon (S), surgeon volume (Svb), and day of admit (Da) and 





Delivery System-Centered Non-comorbidity, Patient-Related Comorbidities 
Delivery System IVs Patient-Related IVs 
 
Figure 17. New Partition of IVs into Delivery System and Patient-Related IVs. 
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In the introduction to this project, there was a discussion of the emerging trend of 
providers (for knee and hip replacements, the surgeons) to be increasingly contracted 
under value-based payment models that reimburse for delivering high-quality outcomes, 
often without taking into consideration the differential risks posed by varying 
comorbidities (patient risk) in the patient population. One of the perceived and 
unintended side effects of this is what is called “cherry picking,” where some providers 
select patients with no or few comorbidities and therefore have healthier patient 
populations with a lower risk of adverse outcomes. Similarly, refraining from cherry 
picking behavior would result in a patient population that would have a greater risk of 
adverse outcomes than their cherry-picked peers. Often, there is a suspicion that cherry 
picking may be occurring, but little evidence is provided to support this argument. 
Regardless, one cannot make a fair or valid comparison of outcomes across providers 
without looking at patient risk. 
The results of this project show that the Delivery System itself plays a role in 
these outcomes. The surgeon, the surgeon’s volume, and the location were all very 
predictive of SNF and Tcb.  If patients seeking care are being turned away because of 
their comorbidities out of concern that they will result in higher-cost care, then the results 
that the delivery system is more predictive of the total cost than patient comorbidities has 
implications. 
The best model predicting Complication (Cp) includes IVs that are Comorbidity 
IVs as well as non-comorbidity IVs within All IVs. From the best model Ageb Cp : 
Nrb Cp : Ruh Cp : Rhd Cp : Rku Cp : Rro Cp, two submodels were generated; one with 
the subset of IVs that are Delivery System only, and one with IVs that are Patient-
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Related only. Separate Occam runs were then conducted, and the %ΔH of each of the 
new submodels is presented in Table 94 below. Looking at the DV Complication (Cp) 
for the knee patients, Table 94 shows that all of the information in the model (%ΔH) is 
attributed to the Patient-Related IVs. In other words, it is indeed the patient’s individual 
comorbidities that predict Complication (Cp). This is also true for the hip replacement 
patients.  
Table 94. Delivery System vs. Patient-Related Submodels 
Comparison of Reduction of Uncertainty for DV Complication (Cp). 
DV: Complication (Cp) 
Knee 
Full Model by BIC for Cp:  %ΔH (Total) 
IV:AgebCp:NrbCp:CpRuh:CpRhd:CpRku:CpRro 10.40 
Patient Related IVs: %ΔH (patient-related) 
IV:AgebCp:NrbCp:CpRuh:CpRhd:CpRku:CpRro 10.40 
Delivery System IVs: %ΔH (delivery system) 
None 0.00 
Hip 
Best Model by BIC for Cp: %ΔH (Total) 
IV:AgebCp:NrbCp:CpRrd:CpRca:CpRhd:CpRpl 13.46 
Patient Related IVs: %ΔH (patient-related) 
IV:AgebCp:NrbCp:CpRrd:CpRca:CpRhd:CpRpl 13.46 
Delivery System IVs: %ΔH (delivery system) 
None 0.00 
 
When looking at the DV Skilled Nursing Facility (SNF), there is a bit of a mix of 
Patient-Related and Delivery System IVs, although the majority of the information is 
provided by the Patient-Related IVs (Table 95). Note that the reductions of uncertainty 
are not expected to be strictly additive. For example, in the Knee values of Table 95, 
19.94 is not the sum of 16.08 + 3.14. Entropy and entropy reduction numbers are not 
expected to show linearity or additivity; they are nonlinear expressions. 
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Table 95. Delivery System vs. Patient-Related Submodels 
Comparison of Reduction of Uncertainty for DV Skilled Nursing Facility (SNF). 
DV: Skilled Nursing Facility (SNF) 
Knee 




Patient Related IVs: %ΔH (patient-related) 
IV:FcSNF:SNFAgeb:SNFNrb:SNFRmd:SNFRug:SNFRhf 16.08 
Delivery System IVs: %ΔH (delivery system) 
IV:LSNF:SNFSvb 3.14 
Hip 
Best Model by BIC for SNF: %ΔH (Total) 
IV:FcSNF:SNFAgeb:SNFSvb:SNFNrb 23.61 
Patient Related IVs: %ΔH (patient-related) 
IV:FcSNF:SNFAgeb:SNFNrb 17.21 
Delivery System IVs: %ΔH (delivery system) 
IV:SNFSvb 7.53 
 
Readmission is not very well predicted, but when it is, the information is captured 
by Patient-Related IVs (Table 96), as there are no IVs in the model that are either 
Delivery System IVs or even All IVs.  
Table 96. Delivery System vs. Patient-Related Submodels 
Comparison of Reduction of Uncertainty for DV Readmission (Re). 
DV: Readmission (Re) 
Knee 
Full Model by BIC for Re:  %ΔH (Total) 
IV:RciRe:RcoRe:RgpRe:RcjRe 3.77 
Patient Related IVs: %ΔH (patient-related) 
IV:RciRe:RcoRe:RgpRe:RcjRe 3.77 
Delivery System IVs: %ΔH (delivery system) 
None 0.00 
Hip 
Best Model by BIC for Re: %ΔH (Total) 
IV:RhpRe:RddRe:RpaRe:RepRe:RheRe:RysRe:RkiRe 5.53 
Patient Related IVs: %ΔH (patient-related) 
IV:RhpRe:RddRe:RpaRe:RepRe:RheRe:RysRe:RkiRe 5.53 
Delivery System IVs: %ΔH (delivery system) 
None 0.00 
 
The analysis of the DV total cost differs considerably from the other DVs in the 
relative importance of Patient-Related versus Delivery System IVs. Recall the concern 
that sicker patients cost more and the subsequent cherry picking behavior. By partitioning 
the IVs, it is shown that nearly all of the information about total cost (Tcb) is attributed to 
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the Delivery System (i.e., Surgeon) and not the patient’s risk (i.e., Nrb). In fact, for the 
knee patients, the %ΔH using only the Delivery System IV surgeon (S) is 23.71 
(Table 97) and the Patient-Related IV, number of risks (Nrb), only reduces uncertainty 
by 1.82%. This predictive effect of surgeon (S) could be due to either the surgeon being a 
more efficient provider or an artifact of the surgeon “cherry picking” and selecting 
healthier patients with lesser numbers of risks (Nrb). An Occam search was thus 
performed looking at the predictive effect of Nrb on S, and the resulting %ΔH for knee 
data was 3.24 and 2.32 for hip—not a strong association. There does not appear to be 
strong evidence for cherry picking in this project’s data set. Rather, the efficiency of 
surgeons (i.e their practice patterns) is a likely culprit. Measures of surgeon efficiency 
would be good additions for an enhanced delivery-system data set. For the Hip patients it 
is a similar scenario, where the Delivery System IVs location (L) and surgeon volume 
(Svb) reduce uncertainty by 19.71%, while Patient-Related IVs number of risks (Nrb) 
reduce uncertainty by 0.88% (Table 97). Location (L) alone reduces uncertainty of Tcb 
by 13.44%, and surgeon volume (Svb) by 13.15% as seen below in Table 97. 
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Table 97. Delivery System vs. Patient-Related Submodels 
Comparison of Reduction of Uncertainty for DV Total Cost (Tcb). 
DV: Total Cost (Tcb) 
Knee 
Full Model by BIC for Tcb:  %ΔH (Total) 
IV:STcb:TcbNrb 25.13 
Patient Related IVs: %ΔH (patient-related) 
IV:TcbNrb 1.82 
Delivery System IVs: %ΔH (delivery system) 
IV:STcb 23.71 
Hip 
Best Model by BIC for Tcb:  %ΔH (Total) 
IV:LTcb:TcbSvb:TcbNrb 21.19 
Patient Related IVs: %ΔH (patient-related) 
IV:TcbNrb 0.88 
 
Delivery System IVs: %ΔH (delivery system) 
IV:LTcb:TcbSvb 19.71 
> IV:LTcb 13.44 
> IV:SvbTcb 13.15 
 
The effect of delivery system variables on total cost is sizeable. Larger and larger 
data repositories are being cultivated by health systems, and interoperability between 
electronic health record systems, in addition to the collection of patient-reported health 
data and increasing genomic data collection, will result in increasingly rich data sets. 
However, as tentatively suggested from the results of the analysis in this project, 
increasing the quantity of patient-related data may not provide better predictions. Total 
Cost in particular was predicted by variables in the domain of the delivery system. In this 
project, a very small subset of possible delivery system IVs were used. As practitioners 
move forward with developing predictive analytics in healthcare, new domains of data 
measuring how the healthcare system delivers care ought to be created and included in 
these efforts. These variables might represent surgeon efficiency (e.g., implant selection, 
dedicated OR staff, surgical time, etc.) or care delivery processes (time to ambulation, 
pain management techniques, preoperative patient education, etc.). Future research 
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should be conducted to further identify additional variables representative of the delivery 
system and tested for their effect on outcomes.   
Readmissions were not well predicted by this project’s data. Possibilities are 
either (a) that the delivery system and patient comorbidities are not the correct domains 
informative of readmissions, or (b) readmissions are unpredictable. In order to test the 
former, additional data should be generated. There is some evidence that patient social 
and demographic factors (e.g., living alone, income, education, etc.) and historic 
utilization patterns (e.g., number of ED visits in prior 12 months) are helpful in predicting 
readmissions; however, this data is not readily available by health systems. 
Classifying Patients as Higher or Lower Risk for Adverse Outcomes  
Predictive models can augment clinical decision-making by providing additional 
information. The models resulting from this research provide new information about risk 
for a sizeable proportion of the patient population. Table 98 summarizes, for all the DVs, 
the percent of patients in the sample who are at increased and decreased risk, where this 
increase or decrease of risk is defined as more than a 10% difference between the 
conditional probability of an adverse outcome given the predictors and the marginal 
probability of this outcome, where this difference is statistically significant at the 
0.05 level. 
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Table 98. Summary of Decreased and Increased IV States by DV 
(Cp=Complication, SNF=Skilled Nursing Facility, Re=Readmission, Tcb=Total Cost). 
Knee 
    Cp SNF Re Tcb 
All IVs 
Decreased Risk IV States 40.50% 25.90% 0.00% 21.86% 
Increased Risk IV States 15.73% 19.63% 4.64% 21.49% 
% Total 56.23% 45.53% 4.64% 43.35% 
Comorbidity IVs 
Decreased Risk IV States 76.36% 75.46% 0.00% 0.00% 
Increased Risk IV States 16.86% 13.93% 4.64% 0.00% 
% Total 93.22% 89.39% 4.64% 0.00% 
Hip 
    Cp SNF Re Tcb 
All IVs 
Decreased Risk IV States 47.27% 46.41% 52.50% 28.30% 
Increased Risk IV States 13.51% 24.69% 1.22% 21.53% 
% Total 60.78% 71.10% 53.72% 49.83% 
Comorbidity IVs 
Decreased Risk IV States 71.98% 42.79% 45.69% 0.00% 
Increased Risk IV States 3.43% 11.45% 0.56% 0.34% 
% Total 75.41% 54.24% 46.25% 0.34% 
 
In the summary of results that follows, all of the patients at increased or decreased 
risk, relative to the margins, across the different IV states for each model are tallied up, 
and the percent of the whole sample is calculated. Additionally, a weighted average of the 
risk ratios (weighted by the frequencies of the IV states) shows the average risk across 
the multiple IV states in the model. While the fraction of patients at increased or 
decreased risk is statistically significant, the average risk ratio has not been subjected to 
any statistical test. All models discussed in this section are from the All IVs searches, as 
individual patient comorbidities are included within All IVs.  
Complications 
For example, a complication (Cp) was observed in 4.73% (32 patients) of the 
4,336 patients in the knee data set. The simplest model based on this value, taking into 
account nothing else about the patients or delivery system, would predict that 4.73% of 
knee patients will experience complications. However, the best model from this project’s 
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analyses (Ageb Cp : Nrb Cp : Ruh Cp : Rhd Cp : Rku Cp : Rro Cp) identified several 
groups of patients who were at increased risk of Cp with particular combinations of IV 
states from the model (Table 24). Considering these high-risk groups together, 15.73% of 
the total patients in the sample had an increased risk of complication (Table 99).  For 
these patients at increased risk, the weighted average risk ratio is 2.41; thus 11.40% 
(or 78 patients) out of that group (15.73% of the whole) would be predicted to experience  
complications (that is, 2.41 times the observed marginal complication rate of 4.73% for 
the knee data set).  
Table 99. Increased and Decreased Risk IV States for Complication (Cp). 
Complication (Cp)     
Knee (All IVs)     
Model: Ageb Cp : Nrb Cp : Ruh Cp : Rhd Cp :  
Rku Cp : Rro Cp Freq % of Cases Ratio Average Margin 
Increased Risk IV States 682 15.73% 2.41 11.40 
Decreased Risk IV States 1756 40.50% 0.32 1.51 
No difference (by significance or frequency) 1898 43.77%     
Total 3654     4.73 
Hip (All IVs)     
Model: Ageb Cp : Nrb Cp : Rrd Cp : Rca Cp : Rhd Cp :  
Rpl Cp Freq % of Cases Ratio Average Margin 
Increased Risk IV States 433 13.51% 2.88 14.75 
Decreased Risk IV States 1515 47.27% 0.34 1.74 
No difference (by significance or frequency) 1257 39.22%     
Total 3205     5.12 
 
Not only do the risk groups show the IV states that put patients at greater risk of 
having a complication (Cp), but they show the groups of patients who were at decreased 
risk. There were several groups of knee patients (Table 24) whose IV states for the model 
Ageb Cp : Nrb Cp : Ruh Cp : Rhd Cp : Rku Cp : Rro Cp predicted a decreased risk of 
Cp (blue rows). Added together, 40.50% of the knee patients were identified as at 
decreased risk of Cp (Table 99). Of these patients, 1.51% would be expected to have 
complications compared to the observed rate of 4.73% for the entire sample. 
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For the patients with hip replacements, the best model predicting a complication, 
Ageb Cp : Nrb Cp : Rrd Cp : Rca Cp : Rhd Cp : Rpl Cp, uncovered IVs whose states 
resulted in 13.51% of the patients identified as at higher risk of Cp (Table 99). Of these, 
14.75% would be expected to have Cp, which was 2.88 times the observed rate of 5.12% 
for the entire hip data set. Of the hip patients, 47.27 would be expected to have decreased 
risk of Cp, with 1.74% expected to have Cp. 
Discharge to skilled nursing facility  
The best All IVs models predicting discharge to a skilled nursing facility (SNF) 
also presented IVs whose combination of states resulted in higher risk or lower risk 
scenarios for each specific combination of states. These IV states were analyzed in the 
models’ fit, (detailed in Table 49 and Table 57). These tables presented rows where the 
IV states of the model resulted in increased risk (orange) and decreased risk (blue). 
Considered together, the IV states can be tallied up to show the percentage of patients in 
each of the risk groups, their actual rate of discharge to SNF, as well as the average risk 
ratio per risk group.  
Table 100 summarizes the risk groups of each model for SNF across both the hip 
and the knee data sets. The best All IVs model in the knee data set for SNF resulted in 
19.63% of the total sample expected to be at increased risk with an expected SNF rate of 
39.66, much higher than the observed rate of 17.55% for the entire sample. Lower risk of 
SNF was predicted for 25.90% of knee cases, of which 3.34% would be expected to be 
discharged to a SNF (compared to the observed rate of 17.55% of the entire knee 
sample). 
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Table 100. Increased and Decreased Risk IV States for Skilled Nursing Facility (SNF) 
SNF     
Knee (All IVs)     
Model: L SNF : Fc SNF : Ageb SNF : Svb SNF : Nrb SNF 
: Rmd SNF : Rug SNF : Rhf SNF Freq 
% of Cases 
Ratio Average Margin 
Increased Risk IV States 851 19.63% 2.26 39.66 
Decreased Risk IV States 1123 25.90% 0.19 3.34 





Hip (All IVs) 
  
Model: Fc SNF : Ageb SNF : Svb SNF : Nrb SNF Freq % of Cases Ratio Average Margin 
Increased Risk IV States 791 24.69% 2.71 38.65 
Decreased Risk IV States 1487 46.41% 0.19 2.71 
No difference (by significance or frequency) 926 28.90% 
  




The All IVs model for the hip data set placed 24.69% in a high-risk group and 
46.41% of patients in a lower-risk group (Table 100). Of these patients, the high-risk 
group had an expected SNF rate of 38.65% compared with the overall observed SNF rate 
for the entire hip sample of 14.26%, while the low-risk group had an expected SNF rate 
of 2.71%. 
Readmissions 
Readmissions were not as predictable as the DVs Cp and SNF. For the knee data, 
4.64% of patients were in a higher-risk group compared to the observed readmission of 
2.61% of the overall knee data set. Of the higher-risk patients identified, 9.11% had a 
predicted readmission (Re) on the basis of an average risk ratio of 3.49 (Table 101). 
There were no combinations of IV states that resulted in patients being considered at 
lower risk of Re. 
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Table 101. Increased and Decreased Risk IV States for Readmission (Re). 
Readmission     
Knee (All IVs)     
Model: Rci Re : Rco Re : Rgp Re : Rcj Re Freq % of Cases Ratio Average Margin 
Increased Risk IV States 201 4.64% 3.49 9.11 
Decreased Risk IV States 0 0.00%     
No difference (by significance or frequency) 4133 95.36%     
Total 4334     2.61 
Hip (All IVs)     
Model: Rhp Re : Rdd Re : Rpa Re : Rep Re : Rhe Re :  
Rys Re : Rki Re 
Freq % of Cases Ratio Average Margin 
Increased Risk IV States 39 1.22% 4.79 13.03 
Decreased Risk IV States 1680 52.50% 0.64 1.74 
No difference (by significance or frequency) 1481 46.28%     
Total 3200     2.72 
 
 The average readmission (Re) rate for the overall hip sample was 2.72%. The best 
models for the hip data set for readmission (Re) identified groups of patients both at 
higher risk and at lower risk of readmission with 1.22% of patients being classified into 
the higher-risk group and 52.50% of patients being classified at lower risk. Of the very 
small percent of patients placed in the higher-risk group, 13.03% of these would be 
predicted to have a readmission (Table 101). For those in the lower-risk group, 1.74% 
would be predicted to be readmitted. 
Total cost 
The best All IVs model from the knee data set identified several groups of patients 
whose particular combinations of IV states from the model S Tcb : Nrb Tcb (Table 76) 
would be expected to have higher total cost (Tcb). Considering all of these groups of 
patients together, 21.49% of the total patients (Table 102) were placed in the higher 
expected cost group, with an expected cost of $20,907.88, higher (although not tested for 
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statistical significance) than the average of the total knee data set ($18,502.55). For this 
same model, 21.86% of patients had a lower expected cost of $16,282.24.  
Table 102. Increased and Decreased Risk IV States for Total Cost (Tcb). 
Total Cost Binned (Tcb)     
Knee (All IVs)     
Model: S Tcb : Nrb Tcb Freq % of Cases Ratio Average Expected Value 
Increased Expected Cost IV States 932 21.49% 1.13 $20,907.88  
Decreased Expected Cost IV States 948 21.86% 0.88 $16,282.24  
No difference (by significance or frequency) 2456 56.64%     
Total 4336     $18,502.55  
Hip (All IVs)     
Model: L Tcb : Svb Tcb : Nrb Tcb Freq % of Cases Ratio Average Expected Value 
Increased Expected Cost IV States 690 21.53% 1.11 $20,636.51  
Decreased Expected Cost IV States 907 28.30% 0.88 $16,360.48  
No difference (by significance or frequency) 1608 50.17%     
Total 3205     $18.591.45 
 
The best model for hip (L Tcb : Svb Tcb : Nrb Tcb) also identified groups of 
patients who would be expected to have total cost (Tcb) both higher and lower than the 
average of $18,591.45. Of the hip patients, 21.53% were calculated to have an expected 
cost of $20,636.51, while 28.30% would be expected to have a total cost of $16,360.48 
(Table 102). 
Methodological Considerations 
In addition to the clinical impacts, this project provides two primary 
methodological contributions. The first of these is the comparison of Reconstructability 
Analysis (the primary methodology of this project) to the more common approach of 
logistic regression. The second contribution is the demonstration of multiple techniques 
that exemplify and augment the use of RA for the analysis of biomedical data. 
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Relating RA to LR 
RA, as implemented in the Occam software package, was shown to produce 
equivalent results to LR models implemented in the R programming language, for those 
cases where the two methods overlap. This equivalency was verified with the measures 
Alpha (p-value), Δdf, ΔLR, ΔAIC, and odds ratios (OR) calculated from the RA model’s 
conditional probability distributions. RA detected novel variables and interaction effects 
that were not found in the LR analysis. RA was demonstrated to provide a distinct and 
useful approach for searching for novel variables and interaction effects that resulted in 
stronger predictions. LR does not consider the full lattice of structures that RA does, nor 
does LR, as normally implemented in software, provide an approach for searching this 
lattice. The information-theoretic RA used in this research project generated an entropy 
reduction (%ΔH), useful in interpreting the results, but not available with other methods. 
The LR model augmented with interactions found by RA provided for an 
interesting test of the methods; it showed that non-hypothesized interaction effects 
discovered by RA offered additional predictive strength when added to LR models 
(Table 18). The models generated as the primary results of this project are therefore 
likely to be either equivalent or more predictive than an LR analysis could have 
generated. RA is useful as a standalone method and has the potential to generate more 
predictive models than is possible using the LR methodology. 
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Augmenting RA Occam Results   
This project supplemented Occam’s standard outputs with existing nominal 
variable techniques that may be useful to researchers using the RA method in future 
analysis of biomedical data. The use of risk ratios, expected value calculations, tiered 
classifications of variables, and decision trees are all techniques that served to help make 
RA results visible and comprehensible. 
Tiered Classification System of Important Predicting Variables 
In this project, the importance of the IVs was assessed according to a multi-tiered 
classification system. This system allowed the identification and communication of 
important variables both within and across multiple models. RA yielded multiple models, 
which differed in how aggressively or conservatively they asserted predictive relations. 
While the models selected to look at in greater detail in the results section of this project 
were selected by the more conservative BIC criterion, the models and their variables that 
were selected by the less conservative AIC criterion are also relevant. While Tier 1 best 
predicting variables included only those from the best BIC models from All IVs, Tier 2 
expanded and included variables detected as important predictors from the AIC selection. 
Decision Trees to Summarize Fit Results 
Each model’s variables show the IVs and IV relationships that are important, but 
it is the model’s internal structure, namely its conditional probability distribution 
(Occam’s “fit” output), that allows the actual predictions of the model. These conditional 
probability distributions require some further analysis in order to determine the IV states 
of the model that are most important. In this research project, IV states with a frequency 
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≥ 10 and a p-value ≤ 0.05 were selected as thresholds, and IV states that did not meet 
these thresholds were removed from further analysis. Even with this reduction in the 
model IV states, the number of IVs, and the number of states for each of these IVs, 
resulted in fairly large tables, and the combinations of IV states that were important were 
not always readily comprehensible. Displaying combinations of important IV states in 
decision trees provides a visualization of results that is easily understood by a variety of 
audiences, allowing complex predictive models to offer descriptive insights from each 
model. 
Generating Continuous Predictions 
In this research project, continuous expected value predictions were generated for 
total cost with the b-systems approach (Zwick, Fusion, & Wilmot). RA as programmed in 
Occam calculated probabilities of the DV in low-cost, mid-cost, and high-cost bins, 
conditioned on the model’s IV states. These probabilities were used as weights on the 
expected value of each bin (the average value of each bin) to calculate the expected value 
for each of the IV states. Instead of using the bin with the highest probability to make a 
prediction, ignoring other bins whose probabilities, though smaller, may still not be 
negligible, this project used a weighted average which took into account how much the 
model predicted for the probability of each bin. Instead of picking one out of three bins 
for each of the IV states of the model, this method allowed for a finer-grained continuous 
prediction, with the ability to predict more accurately. Other augmentations of RA can be 
used to generate continuous predictions, which will be discussed in the Future Research 
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section to follow. Such continuous predictions could in principle be compared to the 
prediction of regression methods. 
Risk Ratios  
Recall that each predictive model had an associated conditional probability 
distribution for all the DV states for each of the IV states that were observed. Each 
probability of an adverse DV state given a particular IV state was then divided by 
probability of the adverse outcome for the full sample. This calculated ratio conveyed the 
effect size, while the p-value for that IV state assessed the significance of this effect size, 
more precisely the statistical significance of the deviation of the IV conditional 
probabilities from the margins. This ratio allowed for the effect size of each predictive 
model to be compared across hip and knee data sets, for All IVs and Comorbidity IVs, and 
across each of the four DVs. The risk ratios from the individual model results were then 
averaged by the weighted frequency, thus allowing comprehensible and comparable 
average risk ratios for higher-risk and lower-risk IV states. Additionally, when multiplied 
by the margin of the overall sample, the risk ratio allowed for a new calculation of the 
expected rate of the outcome (Cp, SNF, and Re) and the expected value (Tcb) for the 
higher-risk and lower-risk IV states. 
In this project, an effect size of 10% (a ratio ≥ 1.10 or ≤ 0.90) was considered to 
be a meaningful effect size. The selection of effect size depended on what was justifiable 
in the clinical and financial context of hip and knee replacement. At the time this research 
project was conducted, the largest payer of hip and knee replacements, Center for 
Medicare and Medicaid Services (CMS), had just implemented the first year of a 
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five-year bundled payment model for hip and knee replacements. In this program, 
hospitals stand to gain or lose based on a percentage of CMS’s contracted price (target 
price). In year one of this program, gains (upside risk) and losses (downside risk) are 
capped at 5%, but will increase to 20% in the remainder of the program. At the same time 
that the risk is increased, the reimbursement prices will also be declining. This places 
hospitals at increasing risk of owing money back to CMS. 
The following is a rough example of what the effect size looks like in terms of 
total cost. Looking at the higher-risk IV states (with the 10% or greater effect size) results 
in 324 hip patients at increased risk of higher expected total cost. Overall, the expected 
total cost for these 324 patients is $6,780,339. If these same 324 patients were instead 
expected to have the average total cost, this would be approximately $6,023,629—
a difference of $756,709, or about $2,335 per patient. This difference is a real opportunity 
if care could be tailored for these patients so that costs for them could be reduced. If only 
half of the opportunity is realized in terms of cost savings, that is still about $1,167 per 
patient. The 5% reduction in payment (CMS pricing based on total average cost) is about 
$930 in reduced payments, so this $1,167 would more than offset the reduction of CMS 
reimbursement.  The clinical impacts, one could argue, are even more meaningful. 
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Future Research & Applications   
Future research should be performed in order to (a) address limitations of the 
current project, and (b) facilitate the real-world application of these models. There are at 
least three primary areas for future research that should be considered to address the 
limitations of this project: (1) The data used in this project must be updated according to 
new diagnosis coding standards and claims data availability; (2) data sets should be 
divided into training and test splits; and (3) additional RA techniques should be explored 
that may create more powerful analyses. 
Potential applications of this research for hip and knee replacement surgery 
include enhancing value through measuring quality and implementing real-time risk 
prediction. Additional potential applications of the RA methodology used in this project 
are both desirable and feasible in clinical services beyond orthopedics, such as 
cardiovascular interventions.  
RA Analysis 
This project did not exhaust the RA methodological toolbox. Future research 
could use state-based RA modeling to create more powerful analyses. Additionally, other 
techniques for dealing with the continuous DV Total Cost should be explored, such as 
“K-systems” and “U-systems” analysis (Zwick, 2011b). Lastly, training and test splits of 
the data would allow for comparisons of sensitivity and specificity. 
State-based Models 
Taking only the most important predictor variables, state-based modeling would 
allow for the detection of interaction effects at a finer resolution. This ultra-fine-grained 
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view may pick out subtle interaction effects that went undetected in the coarse and fine-
grained exploratory searches that were used in this project. It is possible that the state-
based model will provide a larger reduction in uncertainty (% ΔH) and better %correct 
than the best variable-based model with loops generated in this project.  
K-systems and U-systems Analysis 
This project derived continuous values for the binned DV Total Cost using 
expected value calculations, which is referred to as b-systems analysis in the literature 
(Zwick, 2011b). There are other RA techniques that are available for the analysis of 
continuous functions (i.e., total cost), such as k-systems and u-systems analysis. In 
k-systems analysis, continuous function values are treated as pseudo frequencies, whereas 
in u-systems they are treated as the expected value of a lottery (Zwick, 2011b).  
Training/Test Splits 
This project was exploratory in nature. Although an optimal confirmatory test of 
results found by exploratory modeling requires the availability of new data, a kind of 
confirmatory test is accomplished via the use of training and test splits of the data. The 
training portion of the data is used to find and fit the predictive models, and the test 
portion is used to validate these models. Ideally, multiple training/test splits should be 
used to obtain a probability distribution of test data outcomes, including but not limited to 
%correct. This standard measure would allow easy comparisons of RA with other 
prediction methods.  Test data can be used to calculate additional useful measures, such 
as sensitivity and specificity and their tradeoff in the ROC curve. 
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Binning 
In this project, binning (e.g., of the IVs age and surgeon volume and the DV total 
cost) was done, wherever possible, with equally sampled bins, which is mathematically 
optimal for prediction; this is as opposed to binning according to field-specific 
substantive conventions. While the use of three bins allows for detection of nonlinearities 
and a uniform distribution allows for optimal predicting power, other binning rules could 
be tested in future work. For example, when age was binned into three equal-sample-
sized bins, the age for enrollment onto Medicare was not selected as one of the bin 
boundaries. Binning according to the commonly used age groups in health outcomes 
research may change the predictions, which could be informative and could also have 
implications for healthcare policy. 
Enhancing the Data 
Updating Coded Data 
The primary procedure codes used in this project—both those indicating hip or 
knee replacement procedures and those indicating patient comorbidities—were 
constructed from ICD-9 diagnosis codes. Effective October 2015, new ICD-10 coding 
standards were introduced. These new coding standards are not simply an updated 
version of the previous coding schema. There are more than ten times as many procedure 
codes and five times as many diagnosis codes in ICD-10 than in its ICD-9 predecessor. 
This update allows for a much more detailed system of coding. A single diagnosis code in 
ICD-9 may now be broken down into much more specific diagnosis codes. Most certainly 
this finer resolution of coding will provide for new discoveries as to the most predictive 
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patient comorbidity variables. While dual coding for ICD-9 and ICD-10 is still occurring 
in order for existing initiatives to be sustained, there is no doubt that ICD-9 coding will 
soon be phased out completely. 
Social Determinants of Health 
Social determinants of health, such as poverty, access to healthcare services, and 
racism, may be important predictors of differences in health outcomes. Widespread 
collection and measurement of social determinants would need to be initiated in order to 
have consistent and available data for predictive models. 
Adding Post-Discharge Data 
Additional enrichment to the data could be performed to enhance the dependent 
variables used in this project. One limitation in this project is in the DV Total Cost. The 
DV Total Cost only captures costs associated with the inpatient procedure, and does not 
include post-discharge costs. These post-discharge costs may be incurred by the 
utilization of a skilled nursing facility (SNF) as well as by Readmissions and other post-
discharge services (i.e., outpatient therapy, home health visits, etc.). Payer claims data 
would allow for Total Cost to extend beyond the inpatient stay, and beyond that, a DV 
representative of a 90-day episode could be constructed. Additionally, the DV 
Complication only captured complications that occurred within the inpatient stay, and 
does not include events post-discharge. Joint replacement patients may do well in the 
hospital but suffer complications post-discharge that indicate poor quality and incur 
additional costs. Bundled payments (such as the 90-day CJR model) will increasingly 
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drive healthcare systems to be able to capture costs and outcomes that extend beyond the 
initial inpatient surgical encounter. 
As health systems form Accountable Care Organizations (ACOs) and as CMS 
reimbursement models increase, access to claims data is more feasible than was the case 
historically. ACOs and CMS have rich data sources with very detailed claims data. 
Claims data provides an effective way to look at the utilization in services and could be 
used to create more meaningful and stronger predictions. At this time, however, detailed 
claims data is not available for all patients. Additionally, uncertainty about how claims 
data can be used often results in restrictions that block the ACO and CMS data from 
being part of the healthcare organization’s larger data repositories. The propensity for 
healthcare systems to treat analysis of data as a research effort, rather than a quality 
improvement and patient care effort, prevents most analytical efforts—and certainly 
anything referred to as “exploratory” analysis—from occurring. However, as the terms 
“big data” and “predictive analytics” become a more mainstream part of the vocabulary 
of healthcare delivery systems, ACO and CMS claims data will have the potential to 
become part of the larger data environment with greater access for use in predictive 
analytics. 
Adding the Delivery System Data Domain  
Currently, the handful of predictive analytics tools that exist use only patient 
comorbidity IVs. This project also utilized delivery system variables, but only a subset of 
the potential variables that may impact predictions. The small number of delivery system 
IVs that were used in this project turned out to be very important predictors in a number 
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of the models. In order to enhance value through better predictions, healthcare systems 
will need to look at the processes of care, including the clinicians, locations, medications, 
implants, and other supplies used in those processes as potentially predictive of patient 
outcomes and cost. 
Reimbursement & Allocation of Payments 
Hip and knee replacements are the first set of procedures in the bundled payment 
Comprehensive Care for Joint Replacement (CJR) model. As discussed in the 
introduction to this project, this model includes fixed payments to the delivery system 
based on DRG. If these payments exceed the cost of the episode, the leftover dollars are 
eligible to be paid out in collaborator “cost savings” or “gainsharing” payments. In these 
collaborator agreements, it is often the surgeon who is identified as the collaborator, and 
how the payments are allocated is determined by the hospital. Such payments can serve 
as an incentive to reward surgeons not only for low-cost care, but for quality outcomes as 
well. Incorporating risk into the projection of expected outcomes can help drive better 
care without penalizing surgeons for taking on sicker patients. As delivery systems 
determine how to allocate savings among surgeon collaborators under the CJR model, 
using a quality measure (discussed below) that adequately accounts for predicted patient 
risk would be worth considering. 
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Translating Predictions into Value 
Real-Time Risk Prediction 
In the introduction to this project, a primary justification for this research was that 
predictive models have utility both for retrospectively predicting risks and outcomes for 
quality measurement, and—potentially—also for real-time prediction. 
Many total joint replacement patients prefer to be in and out of the hospital as 
quickly as possible, and hospitals (and outpatient surgery centers) are now marketing 
short-stay joint procedures as a way to attract healthy patients. However, this preference 
must be considered alongside patient risk and clinical appropriateness, and the risk 
algorithms for determining which patients may qualify for these short stays are lacking. 
In other instances, healthy patients who may qualify as short-stay candidates request to 
stay in the hospital as long as possible with expectations to be discharged to a skilled 
nursing facility. Under a fee-for-service reimbursement model, patients and providers had 
no incentive to guard against patient preference as the primary driver of length of stay or 
discharge setting. As fee-for-service comes to an end in joint replacement, patient 
preference or physician practice patterns alone can no longer be the primary driver of 
appropriate care. Assessing patient risk in real time could in principle augment clinical 
decision-making and provide additional evidence supporting a short-stay care pathway 
for low-risk patients, or a more resource-intensive care pathway for high-risk patients. 
Furthermore, increasing the education of patients about their individual risks can help set 
expectations about their individualized care pathways. 
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Retrospective analysis is much simpler than developing and operationalizing a 
near-real-time risk-prediction solution in a healthcare organization. To make predictions 
in near real time, one would need access to or integration with an electronic health record 
(EHR) system or another data aggregation system overlaying the EHR. This additional 
application layer would need to access the patient’s clinical data and transform the data 
into a structured format according to predefined rules similar to the procedures used to 
create the data sets used in this project. Predictive models would have to be updated and 
calibrated on a continuing basis, to improve the models based on their performance in 
prediction and to keep up with clinical coding schema changes. 
Not only would models need to be integrated with the clinical electronic health 
record system, but the model predictions would need to be accessible within the EHR in 
order for the clinicians at the point of care to utilize the output to support real-time 
decision making. Recent advances in machine learning and AI techniques have increased 
focus on the development of the algorithms but have given less attention to how 
predictions made by algorithms might inform patient care in real-time clinical work 
streams. Great predictions do not help if no action is taken. 
Integrating predictions into the everyday workflows of clinical staff is much more 
than a technical feat. It is an organizational undertaking that would require the buy-in of 
health system leadership and of the clinical teams. The development of predictive models 
is only a first step. Few health systems currently use predictive analytics at scale to 
influence health care delivery, and strategies that successfully implement predictive risk 
algorithms into clinical practice must still be identified (Parikh, Kakad & Bates, 2016). 
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Measuring Quality & Outcomes 
With value defined as outcomes achieved per dollar spent, an increasing focus of 
concern will be the optimization of that ratio. Deploying predictive analytics at the point 
of care can help improve this ratio by focusing costly resources on higher-risk patients. 
Tailoring patient care with increased precision thus has the potential not only to lower the 
overall cost of care, but to improve outcomes by ensuring that higher-risk patients are 
provided the extra care necessary to ensure good outcomes. In addition to optimizing care 
in real time, the demonstration of value requires the measurement of outcomes. 
Adequately measuring the quality of the outcome achieved is essential both for fair 
measurement of hospital or physician quality and for identifying the causes of variation 
in care, both of which will be required in order to strategically focus quality improvement 
initiatives. A widely-accepted measurement of quality across healthcare providers is an 
observed versus expected ratio. The denominator of this ratio is the sum of predicted risk 
of a given outcome while the numerator is the actual observed occurrences of this 
outcome. In the field of cardiac surgery, the Society of Thoracic Surgeons (STS) Risk 
Score (Shahian et al., 2009) generates an O/E ratio for mortality in addition to a number 
of specific complications. The resulting scores from the O/E ratios are used as measures 
of quality both at a hospital and a surgeon level. For example, if Dr. A’s patients were 
predicted to have a higher risk of complications given their comorbidity IVs, and 
subsequently the observed complications were calculated, then an observed versus 
expected ratio could be constructed and used as a measure of quality. If the cohort of 
patients had fewer complications than predicted, then the ratio would be less than one, 
and this distance from one could be considered a measure indicating higher quality 
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outcomes. If the ratio is greater than one, then this would indicate surgeon performance 
was worse than expected. The result of this observed versus predicted ratio can then be 
assessed across physicians in a relatively fair, “apples-to-apples” comparison. Similar to 
cardiac surgery, joint replacement surgeons are considered the most accountable for the 
quality and outcomes of the joint replacement procedure. However, unlike cardiac 
surgery, there is no widely accepted observed versus expected risk score in joint 
replacement. 
Value Beyond Orthopedics 
 A primary justification for this project was that better predictions, utilized for 
quality measurement and real-time predictive analytics, could enhance value in 
healthcare. This project demonstrated that Reconstructability Analysis (RA) can create 
useful models of outcomes in hip and knee replacements. Hip and knee replacements are 
the first procedures mandated under a bundled payment model by CMS. Other payers are 
coming to the payment reform table as well, and the list of conditions and procedures that 
CMS and other payers will be transitioning to innovative reimbursement models is 
extensive. In fact, CMS has set a goal, for both public and private payers, to shift 80% of 
their populations into value-based alternative payment models in the next five years 
(Rajkumar, Conway & Tavenner, 2014). The drive to achieve greater value across 
multiple clinical domains is now an imperative for healthcare systems.  
CMS has passed legislation for two cardiac bundled payments set to launch in 
2018 which will cover Acute Myocardial Infarction (AMI) and Coronary Artery Bypass 
Graft (CABG) procedures (Song & Blumenthal, 2016). Similar to joint replacement 
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procedures, these cardiac procedures have high variation in cost and outcomes. Unlike 
the field of orthopedics, the cardiovascular field has been collecting data and measuring 
quality and outcomes utilizing risk models for decades. In fact, cardiovascular procedures 
are some of the most well studied procedures, with highly validated risk models. The 
Society of Thoracic Surgeons’ (STS) Cardiac Surgery Risk Model has been developed 
over a 20-year period, and is continuously updated based on STS registry data (Shahian 
et al., 2009). The data that is used for this model is manually abstracted from patient 
charts by clinicians and hand-entered into a certified STS database. This curated registry 
data is then submitted to the national STS registry, and model updates are performed. 
Standard Logistic Regression (LR) has been the primary method for STS model 
development, with the most recent updates to the model using backwards stepwise LR for 
feature selection in order to determine predictor variables for model updates. The updated 
STS model is considered to have excellent performance, but it is certainly plausible the 
performance could be improved.  
Literature in cardiac risk prediction confirms LR to be the standard approach 
within the broader cardiac field (Nilsson, Algotsson, Höglund, Lührs & Brandt, 2006; 
Thalji, Suri, Greason & Schaff, 2014). However, researchers view more recent techniques 
such as Neural Networks (NNs) as holding promise. Nilsson et al., (2006) discuss NNs as 
a method that could improve risk prediction given their capacity to model complex, 
nonlinear relationships, but concede that only a few studies have been done in this area 
and that further investigation is required. As discussed in the literature review of this 
project, NNs are promising, but their “black box” nature results in models that lack 
explainability. This lack of transparency can pose a problem with clinician buy-in during 
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implementation in a clinical setting. Perhaps the need for explainability will diminish 
over time as NNs prove their worth, and trust in these models increases. 
Reconstructability Analysis (RA) has both the capacity to model complex, 
nonlinear relationships, and the ability to produce models that are transparent and 
intuitive to understand. This project showed that RA was able to find a more predictive 
model than stepwise LR, and included additional predictor variables and interaction terms 
not detected using stepwise LR. It would be of great interest to cardiac clinicians and 
researchers if RA could improve on the STS Risk Score predictions. If RA can provide 
new insights with stronger predictions in the cardiovascular domain, it is likely the 
methodology would be able to add value across the full spectrum of clinical service lines. 
The field of cardiovascular risk prediction may benefit from additional analytical 
approaches used in this project, beyond potentially detecting novel predictor variables 
and interaction effects. This project demonstrated the importance of delivery system IVs 
in predicting outcomes. Currently, the risk prediction efforts in the cardiovascular domain 
limit predictors to patient-related comorbidity IVs. Additionally, the use of risk ratios 
would be intuitive and meaningful to clinicians in understanding—beyond simply the 
significance of the prediction—the magnitude of the expected effect. The use of tiered 
analysis of predictors may reveal common predictors across cardiac and joint 
replacement surgeries and allow for a broader implementation of predictive analytics in 
clinical care and the measurement of quality across clinical domains. 
Enhancing value through better predictions is an increasing imperative across 
multiple clinical domains. As demonstrated in this project, Reconstructability Analysis is 
an approach that may strengthen or augment existing predictions and even perhaps 
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replace existing methods. With risk and outcomes adequately predicted, areas for 
potential improvement become clearer, and focused changes can be made to drive 
improvements in patient care. Better predictions, such as those resulting from the 
Reconstructability Analysis methodology, can thus support improvement in value—better 
outcomes at a lower cost. As reimbursement increasingly evolves into value-based 
programs, understanding the outcomes achieved and customizing patient care to reduce 
unnecessary costs while improving outcomes will be active areas for clinicians, 
healthcare administrators, researchers, and data scientists for many years to come. 
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Appendix: Supplementary Tables 
Table 103. Full List of IVs in Hip and Knee Data Sets with Variable IDs. 
# ICD-9 Code ICD-9 Description Variable ID 
1 RISK 135 Sarcoidosis Rs 
2 RISK 174.9 Malignant neoplasm of breast (female), unspecified Rb 
3 RISK 185 Malignant neoplasm of prostate Rnp 
4 RISK 202.8 Other malignant lymphomas Rly 
5 RISK 204.1 Lymphoid leukemia chronic Rle 
6 RISK 238.75 Myelodysplastic syndrome, unspecified Rmp 
7 RISK 242 Thyrotoxicosis with or without goiter Rth 
8 RISK 244 Acquired hypothyroidism Rh 
9 RISK 244.9 Unspecified acquired hypothyroidism Rhy 
10 RISK 246.9 Unspecified disorder of thyroid Rtd 
11 RISK 250 Diabetes mellitus Rdi 
12 RISK 250.4 Diabetes with renal manifestations Rdr 
13 RISK 250.5 Diabetes with ophthalmic manifestations Rdo 
14 RISK 250.6 Diabetes with neurological manifestations Rdn 
15 RISK 253.6 Other disorders of neurohypophysis Rne 
16 RISK 255.41 Glucocorticoid deficiency Rgd 
17 RISK 257.2 Other testicular hypofunction Rte 
18 RISK 266.2 Other B-complex deficiencies Rbc 
19 RISK 268.2 Osteomalacia, unspecified Rou 
20 RISK 268.9 Unspecified vitamin D deficiency Rvd 
21 RISK 272 Disorders of lipoid metabolism Rli 
22 RISK 272.1 Pure hyperglyceridemia Rhg 
23 RISK 272.2 Mixed hyperlipidemia Rmh 
24 RISK 272.4 Other and unspecified hyperlipidemia Ruh 
25 RISK 274.9 Gout, unspecified Rg 
26 RISK 275.03 Disorders of phosphorus metabolism Rpm 
27 RISK 275.49 Other disorders of calcium metabolism Rcd 
28 RISK 276.1 Hyposmolality and/or hyponatremia Rhh 
29 RISK 276.8 Hypopotassemia Rhp 
30 RISK 277.7 Dysmetabolic syndrome X Rdy 
31 RISK 278 Overweight, obesity and other hyperalimentation Roo 
32 RISK 278.01 Morbid obesity Rmo 
33 RISK 278.02 Overweight Rov 
34 RISK 280 Iron deficiency anemias Ria 
35 RISK 280.9 Iron deficiency anemia, unspecified Rid 
36 RISK 281.9 Unspecified deficiency anemia Ram 
37 RISK 285.1 Acute posthemorrhagic anemia Rph 
38 RISK 285.21 Anemia in chronic kidney disease Rck 
39 RISK 285.29 Anemia of other chronic disease Ran 
40 RISK 285.9 Anemia, unspecified Rau 
41 RISK 287.5 Thrombocytopenia, unspecified Rtc 
42 RISK 289.81 Primary hypercoagulable state Rhs 
43 RISK 294.8 
Other persistent mental disorders due to conditions classified 
elsewhere 
Rmd 
44 RISK 295.9 Unspecified schizophrenia Rsc 
45 RISK 296.8 Other and unspecified bipolar disorders Rbp 
46 RISK 300 Anxiety, dissociative and somatoform disorders Rad 
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# ICD-9 Code ICD-9 Description Variable ID 
47 RISK 300.01 Panic disorder with agoraphobia Rpd 
48 RISK 300.02 Generalized anxiety disorder Rga 
49 RISK 300.4 Dysthymic disorder Rdd 
50 RISK 303.9 Other and unspecified alcohol dependence Rup 
51 RISK 303.91 Other and unspecified alcohol dependence, continuous Rah 
52 RISK 303.93 Other and unspecified alcohol dependence, in remission Rrn 
53 RISK 304 Drug dependence Rdg 
54 RISK 304.01 Opioid type dependence continuous use Rop 
55 RISK 305 Nondependent abuse of drugs Rab 
56 RISK 305.03 Alcohol abuse, in remission Rra 
57 RISK 305.1 Tobacco use disorder Rtu 
58 RISK 309.81 Posttraumatic stress disorder Rps 
59 RISK 311 Depressive disorder, not elsewhere classified Rde 
60 RISK 314 Hyperkinetic syndrome of childhood Rhk 
61 RISK 314.01 Attention deficit disorder with hyperactivity  Rat 
62 RISK 327.23 Obstructive sleep apnea Ros 
63 RISK 331 Other cerebral degenerations Rce 
64 RISK 332 Parkinson's disease Rpa 
65 RISK 333.94 Restless legs syndrome Rrl 
66 RISK 338.29 Other chronic pain Rcp 
67 RISK 338.4 Chronic pain syndrome Rpc 
68 RISK 340 Multiple sclerosis Rms 
69 RISK 345.9 Epilepsy unspecified Rep 
70 RISK 346.9 Migraine unspecified Rmu 
71 RISK 355.9 Mononeuritis of unspecified site Rmn 
72 RISK 356.9 Unspecified hereditary and idiopathic peripheral neuropathy Rpn 
73 RISK 357.2 Polyneuropathy in diabetes Rpo 
74 RISK 357.6 Polyneuropathy due to drugs Rpp 
75 RISK 362.01 Background diabetic retinopathy Rba 
76 RISK 362.5 Degeneration of macula and posterior pole of retina Rdm 
77 RISK 365.9 Unspecified glaucoma Rug 
78 RISK 366.9 Unspecified cataract Rcr 
79 RISK 369.4 Legal blindness, as defined in USA Rlb 
80 RISK 369.6 Profound vision impairment one eye Rip 
81 RISK 369.8 Unqualified visual loss, one eye Rvl 
82 RISK 386 
Vertiginous syndromes and other disorders of vestibular 
system 
Rve 
83 RISK 388.3 Tinnitus Rti 
84 RISK 389.9 Unspecified hearing loss Rhl 
85 RISK 397 Diseases of other endocardial structures Res 
86 RISK 401.1 Benign essential hypertension Rbe 
87 RISK 401.9 Unspecified essential hypertension Rhe 
88 RISK 403.9 Unspecified hypertensive renal disease Rrd 
89 RISK 413.9 Other and unspecified angina pectoris Rap 
90 RISK 414 Other forms of chronic ischemic heart disease Rci 
91 RISK 414.01 Coronary atherosclerosis of native coronary artery Rca 
92 RISK 414.8 Other specified forms of chronic ischemic heart disease Rsf 
93 RISK 416.8 Other chronic pulmonary heart diseases Rhd 
94 RISK 424 Other diseases of endocardium Rec 
95 RISK 424.1 Aortic valve disorders Rav 
96 RISK 425.4 Other primary cardiomyopathies Rcm 
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# ICD-9 Code ICD-9 Description Variable ID 
97 RISK 426.11 First degree atrioventricular block Rfd 
98 RISK 426.3 Other left bundle branch block Rol 
99 RISK 426.4 Right bundle branch block Rrb 
100 RISK 427 Cardiac dysrhythmias Rys 
101 RISK 427.31 Atrial fibrillation Raf 
102 RISK 427.32 Atrial flutter Rfl 
103 RISK 427.69 Other premature beats Rpb 
104 RISK 427.89 Other specified cardiac dysrhythmias  Rod 
105 RISK 427.9 Cardiac dysrhythmia, unspecified Ruc 
106 RISK 428 Heart failure Rhf 
107 RISK 428.3 Diastolic heart failure Rdh 
108 RISK 428.32 Chronic diastolic heart failure Rdf 
109 RISK 429.9 Heart disease, unspecified Rht 
110 RISK 433.1 Occlusion and stenosis of carotid artery Roc 
111 RISK 441.4 Abdominal aneurysm without mention of rupture Raa 
112 RISK 443 Other peripheral vascular disease Rpe 
113 RISK 443.9 Peripheral vascular disease, unspecified Rpv 
114 RISK 457.1 Other lymphedema Roe 
115 RISK 458.9 Hypotension, unspecified Rho 
116 RISK 459.81 Venous (peripheral) insufficiency, unspecified Rvi 
117 RISK 477 Allergic rhinitis Rar 
118 RISK 477.9 Allergic rhinitis, cause unspecified Ral 
119 RISK 491.2 Obstructive chronic bronchitis Rcb 
120 RISK 491.9 Unspecified chronic bronchitis Rbh 
121 RISK 492.8 Other emphysema Rem 
122 RISK 493 Asthma Ras 
123 RISK 493.2 Chronic obstructive asthma Rco 
124 RISK 493.9 Asthma unspecified Rua 
125 RISK 496 Chronic airway obstruction, not elsewhere classified Rao 
126 RISK 515 Postinflammatory pulmonary fibrosis Rpf 
127 RISK 518.89 Other diseases of lung, not elsewhere classified Rld 
128 RISK 530.1 Esophagitis Reg 
129 RISK 530.11 Reflux esophagitis Rre 
130 RISK 530.81 Esophageal reflux Rer 
131 RISK 530.85 Barrett's esophagus Rbr 
132 RISK 553.3 
Diaphragmatic hernia without mention of obstruction or 
gangrene 
Rhw 
133 RISK 555.9 Regional enteritis of unspecified site Rrg 
134 RISK 556.9 Ulcerative colitis, unspecified Rcl 
135 RISK 558.9 
Other and unspecified noninfectious gastroenteritis and 
colitis 
Rng 
136 RISK 562.1 Diverticula of colon Rdv 
137 RISK 564 Functional digestive disorders not elsewhere classified Rfu 
138 RISK 564.09 Other constipation Rcs 
139 RISK 564.1 Irritable bowel syndrome Rir 
140 RISK 571.8 Other chronic nonalcoholic liver disease Rnl 
141 RISK 583.81 
Nephritis and nephropathy, not specified as acute or chronic, 
in diseases classified elsewhere  
Rnn 
142 RISK 585.2 Chronic kidney disease, Stage II (mild) Rki 
143 RISK 585.3 Chronic kidney disease, Stage III (moderate) Rkd 
144 RISK 585.4 Chronic kidney disease, Stage IV (severe) Rks 
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# ICD-9 Code ICD-9 Description Variable ID 
145 RISK 585.9 Chronic kidney disease, unspecified Rku 
146 RISK 593.9 Unspecified disorder of kidney and ureter Rud 
147 RISK 596 Other disorders of bladder Rdb 
148 RISK 599 Other disorders of urethra and urinary tract Ruu 
149 RISK 600 Hyperplasia of prostate Rpl 
150 RISK 600.01 
Hypertrophy (benign) of prostate and urinary obstruction and 
lower urinary tract symptoms 
Ruo 
151 RISK 600.9 Hyperplasia of prostate unspecified Rpu 
152 RISK 601.9 Prostatis, unspecified Rpt 
153 RISK 607.84 Impotence of organic origin Rim 
154 RISK 625.6 Stress incontinence, female Rsi 
155 RISK 695.3 Rosacea Rro 
156 RISK 696 Psoriasis and similar disorders Rsd 
157 RISK 696.1 Other psoriasis Rsr 
158 RISK 70.54 Repair of cystocele with graft or prosthesis Rgp 
159 RISK 70.7 Other Repair of Vagina Rrv 
160 RISK 710 Diffuse diseases of connective tissue Rct 
161 RISK 710.2 Sicca syndrome Rss 
162 RISK 712.36 Chondrocalcinosis, unspecified lower leg Rcu 
163 RISK 714 
Rheumatoid arthritis and other inflammatory 
polyarthropathies 
Rrh 
164 RISK 715.15 Osteoarthrosis, localized, primary, pelvic region and thigh Rlp 
165 RISK 715.25 Osteoarthrosis, localized, secondary, pelvic region and thigh Roh 
166 RISK 715.35 
Osteoarthrosis, localized, not specified whether primary or 
secondary, pelvic region and thigh 
Roa 
167 RISK 715.36 
Osteoarthrosis, localized, not specified whether primary or 
secondary, lower leg 
Rll 
168 RISK 715.9 Osteoarthrosis unspecified whether generalized or localized Rgo 
169 RISK 715.95 
Osteoarthrosis, unspecified whether generalized or localized, 
pelvic region and thigh 
Rgt 
170 RISK 715.96 
Osteoarthrosis, unspecified whether generalized or localized, 
lower leg 
Rog 
171 RISK 716.16 Traumatic arthropathy, lower leg Rta 
172 RISK 716.95 Arthropathy, unspecified, pelvic region and thigh Ray 
173 RISK 716.96 Arthropathy, unspecified, lower leg Rul 
174 RISK 717.6 Loose body in knee Rlo 
175 RISK 717.7 Chondromalacia of patella Rch 
176 RISK 718.45 Contracture of joint, pelvic region and thigh Rjc 
177 RISK 718.46 Contracture of joint, lower leg Rcj 
178 RISK 719.06 Effusion of joint, lower leg Rej 
179 RISK 719.46 Pain in joint, lower leg Rjp 
180 RISK 721 Spondylosis and allied disorders Rso 
181 RISK 721.3 Lumbosacral spondylosis without myelopathy Rls 
182 RISK 721.9 Spondylosis of unspecified site Rsu 
183 RISK 722.4 Degeneration of cervical intervertebral disc Ric 
184 RISK 722.52 Degeneration of lumbar or lumbosacral intervertebral disc Rdl 
185 RISK 724 Other and unspecified disorders of back Rdu 
186 RISK 724.02 
Spinal stenosis, lumbar region, without neurogenic 
claudication 
Rsp 
187 RISK 724.2 Lumbago Rlu 
188 RISK 724.3 Sciatica Rsa 
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189 RISK 724.5 Backache, unspecified Rbu 
190 RISK 725 Polymyalgia rheumatica Rpy 
191 RISK 726.5 Enthesopathy of hip region Ren 
192 RISK 727 Other disorders of synovium tendon and bursa Rst 
193 RISK 727.09 Other synovitis and tenosynovitis Rsy 
194 RISK 728.87 Muscle weakness (generalized) Rmw 
195 RISK 729.1 Myalgia and myositis, unspecified Rma 
196 RISK 731 
Oseitis deformans and osteopathies associated with other 
disorders classified elsewhere 
Rot 
197 RISK 732.1 Juvenile osteochondrosis of hip and pelvis Rjo 
198 RISK 733 Other disorders of bone and cartilage Rbn 
199 RISK 733.01 Senile osteoporosis Rse 
200 RISK 733.2 Cyst of bone Rcy 
201 RISK 733.29 Other bone cyst Rob 
202 RISK 733.4 Aseptic necrosis of bone Rnb 
203 RISK 733.42 Aseptic necrosis of head and neck of femur Rnr 
204 RISK 733.82 Nonunion of fracture Rfr 
205 RISK 733.9 Other and unspecified disorders of bone and cartilage Rdc 
206 RISK 733.99 Other disorders of bone and cartilage Rcg 
207 RISK 736.6 Other acquired deformities of knee Raq 
208 RISK 736.79 Other acquired deformities of ankle and foot Rak 
209 RISK 736.81 Unequal leg length (acquired) Rla 
210 RISK 736.89 Other acquired deformity of other parts of limb Rdp 
211 RISK 737.3 Kyphoscoliosis and scoliosis Rky 
212 RISK 738.4 Acquired spondylolisthesis Rsl 
213 RISK 755.63 Other congenital deformity of hip (joint) Rhj 
214 RISK 780.4 Dizziness and giddiness Rdz 
215 RISK 780.52 Insomnia, unspecified Riu 
216 RISK 780.57 Unspecified sleep apnea Rae 
217 RISK 780.93 Memory loss Rml 
218 RISK 782.3 Edema Red 
219 RISK 784 Symptoms involving head and neck Rhn 
220 RISK 785 Symtoms involving cardiovascular system Rcv 
221 RISK 785.2 Undiagnosed cardiac murmurs Rum 
222 RISK 788.2 Retention of urine Rur 
223 RISK 788.3 Urinary incontinence Rin 
224 RISK 788.31 Urge incontinence Rit 
225 RISK 788.41 Urinary frequency Ruf 
226 RISK 790.29 Other abnormal glucose Rgl 
227 RISK 790.92 Abnormal coagulation profile Rpr 
228 RISK E932.0 
Adrenal cortical steroids causing adverse effects in 
therapeutic use 
Ref 
229 RISK E933.1 
Antineoplastic and immunosuppressive drugs causing 
adverse effects in therapeutic use 
Rai 
230 RISK V08 
Asymptomatic human immunodeficiency virus (HIV) 
infection status 
Rhi 
231 RISK V85.4 Body mass index 40 and over, adult Rmi 
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Table 104. Literature-based IVs Retained for Hip and Knee Data Sets after Variable Reduction. 









1 RISK 250 Diabetes mellitus Rdi yes yes yes 
2 RISK 250.4 Diabetes with renal manifestations Rdr yes yes no 
3 RISK 250.5 Diabetes with ophthalmic manifestations Rdo yes yes no 
4 RISK 250.6 Diabetes with neurological manifestations Rdn yes yes yes 
5 RISK 278 
Overweight, obesity and other 
hyperalimentation 
Roo yes yes yes 
6 RISK 278.01 Morbid obesity Rmo yes yes yes 
7 RISK 278.02 Overweight Rov yes yes yes 
8 RISK 401.1 Benign essential hypertension Rbe yes yes yes 
9 RISK 401.9 Unspecified essential hypertension Rhe yes yes yes 
10 RISK 414 Other forms of chronic ischemic heart disease Rci yes yes yes 
11 RISK 414.01 
Coronary atherosclerosis of native coronary 
artery 
Rca yes yes yes 
12 RISK 428 Heart failure Rhf yes yes yes 
13 RISK 428.3 Diastolic heart failure Rdh yes yes yes 
14 RISK 428.32 Chronic diastolic heart failure Rdf yes yes no 
15 RISK 443 Other peripheral vascular disease Rpe yes yes yes 
16 RISK 443.9 Peripheral vascular disease, unspecified Rpv yes yes yes 
17 RISK 491.2 Obstructive chronic bronchitis Rcb yes yes no 
18 RISK 491.9 Unspecified chronic bronchitis Rbh yes yes no 
19 RISK 492.8 Other emphysema Rem yes yes yes 
20 RISK 493 Asthma Ras yes yes no 
21 RISK 493.2 Chronic obstructive asthma Rco yes yes yes 
22 RISK 493.9 Asthma unspecified Rua yes yes yes 
23 RISK 496 
Chronic airway obstruction, not elsewhere 
classified 
Rao yes yes yes 
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Table 105. 62 Single Predicting IVs for DV SNF (Hip data). 
MODEL dDF dLR Alpha %dH(DV) dAIC dBIC Inc.Alpha p < 0.05 Keep Lit 
Rhy 1 38.48 0.00 1.47 36.48 30.41 0.00 yes 
 
Rhe 1 33.53 0.00 1.28 31.53 25.46 0.00 yes yes 
Rav 1 24.07 0.00 0.92 22.07 15.99 0.00 yes 
 
Rrd 1 23.96 0.00 0.91 21.96 15.89 0.00 yes 
 
Rao 1 23.68 0.00 0.90 21.68 15.61 0.00 yes yes 
Rhf 1 20.94 0.00 0.80 18.94 12.87 0.00 yes yes 
Rnr 1 19.36 0.00 0.74 17.36 11.29 0.00 yes 
 
Rbn 1 18.32 0.00 0.70 16.32 10.25 0.00 yes 
 
Rhh 1 16.05 0.00 0.61 14.05 7.98 0.00 yes 
 
Rkd 1 15.87 0.00 0.60 13.87 7.80 0.00 yes 
 
Rdi 1 15.85 0.00 0.60 13.85 7.77 0.00 yes yes 
Rin 1 14.43 0.00 0.55 12.43 6.36 0.00 yes 
 
Rse 1 14.15 0.00 0.54 12.15 6.08 0.00 yes 
 
Raf 1 13.66 0.00 0.52 11.66 5.59 0.00 yes 
 
Rci 1 13.22 0.00 0.50 11.22 5.15 0.00 yes yes 
Rhd 1 12.89 0.00 0.49 10.89 4.82 0.00 yes 
 
Rau 1 12.38 0.00 0.47 10.38 4.31 0.00 yes 
 
Rku 1 11.28 0.00 0.43 9.28 3.21 0.00 yes 
 
Rug 1 11.28 0.00 0.43 9.28 3.21 0.00 yes 
 
Rdh 1 10.91 0.00 0.42 8.91 2.84 0.00 yes yes 
Rml 1 10.91 0.00 0.42 8.91 2.84 0.00 yes 
 
Rop 1 9.80 0.00 0.37 7.80 1.73 0.00 yes 
 
Rdm 1 8.66 0.00 0.33 6.66 0.59 0.00 yes 
 
Rld 1 8.58 0.00 0.33 6.58 0.51 0.00 yes 
 
Rsi 1 8.38 0.00 0.32 6.38 0.30 0.00 yes 
 
Rca 1 8.37 0.00 0.32 6.37 0.29 0.00 yes yes 
Rhl 1 7.46 0.01 0.28 5.46 -0.62 0.01 yes 
 
Rod 1 7.38 0.01 0.28 5.38 -0.69 0.01 yes 
 
Rph 1 6.97 0.01 0.27 4.97 -1.11 0.01 yes 
 
Rvi 1 6.75 0.01 0.26 4.75 -1.32 0.01 yes 
 
Rec 1 6.75 0.01 0.26 4.75 -1.32 0.01 yes 
 
Rhj 1 6.34 0.01 0.24 4.34 -1.73 0.01 yes 
 
Rmd 1 6.19 0.01 0.24 4.19 -1.88 0.01 yes 
 
Rpc 1 6.19 0.01 0.24 4.19 -1.88 0.01 yes 
 
Ruu 1 6.19 0.01 0.24 4.19 -1.88 0.01 yes 
 
Rog 1 5.80 0.02 0.22 3.80 -2.27 0.02 yes 
 
Rcg 1 5.58 0.02 0.21 3.58 -2.49 0.02 yes 
 
Rip 1 5.58 0.02 0.21 3.58 -2.49 0.02 yes 
 
Rad 1 5.08 0.02 0.19 3.08 -2.99 0.02 yes 
 
Rh 1 4.94 0.03 0.19 2.94 -3.13 0.03 yes 
 
Rdl 1 4.77 0.03 0.18 2.77 -3.30 0.03 yes 
 
Rsp 1 4.64 0.03 0.18 2.64 -3.43 0.03 yes 
 
Rrn 1 4.32 0.04 0.16 2.32 -3.75 0.04 yes 
 
Ram 1 4.30 0.04 0.16 2.30 -3.77 0.04 yes 
 
Rap 1 4.30 0.04 0.16 2.30 -3.77 0.04 yes 
 
Ray 1 4.30 0.04 0.16 2.30 -3.77 0.04 yes 
 
Ria 1 4.30 0.04 0.16 2.30 -3.77 0.04 yes 
 
Rem 1 4.18 0.04 0.16 2.18 -3.89 0.04 yes yes 
Rpn 1 4.16 0.04 0.16 2.16 -3.91 0.04 yes 
 
 
- 229 - 
MODEL dDF dLR Alpha %dH(DV) dAIC dBIC Inc.Alpha p < 0.05 Keep Lit 
Rpo 1 4.02 0.05 0.15 2.02 -4.05 0.05 yes 
 
Roc 1 3.98 0.05 0.15 1.98 -4.09 0.05 yes 
 
Rra 1 3.98 0.05 0.15 1.98 -4.09 0.05 yes 
 
Rde 1 3.76 0.05 0.14 1.76 -4.32 0.05 yes 
 
Rbe 1 3.08 0.08 0.12 1.08 -4.99 0.08 
 
yes 
Rpv 1 2.85 0.09 0.11 0.85 -5.22 0.09 
 
yes 
Rdn 1 2.78 0.10 0.11 0.78 -5.29 0.10 
 
yes 
Roo 1 1.28 0.26 0.05 -0.72 -6.79 0.26 
 
yes 
Rpe 1 1.26 0.26 0.05 -0.74 -6.81 0.26 
 
yes 
Rco 1 1.05 0.30 0.04 -0.95 -7.02 0.30 
 
yes 
Rov 1 0.86 0.35 0.03 -1.14 -7.21 0.35 
 
yes 
Rmo 1 0.68 0.41 0.03 -1.32 -7.39 0.41 
 
yes 




Component Fit Tables for Knee SNF (All IVs) 
Table 106. Component Fit Table for IV Ageb in (Knee) All IVs 
Best Model L SNF : Fc SNF : Ageb SNF : Svb SNF : Nrb SNF : Rmd SNF : Rug SNF : Rhf SNF. 
Blue rows indicate ratio < 0.90 and orange rows indicate ratio > 1.10. 
 IV Data obs. p(DV|IV)   
# Ageb freq SNF=1 SNF=2 Ratio p(margin) 
 1 1 1490 94.50 5.50 0.31 0.00 
 2 2 1411 86.11 13.89 0.79 0.00 
 3 3 1435 66.34 33.66 1.92 0.00 
    4336 82.45 17.55 1.00   
 
Table 107. Component Fit Table for IV Svb in (Knee) All IVs 
Best Model L SNF : Fc SNF : Ageb SNF : Svb SNF : Nrb SNF : Rmd SNF : Rug SNF : Rhf SNF. 
Blue rows indicate ratio < 0.90 and orange rows indicate ratio > 1.10. 
(Ratios between 0.91 and 1.09 are close to the margins and are excluded.) 
 IV Data obs. p(DV|IV)   
# Svb freq SNF=1 SNF=2 Ratio p(margin) 
1 2 1518 78.33 21.67 1.23 0.00 
2 3 1374 86.25 13.76 0.78 0.00 
    4336 82.45 17.55 1.00   
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Table 108. Component Fit Table for IV Nrb in (Knee) All IVs 
Best Model L SNF : Fc SNF : Ageb SNF : Svb SNF : Nrb SNF : Rmd SNF : Rug SNF : Rhf SNF. 
Blue rows indicate ratio < 0.90 and orange rows indicate ratio > 1.10. 
(Ratios between 0.91 and 1.09 are close to the margins and are excluded.) 
 IV Data obs. p(DV|IV)   
# Nrb freq SNF=1 SNF=2 Ratio p(margin) 
1 1 1309 89.61 10.39 0.59 0.00 
2 3 1553 75.34 24.66 1.41 0.00 
    4336 82.45 17.55 1.00   
 
Table 109. Condensed Component Fit Table for Rmd, Rug, and Rhf for (Knee) All IVs for IV Rmd. 
Blue rows indicate ratio < 0.90 and orange rows indicate ratio > 1.10. 
(Ratios between 0.91 and 1.09 are close to the margins and are excluded.) 
     Data obs. p(DV|IV)     
IV State freq SNF=1 SNF=2 Ratio p(margin) 
Rmd 1 19 21.05 78.95 4.50 0 
Rug 1 86 54.65 45.35 2.58 0 
Rhf 1 87 54.02 45.98 2.62 0 
    4336 82.45 17.55 1.00   
 
Component Fit Tables for Knee (Comorbidity IVs Only) 
Table 110. Condensed Component Fit Table for IVs Rmd, Rpa, Rug, Rhe, Rhe, Rhf, 
Rku, Rbn, and Rin for (Knee) Comorbidity IVs  
Best Model Rhy SNF : Rau SNF : Rmd SNF : Rpa SNF : Rug SNF : Rhe SNF : 
Rhf SNF : Rku SNF : Rbn SNF : Rin SNF. 
Blue rows indicate ratio < 0.90 and orange rows indicate ratio > 1.10. 
(Ratios between 0.91 and 1.09 are close to the margins and are excluded.) 
    Data obs. p(DV|IV) 
 
  
IV State freq SNF=1 SNF=2 ratio p(margin) 
Rmd 1 19 21.05 78.95 4.50 0.00 
Rpa 1 26 53.85 46.15 2.63 0.00 
Rug 1 86 54.65 45.35 2.58 0.00 
Rhe 0 1963 84.77 15.23 0.87 0.01 
Rhe 1 2373 80.53 19.47 1.11 0.01 
Rhf 1 87 54.02 45.98 2.62 0.00 
Rku 1 87 57.47 42.53 2.42 0.00 
Rbn 1 149 65.77 34.23 1.95 0.00 
Rin 1 40 50.00 50.00 2.85 0.00 
    4336 82.45 17.55 1.00   
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Component Fit Tables for Hip SNF (All IVs) 
Table 111. Component Fit Table for IV Fc in (Hip) All IVs 
Best Model Fc SNF : Ageb SNF : Svb SNF : Nrb SNF. 
Blue rows indicate ratio < 0.90 and orange rows indicate ratio > 1.10. 
(Frequencies < 10 are excluded and ratios between 0.91 and 1.09 
are close to the margins and are excluded.) 
 IV Data obs. p(DV|IV)   
# Fc freq SNF=1 SNF=2 Ratio p(margin) 
1 1 1598 75.78 24.22 1.70 0.00 
2 2 1501 96.67 3.33 0.23 0.00 
3 3 61 70.49 29.51 2.07 0.00 
6 6 19 100.00 0.00 0.00 0.08 
    3204 85.74 14.26     
 
Table 112. Component Fit Table for IV Ageb in (Hip) All IVs 
Best Model Fc SNF : Ageb SNF : Svb SNF : Nrb SNF. 
Blue rows indicate ratio < 0.90 and orange rows indicate ratio > 1.10. 
 IV Data obs. p(DV|IV)   
# Ageb freq SNF=1 SNF=2 Ratio p(margin) 
1 1 1089 95.23 4.78 0.33 0.00 
2 2 1027 92.11 7.89 0.55 0.00 
3 3 1088 70.22 29.78 2.09 0.00 
    3204 85.74 14.26 1.00   
 
Table 113. Component Fit Table for IV Svb in (Hip) All IVs 
Best Model Fc SNF : Ageb SNF : Svb SNF : Nrb SNF. 
Blue rows indicate ratio < 0.90 and orange rows indicate ratio > 1.10. 
 IV Data obs. p(DV|IV)   
# Svb freq SNF=1 SNF=2 Ratio p(margin) 
1 1 1067 82.19 17.81 1.25 0.00 
2 2 1053 78.16 21.84 1.53 0.00 
3 3 1084 96.59 3.41 0.24 0.00 
    3204 85.74 14.26 1.00   
 
Table 114. Component Fit Table for IV Nrb in (Hip) All IVs 
Best Model Fc SNF : Ageb SNF : Svb SNF : Nrb SNF. 
Blue rows indicate ratio < 0.90 and orange rows indicate ratio > 1.10. 
(Ratios between 0.91 and 1.09 are close to the margins and are excluded.) 
 IV Data obs. p(DV|IV)   
# Nrb freq SNF=1 SNF=2 Ratio p(margin) 
1 1 1111 91.81 8.19 0.57 0.00 
2 3 1012 77.17 22.83 1.60 0.00 
    3204 85.74 14.26 1.00   
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Table 115. Fit Table (Hip) for Comorbidity IVs for 
Best Model Rhy SNF : Rhh SNF : Rug SNF :Rhe SNF : Rrd SNF : 
Rav Rbn SNF : Rao SNF : Rse SNF : Rnr SNF. 
Blue rows indicate ratio < 0.90 and orange rows indicate ratio > 1.10. 
(Ratios between 0.91 and 1.09 are close to the margins and are indicated in gray.) 
 
IVs Data Model   
  obs. p(DV|IV) calc. q(DV|IV)   
# Rhy Rhh Rug Rhe Rrd Rav Rao Rbn Rse Rnr freq SNF=1 SNF=2 SNF=1 SNF=2 Ratio p(margin) 
1 0 0 0 0 0 0 0 0 0 0 1371 92.34 7.66 92.15 7.85 0.55 0.00 
10 0 0 0 0 1 0 0 0 0 0 42 71.43 28.57 74.60 25.40 1.78 0.04 
18 0 0 0 1 0 0 0 0 0 1 49 73.47 26.53 68.93 31.07 2.18 0.00 
20 0 0 0 1 0 0 0 1 0 0 43 79.07 20.93 75.02 24.98 1.75 0.04 
22 0 0 0 1 0 0 1 0 0 0 26 76.92 23.08 72.01 27.99 1.96 0.05 
26 0 0 0 1 0 1 0 0 0 0 10 50.00 50.00 44.64 55.37 3.88 0.00 
50 1 0 0 0 1 0 0 0 0 0 14 78.57 21.43 59.33 40.67 2.85 0.01 
53 1 0 0 1 0 0 0 0 0 0 171 74.85 25.15 75.84 24.16 1.69 0.00 
56 1 0 0 1 0 0 0 1 0 0 12 66.67 33.33 59.87 40.13 2.81 0.01 
 3204 85.74 14.26 85.74 14.26   
 
Table 116. Condensed Component Fit Table for Comorbidity IVs in (Hip) 
Best Model, Rhy SNF : Rhh SNF : Rug SNF :Rhe SNF : Rrd SNF : 
Rav Rbn SNF : Rao SNF : Rse SNF : Rnr SNF. 
Orange rows indicate ratio > 1.10. 
(Frequencies < 10 and ratios between 0.91 and 1.09 are close to the margins and are excluded.) 
  Data obs. p(DV|IV)   
IV State freq SNF=1 SNF=2 Ratio p(margin) 
Rhy 1 386 74.61 25.39 1.78 0.00 
Rhh 1 10 30.00 70.00 4.91 0.00 
Rug 1 48 66.67 33.33 2.34 0.00 
Rhe 1 1464 81.83 18.17 1.27 0.00 
Rrd 1 77 63.64 36.36 2.55 0.00 
Rao 1 86 65.12 34.88 2.45 0.00 
Rse 1 11 36.36 63.64 4.46 0.00 
Rnr 1 99 68.69 31.31 2.20 0.00 
  
 
3204 85.74 14.26 1.00 
 
 
Table 117. Component Fit Table for Interaction Rav Rbn in (Hip) 
Best Model Rhy SNF : Rhh SNF : Rug SNF :Rhe SNF : Rrd SNF : 
Rav Rbn SNF : Rao SNF : Rse SNF : Rnr SNF. 
Orange rows indicate ratio > 1.10. 
(Frequencies < 10 and ratios between 0.91 and 1.09 are close to the margins and are excluded.) 
 IVs Data obs. p(DV|IV)  
# Rav Rbn freq SNF=1 SNF=2 Ratio p(margin) 
1 0 1 147 72.11 27.89 1.96 0.00 
2 1 0 25 40.00 60.00 4.21 0.00 
   
3204 85.74 14.26 1.00 
 
 
